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Ever Tried. 
Ever Failed. 
No Matter. 
Try Again. 
Fail Again. 
Fail Better. 
- S. Beckett - 
 
 
 
Try not. 
Do. 
Or do not ! 
- Yoda - 
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ABSTRACT 
In eukaryotes, the biogenesis of secretory proteins requires their translocation into the endoplasmic 
reticulum (ER) through the Sec61 channel. Proteins passing through the secretory pathway are 
under the control of the ER quality control (ERQC). Proteins that fail to fold are recognized and 
dislocated from the ER back into the cytosol for proteasomal degradation, a process known as ER-
associated degradation (ERAD). The composition of the retrotranslocation channel is controversial, 
but dislocation of many soluble substrates is dependent on the Sec61 channel. The proteasome 19S 
regulatory particle (RP), which binds and unfolds substrates destined for proteasomal degradation, 
binds directly to the Sec61 channel via its base and is required and sufficient for the 
retrotranslocation of specific misfolded proteins. 
This thesis describes the identification of a sec61 mutant, carrying a point mutation in the ER-
lumenal loop 7 of Sec61p, displaying reduced affinity of the Sec61 channel for the 19S RP in a 
proteasome binding assay using ER-derived reconstituted proteoliposomes. The sec61-S353C 
mutant neither displayed defective protein import into the ER nor elevated ER stress levels in intact 
cells. In a cell-free assay a reduction in retrotranslocation of a 19S RP-dependent ERAD substrate in 
the presence of limiting concentrations of proteasomes was detected for sec61-S353C. This 
suggests that conformational changes in Sec61p hinging on the large ER-lumenal loop 7 are 
prerequisites for 19S RP binding to the channel. The data indicate that the interaction between the 
Sec61 channel and the 19S RP is pivotal for the export of specific substrates from the ER to the 
cytosol for degradation by the 26S proteasome.  
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ZUSAMMENFASSUNG 
In Eukaryoten erfordert die Biogenese sekretorischer Proteine deren Translokation in das 
Endoplasmatische Retikulum (ER) durch den Sec61-Kanal. Proteine des sekretorischen Weges 
unterliegen der ER-Qualitätskontrolle (ERQC). Fehlgefaltete Proteine werden erkannt und zur 
proteasomalen Degradation zurück ins Cytosol disloziert; ein Prozess, der als ER-assoziierte 
Proteindegradation (ERAD) bezeichnet wird. Die Zusammensetzung des Retrotranslokationskanals 
ist strittig, jedoch erfordert die Dislokation vieler löslicher Substrates den Sec61-Kanal. Das 19S 
Regulatorische Partikel (RP), das proteasomal zu degradierende Substrate erkennt und entfaltet, 
bindet direkt an den Sec61-Kanal mittels seines Basis-Komplexes und ist weiterhin nötig und 
ausreichend für die Retrotranslokation bestimmter fehlgefalteter Proteine. 
Die vorliegende Arbeit beschreibt die Identifizierung einer sec61 Mutante, die eine Punktmutation im 
ER-lumenalen Loop 7 von Sec61p besitzt, die zu einer reduzierten Affinität des Kanals für das 19S 
RP führt. Die Mutante sec61-S353 weist weder Defekte in der Proteintranslokation in das ER, noch 
erhöhte ER-Stresslevel in intakten Zellen auf. In einem zellfreien System konnte für sec61-S353C 
eine Reduzierung der Retrotranslokation eines 19S RP-abhängigen ERAD Substrates in der 
Anwesenheit limitierender Proteasomen-Konzentrationen detektiert werden. Die Resultate deuten 
darauf hin, dass Konformationsänderungen in Sec61p um den ER-lumenalen Loop 7 Voraussetzung 
für die 19S RP Bindung an den Sec61-Kanal sind, und dass die Interaktion des Sec61-Kanals mit 
dem 19S RP von Bedeutung für den Export bestimmter Substrate vom ER ins Cytosol zur 
Degradation durch das Proteasom ist. 
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1 INTRODUCTION 
 
1.1 THE SECRETORY PATHWAY 
 
1.1.1 CELLULAR COMPARTMENTALIZATION 
One fundamental principle found in eukaryotes as well as in prokaryotes is the compartmentalization 
of cells (Martin, 2010). The separation into cellular spaces allows otherwise incompatible processes 
to occur simultaneously inside one cell by providing the cell with different environments that facilitate 
specific metabolic functions. This results in the high specificity and regulation of cellular processes 
by e.g. locating enzymes that catalyze consecutive reactions in close proximity to each other  (Chen 
et al., 2005; Herrmann & Spang, 2008). Eukaryotic cells contain various organelles, such as 
mitochondria, the endoplasmic reticulum (ER) and the Golgi apparatus (Weeden, 1981; Allen, 2003; 
Carrie et al., 2009; Zimmer, 2009; Martin 2010). Prokaryotic cells, which do not contain membrane-
bound compartments per se, have developed a different form of compartmentalization, also referred 
to as self- or autocompartmentalization (Lupas et al., 1997b). In prokaryotes, compartmentalization 
is only comparable to that of eukaryotes to a certain extend, as seen in the separation between 
cytoplasm, inner and outer membrane as well as the periplasm in Gram-negative bacteria (Lupas et 
al., 1997b; Kerfeld et al., 2005; Martin, 2010). In both, prokaryotes and eukaryotes, however, 
proteins are synthesized in the cytoplasm; the only exception being a subset of proteins synthesized 
by mitochondria and plastids which are coded for by the genomes of these semiautonomous 
organelles (Palade, 1975; Blobel, 1980; Warren & Wickner, 1996). Due to the existence of specific 
compartments, delivery of many proteins to these various locations is a prerequisite for proper 
cellular function (Wickner & Schekman, 2005).  
 
 
1.1.2 TARGETING SEQUENCES 
Protein transport to the correct compartment within the cell is determined by targeting sequences, 
specific amino acid sequences present at the N-terminus or C-terminus of proteins destined for 
locations other than the cytosol (Breitfeld et al., 1989; von Heijne, 1990; Kim & Hwang, 2013). 
Depending on the nature of these sorting signals (secretory signal peptides, nuclear localization 
signals, mitochondrial targeting peptides, peroxisomal targeting sequences etc.), proteins are 
directed to their final destination, such as the secretory pathway, the nucleus, the mitochondria and 
the peroxisome, accordingly (Blobel & Sabatini, 1971; Schechter et al., 1975; Dobberstein et al., 
1977; Maccecchini et al., 1979). Targeting sequences are recognized by receptors found in the 
cytoplasm or at the cytoplasmic face of the appropriate organelle and are removed in many cases 
1 INTRODUCTION 
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once the protein has been targeted correctly (Blobel & Dobberstein, 1975a, 1975b; McGeoch, 1985; 
Chou & Elrod, 1999). 
First introduced by Blobel and Sabatini, followed by the experimental verification by Milstein and 
colleagues, the existence of N-terminal targeting peptides for secretory proteins (= signal peptides) 
led to the development of the signal hypothesis (Blobel & Sabatini, 1971, Milstein et al., 1972; 
improved by Blobel & Dobberstein, 1975a, 1975b). Once it became clear that the secretion of 
proteins depends on N-terminal signal sequences, which lead to their translocation across the ER 
membrane, it soon became obvious that the nature of signal sequences is mainly hydrophobic (von 
Heijne, 1984). The signal peptides that target secretory proteins to the ER were the first targeting 
sequences to be investigated (von Heine & Abrahmsén, 1989). Eukaryotic and bacterial signal 
peptides all share a similar structure: an N-terminal net-positively charged region (n-region), a 
central hydrophobic region (h-region) and a slightly polar C-terminal region (c-region) (ref. Figure 
1.1.2.1; von Heijne, 1990). The c-region is the most conserved part of the signal peptides containing 
the cleavage site for signal peptidase (von Heijne, 1983, 1985; Gierasch, 1989; Hegde & Bernstein, 
2006). The consensus cleavage site is determined by small residues at positions -1 and -3 relative to 
the cleavage site (von Heijne, 1986). The specific residues at position -1 and -3 relative to the 
cleavage site have been suggested to contact the signal peptidase near its active site (von Heijne, 
1985; Gierasch, 1989; von Heijne & Abrahmsén, 1989; Hegde & Bernstein, 2006). The c-region has 
also been suggested to form a β-strand that binds to the signal peptidase (SP) (Paetzel et al., 1998). 
The h-region is thought to form an α-helix when bound to signal recognition particle (SRP; ref. 1.2.2), 
whereas the n-region might bind SRP (Batey et al., 2000). 
Proteins that are transported into the ER but are not destined for secretion contain retention 
sequences: the C-terminal retention sequence KDEL (mammalian cells; yeast: HDEL; for soluble 
proteins) and the K(X)KXX peptides (X = any amino acid; for membrane proteins) (Munro & Pelham, 
1987; Cosson & Letourneur, 1994; Pelham, 1995; Barlowe et al., 2000). Soluble proteins destined to 
reside in the ER, which are accidentally incorporated into COPII-coated vesicles, are recognized by 
Golgi-resident KDEL-receptors (Aoe et al., 1998). The resulting complex is then returned to the ER 
via COPI vesicles (Munro & Pelham, 1987; Pelham, 2000). Escaped ER membrane proteins are 
recycled back to the ER by the K(X)KXX peptides at the cytosolic C-terminus of the proteins (type I 
transmembrane ER proteins, in yeast and mammalian cells) which directly bind to the COPI coat in 
the Golgi and are transported back to the ER (Jackson et al., 1993; Cosson & Letourneur, 1997; 
Gaynor et al., 1994; Pelham, 1995; Ma & Goldberg, 2013). A retrieval signal found in type II 
transmembrane proteins is the N-terminal XXRR motif that is found in mammalian cells (Jackson et 
al., 1990; Schutze et al., 1994).  
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Figure 1.1.2.1. Signal sequences of secretory proteins. Schematic representation of the tripartite 
composition of the N-terminal protein targeting sequence of secretory proteins. The sequence consists of a net-
positively charged n-domain at the N-terminus, a central hydrophobic h-domain and a slightly polar c-domain, 
which contains the signal peptidase (SP) consensus cleavage site defined by small residues at position -1 and 
-3 relative to the cleavage site. The mature protein part is depicted in grey (adapted from Martoglio & 
Dobberstein, 1998). 
 
 
1.1.3 THE ROUTE OF SECRETORY PROTEINS THROUGH THE SECRETORY PATHWAY 
In eukaryotes, nuclear-encoded proteins can be divided according to their location within the cell into 
cytosolic, mitochondrial, chloroplast, peroxisomal, nuclear and secretory proteins. Secretory proteins 
and transmembrane proteins of the secretory pathway, account for about 30 % of the eukaryotic 
proteome (Ghaemmaghami et al., 2003). Their synthesis and maturation route is called the secretory 
pathway, which comprises the ER, Golgi apparatus, vacuoles (lysosomes), endosomes and the 
plasma membrane (ref. Figure 1.1.3.1). Not only proteins destined for secretion by the cell enter the 
secretory pathway, but also transmembrane proteins and proteins resident in exocytic and endocytic 
compartments (Mellman & Warren, 2000; Vazquez-Martinez et al., 2012). 
The secretory pathway, which is essential and highly conserved in eukaryotes, transports                  
newly synthesized proteins, following their import into the ER, via the Golgi apparatus to their final 
destinations and, on their way along the pathway, ensures their maturation by folding and covalent 
modifications (Rapoport, 2007). One specific feature of the secretory pathway is the vesicular 
transport by which the compartments that form the endomembrane system communicate with one 
another as well as the extracellular environment (Rothman & Wieland, 1996; Schekman & Orci, 
1996). Regardless of their final destination, all secretory proteins first enter the ER on their way 
along the secretory pathway through the Sec61 translocation channel (Rapoport, 2007).  
The ER is the major site of protein maturation and biosynthesis. Here, proteins fold, oligomerize, 
acquire disulfide (S-S) bonds and N-linked oligosaccharide chains as soon as they are translocated 
into the lumen of the organelle (Dill, 1985; Braakman et al., 1992; Zapun et al., 1999). At the same 
time the ER is the site of protein quality control (ER Quality Control (ERQC); ref. 1.3.2), an essential 
mechanism, which ensures that only properly folded, modified and assembled proteins leave the ER 
SPase
CN
6-15 aa
15-50 aa
n h c
+
-3 -1
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via ER-derived transport vesicles (Ellgaard & Helenius, 2003; Sitia & Braakman, 2003; Määttänen et 
al., 2010). Proteins, which are improperly folded and are therefore likely to form toxic aggregates, 
are recognized and degraded via the ER-associated Degradation (ERAD; ref. 1.6) pathway 
(Lippincott-Schwartz et al., 1988; Dobson, 2004; Tyedmers et al., 2010). During ERAD, misfolded 
proteins are recognized and retrotranslocated via the retrotranslocon into the cytosol, where they are 
degraded by the 26S proteasome (ref. 1.5.2) (Sommer & Jentsch, 1993; Kostova & Wolf, 2003; 
Römisch, 2005; Vembar & Brodsky, 2008). Misfolded proteins that are not properly recognized and 
degraded as such accumulate in the ER lumen, thereby inducing the Unfolded Protein Response 
(UPR; ref. 1.4), a signaling pathway which leads to the activation of genes involved in ERAD as well 
as others that help clear the high load of misfolded proteins in the ER (Travers et al., 2000; 
Korennykh & Walter, 2012). 
Proteins that pass the ERQC are transported further through the secretory pathway. They are 
packaged into ER-derived COPII vesicles, which bud from so-called ER exit sites - ribosome-free 
subdomains of the ER, which have been suggested to form spontaneously (Bannykh & Balch, 1997; 
Barlowe, 2000; Hammond & Glick, 2000). Upon budding from the ER the COPII vesicles presumably 
fuse to form the ER-Golgi intermediate compartment (ERGIC) (Lee et al., 2004c). The ERGIC is an 
early site of protein sorting which is mediated by COPI vesicles (Bannykh & Balch, 1997; Barlowe, 
2000; Klumpermann, 2000). Proteins destined for further transport remain in the ERGIC whereas 
some proteins, such as cargo receptors, are recycled back to the ER for reuse (Orci et al., 2000; 
Appenzeller-Herzog & Hauri, 2006). From the ERGIC proteins move through the various Golgi 
compartments (cis Golgi network (CGN), cis cisternae, medial cisternae, trans cisternae, trans Golgi 
network (TGN)), each containing a compartment-specific set of enzymes (Becker & Melkonian, 
1996; Rossanese et al., 1999; Mellman & Warren, 2000; Bard & Malhotra, 2006). Whereas COPII-
coated vesicles mediate anterograde transport to the Golgi, COPI vesicles mediate retrograde 
transport from the Golgi apparatus to the ER and between Golgi cisternae (Klumpermann, 2000; 
Orci et al., 2000; Duden, 2003). New findings, however, suggest that COPI-coated vesicles might be 
involved in anterograde transport as well, although this mechanism has not yet been fully elucidated 
(Moelleken et al., 2007). Two models have been suggested by which secretory proteins move 
through the Golgi apparatus (Glick, 2000). The first model proposes that transport involves the 
formation of transport vesicles and their movement through the various Golgi compartments. In this 
model, the Golgi compartments remain stable entities, which are maintained by vesicular transport-
mediated import and export of material (Rothman & Wieland, 1996; Farquhar & Palade, 1998; Glick, 
2000; Pelham & Rothman, 2000). In the second model, the cisternal maturation model, cis cisternae 
are formed de novo and gradually mature to become medial and then trans cisternae by 
accumulating medial and trans enzymes, a process that is mediated by retrograde traffic of vesicles 
from later cisternae containing the appropriate enzymes (Glick & Malhotra, 1998; Losev et al., 2006; 
Emr et al., 2009). Proteins that are destined for post-Golgi destination are packaged into clathrin-
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coated vesicles. These vesicles move from the Golgi to the plasma membrane as well as to the 
endosome or vacuole (lysosome) and from the plasma membrane to the endosome (Schmid, 1997; 
Lemmon, 2001). 
During vesicular traffic, vesicles bud from donor compartments, move to and eventually fuse with 
acceptor compartments. These budding- and fusion-events are mediated largely by SNARE (soluble 
N-ethylmaleimide-sensitive-factor attachment receptor) proteins and Rab-GTPases (Novick & 
Brennwald, 1993; Pfeffer, 1994; Zerial & McBride, 2001).  
Rab GTPases are a family of Ras-like enzymes that play important roles in the secretory and 
endocytic pathways (Allan et al., 2000; Zerial & McBride, 2001; Pfeffer & Aivazian. 2004; Hutagalung 
& Novick, 2011). They have been suggested to be involved in processes that mediate recognition of 
fusion partners during vesicular traffic (Allan et al., 2000). Thus, Rabs act to facilitate SNARE 
complex formation but are not core elements of such complexes (Fasshauer et al., 1997, 1998; Otto 
et al., 1997, Mayer, 1999). SNARE proteins are found on vesicles (v-SNAREs) and target 
membranes (t-SNAREs) and together with Rab proteins they mediate fusion of vesicles with the 
target membrane (Rothman et al., 1994; Jahn & Südhof, 1999; Swanton et al., 2000; Duman & 
Forte, 2003; Ohya et al., 2009).  
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Figure 1.1.3.1. The secretory pathway. (1) Secretory proteins are translocated into the ER either 
cotranslationally or posttranslationally. Upon import into the ER the proteins’ signal sequences are cleaved-off 
by signal peptidase. Newly synthesized poypeptide chains are inserted into the ER membranes or cross it into 
the ER lumen. In the ER secretory proteins are modified (e.g. glycosylated in the case of glycoproteins) and 
fold. Folding in the ER is assisted by chaperones in the ER lumen. Secretory proteins that fail to fold properly 
are recognized by the ERQC and are retrotranslocated into the cytosol where they are degraded by 26S 
proteasomes (not shown). (2) Some proteins, e.g. ER enzymes, stay in the ER. The remaining proteins move 
further along the secretory pathway. They are packaged into COPII-coated vesicles and transported to the cis-
Golgi complex via the ERGIC (3). (4) Missorted ER-resident proteins containing a sorting signal for ER retrieval 
(as well as vesicle membrane proteins needed for reuse) are transported back to the ER in COPI-coated 
vesicles. (5) Secretory proteins destined for secretion or other locations within the cell are transported from the 
cis-Golgi complex to the trans-Golgi complex. (6) In the trans-Golgi complex proteins destined for post-Golgi 
destinations are packaged into clathrin-coated vesicles and are either transported to the plasma membrane for 
secretion into the extracellular space (7) or move in clathrin-coated vesicles from the Golgi to endosomes 
(clathrin-coated vesicles containing AP-1 adaptor protein complex) (8) or directly to lysosomes (vacuoles in 
yeast and plants) (clathrin-coated vesicles containing AP-3 adaptor complex) (9). (10) During endocytosis 
extracellular and membrane proteins are taken up in vesicles budding from the plasma membrane. These 
vesicles can move proteins to endosomes and vacuoles (adapted from Grant & Sato, 2006; Miller & Krijsne-
Locker, 2008). 
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1.2 PROTEIN TRANSLOCATION INTO THE ENDOPLASMIC RETICULUM  
  
1.2.1 THE ER AS CENTRAL COMPARTMENT DURING PROTEIN SECRETION 
The ER is the organelle within the cell that coordinates the biosynthesis, maturation, quality control 
and degradation of secretory and membrane proteins via multiple pathways. Thus, the ER plays a 
crucial role in the cell, enabling it to cope with the large diversity of proteins that enter the ER on their 
way through the secretory pathway (Farquhar & Hauri, 1997; Powell & Latterich, 2000). 
Secretory proteins enter the ER via the Sec61 translocon, which forms a protein-conducting channel 
in the ER membrane (ref. 1.2.4), either as they are still being synthesized on the ribosome 
(cotranslational protein import; ref. 1.2.2) or after they have been fully synthesized (posttranslational 
protein import; ref. 1.2.3) (Johnson & van Waes, 1999; Zimmermann et al., 2011; Park & Rapoport, 
2012). Protein complexes mediating co- and posttranslational import differ in their composition (ref. 
Figure 1.2.1.1). In yeast cells, proteins are imported both cotranslationally and posttranslationally, 
whereas in mammalian cells the vast majority of proteins enter the ER cotranslationally (Gilmore et 
al., 1982; Bird et al., 1987; Panzner et al., 1995; Ng et al., 1996; Lakkaraju et al., 2012; Lang et al., 
2012). Both modes of protein translocation share the removal of the N-terminal ER targeting 
sequence of the secretory protein by the multi-subunit enzyme SP located on the ER membrane 
(Dalbey & von Heijne, 1992; Weihofen et al., 2002). Following signal sequence cleavage, 
oligosaccharyltransferase (OST) glycosylates proteins containing the recognition sequence Asn-X-
Ser/Thr (Johnson & van Waes, 1999). ER-specific modifications are the addition of 
glycosylphophatidylinositol anchors (GPI-anchor) and N-linked glycans, both of which are 
synthesized as lipid-linked precursors at the ER membrane (Tatu et al., 1993; Spurway et al., 2001).  
The functionally diverse group of tail-anchored (TA) proteins takes in a specific role (Borgese et al., 
2003a, 2003b). TA proteins are targeted posttranslationally for insertion into the ER membrane, 
using C-terminal anchors, in yeast and mammals but use a different pathway, the TRC40/GET 
pathway (TRC = transmembrane recognition complex; GET = guided entry of TA proteins) (Kutay et 
al., 1995). Factors involved in TA membrane protein integration into the ER membrane are the SRP, 
cytosolic chaperones or the TRC (Abell et al., 2004, 2007; Rabu et al., 2008; Stefanovic & Hegde, 
2007). Various studies have suggested that TA membrane protein integration into the ER membrane 
is not Sec61-dependent (Kutay et al., 1995, Steel et al., 2002, Yabal et al., 2003; Brambillasca et al., 
2005; Stefanovic & Hegde, 2007; Lang et al., 2012). While, some TA membrane proteins can enter 
the ER membrane unassisted, others require the SR or TRC receptor in the ER membrane (Abell et 
al., 2004; Brambillasca et al., 2005, 2006; Vilardi et al., 2011). Once inserted into the ER, TA 
proteins are sorted to their respective resident organelles via vesicular transport (Beilharz et al., 
2003). 
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Figure 1.2.1.1. Translocation complexes in S. cerevisiae. In yeast, depending on the mode of translocation 
into the ER, different proteins in or at the ER membrane associate to form complexes, which mediate co- or 
posttranslational import as indicated. During cotranslational import the translocation channel forming protein 
Sec61p associates with Sss1p and Sbh1p to form the Sec61 complex, which is the minimal complex during 
cotranslational protein import. Sec63p is also involved in cotranslational protein translocation (not depicted 
here) The Ssh1 complex is an alternative cotranslational translocation complex. Here, the central component is 
Ssh1p, which is associated with Sss1p and Sbh2p, a homologue of Sbh1p. This complex is not essential. 
During posttranslational import the Sec61 complex associates with the tetrameric Sec63 complex forming the 
heptameric SEC complex. The ER-lumenal Hsp70-chaperone Kar2p is involved in posttranslational import. 
(adapted from Finke, 1999; Unger, 2000). 
 
 
1.2.2 COTRANSLATIONAL PROTEIN TRANSLOCATION INTO THE ER 
During cotranslational protein import into the ER, secretory and membrane proteins are recognized 
and translocated across the ER membrane through the Sec61 translocon as soon as they emerge 
from the ribosome (Andrews & Johnson, 1996; Hanein et al., 1996; Menetret et al., 2000; Park & 
Rapoport, 2012). This mode of translocation has been shown to be essential in mammalian cells but 
not in S. cerevisiae (Hann & Walter, 1991; Mutka & Walter, 2001). 
Cotranslational protein import involves binding of the signal recognition particle (SRP) to the 
hydrophobic domain of the signal sequence or a transmembrane domain (TMD) in the nascent 
polypeptide, which leads to the formation of the so-called ribosome-nascent chain-SRP complex 
(RNC-SRP complex) (ref. Figure 1.2.2.1; Walter & Blobel, 1980, 1981a; Walter et al., 1981; 
Anderson et al., 1982). The RNC-SRP complex is targeted to the ER membrane via the SRP 
receptor (SR) (Gilmore et al., 1982a, 1982b; Walter & Johnson, 1994). Upon interaction of SRP with 
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Beckman et al., 1997; Park & Rapoport, 2012). Membrane proteins are laterally released into the 
lipid bilayer by the Sec61 complex (Menetret et al., 2000; van den Berg et al., 2004; Trueman et al., 
2011; Park & Rapoport, 2012). 
Eukaryotic SRP is an evolutionarily conserved ribonucleoprotein particle (RNP) that consists of one 
RNA molecule and six polypeptides (Walter & Blobel, 1980, 1982). SRP is an essential component 
during cotranslational targeting to the ER in mammals (Walter & Blobel, 1980, 1982). Mammalian 
SRP consists of the 7SL RNA and the two monomeric protein subunits SRP19 and SRP54 as well 
as the two heterodimers SRP68/72 and SRP9/14 (Walter & Blobel, 1980, 1982). In yeast, SRP 
consists of the scR1 RNA and the subunits Srp72p, 68p, 54p, 21p, Sec65p (Srp19p) and Srp14p 
(Hann & Walter, 1991). Five of these subunits are homologous to the respective mammalian 
subunits (Amaya et al., 1990; Stirling & Hewett, 1992). Instead of the SRP9/14 heterodimer, yeast 
SRP contains the Srp14p-homodimer (Strub et al. 1999; Mason et al. 2000). It further contains the 
Srp9p-related protein Srp21p and scR1 RNA (Brown et al. 1994). The yeast scR1 RNA (522 
nucleotides) consists of four domains (I – IV), which bind to the SRP protein subunits (Felici et al., 
1989).  
Eukaryotic SRP can be divided into an Alu and an S domain (Ullu et al. 1982; Lakkaraju et al., 2008). 
The 7SL RNA contains an Alu sequence, which forms the Alu domain with the SRP9/14 
heterodimer, as well as an S segment (van Nues & Brown, 2004; Lakkaraju et al., 2008). The Alu 
domain causes an elongation arrest or retardation until targeting of the RNC-SRP complex to the 
translocon is complete (Siegel & Walter, 1985; Mason et al., 2000). The SRP S domain consists of 
the SRP-RNA-specific S segment of the RNA, SRP54, SRP68/SRP72 und SRP19 (Gundelfinger et 
al., 1983; Siegel & Walter, 1988). The S domain mediates signal sequence binding and targeting 
(Siegel & Walter, 1988). The SRP68/SRP72 dimer in particular is involved in the interaction of SRP 
with the SR, rendering it essential for translocation (Siegel & Walter, 1988). SRP19 binds to the tips 
of the 7S RNA’s domains III and IV aligning them in parallel, which is prerequisite for binding of 
SRP54 to domain IV (Hainzl et al. 2002; Kuglstatter et al. 2002; Oubridge et al. 2002). In mammalian 
cells the heterodimer SRP68/72 binds to distinct positions in domains II-IV, which comprise the 
nuclease-resistent S domain of SRP (Gundelfinger et al., 1983; Siegel and Walter, 1986; Zopf et al., 
1990; van Nues & Brown, 2004).  
The conserved SRP54 (54 kDa) subunit of SRP, which harbors GTPase activity, mediates binding to 
the signal sequence at the N-terminus of secretory or membrane proteins thereby increasing the 
affinity of GTP for SRP (Siegel & Walter, 1988; Lütcke et al., 1992). SRP54 not only interacts with 
the signal sequence but also with the SRP-RNA and the SRP receptor (SR) (Krieg et al., 1986; 
Kurzchalia et al., 1986; Siegel & Walter, 1988; Römisch et al., 1989; Bernstein et al., 1989; Zopf et 
al., 1990). 
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The eukaryotic SR is a heterodimeric complex consisting of SRα (69 kDa) and SRβ (30 kDa) (Tajima 
et al., 1986; Miller et al., 1995). The SR is located on the surface of the ER and is anchored to the 
ER membrane via the N-terminal TMD of SRβ (Miller et al., 1995). 
SRα mediates the interaction between SRP and the ER by binding to SRβ via its N-terminus (Miller 
et al., 1995; Young et al., 1995; Ogg et al., 1998; Andrews et al., 1989). Assembly of the SRα-SRβ 
heterodimer depends on GTP-binding to SRβ, which displays GTPase activity (Miller et al., 1995). 
The GTPase domain of SRβ is essential for SR function (Ogg et al., 1998). It is involved in mediating 
the binding of RNC to the translocon (Miller et al., 1995). Yeast SRα and SRβ are both necessary for 
cotranslational protein import (Fulga et al., 2001; Helmers et al., 2003). 
During SRP-dependent translocation the RNC is transported to the protein translocation channel 
very efficiently (ref. Figure 1.2.2.1; Lütcke et al., 1992). Binding of SRP to the secretory protein 
happens early during translocation as SRP is associated with ribosomes close to the ribosomal 
polypeptide exit tunnel. This enables SRP to screen the nascent polypeptide chain for the presence 
of a signal sequence (Walter & Blobel, 1980; Walter & Johnson, 1994). Thus, the SRP-RNC complex 
is formed as soon as the signal sequence of the nascent polypeptide chain emerges from the exit 
site of the large ribosomal subunit. Subsequently, binding of the SRP to the RNC remains stable until 
the RNC reaches the SR complex in the ER membrane (Walter & Johnson, 1994; Keenan et al., 
2001). 
The signal sequence is bound by the SRP54 subunit of SRP increasing its affinity for the ribosome. 
At this point the translation is stalled (Walter et al., 1980, 1981b; Mason et al., 2000). The formation 
of the RNC-SRP complex also increases the affinity of SRP54 for GTP, thereby increasing the 
affinity of SRP for SR (Gilmore et al., 1982a; Meyer et al., 1982; Bacher et al., 1996). Through 
binding of SRP to SR, the affinity of SRα for GTP is increased (Bacher et al., 1996). Binding of SRα 
and SRP to GTP stabilizes the RNC-SR-SRP complex (Rapiejko & Gilmore, 1997). As the RNC-SRP 
complex is targeted to the SR, SRα binding to SRP leads to GTP hydrolysis (SRP54-SRα GTPase 
cycle; Rapiejko & Gilmore, 1992, 1997; Bacher et al., 1996; Halic et al., 2006). This results in the 
dissociation of the SRP54 from the signal sequence and eventually SRP is released into the cytosol 
(Rapiejko & Gilmore, 1997). At the same time the RNC is transferred to the Sec61 complex (Song et 
al., 2000). The ribosome associates with the translocon, which destabilizes the interaction between 
SRβ and the ribosome, and the ribosome stays associated with the Sec61 channel until it translates 
a non-secretory protein (Potter & Nicchitta, 2000, 2002; Fulga et al., 2001). SRβ regulates the 
transfer of the nascent polypeptide chain from SRP to the translocon (Bacher et al., 1999). 
Dissociation of SRP needs to happen prior to the association of the RNC with the translocon as the 
binding sites on the ribosome’s large subunit for SRP54 and Sec61 overlap (Halic et al., 2006). 
The SRP9/14-mediated elongation arrest is abolished after transfer of the signal sequence into the 
translocon and dissociation of the SRP from the ribosome and SR subunits from the translocon 
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(Neuhof et al., 1998). Elongation arrest probably serves to ensure efficient translocation by keeping 
the polypeptide chain in a translocation competent state (Siegel & Walter, 1985, 1986; Thomas et 
al., 1997; Mason et al., 2000; Nagai et al., 2003).  
The protein-conducting channel in the ER membrane is the Sec61 complex consisting of the three 
subunits Sec61p, Sbh1p and Sss1p in yeast (mammalian cells: Sec61α, β and γ) (van den Berg et 
al., 2004; Park & Rapoport, 2012). Also required for protein import into the ER is the ER-lumenal 
chaperone Kar2p (yeast; mammalian cells: BiP = Immunoglobulin heavy chain binding protein; also 
known as GRP78: glucose-regulated protein of 78 kDa), a member of the Hsp70 family (heat shock 
protein of about 70 kDa) and one of the most abundant chaperones in the ER lumen (Vogel et al., 
1990; Brodsky et al., 1995; Young et al., 2001). Members of the Hsp70-family function in an ATP-
dependent manner and with the aid of Hsp40 co-chaperones and so-called nucleotide exchange 
factors (NEF) (Bukau & Horwich, 1998; Sousa & Lafer, 2006; Kampinga & Craig, 2010). BiP (Kar2p) 
is involved in protein import into the ER as well as in protein folding (ref. 1.3) and degradation (ref. 
1.6) as well as in the regulation of the UPR (ref. 1.4) (Haas & Wabl, 1983; Munro & Pelham, 1986; 
Flaherty et al., 1990; Bukau & Horwich, 1998; Alder et al., 2005; Schäuble et al., 2012).  
For the ER membrane protein Sec63p a role in co-translational protein import into the ER has been 
suggested in mammals and yeast (Brodsky et al., 1995; Young et al., 2001; Lang et al., 2012; 
Schäuble et al., 2012). The driving force during cotranslational protein import into the ER has been 
suggested to be the elongation of the nascent polypeptide chain on the translating ribosome 
(Hamman et al., 1998; Pilon et al., 1998). During protein import, SP cleaves off the signal sequence 
(Weihofen et al., 2002, Zimmermann et al., 2011). 
Components involved in cotranslational import into the ER of mammalian cells only are TRAM 
(translocation-associated membrane protein) and the TRAP complex (translocon-associated protein) 
(Fons et al., 2003; Zimmermann et al., 2011). TRAM seems to be needed for the translocation of 
specific secretory proteins (Görlich & Rapoport, 1993). It has also been suggested to be involved in 
cotranslational integration of membrane proteins (Do et al., 1996; Knight & High, 1998; Hegde et al., 
1998). TRAP has been suggested to be involved in the translocation of another subset of secretory 
proteins (Fons et al., 2003). 
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Figure 1.2.2.1 Cotranslational protein translocation into the ER of S. cerevisiae. Start = TOP LEFT: As 
presecretory proteins are synthesized by ribosomes in the cytosol, SRP binds their signal sequences. Binding 
of SRP leads to an elongation arrest of the nascent protein. The RNC-SRP complex binds to the SR (consisting 
of SRα and SRβ) in the ER membrane thus targeting the ribosome to the translocon. The signal sequence is 
inserted into the translocon and SRP dissociates from the SR into the cytosol. SR dissociates from the 
translocon. The ER-lumenal chaperone Kar2p (BiP) is recruited by Sec63p and assists in folding of the nascent 
polypeptide chain. As soon as the cleavage site is accessible SP cleaves off the signal sequence (not shown). 
Secretory glycoproteins are modified by OST with N-linked glycans during and after import (not shown). After 
termination of translation ribosomes only dissociate from the translocons when they translate non-secretory 
proteins (adapted from Park & Rapoport, 2012). 
 
 
1.2.3 POSTTRANSLATIONAL PROTEIN TRANSLOCATION INTO THE ER 
Although not as well understood as cotranslational translocation (especially in higher eukaryotes), 
posttranslational protein import in S. cerevisiae has been shown to be an essential translocation 
mode (ref. Figure 1.2.3.1; Corsi & Schekman, 1996; Kalies & Hartmann, 1998). During 
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posttranslational translocation are known (Rapoport et al., 1999; Zimmermann et al., 2011). In yeast, 
the trimeric Sec61 complex (Sec61p, Sbh1p and Sss1p) associates with the tetrameric Sec63 
complex (Sec63p, Sec62p, Sec71p and Sec72p) to form the heptameric SEC complex (ref. Figure 
1.2.1.1; Deshaies et al., 1991; Panzner et al., 1995). This complex together with ATP and the ER-
lumenal protein Kar2p (BiP) has been shown to be sufficient in vitro for posttranslational protein 
import (Brodsky & Schekman, 1993; Panzner et al. 1995). 
Crosslinking studies have indicated that Sec61p interacts with signal sequences in an ATP- and 
Kar2p (BiP)-independent manner (Plath et al., 1998). The binding site for the signal sequence is 
located between TMD 2 and 7 of Sec61p. The signal sequence forms a helix that is close to Sec62p 
and Sec71p (Plath et al., 1998). The C-terminus of the protein could be crosslinked to Sec72p but 
not to Sec63p, Sbh1p and Sss1p (Plath et al., 1998; Matlack et al., 1998; van den Berg et al., 2004). 
Posttranslational protein import into the ER is driven by protein folding and ∼ modifications, and is 
assisted by the Hsp70 protein Kar2p (BiP) (Brodsky & Schekman, 1993; Scidmore et al., 1993). 
Kar2p (BiP) binds to the DnaJ homology domain of Sec63p, which recruits the chaperone to the ER 
membrane, mediating binding to the imported protein (Lyman & Schekman, 1995; Corsi & 
Schekman, 1997; Matlack et al., 1999; Misselwitz et al., 1999; Tyedmer et al., 2003). It has been 
suggested that ATP hydrolysis by Kar2p (BiP) provides the energy required for the interaction of 
Kar2p (BiP) and the ER-lumenal DnaJ-domain of Sec63p, which is important for the transit of the 
precursor through the ER membrane and the release of the protein into the ER lumen (ref. 1.2.4.4; 
Lyman & Schekman 1995, 1997; Corsi & Schekman, 1997; Matlack et al., 1999; Misselwitz et al., 
1999; Tyedmers et al., 2003).  
There are two models for the pulling-in of the protein by Kar2p (BiP). The “Brownian ratchet” model, 
which is the preferred model, proposes that BiP binds to segments of the translocating protein 
thereby preventing sliding back towards the cytosol (Matlack et al., 1997, 1998). Here, the 
translocation rate is limited by the rate at which translocating preproteins spontaneously unfold 
(Sanders et al., 1992; Matlack et al., 1999). The “translocation motor” model suggests that Kar2p 
(BiP) binds to the translocating chain and actively pulls the protein through the channel by an ATP-
driven conformational change (Schatz and Dobberstein, 1996). Both scenarios seem possible and 
might depend on the folding state of the precursor protein (Simon et al., 1992; Glick, 1995; Schatz 
and Dobberstein, 1996; Matlack et al., 1998). 
As for cotranslational import, during posttranslational import into the ER, the signal sequence is 
cleaved off by SP and OST modifies glycoproteins by adding N-linked glycans to the Asn-X-Ser/Thr 
glycosylation site all of which promotes folding and hence import (Rapoport et al., 1999; 
Zimmermann et al., 2011). 
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Figure 1.2.3.1. Posttranslational protein translocation into the ER of S. cerevisiae. Start = TOP LEFT: 
Following its synthesis in the cytosol the unfolded secretory polypeptide containing an N-terminal signal 
sequence is kept in solution by cytosolic chaperones. The completed polypeptide chain is targeted to the SEC 
complex where it binds with its signal sequence to the Sec63 complex (i.e. to Sec62p, Sec71p, Sec72p; not 
shown) and is then transferred to Sec61p in the core complex of the translocon. Cytosolic chaperones are 
released from the polypeptide upon entry into the translocon. Protein import is assisted by the ER-lumenal 
chaperone Kar2p (BiP). Kar2p is recruited and activated by Sec63p. Sec63p containing a DnaJ domain 
interacts with Kar2p in its ATP-bound state thereby stimulating ATP hydrolysis. In its ADP-bound state Kar2p 
binds polypeptides emerging from the translocation channel. As soon as the polypeptide has passed through 
the channel another Kar2p molecule binds. This process is repeated until the polypeptide is fully translocated. 
Kar2p is then released upon exchange of ADP to ATP (opens the binding pocket of Kar2p). During protein 
import SP cleaves the signal sequence and in the case of secretory glycoproteins OST modifies proteins by 
adding N-linked glycans (not shown) (adapted from Park & Rapoport, 2012). 
 
 
1.2.4 THE ER PROTEIN TRANSLOCATION CHANNEL 
 
1.2.4.1 CO- AND POSTTRANSLATIONAL PROTEIN IMPORT INTO THE ER CONVERGE AT THE TRANS-
LOCON 
The eukaryotic translocation channel is formed by the Sec61 complex. In S. cerevisiae this 
evolutionarily conserved heterotrimeric complex consists of the three membrane protein subunits 
Sec61p, Sss1p and Sbh1p (ref. Figure 1.2.1.1; Panzner et al., 1995; Hanein et al., 1996; Beckmann 
et al., 1997). The Sec61 complex is the essential membrane component for protein translocation 
(Deshaies & Schekman, 1987). Depending on the mode of translocation, the translocation channel 
needs to associate with other components in order to gain its full translocation capacity (Görlich & 
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Rapoport, 1993). The ribosome is the main driving force during cotranslational translocation, when 
the newly synthesized polypeptide moves directly from the translating ribosome into the translocation 
channel, a process that is fueled by the energy gained from ribosomal GTP hydrolysis during 
translation (Connolly & Gilmore, 1986; Görlich et al., 1992; Bange et al., 2007). Posttranslationally 
translocated proteins that are first fully synthesized in the cytosol before they are translocated across 
the ER membrane require the association of the Sec61 complex with the tetrameric Sec63p complex 
and the ER-lumenal chaperone Kar2p (BiP) (Matlack et al., 1999; Rapoport, 2007; Zimmermann et 
al., 2011; Park & Rapoport, 2012). 
 
 
1.2.4.2 THE SEC61 COMPLEX 
The Sec61 complex is the central component during protein import of secretory and membrane 
proteins (Wilkinson et al., 1996). It not only forms the translocation channel, it also serves as the 
ribosome receptor and recognizes signal sequences (Park & Rapoport, 2012). The translocation 
channel is remarkable as it transports a large variety of secretory and membrane proteins across the 
ER membrane which is an essential step during biosynthesis of these proteins. Secretory proteins 
and membrane proteins are targeted to the membrane by the hydrophobic signal sequence or a 
hydrophobic transmembrane (TM) segment, respectively (Görlich et al., 1992; Hartmann et al., 1994; 
Panzner et al., 1995). While soluble proteins are transported across the membrane through the 
protein-conducting channel, membrane proteins are released into the lipid bilayer through a lateral 
opening in the channel, called the lateral gate, as soon as the hydrophobic TM segment traverses 
the channel (Trueman et al., 2011). The fact that the translocation channel is able to distinguish such 
a variety of proteins gives it a special role in the secretory pathway. Trimeric complexes homologous 
to the mammalian complex have been identified in various eukaryotic and prokaryotic organisms 
(Schatz & Beckwith, 1990; Görlich et al., 1992; Panzner et al., 1995; Finke et al., 1996). The 
mammalian Sec61 complex consists of Secα, Secβ and Secγ, which are homologous to the 
S. cerevisiae subunits Sec61p, Sbh1p and Sss1p, respectively (Görlich et al., 1992; Hartmann et al., 
1994, Panzner et al., 1995; van den Berg et al., 2004). Protein translocation in prokaryotes is 
mediated by the SecYEG complex, consisting of the subunits SecY, SecE and SecG (Stirling et al., 
1992; Görlich et al., 1992; Hartmann et al., 1994; Breyton et al., 2002). 
 
 
1.2.4.2.1 THE SEC61P SUBUNIT 
Sec61p, with its highly conserved sequence is essential in S. cerevisiae and Escherichia coli (E. coli) 
(Mothes et al., 1994; van den Berg et al., 2004). It not only functions as the ribosome receptor in the 
ER membrane during cotranslational translocation, but it is also the subunit that forms the active 
translocation pore interacting with the translocating polypeptides (Görlich et al., 1992; Sanders et al., 
1 INTRODUCTION 
 
	   29	  
1992; Kalies et al., 1994: Mothes et al., 1994; Prinz et al., 2000; Levy et al., 2001). Moreover, 
Sec61p has been suggested to be the central component during ERAD involved in the formation of 
the retrotranslocation channel and as the proteasome binding site during ERAD (ref. 1.6.1; 
McCracken & Brodsky, 1996; Wiertz et al., 1996b; Pilon et al., 1997, 1998; Schmitz et al., 2000, 
2005). Although the nature of the retrotranslocon is still under debate, retrotranslocation of many 
soluble substrates depends on the Sec61 channel (Pilon et al., 1997, 1998; Kalies et al., 2005; 
Römisch, 2005; Ng et al., 2007; Schäfer & Wolf, 2009). The role of Sec61p in ERAD is supported by 
studies in S. cerevisiae, which have revealed that mutations in TMD 3 and TMD 4 as well as in loop 
(L) 4 cause defects in retrotranslocation (Pilon et al., 1997; Wilkinson et al., 2000). 
The Sec61p subunit (S. cerevisiae; mammals: Secα; archea and bacteria: SecY) of the Sec61 
complex displays a highly conserved structure consisting of ten TMDs (TMD 1-10) with the C- and 
N-termini as well as L 2, 4, 6 and 8 in the cytosol and L 1, 3, 5 and 7 facing the ER-lumenal side (ref. 
Figure 1.2.4.2.1.1; Akiyama & Ito, 1987; Görlich et al., 1992; Stirling, 1993; Hartmann et al., 1994; 
Wilkinson et al., 1996; Johnson & van Waes, 1999; Raden et al., 2000).  
The crystal structure of the M. jannaschii protein-conducting channel has revealed that the α-subunit 
(Sec61p in S. cerevisiae; Secα in mammals; SecY in archea and bacteria) is open on one side 
(viewed from the top) and surrounded by the γ-subunit (Sss1p in S. cereviaise; Secγ in mammals; 
SecE in archea and bacteria) on two sides which makes limited contact with TMD 1, TMD 5, TMD 6 
and TMD 10, thereby acting as a clamp holding the two halves of the α-subunit together (van den 
Berg et al., 2004). The β-subunit (Sbh1p in S. cerevisiae; Secβ in mammals and archaea; SecG in 
bacteria) is only peripherally associated with the α-subunit (van den Berg et al., 2004). The whole 
Sec61p structure can be divided into two halves (TMD 1-5 and TMD 6-10), which are connected by a 
loop between TMD 5 and TMD 6 (van den Berg et al., 2004). The crystal structure also shows that 
some of the ten TMDs are not perpendicular to the plane of the ER membrane (TMD 2, TMD 5, TMD 
7) and some do not span the membrane entirely (TMD 9, TMD 10) (van den Berg et al., 2004). A 
quite remarkable feature in the Sec61p/Secα structure is the segment between TMD 1 and TMD 2a. 
This segment forms a long loop that ends in a short helix (= TMD 2a), the so-called plug (ref. Figure 
1.2.4.2.1.1; van den Berg et al., 2004). TMD 2a is connected to TMD 2b by a segment that 
resembles a β-hairpin loop (ref. Figure 1.2.4.2.1.1; van den Berg et al., 2004). One model suggests 
that the membrane barrier is maintained by the plug and the so-called pore ring during the Sec61 
channel’s resting state as well as during translocation (van den Berg et al., 2004; Li et al., 2007; 
Saparov et al., 2007; Zimmer et al., 2008; Park & Rapoport, 2011). The pore ring consists of six 
hydrophobic residues and interacts with the plug in the resting channel (van den Berg et al., 2004; Li 
et al., 2007). During translocation the plug is displaced and the pore ring forms a seal around the 
translocating polypeptide thereby maintaining a barrier for small molecules during translocation (ref. 
1.2.4.5; van den Berg et al., 2004; Li et al., 2007; Saparov et al., 2007; Junne et al., 2010; Park & 
Rapoport, 2011). The crystal structure of the Sec61 complex has also shown that L 6 and 8 and the 
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C-terminal tail of Sec61p are accessible for cytosolic binding partners, supporting data from sec61 
mutants defective in ribosome binding and cotranslational import, that suggest that those domains 
are important for the binding of ribosomes and respective binding partners (Pool et al., 2002; Raden 
et al., 2000; Song et al., 2000; van den Berg et al., 2004). It has been demonstrated that ribosomes 
and proteasomes compete for binding to the translocation channel, but bind to different sites in 
Sec61p (Lee et al., 2004b; Kalies et al., 2005; Ng et al., 2007). While the binding site for 26S 
proteasomes still needs to be elucidated, for ribosomes L 8 has been identified to be the binding 
site. A sec61 mutant (sec61R406E) with a point mutation in a conserved part of L 8 has shown 
reduced affinity for ribosomes but not for proteasomes (Cheng et al., 2005; Kalies et al., 2005; Ng et 
al., 2007).  
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Figure 1.2.4.2.1.1. The Sec61p subunit. (A) The predicted topology model of Sec61p shows that the protein 
(480 amino acids) consists of ten TMDs. Both, the N- and C-termini are located towards the cytosol. The 
dimensions of the TMDs have been modified according to van den Berg et al., 2004: TMD1: P23-L51; TMD2: T76-
Q102; TMD3: R111-G137; TMD4: P148-K173; TMD5: G180-A223; TMD6: P242-Y265; TMD7: S289-Q312; TMD8: I360-I381; 
TMD9: A421-G443, TMD10: S444-Y459 (adapted from Wilkinson et al., 1996; Raden et al., 2000; van den Berg et 
al., 2004). (B) Crystal structure of the M. jannaschii  SecY complex (3.2 Å). Shown is the closed SecY channel 
viewed from the cytosol (LEFT) and from the side extending through the plasma membrane (RIGHT). The 
positions of the α-, β- and γ-subunit are indicated. Highlighted are the two halves of SecY surrounding the 
translocation pore, the C-terminal domain (red; TMD 6-10) and the N-terminal domain (blue; TMD 1-5). The 
plug (yellow), the pore ring (green) and the lateral gate (LEFT), all of which play important roles during 
translocation, are indicated (van den Berg et al., 2004; taken from Park & Rapoport, 2012). 
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1.2.4.2.2 THE SBH1P SUBUNIT  
Sbh1p (Sec61β homologue; S. cerevisiae: Sbh1p; mammals: Sec61ß, archaea: Secß; bacteria: 
SecG) is a tail-anchored protein with one transmembrane span and the N-terminus in the cytosol 
(Panzner et al., 1995; Toikkanen et al., 1996). S. cerevisiae contains a second gene, SBH2, which is 
homologous to SBH1 and encodes the β-subunit of the Ssh1 complex (Ssh1p, Sbh2p, Sss1p) (ref. 
1.2.4.3 and Figure 1.2.1.1; Finke et al., 1996; Toikkanen et al., 1996). Sbh1p and Sbh2p are not 
essential in yeast but deletion of both genes makes cells temperature-sensitive (Stirling et al., 1993; 
Hartmann et al., 1994; Finke et al., 1996; Toikkanen et al., 1996; Kalies et al., 1998). The M. 
jannaschii crystal structure shows that the helical transmembrane span of the β-subunit is preceded 
by a cytosolic segment that is disordered, and hence not visible in the crystal, and that contact of the 
β-subunit with the α-subunit is only limited (ref. Figure 1.2.4.2.1.1.B; van den Berg et al., 2004; Park 
& Rapoport, 2012). The TMD of Sbh1p has been shown to be sufficient to suppress temperature-
sensitive growth of Δsbh1 Δsbh1 yeast and also for interaction with Sec61p (Feng et al., 2007). 
Sbh1p has been suggested to be involved in the insertion of secretory proteins into the channel and 
also has been shown to interact with the SP complex and the OST complex (Kalies et al., 1998; 
Chavan et al., 2005; Feng et al., 2007). Biochemical studies with Sbh2p revealed that its cytosolic 
domain mediates interaction of SR with the Ssh1 complex (Jiang et al., 2008). 
 
 
1.2.4.2.3 THE SSS1P SUBUNIT 
The Sss1p (Sec sixty-one suppressor; S. cerevisiae: Sss1p; mammals: Sec61γ; archaea and 
bacteria: SecE) subunit is a tail-anchored protein consisting of two α-helices with the N-terminal helix 
lying on the cytosolic surface of the membrane and the C-terminal helix traversing the ER membrane 
at an angle, such that the protein surrounds the Sec61p TMDs like a clamp (ref. Figure 1.2.4.2.1.1; 
Esnault et al., 1993, 1994; Hartmann et al., 1994; van den Berg et al. 2004; Osborne et al., 2005). 
The subunit is conserved and essential for protein import (Esnault et al., 1994; Hartmann et al., 
1994; Finke et al., 1995; Wilkinson et al., 2010). In S. cereviaise, sss1 null mutants could be 
complemented using the human homologue (Hartmann et al., 1994). Just like Sec61p, Sss1p is 
essential in S. cerevisiae and SecE in E. coli (Mothes et al., 1994). The N-terminal helix of Sss1p 
displays an amphipathic character with the hydrophobic part facing the membrane where it contacts 
the C-terminal part of Sec61p (ref. Figure 1.2.4.2.1.1; Murphy & Beckwith, 1994; Satoh et al., 2003; 
van den Berg et al., 2004). A short β-strand follows this helix, which forms a sheet with a part of a β-
hairpin that is formed between TMD 6 and TMD 7 of Sec61p (ref. Figure 1.2.4.2.1.1; van den Berg et 
al., 2004). The TMD of Sss1p seems to act as a clamp holding the two halves of Sec61p together 
(ref. Figure 1.2.4.2.1.1; van den Berg et al., 2004). Data from the crystal structure of the M. 
jannaschii SecY complex have shown that the TMD is a long helix that makes contact with the TMD 
1, 5, 6 and 10 of the α-subunit (van den Berg et al., 2004). Moreover, data from crosslinking 
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experiments also revealed that Sss1p interacts with TMD 8 as well as TMD 6 and TMD 7 of Sec61p 
(ref. Figure 1.2.4.2.1.1). This interaction has been suggested to have a stabilizing effect on the 
channel (Esnault et al., 1994; Wilkinson et al., 1997). During its interaction with Sec61p, Sss1p might 
play a crucial role during plug removal for channel opening. It has also been suggested to act as a 
surrogate signal sequence (Plath et al., 1998; van den Berg et al., 2004). Sss1p not only interacts 
with Sec61p, it has also been suggested to bind to Ssh1p (in the Ssh1 complex; ref. 1.2.4.3) and 
interact with the OST complex. Interaction with the latter has been suggested to be important for 
efficient N-linked glycosylation of glycoproteins as it might mediate binding of OST to the 
translocation channel (Scheper et al., 2003; Chavan et al., 2005). 
 
 
1.2.4.2.4 THE TRANSLOCATION MODEL 
Data from biochemical studies and from structural analyses of the translocon have led to the 
development of a translocation model (Deshaies et al., 1991; Görlich & Rapoport, 1993; Panzner et 
al., 1995; van den Berg et al., 2004): 
During translocation the Sec61 complex has been suggested to form oligomers consisting of two to 
four complexes (Beckman et al., 1997; Manting et al., 2000; Menetret et al., 2000; Beckmann et al., 
2001; Breyton et al., 2002; Morgan et al., 2002; Duong, 2003; Mori et al. 2003; van den Berg et al., 
2004). It has been proposed, however, that a single Sec61 complex is sufficient to form a functional 
translocation channel, although it might exist as a dimer or tetramer (i.e. a dimer of dimers) 
(Veenendaal et al., 2001; Mori et al., 2003; Snapp et al., 2004; Cannon et al., 2005; Devile et al., 
2011). Oligomerization might be necessary in order to recruit various accessory components of the 
import machinery (e.g. SP, OST, TRAM, TRAP) (Yahr & Wickner, 2000; Duong et al., 2003; van den 
Berg et al., 2004). 
The X-ray structure of the M. jannaschii protein-conducting channel has helped immensely in 
understanding the basic mechanism underlying translocation (ref. Figure 1.2.4.2.1.1; van den Berg 
et al., 2004). While the closed versus the translocating channel have been proposed to be 9-15 Å 
and 40-60 Å respectively, data from the M. jannaschii structure suggest the size of the closed 
channel entrance to be 20-25 Å (Hamman et al., 1997, 1998; van den Berg et al., 2004). The 
translocation pore formed by one copy of the Sec61 complex is sealed by the so-called pore ring 
and the plug (TMD 2a) before translocation occurs (Beckmann et al., 1997; Menetret et al., 2000; 
Beckmann et al., 2001; Morgan et al., 2002; Manting et al., 2000). Depending on the mode of 
translocation the channel partners (i.e. ribosomes or the Sec62/63p complex in eukaryotes) bind, 
which partially opens the lateral gate (Zimmer et al., 2008; Tzukasaki et al., 2008). Binding of 
channel partners alone, however, is insufficient to open the channel (Simon & Blobel, 1991; Matlack 
et al., 1998; van den Berg et al., 2004). Opening of the protein-conducting channel is triggered by 
binding of the signal sequence, which intercalates between TMD 2b and TMD 7 of Sec61p such that 
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the substrate is inserted into the channel in a loop (Jungnickel & Rapoport, 1995; Plath et al., 1998; 
van den Berg et al., 2004; Zimmer et al., 2008). It has been suggested that signal sequence binding 
destabilizes those interactions of the plug that keep it in the centre of the pore (van den Berg et al., 
2004). In order for the channel to open and to be translocation-competent, the plug needs to be 
displaced (Becker et al., 2009; Zimmer et al., 2008; du Plessis et al., 2009). It has been suggested 
that signal sequence binding further promotes separation of TMD 2b and TMD 7 resulting in the 
displacement of the plug to its open state position, which is close to the γ-subunit (van den Berg et 
al., 2004). More recent studies, however, indicate that signal sequence insertion only partially opens 
the channel (Wilkinson et al., 2010; Trueman et al., 2011). It has been suggested that Sss1p may 
play a role during translocation by completing channel opening and thus activating the translocon 
(Wilkinson et al., 2010). The clamp domain of Sss1p has been proposed to undergo a 
rearrangement relative to the hinge domain of Sec61p, which would eventually promote lateral gate 
opening (Wilkinson et al., 2010). As a result, the polypeptide chain would be able to fully access the 
channel (van den Berg et al., 2004; Wilkinson et al., 2010). Once the channel is open, the mature 
region of the polypeptide is properly inserted into the channel with the pore ring forming a seal 
around the translocating polypeptide chain (van den Berg et al., 2004; Park & Rapoport, 2012). The 
signal sequence is finally cleaved-off by SP as soon as the cleavage site is accessible at the 
lumenal end of the channel (Böhni et al., 1988; Dalbey & von Heijne, 1992; Paetzel et al., 1998; 
Chen et al., 2001). The channel returns to its closed state when the polypeptide has been fully 
translocated, with the plug moving back to its closed state position (van den Berg et al., 2004). 
Although the biosynthesis of membrane proteins is less well understood, the scenario could be 
similar. TMDs might move into the lipid bilayer through the so-called lateral gate (van den Berg et al., 
2004; Trueman et al., 2011). It has been shown that during lateral gate opening TMD 7, 8 and 9 of 
Sec61p move outwards, resulting in TMD 9 being close to the cytosolic domain of Sss1p (van den 
Berg et al., 2004; Wilkinson et al., 2010). This indicates that both TMD 9 of Sec61p and Sss1p 
mediate complete channel opening and translocon activation (Zimmer et al., 2008; Wilkinson et al., 
2010; Trueman et al., 2011). 
 
 
1.2.4.3. THE SSH1 COMPLEX 
In S. cerevisiae, there is another trimeric complex homologous to the Sec61 complex suggested to 
be involved in cotranslational import (Finke et al., 1996). The Ssh1 complex consists of Ssh1p (Sec 
sixty-one homologue; about 34 % homology), Sbh2p (Sec sixty-one β homologue) and Sss1p (Finke 
et al., 1996; Prinz et al., 2000; Wittke et al., 2002). This complex is likely to be involved in 
cotranslational import, which is supported by studies that have shown that Ssh1p can interact with 
ribosomes and signal sequences of a subset of proteins and that growth of ∆ssh1 cells is 
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compromised when the gene encoding a subunit of SRP is disrupted (Finke et al., 1996; Prinz et al., 
2000; Wilkinson et al., 2001; Wittke et al., 2002).  
The central component of the complex, Ssh1p, is nonessential as deduced as ∆ssh1 mutants are 
alive (Finke et al., 1996; Plemper et al., 1997; Gillece et al., 2000; Wilkinson et al., 2001). Although 
homologous to Sec61p, Ssh1p does not seem to be functionally interchangeable with Sec61p, as it 
does not complement lethal sec61 mutations (Wilkinson et al., 2001).  
Initial studies on Ssh1p have shown that Δssh1 mutants are proficient in protein translocation into 
the ER as well as in retrotranslocation of misfolded glycoproteins from the ER lumen to the cytosol 
(Finke et al., 1996, Plemper et al., 1997; Gillece et al., 2000). A Δssh1 mutant containing the sec61-
2 temperature-sensitive allele is not viable at the permissive temperature for the sec61-2 allele 
(Finke et al., 1996).  
Ssh1p binds ribosomes with the same affinity as Sec61p (Finke et al., 1996; Prinz et al., 2000). More 
recent data from Wilkinson et al. (2001) support the existence of two separate, functionally 
nonequivalent translocons in the yeast ER, containing Sec61p and Ssh1p, respectively, both of 
which mediate translocation and dislocation. In a set of elegant experiments the authors showed that 
Ssh1p is involved in SRP-dependent translocation (Wilkinson et al., 2001). ∆ssh1 cells are defective 
in co- and posttranslational import and show defects in the retrotranslocation of CPY* and an 
induction of the UPR (Wilkinson et al., 2001). Thus, during fast growth, Sec61 channels probably 
provide insufficient translocation capacity on their own. Under normal growth conditions the demand 
for proper secretory pathway function is crucial. In the absence of Sec61p, however, protein 
translocation into the ER through the Ssh1p channel is not sufficient for cells to survive, i.e. as 
Ssh1p channels cannot import posttranslationally, at least one posttranslational substrate must be 
essential (Wilkinson et al., 2001). It is, however, likely that Ssh1p serves as a “back-up” or reserve 
translocon, which, under certain growth conditions, provides the cell with physiological flexibility 
(Wilkinson et al., 2001). 
Recent analyses using an SRP-dependent substrate revealed that this substrate was targeted 
preferably to Ssh1p suggesting that Ssh1p might act as a protein-conducting channel comparable to 
Sec61p (Spiller & Stirling, 2011). Moreover, Ssh1p-mediated translocation using the model 
substrates also involved Sec63p, revealing an interaction between Ssh1p and Sec63p in 
cotranslational translocation (Spiller & Stirling, 2011). 
In yeast, a GEF-role for the β-subunits of the translocon (Sbh1p and Sbh2p) during SR-
heterodimerization has been shown (Toikkanen et al., 1996; Legate et al., 2000; Schwartz & Blobel, 
2003). The interaction between the subunits and the GTPase domain of SRβ mediates dissociation 
of GDP from SRβ (Helmers et al., 2003). Sbh2p has also been suggested to recognize a substrate-
specific feature of the RNC and to mediate differential targeting of a model substrate to the Ssh1 
complex, which is in line with indications that Sbh1/Sbh2 mediate interaction between the translocon 
and SR (Spiller et al., 2011; Jiang et al., 2008).  
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1.2.4.4 THE SEC COMPLEX 
In S. cerevisiae there are distinct multi-subunit complexes for cotranslational and posttranslational 
protein translocation (ref. Figure 1.2.1.1; Park & Rapoport, 2012). During posttranslational import the 
Sec61 complex (Sec61p, Sbh1p, Sss1p) associates with the tetrameric Sec63 complex (Sec62p, 
Sec63p, Sec71p, Sec72p) forming the heptameric SEC complex (Deshaies et al., 1991; Panzner et 
al., 1995; Wittke et al., 1999). This complex does not bind to ribosomes supporting its role during 
posttranslational translocation for which it is essential (Brodsky & Schekman, 1993; Panzner et al., 
1995). The function of its individual components, however, is not yet fully understood.  
The essential subunit Sec62p (yeast: 32 kDa) is a transmembrane protein with two TMDs and its C- 
and N-termini facing the cytosol (Deshaies & Schekman, 1989, 1990). Mammalian Sec62p has been 
shown to associate with ribosomes suggesting a role during cotranslational import (Müller et al., 
2010). Sec62p has been suggested not to be involved in ERAD, as a sec62 mutant does not display 
defective ERAD for the ERAD substrates CPY* and Δgpαf, and Sec62p is not found in proteasome-
associated Sec61 complexes (Pilon et al., 1997; Plemper et al., 1997; Ng et al., 2007). 
Sec63p (75 kDa) has three transmembrane domains, with its N-terminus located towards the ER-
lumen and the C-terminus towards the cytosol (Feldheim et al., 1992; Brodsky & Schekman, 1993). 
Further, it contains a DnaJ domain in the ER-lumenal loop between TMD 2 and TMD 3 (Feldheim et 
al., 1992; Scidmore et al., 1993). Sec63p interacts via its DnaJ domain with the ER-lumenal Hsp70 
chaperone Kar2p (BiP), recruiting it for co- and posttranslational import (Brodsky et al., 1995; 
Misselwitz et al., 1999; Tyedmers et al., 2000; Hendershot, 2004). This interaction is a prerequisite 
for posttranslational translocation (Matlack et al., 1997, 1999; Scidmore et al., 1999). In yeast, 
however, it has been suggested to play a role in cotranslational import depending on the nature of 
the signal sequence (Spiller & Stirling, 2011; Lang et al., 2012; Mades et al., 2012). Studies using 
human cell lines have indicated that here Sec63p is not essential for cotranslational import but is 
involved in the biogenesis of polytopic transmembrane proteins. It has been shown that 
overexpression of SEC63 in mammalian cells reduces the levels of certain multi-spanning 
membrane proteins and vice versa assigning Sec63p a nonessential regulator role in cotranslational 
insertion of certain transmembrane proteins (Mades et al., 2012). Further, as Sec63p in mammalian 
cells is close to Sec61p, a role as a gatekeeper during expansion of the translocon during 
membrane insertion of proteins is possible (Lang et al., 2012; Mades et al., 2012). Data from 
experiments in human cells have further indicated that the role of Sec63p in polytopic membrane 
protein biogenesis is independent of Sec62p (Mades et al., 2012). Studies in yeast and mammalian 
cells have shown that Sec62p and Sec63p interact with each other (Meyer et al., 2000; Müller et al., 
2010; Harada et al., 2011). In yeast, Sec63p has been described to play a role during ERAD (Pilon 
et al., 1997; Plemper et al., 1997, Ng et al., 2007). A sec63 mutant in the J-domain shows a delayed 
degradation of ERAD substrates, therefore Sec63p is possibly part of the dislocation channel (Pilon 
et al., 1997; Plemper et al., 1997; Gillece et al., 2000).  
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Sec71p (yeast: 24 kDa) is a membrane protein with one transmembrane domain (N-terminus 
towards the ER lumen; two glycosylation sites), which associates with Sec72p (yeast: 21 kDa), a 
soluble protein located on the cytosolic side of the ER (Brodsky & Schekman, 1993; Feldheim et al., 
1993; Feldheim & Schekman, 1994; Panzner et al., 1995). Both proteins are nonessential but 
deletion of both genes causes temperature sensitivity in yeast (Feldheim & Schekman, 1994; Plath 
et al., 1998). Together with Sec62p they have been suggested to act in signal sequence recognition 
during posttranslational import (Lyman & Schekman, 1997). Neither Sec71p nor Sec72p are required 
for ERAD (Fang & Green; 1994; Plemper et al., 1997). 
 
 
1.3 PROTEIN FOLDING/MODIFICATIONS AND THE ER QUALITY CONTROL  
  
1.3.1 PROTEIN FOLDING AND MODIFICATIONS IN THE ER 
The first compartment of the secretory pathway is the ER, which plays an essential role in the 
biogenesis of secretory proteins (Ghaemmaghami et al., 2003; Kanapin et al., 2003; Vazquez-
Martinez et al., 2012). 
Upon their import into the ER (ref. 1.2.2 and 1.2.3) through the Sec61 translocon (ref. 1.2.4) proteins 
destined for secretion or membranes of the secretory pathway meet with the elaborate folding and 
modification machinery of the ER (Deshaies et al., 1991; Gething, 1999; Johnson & Waes, 1999; 
Rapoport, 2007; Braakman & Bulleid, 2011). The unique environment of the ER favours protein 
folding and modifications that would not be possible in the cytosol (Dill et al., 2008). The ER is 
equipped with a high concentration of molecular chaperones that maintain protein solubility and 
assist in protein folding, enzymes that catalyze posttranslational modifications as well as other 
factors that directly mediate protein folding (Jahn & Radford, 2005; McClellan et al., 2005; Bukau et 
al., 2006). The large variety of chaperones, co-chaperones, prolyl-isomerases, glycan-modifiying 
enzymes and other enzymes assist folding and are important for proteins to gain their final structure 
(van Anken & Braakman, 2005). The ER is also the major calcium-storage organelle of the cell and 
proper folding and chaperone function is often dependent on calcium (Wada et al., 1991; Meldolesi 
& Pozzan, 1998). 
Following signal sequence cleavage by SP, OST glycosylates proteins at asparagine (Asn) in the 
recognition site Asn-X-Ser/Thr (Tatu et al., 1993; Johnson & van Waes, 1999; Spurway et al., 2001). 
The aforementioned ER-lumenal chaperone Kar2p (BiP) promotes folding by binding to folding 
intermediates thereby stabilizing the protein and preventing the formation of toxic aggregates (ref. 
1.2.2 and 1.2.3; Hendershot et al., 1995, 1996, 2004). BiP is also involved in the regulation of the 
UPR (ref. 1.4) and targeting of proteins for ERAD (ref. 1.6) (Plemper et al., 1997; Brodsky et al., 
1999; Bertolotti et al., 2000; Kabani et al., 2003; Kimata et al., 2003). 
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Lectin-like chaperones, such as calnexin (CNX) and calreticulin (CRT) are another protein family 
important during protein folding (ref. 1.3.2; Helenius & Aebi, 2004; Vembar & Brodsky, 2008; 
Braakman & Bulleid, 2011). These proteins are able to bind to glycan structures of glycoproteins, 
thereby deciding, depending on the composition of the glycan structure, whether the protein is 
terminally folded or misfolded or whether it needs to undergo another folding cycle (Caramelo & 
Parodi, 2007). Hence, lectin-like chaperones are important components of the ERQC (Bhamidipati et 
al., 2005; Benitez et al., 2011). In addition, glucosidases and mannosidases modify N-linked glycans 
(Zapun et al., 1999). All of these modifications are important for proper protein folding. 
The oxidation, reduction and isomerisation of disulfide bonds are catalyzed by ER-lumenal protein 
disulfide isomerases (PDIs; yeast: Pdip, 4 homoloques), which possess isomerase and thiol 
oxidoreductase activity  (Freedman et al., 1994; Laboissiere et al., 1995; Norgaard et al., 2001; Tu & 
Weismman, 2004; Appenzeller-Herzog & Ellgaard, 2008). PDIs are also involved in multi-subunit 
protein assembly, as they bind proteins, thereby stabilizing intermediates (Wilson et al., 1998).  PDIs 
have also been suggested to be involved in the prevention of aggregate formation and in ERAD of 
several subsrates (Koivu et al., 1987; Gillece et al., 1999; Wahlman et al., 2007; Gauss et al., 2011). 
Peptidyl prolyl isomerases (PPIases) catalyze formation of cis-trans-isomerization of peptidyl-prolyl 
bonds (Kruse et al., 1995; Schmid, 1995) 
Only if secretory proteins are modified and folded accordingly can they leave the ER and be 
transported to their final destination. 
 
 
1.3.2 ER QUALITY CONTROL 
The ERQC is important for the preservation of ER function as the ER has to deal with a big load of 
newly synthesized protein that need to be properly modified and folded prior to reaching their final 
destination (Pryer et al., 1992; Bonifacino & Klausner, 1994; Hammond & Helenius, 1995; Kostova & 
Wolf, 2003; Römisch, 2005). Not all proteins, i.e. an estimated 30 % do not reach their final structure 
and therefore do not move further along the secretory pathway but are retained in the ER before 
they are targeted to ERAD (Schubert et al., 2000; Ellgaard & Helenius, 2003, Sitia & Braakman, 
2003). 
Post-translational modifications as well as proper protein folding and assembly in the ER are 
essential for protein function. Proteins that do not fold properly can interfere with the functions of 
their properly folded counterparts and are prone to form aggregates, which are toxic to the cell 
(Tyedmers et al., 2010). Secretory and membrane proteins are therefore subject to ERQC (Ellgaard 
& Helenius, 2003). During ERQC the protein folding status of a protein is evaluated. If molecular 
chaperones are able to assist in proper folding, the protein can enter ER-to-Golgi transport vesicles 
and is delivered to its final destination. If, however, the protein is not properly folded, it is retained in 
the ER to allow it to undergo further cycles of folding (McCracken & Brodsky, 1996; Ellgaard & 
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Helenius, 2003). Terminally misfolded proteins are subjected to the ERAD (ref. 1.6) pathway during 
which misfolded proteins are transported from the ER to the cytosol and degraded by the cytosolic 
26S proteasome (Brodsky & McCracken, 1999; Römisch, 2005; Sayeed & Ng, 2005; Nakatsukata & 
Brodsky, 2008). If the load of misfolded, aggregated proteins in the ER is bigger than the clearing 
rate, other pathways are induced, such as the UPR (ref. 1.4) or autophagy (Klionsky, 2007; Ron & 
Walter, 2007). 
ERAD is closely linked to the ubiquitin proteasome system (UPS; ref. 1.5) as many ERAD substrates 
are polyubiquitinated and degraded by the 26S proteasome (Chandu & Nandi, 2002, 2004; 
Varshavsky 2005). ERAD substrates are soluble and membane proteins that fail to fold or assemble 
properly or are not posttranslationally modified or damaged (Bonifacino & Klausner, 1994; Hammond 
& Helenius, 1995). The recognition of some soluble ERAD substrates might involve the recognition 
of exposed hydrophobic patches by members of the Hsp70 family, like BiP (Kar2p), and co-
chaperones of the Hsp40 family as well as NEFs (nucleotide exchange factors) (Brodsky et al., 
1999; Gething, 1999; Kabani et al., 2003; Hendershot, 2004; Hegde et al., 2006). BiP (Kar2p) at 
least is part of the multiprotein complex involved in ERAD-L of glycoproteins (Plemper et al., 1997). It 
has been proposed that BiP (Kar2p) is involved in early ERAD substrate recognition (Knittler et al., 
1995; Schmitz et al., 1995; Plemper et al., 1997; Nishikawa et al., 2001; Zhang et al., 2001).  
 
 
1.3.2.1 ER QUALITY CONTROL OF GLYCOPROTEINS 
The attachment of carbohydrate moieties to proteins plays an essential role in a lot of biological 
processes in eukaryotes (Varki, 1993; Haltiwanger & Lowe, 2004; Lehle et al., 2006). The 
importance of glycoproteins is emphasized by the fact that about 50 % of all cellular proteins are 
glycoproteins (Apweiler et al., 1999; Zhou et al., 2007). 
The majority of proteins (∼ 2/3) that are targeted to the secretory pathway are N-linked glycoproteins 
(Knop et al., 1996b; Jakob et al., 1998). During N-linked glycosylation, the oligosaccharide 
GlcNAc2Man9Glc3 (GlcNAc = N-acetylglucosamine; Man = mannose; Glc = Glucose; G3M9) is linked 
to the amino group of the asparagine residue in the consensus sequence Asn-X-Ser/Thr (X = any 
amino acid except proline) of a glycoprotein (Helenius & Aebi, 2004). Upon protein import into the 
ER the OST complex catalysis the attachment of the carbohydrate moiety to proteins (Lehle et al., 
2006). Carbohydrates attached to proteins do not only have an impact on protein conformation, they 
also contribute to protein stability and serve as a signal during ERQC (Knop et al., 1996b; Helenius 
& Aebi, 2004; Hitt & Wolf, 2004; Lehle et al., 2006). 
The mechanism by which N-glycosylated misfolded proteins are targeted to the ERQC is better 
understood than that for unglycosylated proteins. The proposed model suggests that whether a 
protein is degraded or secreted depends on both its structure and the time a protein remains in the 
ER (Jakob et al., 1998). The GlcNAc2Man9Glc3 structure is added during protein import in both yeast 
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and mammalian cells (Ellgaard et al., 1999; Liu et al., 1999). During early folding steps in the 
mammalian ER glucosidase I and II remove the terminal two glucose molecules on the A branch of 
the oligosaccharide moiety leading to GlcNAc2Man9Glc (ref. Figure 1.3.2.1.1; Helenius & Aebi, 2004; 
Aebi et al., 2010). Next, one of the two homologous lectins CNX (membrane protein) or CRT (ER-
lumenal protein) binds to the mono-glucosylated glycan structure (Hammond et al., 1994; Helenius 
et al., 1997; Aebi et al., 2010; Pearse et al., 2010; Stolz et al., 2010). Mammalian ERp57, a member 
of the PDI family, is then recruited to the lectin-bound glycan in a transient interaction (Freedman et 
al., 1994; Holtzman, 1997; Oliver et al., 1999). ERp57 promotes further folding and formation of 
disulfide bonds (Oliver et al., 1999). In yeast, Pdi1p might fulfill ERp57’s task (Buck et al., 2007; 
Gauss et al., 2011). Fully folded proteins are released from the CNX/CRT cycle and glucosidase II 
removes the third terminal glucose of the A branch (Aebi et al., 2010). A correctly folded protein with 
a GlcNAc2Man9 signature can be demannosylated by Golgi-resident mannosidase I and II and move 
further along the secretory pathway (Gabel & Bergmann, 1985; Moremen, 2002;Vembar & Brodsky, 
2008; Aebi et al., 2010). If the protein cannot reach its final conformation, however, it is recognized 
and reglucosylated by UDP-glucose:glycoprotein glucosyltransferase (UGGT) which adds a glucose 
molecule from UDP-glucose to GlcNAc2Man9 (Caramelo et al., 2003; Taylor et al., 2003). The protein 
then re-enters the CNX/(CRT)-ERp57 folding cycle (Helenius & Aebi, 2004). Upon correct folding, 
the glycoprotein is not recognized by UGGT anymore and can be packaged into ER-to-Golgi 
transport vesicles to leave the ER (Helenius, 1994; Caramelo et al., 2004; Warren & Mellman, 1999). 
Terminally misfolded proteins on the other hand are recognized and targeted to ERAD (Vembar & 
Brodsky, 2008). There is no UGGT in S. cerevisiae (Xu et al., 2004; Meaden et al., 2008; Braakman 
& Bulleid, 2011). 
After removal of the third terminal glucose by glucosidase II, ER mannosidase I can access the α1,2-
linked mannose of the glycan’s B branch and removes it (ref. Figure 1.3.2.1.1; Fagioli & Sitia, 2001). 
ER mannosidase I is a slow-acting enzyme, which supports the mannose timer hypothesis (Su et al., 
1993; Helenius et al., 1997). Initially, the resulting GlcNAc2Man8 B-glycan was thought to serve as 
the signal for degradation in both yeast and mammalian cells (Knop et al., 1996b; Liu et al., 1997; 
Jakob et al., 1998; 2001). Early studies proposed that lectins or lectin-like proteins recognize this 
glycan structure on misfolded glycoproteins (Lui et al., 1997; Jabkob et al., 1998; Yang et al., 1998). 
Htm1p/EDEM (EDEM = ER degradation-enhancing α-mannosidase-like protein), which shows 
homology to class I mannosidases, has been suggested to act as a lectin (Jakob et al., 2001; 
Hosokawa et al., 2001; Mast et al., 2005; Clerc et al., 2009). In mammals three α1,2-mannosidases 
(EDEM1-3; EDEM1 and EDEM3 are homologous to Htm1p) have been identified (Kanehara et al., 
2007; Olivari & Molinari, 2007). EDEMs are soluble ER-lumenal proteins that show mannosidase 
activity, i.e at least EDEM1 and 3 (Hirao et al., 2006; Olivari et al., 2006). The removal of the 
terminal α1,2-linked mannose of the A branch enables the protein to exit the CNX/CRT cycle and the 
additional trimming of the C branch down to GlcNAc2Man6 and GlcNAc2Man5 structures generates 
1 INTRODUCTION 
 
	   41	  
the final ERAD signal (Moremen & Molinari, 2006; Molinari, 2007). The signal leads to 
retrotranslocation, ubiquitination and proteasomal degradation of the protein. 
In S. cerevisiae, there is no mechanism comparable to the CNX/CRT cycle known to date 
(Fernandez et al., 1994; Vembar & Brodsky, 2008; Clerc et al., 2009). There is, however, a 
homologue to CNX, Cne1p, whose exact role in ERAD is unclear (Parlati et al., 1995; Knop et al., 
1996b; Xu et al., 2004a, 2004b; Kimura et al., 2005; Kostova & Wolf, 2005; Clerc et al., 2009). For 
Cne1p binding of monoglucoyted oligosaccharaides (G1M9) was demonstrated using lectin site 
mutants (Xu et al., 2004a; Hosokawa et al., 2010). For a subset of glycosylated and nonglycosylated 
substrates Cne1p exhibits chaperone activity  (Parlati et al., 1995; Xu et al., 2004a, 2004b). It was 
also found to be involved in the quality control of some underglycosylated forms of CPY* where the 
role of Cne1p was antagonistic to Htm1p: When Htm1p was absent the substrate was stabilized and 
when Cne1p was absent degradation was accelerated (Kostova & Wolf, 2005). Under heat stress 
conditions Cne1p interacts with Kar2p (BiP) and Pdi1p which have been suggested to partly recover 
the function of Cne1p in Cne1p-disrupted cells (Brodsky et al., 1999; Zhang et al., 2008a, 2008b). 
The yeast α1,2-mannosidase homologue Htm1p/Mnl1p (Htm1 = homologous to mannosidase 1; 
Mnl1 = mannosidase-like protein 1) removes the terminal α1,2-mannose molecules from the C 
branch of the GlcNAc2Man8-glycan generated by mannosidase I (α1,2-exomannosidase) (Hosokawa 
et al., 2001; Jakob et al., 2001; Mast et al., 2005; Hirao et al., 2006; Clerc et al., 2009). The resulting 
GlcNAc2Man7 C-glycan has been proposed to serve as the degradation signal (Clerc et al., 2009).  
Studies in yeast have shown that whereas ER mannosidase I works on the B branch and produces a 
terminal α1,3-linked mannose, Htm1p works on the C branch leading to an α1,6-linked mannose 
(Clerc et al., 2009). Mammalian EDEM1 and EDEM3 also seem to work on the α1,2-linked mannose 
of the A branch (Hirao et al., 2004, Olivari et al., 2006; Clerc et al., 2009). Htm1p has been shown to 
be involved in ERAD-L (Vashist & Ng, 2004). Htm1p also interacts with Pdip, which has been shown 
to recognize misfolded proteins and target them to the retrotranslocon  (Gillece et al., 1999; Krogan 
et al., 2006; Clerc et al., 2009). 
Another α1,2-mannosidase has been identified, Mnl2, trimming the glycan structure on the A branch, 
resulting in a GlcNAc2Man5 species, which has been suggested to be recognized by the lectin Yos9p 
(ref. Figure 1.3.2.1.1; Aebi et al., 2010; Benitez et al., 2011). 
The mannose 6-phosphate homology domain of Yos9p is essential for ERAD-L of glycoproteins 
(Buschhorn et al., 2004; Bhamidipati et al., 2005; Kim et al., 2005). Yos9p acts downstream of 
Htm1p binding to α1,6-linked C-glycans generated by Htm1p (Quan et al., 2008; Clerc et al., 2009). 
It is part of the Hrd1 complex (ref. 1.4), which is formed around the Hrd1p E3 ligase (Gardner et al., 
2000; Carvalho et al., 2006). Misfolded proteins complexed to chaperones or lectins interact with 
Hrd3p (of the Hrd1 complex), which seems to initiate export and degradation (Plemper et al., 1999a; 
Gardner et al., 2000). Yos9p is one of the targeting lectins which ferries misfolded proteins to the 
Hrd1 complex (Vashist & Ng, 2004; Denic et al., 2006; Gauss et al., 2006; Quan et al., 2008). 
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Figure 1.3.2.1.1. N-glycan processing in the ER. In S.cerevisiae N-glycan processing and recognition 
starts with the attachment of the GlcNAc2Man9Glc3 oligosaccaride to asparagines in the consensus motif 
Asn-X-Ser/Thr by OST. The glucose residues are sequentially processed by glucosidase I an II. 
Monoglucosylated N-linked oligosaccharides are recognized by the yeast CNX homologue Cne1p (not 
shown; Xu et al., 2004a). The terminal α1,2-linked mannose on the B branch of the glycan is processed 
by ER α1,2-mannosidase (Mns1) resulting in the B-glycan GlcNAc2Man8. Htm1p trims the α1,2-linked 
mannose on the C branch generating GlcNAc2Man7. This structure (or a Man5-structure generated by 
Mnl2), containing a terminal α1,6-linked mannose, can then be recognized by the lectin Yos9p (not 
shown) as the degradation signal and the glycoprotein is subjected to the ERAD pathway (adapted from 
Benitez et al., 2011). 
 
 
1.4 THE UNFOLDED PROTEIN RESPONSE  
The UPR is an ER-to-nucleus signal transduction pathway that is tightly linked to the ERAD pathway 
(Casagrande et al., 2000; Friedlander et al., 2000; Travers et al., 2000; Spear & Ng, 2001; 
Korennykh & Walter, 2012). This cellular protection mechanism, which is triggered by the 
accumulation of unfolded or incompletely folded secretory or membrane proteins in the ER, is vital 
for maintaining cellular function under ER stress conditions (Korennykh & Walter, 2012). The primary 
function of the UPR is to sense accumulation of misfolded proteins in the ER and to trigger a cellular 
response that enables the cell to cope with the protein overload. As a result, the folding capacity of 
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the ER as well as the degradation capacity for misfolded proteins is increased while the amount of 
newly translated proteins entering the ER is reduced (Ng et al., 2000; Spear & Ng, 2003). 
In S. cerevisiae the key components of the UPR are the ER membrane protein Ire1p (inositol-
requiring protein 1) and the transcription factor (TF) Hac1p that mediate the signal transmission from 
the ER to the nucleus (Cox et al., 1993; Mori et al., 1993; Cox & Walter, 1996; Mori et al., 1996; 
Nikawa et al., 1996; Travers et al., 2000; Ma & Hendershot, 2001).  
Ire1p consists of an N-terminal sensor domain located in the ER lumen and a C-terminal CDK2-like 
serine/threonine kinase domain fused to a ribonuclease domain (RNase) in the cytosol (ref. Figure 
1.4.1; Welihinda & Kaufman, 1996; Sidrauski & Walter, 1997). Detection of misfolded proteins by the 
sensor domain leads to Ire1p oligomerization resulting in RNase activation (Shamu & Walter, 1996; 
Credle et al., 2005; Aragon et al., 2009; Korennykh et al., 2009, 2011). Two models have been 
suggested explaining the sensor mechanism: The first model involves competitive binding of 
misfolded proteins and the Ire1p sensor domain to the ER chaperone BiP (Bertolotti et al., 2000; 
Zhou et al., 2006). In a normally growing cell with the ER in homeostasis BiP is associated with Ire1p 
(Bertolotti et al., 2000; Kimata et al., 2003, 2004). When misfolded proteins accumulate in the ER, 
BiP is recruited and dissociates from the sensor domain (Dorner et al., 1992; Ng et al., 1992; Beh & 
Rose, 1995). As a result, Ire1p oligomerizes and undergoes trans-autophosphorylation and thus gets 
activated (Shamu & Walter, 1996; Bertolotti et al., 2000; Kimata et al., 2003; Zhou et al., 2006). The 
second model suggests that misfolded proteins directly bind to the sensor domain of Ire1p also 
leading to the activation of Ire1p (Credle et al., 2005; Gardner & Walter, 2011). This model further 
implies that BiP acts as a mediator that keeps Ire1p monomer concentrations at a distinct level, 
which is needed for sufficient sensing of misfolded proteins (Pincus et al., 2010). 
High-order oligomerization of Ire1p in the plane of the ER membrane is needed for activation of its 
kinase and RNase domains (Credle et al., 2005; Aragon et al., 2009; Korennykh et al., 2009, 2011). 
The Ire1p kinase domain serves as a scaffold for RNase domain oligomerization (Korennykh et al., 
2009). It has been suggested that four signals are mandatory for successful oligomerization: The 
first two involve the binding of BiP and association of unfolded proteins to the lumenal domain of 
Ire1p. The third is the binding of cofactors to the ATP pocket of the kinase domain of Ire1p and 
finally, the fourth, is the trans-autophosphorylation of the kinase domain (Bertolotti et al., 2000; 
Kimata et al., 2003; Korennykh et al., 2009, 2011; Korennykh & Walter, 2012). 
Nevertheless, it has been shown that the kinase activity of Ire1p is not essential for UPR activation 
(Papa et al., 2003; Chawla et al., 2011; Rubio et al., 2011). It is, however, involved in the regulation 
of RNase domain oligomerization (Korennykh et al., 2009). The autophosphorylation of the Ire1p 
kinase domain results in a stronger Ire1p association and additionally it is also responsible for faster 
shutdown as soon as the ER has adjusted to ER stress (Korennykh et al., 2009; Chawla et al., 2011; 
Rubio et al., 2011). 
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The activated Ire1p RNase excises a translation-inhibitory intron from the 3’ end of the uninduced 
form of the transcription factor HAC1 mRNA (HAC1u; u = uninduced) followed by religation of the two 
exons by tRNA ligase (Sidrauski & Walter, 1997; Kawahara et al., 1998). The resulting HACi mRNA 
(i = induced) encodes the active transcription factor Hac1p (a bZIP transcritption factor) (Shamu & 
Walter, 1996; Sidrauski et al., 1996; Chapman & Walter, 1997; Rügsegger et al., 2001). Hac1p 
enters the nucleus where it binds to the UPR regulatory element (UPRE) in the promoter region of 
the respective UPR target genes, thereby inducing their expression (Mori et al., 1992; Kohno et al., 
1993; Cox & Walter, 1996). Among the UPR target genes are genes encoding proteins involved in 
translocation (translocon subunits), folding (ER-resident chaperones), glycosylation, ER-to-Golgi 
transport and retrieval, lipid biosynthesis, cell wall biosynthesis, vacuolar sorting as well as 
components of the ERAD pathway (Mori et al., 1992; 1998; Cox & Walter, 1996; Sidrauski et al., 
1996; Casagrande et al., 2000; Friedlander et al., 2000; Ng et al., 2000; Tavers et al., 2000; Fewell 
et al., 2001; Patil & Walter, 2001; Higashio & Kohno, 2002). Upon decrease of ER stress the cell 
returns to normal physiological conditions and expression of UPR target genes is reduced 
(Merksamer et al., 2008; Papa, 2012). If the UPR fails to achieve cellular homeostasis, prolonged 
UPR induction leads to apoptosis (Jäger et al., 2012). While in S. cerevisiae only the Ire1p pathway 
is known, in mammalian cells three arms of the UPR mediated by IRE1 (yeast Ire1p homologue), 
ATF6 (activating transcription factor-6) and PERK (protein kinase RNA (PKR)-like ER kinase), 
respectively, have been identified (Niwa et al., 1999; Lee et al., 2002; Schröder & Kaufmann, 2005; 
Bernales et al., 2006). 
The UPR and ERAD are interconnected processes (Casagrande et al., 2000; Friedlander et al., 
2000; Ng et al., 2000; Travers et al., 2000). While the induction of the UPR is required for efficient 
ERAD, defects or reduction in ERAD induce the UPR to ensure cell viability (Casagrande et al., 
2000; Ng et al., 2000; Spear & Ng, 2003). Furthermore, defects in both processes are synthetically 
lethal, although neither of them is essential (Zhou & Schekman, 1999; Travers et al., 2000) 
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Figure 1.4.1. The S. cerevisiae Unfolded Protein Response. Start = LEFT: The ER-membrane protein Ire1p 
remains as inactive monomers under normal physiological conditions due to binding of the ER chaperone BiP 
(Kar2p). The UPR is induced under ER-stress conditions (i.e. when misfolded proteins accumulate in the ER). 
This leads to the titration of BiP off Ire1p (or direct binding of the misfolded protein species to Ire1p). This 
enables Ire1p monomers to form dimers and higher-order oligomers, which then undergo trans-
autophosphorylation. Thus activated Ire1p together with tRNA ligase is involved in the translation of the 
transcription factor Hac1p by excising a translation inhibitory intron from the HAC1 mRNA (HAC1u). Splicing of 
HAC1 mRNA leads to the formation of two exons, which are ligated by tRNA ligase. Translation of the resulting 
HAC1i mRNA leads to the translation of the TF Hac1p. Hac1p enters the nucleus where it binds to the UPRE in 
the promoter region of UPR target genes thereby up-regulating their expression. Translation of UPR-induced 
proteins increases the folding capacity of the ER by remodeling the secretory pathway in such a way that it 
enables the cell to cope with the misfolded protein overload. The normal physiological conditions of the cell are 
regained by the reduction of misfolded proteins in the ER. (P: phosphorylation of the kinase domains; C: kase-
binding cofactors; adapted from Ron & Walter, 2007; Korennykh & Walter, 2012). 
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1.5 THE UBIQUITIN PROTEASOME SYSTEM 
In eukaryotes, the ubiquitin proteasome system (UPS) is the key mechanism for the regulated 
intracellular degradation of proteins (Wang & Maldonado, 2006). The UPS is a complex system that 
is interconnected with a broad range of cellular processes such as cell cycle control, DNA repair, 
transcription, signal transduction etc. (Ciechanover, 1998; Hicke, 2001; Weissman, 2001). It is 
essential as it helps maintaining cellular protein homeostasis, which, if disturbed, can lead to a 
variety of disorders such as neurodegenerative, cardiovascular and oncogenic disorders (Hershko & 
Ciechanover, 1998; Nandi et al., 2006). Tight regulation of the UPS is vital for cellular maintenance 
(Varshavsky, 2005). As part of the protein quality control, the UPS is especially important for the 
regulated degradation of defective proteins, including proteins that are misfolded, denatured, 
incomplete or oxidized. Those or otherwise damaged proteins tend to accumulate and form 
aggregates which are toxic to the cell (Ciechanover & Brundin, 2003; Chandu & Nandi, 2002, 2004).  
The two major players of the UPS are ubiquitin (ref. 1.5.1) and the 26S proteasome (ref 1.5.2). In 
eukaryotes, both are abundant in the nucleus as well as in the cytosplasm (Glickman et al., 1998a; 
Pickart, 2001; Weissman, 2001; Pickart & Cohen, 2004). The degradation of proteins by the UPS 
involves two tightly regulated, consecutive steps: During the first step, the ubiquitination, ubiquitin 
molecules are covalently attached to a UPS substrate. The second step involves the recognition and 
degradation of the substrate by the 26S proteasome (Hershko & Ciechanover, 1998; Chandu & 
Nandi, 2002, 2004; Ciechanover & Brundin, 2003). 
 
 
1.5.1 UBIQUITIN AND UBIQUITINATION 
In eukaryotes, some proteins destined for proteasomal degradation are ubiquitinated (Rock et al., 
1994). During ubiquitination, the small protein modifier ubiquitin (Ub) is covalentely conjugated to a 
lysine residue in the substrate (Glickman & Ciechanover, 2002; Pickart, 2004). The addition of 
further Ub moieties leads to the formation of polyubiquitin chains (Hartmann-Petersen & Gordon, 
2004; Pickart & Eddins, 2004; Kerscher et al., 2006). Substrates containing a chain of at least four 
Ubs are recognized by the 26S proteasome for degradation (Elsasser & Finley, 2005). 
Ubiquitin is a highly conserved protein of about 76 residues ubiquitously expressed in eukaryotes 
(Ciechanover et al., 1978; Wilkinson et al., 1980; Pickart, 2000; Wolf, 2011). It belongs to the 
ubiquitin protein family, a family of structurally conserved protein modifiers which all regulate 
essential functions (Petroski, 2008; Wickliffe et al., 2009). Although different in sequence all 
members of this protein family share one structural feature, the so-called ubiquitin fold (β-grasp fold), 
and the same biochemical mechanism, i.e. the formation of an isopeptide bond between the terminal 
glycine of the protein modifier and an amino group of the target protein (Burroughs et al., 2007). 
Other ubiquitin-like modifiers (UBL), found in all eukaryotes, are NEDD8 (neuronal-precursor-cell-
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expressed developmentally down-regulated protein-8; Rub1 in S. cerevisiae) and SUMO (small 
ubiquitin-like modifier) (Kumar et al., 1993; Rao-Naik et al., 1998; Bayer et al., 1998; Whithy et al., 
1998; Kerscher et al., 2006).  
During ubiquitination mono- or polyubiquitin chains are covalently attached to the target protein. This 
process is ATP-dependent (Ciechanover et al., 1980; Pickart, 2001; Weissman 2001; Ciechanover & 
Iwai, 2004). There are various possible linkages in a polyubiquitin chain. Of the 7 lysines in ubiquitin 
(K6, K11, K27, K29, K33, K48, K63), K11, K29, K48 and K63 have been shown to form polyubiquitin 
chains in vivo, with G76-K48 linked polyubiquitin chains of at least four ubiquitins being the best 
understood type of chain serving as the predominant signal for proteasomal degradation (Chau et 
al., 1989; Dubiel & Gordon, 1999; Thrower et al., 2000; Weissman, 2001; Pickart & Fushman, 2004; 
Windheim et al., 2008; Keating & Bowie, 2009). K29, K11 and even K63 linkages, however, have 
also been suggested to be competent for proteasomal degradation (Baboshina & Haas, 1996; Koegl 
et al., 1999; Jin et al., 2008; Hofman & Pickart, 2001; Kim et al., 2007; Saeki et al., 2009). Less is 
known about the function of otherwise linked polyubiquitin chains. 
Ubiquitination involves three steps, which are mediated by three sets of enzymes: ubiquitin-
activating (E1), ubiquitin-conjugating (E2) and ubiquitin-ligating (E3) enzymes (Hershko et al., 1983). 
During the first step, an E1 enzyme activates the C-terminal glycine (G76) of ubiquitin in an ATP-
dependent manner, resulting in the formation of a ubiquitin-adenylate intermediate (Haas & Rose, 
1982). A thioester linkage is formed between the C-terminal carboxyl group of ubiquitin and the 
sulfhydryl group of the E1 active site cysteine (Jentsch, 1992). The second step is mediated by an 
E2, catalyzing the transfer of ubiquitin from the E1 to the E2 active site cysteine. This leads to the 
formation of a thioester between the E2 and ubiquitin (E2-Ub) (Jentsch, 1992). Finally, upon 
interaction with E2-Ub, an E3 ubiquitin ligase mediates the transfer of ubiquitin to the target protein. 
During this last step, an isopeptide bond is formed between a lysine (ε-amino group) in the target 
protein and the C-terminal glycine of ubiquitin (Hershko et al., 1983; Pickart 2001). 
There are two main types of E3 ubiquitin ligases in eukaryotes: RING (really interesting new gene) 
ubiquitin ligases and HECT (homologous to E6-associated protein carboxy terminus) ubiquitin 
ligases, containing the C-terminal RING or the HECT domain, respectively (Freemont et al., 1991; 
Wang & Pickart, 2006; Deshaies & Joazeiro, 2009). HECT E3s use a cysteine residue within the 
HECT domain as acceptor for ubiquitin from the E2, leading to the formation of a thioester between 
ubiquitin and the HECT E3. The ubiquitin is then transferred to the substrate (Huibregtse et al., 1995; 
Scheffner et al., 1995; Wang & Pickart, 2005). RING E3 enzymes contain the RING domain 
(conserved cysteine- and histine-rich motif), which coordinates zinc ions (Freemont et al., 1991; 
Lorick et al., 1999). Unlike HECT E3s, RING E3s do not form thioesters with ubiquitin; they bring 
ubiquitin-associated E2s close to the substrate and thus mediate the ubiquitin transfer (Deshaies & 
Joazeiro, 2009). The ERAD E3 ligases Hrd1p and Doa10p belong to the family of RING E3 ligases 
(Bordallo et al., 1998; Bays et al., 2001, Ravid et al., 2006; Sato et al., 2009; Carvalho et al., 2010). 
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For RING E3 ligases there are two modes by which polyubiquitination of substrates can be 
mediated: Polyubiquitin chains either form sequentially or are added en bloc to the substrate 
(Deshaies & Joazeiro, 2009; Pierce et al., 2009). During the first mode, single ubiquitin molecules 
associated with an E2 are added sequentially to the substrate (Eletr et al., 2005; Deshaies & 
Joazeiro, 2009). After the transfer the E2 dissociates from the E3 enabling another E2-Ub moiety to 
associate with the E3, enabling the transfer of the next Ub to the substrate (Deshaies & Joazeiro, 
2009). In the second mode polyubiquitin chains preassemble on the E2 and are then tranferred to 
the target protein (Hershko, 1983; Komitzer & Ciechanover, 2000; Li et al., 2007; Ravid & 
Hochstrasser, 2007). An additional class of enzymes, the E4s, has been described to be involved in 
polyubiquitin chain elongation (Hoppe, 2005).  
Deubiquitination is a highly regulated process also involved in many cellular processes such as DNA 
repair and proteasomal protein degradation. Deubiquitinating enzymes (DUBs), which are cysteine 
proteases or metalloproteases, catalyze the removal of ubiquitin from proteins (Nijman et al., 2005; 
Reyes-Turcu et al., 2009). During the UPS, DUBs are essential for ubiquitin recycling, generation of 
monoubiquitin from polyubiquitin chains, activation of ubiquitin precursors as well as reversal of 
ubiquitination (Deshaies & Joazeiro, 2009). 
 
 
1.5.2 THE 26S PROTEASOME 
The most downstream executive component of the UPS is the 26S proteasome, a multi-protein 
complex of about 2.5 MDa in eukaryotes, highly conserved from archaea to eukaryotes (Hershko & 
Ciechanover, 1998; Wolf & Hilt, 2004; Hanna & Finley, 2007; Tomko & Hochstrasser, 2011). In 
S.cerevisiae the majority of 26S proteasomes are associated with the ER and the nuclear envelope 
whereas the remaining pool is free in the cytosol and nucleoplasm (Enenkel et al., 1998). As the 
central protease in the cell the 26S proteasome is confronted with a large number of substrates that 
are destined for degradation (Voges et al., 1999). The assembly of this multi-protein enzyme needs 
to be tightly controlled in order to maintain its sophisticated structure and function (Bedford et al., 
2010). The 26S proteasome plays a vital role during the degradation of ER-dislocated misfolded 
proteins (Voges et al., 1999; Finley, 2009; Murata et al., 2009). The 26S proteasome not only 
degrades polyubiquitinated misfolded proteins, but also proteins with a short half-life and otherwise 
defective proteins (Hershko et al., 2000). Substrates can be delivered to the 26S proteasome via 
different pathways using different types of ubiquitin chains and other modifications (ref. 1.5.1; Rock 
& Goldberg, 1999: Voges et al., 1999; Elsasser & Finley, 2005; Finley, 2009). In eukaryotes, the 
proteasome consists of at least 33 subunits (S. cerevisiae), which assemble into two subcomplexes, 
the 19S regulatory particle (RP) and the 20S core particle (CP) (ref. Figure 1.5.2.1; Peters et al., 
1993; Wolf & Hilt, 2004; Hanna & Finley, 2007; Murata et al., 2009; Bedford et al., 2010). The 20S 
CP is the 670 kDa barrel-shaped subcomplex, which harbours the proteolytically active sites inside 
1 INTRODUCTION 
 
	   49	  
its cavity (ref. 1.5.2.1; Larsen & Finley, 1997; Glickman et al., 1998a; Kunjappa & Hochstrasse, 
2014). The 900 kDa 19S RP plays important roles during the recognition of ubiquitinated proteins 
(ref. 1.5.2.2). It also directs them into the 20S CP central channel for degradation (Groll et al., 2000; 
Verma et al., 2000; Finley et al., 2002; Liu et al., 2002). The 26S holoenzyme consists of one 20S 
CP and either one or two 19S RP at either side of the 20S CP (Peters et al., 1993; Groll et al., 1997; 
Tomko & Hochstrasser, 2011). The 26S proteasomes are highly dynamic structures that undergo 
various conformational changes during the degradation process (Bedford et al., 2010). The 19S RP 
AAA-ATPases have been suggested to undergo conformational changes during ATP binding and 
hydrolysis which are crucial for substrate unfolding and translocation into the 20S CP (ref. 1.5.2.2; 
Babbitt et al., 2005; Horwitz et al., 2007; Kriegenburg et al., 2008; Finley, 2009). The 19S RP may 
act in a similar way during the extraction of misfolded proteins from the ER (Lee et al., 2004a, 
2004b; Ng et al., 2007).  
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Figure 1.5.2.1. The 26S proteasome. (A) Schematic representation of the 26S proteasome, consisting of the 
20S CP and one or two (not shown) 19S RP. The 20S CP consists of two outer hetero-heptameric alpha-rings 
and two inner hetero-heptamieric beta-rings. The subunits β1, β2 and β5 (red) harbour the proteolytic avtivity. 
The 19S RP can be further divided into the base (Rpt1-6, Rpn1, 2, 10 and 13) and the lid (Rpn3, 5-9, 11, 12 
and 15). Proteasome cyclosome (PC) repeat containing subunits (purple), Mpr1 and Pad1 in the N terminus 
(MPN) domain containing subunits (red), proteasome-COP9-eIf3 (PCI) domain containing subunits (dark 
green) and Ub receptros (light green) are indicated (adapted from Ichihara, 2010). (B) Substrate degradation 
model. (I) Polyubiquitylated substrates (S) are recruited to the Ub receptors Rpn10 and Rpn13 (LEFT). (II) 
During the commitment step substrates are bound more tightly to the 26S proteasome by the AAA-ATPases 
(CENTER). (III) Substrates are further transferred to Rpn11 where deubiquitylation occurs prior to protein 
unfolding in the upper AAA-ATPase cavity. Unfolded substrates are translocated into the 20S CP cavity for 
degradation (Lasker et al., 2012; taken from Unverdorben et al., 2014). 
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1.5.2.1 THE 20S CORE PARTICLE 
The 20S proteasome CP is highly conserved among various organisms (Groll et al., 1997; 
Dahlmann et al., 1999; Unno et al., 2002; Groll et al., 2005). It is composed of a stack of four 
heteroheptameric rings, two outer α-rings and two inner β-rings (Groll et al., 1997). Each type of ring 
is formed by seven related α- or β-subunits, respectively (stack arrangement: α1-7; β1-7; β1-7; α1-7; 
ref. Figure 1.6.2.1; Baumeister et al., 1998). While the α-rings serve as docking domains for the 19S 
RP, the β-rings harbour the proteolytically active sites β1, β2 and β5 (Baumeister et al., 1998; Smith 
et al., 2007). The three subunits display caspase-like (cleaving after acidic residues), trypsin-like 
(cleaving after basic residues) and chymotrypsin-like (cleaving after hydrophobic residues) activity, 
respectively (Groll et al., 1997; Baumeister et al., 1998; Voges et al., 1999; Kisselev et al., 2006; 
Sharon et al., 2006). The catalytic sites, located inside the 20S cavity to prevent unspecific 
degradation, degrade substrates into short peptides that range from 4 to 25 amino acids in length 
(Chen & Hochstrasser, 1996; Heinemeyer et al., 1997). These peptides are further processed by 
cellular peptidases into amino acids, which are then recycled by the cell (Lowe et al., 1995; Groll et 
al., 1997; Kisselev et al., 1999; Unno et al., 2002). Substrates enter the 20S cavity through the so-
called gate, which is composed of the N-termini of the α-subunits close to the ends of the barrel 
(Groll et al., 2000). In yeast, engagement of the proteolytic sites stabilizes the whole 26S complex 
(Ferrell et al., 2000; Groll et al., 2000). In yeast as well as in humans, the assembly of the 20S CP is 
a largely conserved process and can take place independently of the 19S RP, or associated with 
other regulators (Velichutina et al., 2004; Hirano et al., 2006, 2008; Kusmierczyk et al., 2008; 
Yashiroda et al., 2008; Murata et al., 2009; Bedford et al., 2010).                                    
 
 
1.5.2.2 THE 19S REGULATORY PARTICLE 
The 19S RP consists of 19 proteins and plays a vital role not only for substrate recognition but also 
for gate opening so that the interior of the 20S CP is accessible for degradation (Glickman et al., 
1998a; Braun et al., 1999; Liu et al., 2002, 2003; Jung & Grune, 2007). The 19S RP is crucial for 
accepting ubiquitinated substrates, as well as for the deubiquitination and unfolding of degradation 
substrates (Hershko et al., 1984; Hough et al., 1986; Braun et al., 1999; Liu et al., 2002). The 19S 
RP can be further divided into two subcomplexes, the lid and the base (ref. Figure 1.5.2.1; Glickman 
et al., 1998a, 1998b). The base subcomplex consists of six AAA-type ATPases (ATPases 
Associated with a variety of cellular Activities), Rpt1-6 (Rpt: Regulatory Particle AAA-ATPase), the 
only ATP-hydrolyzing proteins in the 19S RP, and the four non-ATPase proteins Rpn1, Rpn2, Rpn10 
and Rpn13 (Rpn: Regulatory Particle Non-AAA-ATPase) (Lucero et al., 1995; Fujimuro et al., 1998; 
Glickman et al., 1998a, 1999). The lid subcomplex contains the rest of the Rpn subunits (Rpn3, 
1 INTRODUCTION 
 
	   52	  
Rpn5, Rpn6, Rpn7, Rpn8, Rpn9, Rpn11, Rpn12 and Rpn15) (Beyer, 1997; Finley et al., 1998; Patel 
& Latterich, 1998; Liu et al., 2002; Lasker et al., 2012).  
The six AAA-ATPases (order: Rpt1, Rpt2, Rpt6, Rpt3, Rpt4, Rpt5) in the 19S RP base belong to the 
Walker family of ATPases containing the A (ATP binding) and B motif, two conserved elements 
(Walker et al., 1982). These proteins within the 19S RP form a hexameric ring stacked on top of the 
heptameric ring in the 20S CP (Nandi et al., 2006; Finley et al., 2009; Förster et al., 2009; Zhang et 
al., 2009). The Rpt subunits are important for substrate unfolding, 20S CP gate opening and 
substrate translocation to the 20S CP (Djuranovic et al., 2009; Zhang et al., 2009; Tomko et al., 
2010). Gate opening is mediated by the docking of the C-termini of the AAA-ATPases into the 
pockets created between the α-subunits of the 20S CP (Smith et al., 2007). Rpt 2, Rpt3, and Rpt5 
are especially interesting, as their C-termini have been suggested to open the gate of the 20 CP 
(Smith et al., 2007). For Rpt2 and Rpt3 it has been shown that their C-termini, containing an HbYX 
(hydrophobic-tyrosine-X) motif, are located in the pockets between the 20S CP subunits α3/α4 and 
α1/α2, respectively (Lasker et al., 2012). The HbYX motif has been shown to induce opening of the 
gate (Smith et al., 2007; Tian et al., 2011; Lasker et al., 2012). Rpt5 also contains the HbYX motif, 
but its C-terminus is more flexible and able to occupy pockets α5/α6 or α6/α7 (Lakser et al., 2012). 
The Rpn subunits located in the 19S RP lid and base mediate substrate recognition and transfer to 
the 20S CP (Deveraux et al., 1994; Lam et al., 1997; Lasker et al., 2012). In general, the Rpn 
subunits can be divided into four groups: (1) proteasome cyclosome (PC) repeat-containing subunits 
(Rpn1 and Rpn2), (2) Mpr1 and Pad1 in the N-terminus (MPN) domain.containing subunits (Rpn8 
and Rpn11), (3) proteasome-COP9-eIf (PCI) domain-containing subunits (Rpn3, Rpn5, Rpn6, Rpn7, 
Rpn9 and Rpn12) and (4) Ub receptors (Rpn10 and Rpn13) (Frank, 2006; Förster et al., 2010; 
Lasker et al., 2012). The Ub receptors Rpn10 and Rpn13 (non-essential in yeast) in the base have 
been described to be peripherally located in the 26S proteasome (van Nocker et al., 1996; Seeger et 
al., 2003; Husnjak et al., 2008). Apart from the 19S RP Ub receptors, polyubiquitinated substrates 
can be recognized by shuttling Ub receptors like Dsk2 and Rad23 (Wilkinson et al., 2001). They 
recognize polyubiquitinated substrates and bind them via their ubiquitin-associated domain (UBA) 
and bind to Rpn1, Rpn10 or Rpn13 at their ubiquitin-like domain (UBL) (Wilkinson et al., 2001; Finley 
et al., 2009). Rpn10 and Rpn13 are unrelated in structure and are only 90 Å apart, which is the size 
of a tetraubiquitin chain (Zhang et al., 2009; Sakata et al., 2011). This might explain why 
polyubiquitin chains have been suggested to be at least four ubiquitins long for the degradation 
signal to be fully active (Deveraux et al., 1994; Piotrowski et al., 1997; Lasker et al., 2012). After the 
initial binding, the polyubiquitinated substrate is more tightly bound to the proteasome and via the 
coiled coils of the Rpt4/Rpt5 and Rpt1/Rpt2 dimers, located under Rpn10 and Rpn13 respectively, 
the substrate is further transferred within the proteasome for degradation (Perham, 2000; Peth et al., 
2010). It has been suggested that these coiled coils are flexible structures that undergo a swinging 
motion thereby scanning the space above for prospective substrates, binding them and eventually 
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exposing them to Rpn11 (Smith et al., 2007; Sakata et al., 2011). The movement might even 
mediate gate opening as the coiled coils are located above the Rpt subunits (Rpt2, Rpt3, Rpt5) 
whose C-termini open the gate (Lasker et al., 2012). Rpn11 is located above the gate formed by the 
Rpt subunits and deubiquitinates degradation substrates before they are unfolded in the upper AAA-
ATPase cavity and further translocated into the 20S CP where they are degraded (Smith et al., 2007; 
Bohn et al., 2010; Lasker et al., 2012). 
The non-ATPase subunits Rpn1 and Rpn2, also located in the 19S RP base, are homologous 
proteins displaying a toroid structure (Kajava, 2002; Effantin et al., 2009; Lakser et al., 2012). They 
have been suggested to act as a scaffold binding some proteasomal subunits as well as 
proteasome-associated proteins (Lupas et al., 1997a; Elsasser et al., 2002; Effantin et al., 2009; 
Gomez et al., 2011). Rpn1 is close to the Rpt1/Rpt2 dimer and has been suggested to be a very 
flexible structure, which recruits shuttling ubiquitin receptors and the deubiquitinating enzyme (DUB) 
Ubp6 which docks to the Leucine-rich repeats (LRRs) of Rpn1 (Wilkinson et al., 2001; Elsasser et 
al., 2002; Gomez et al., 2011; Lasker et al., 2012). Rpn2 makes contact with Rpt3/Rpt6 via its 
domain close to the 20S CP and also interacts with the Rpn8/Rpn11 dimer via a toroidal segment 
and Rpn13, Rpn12 and Rpn3 with its distal end (Kajava, 2002). Although the lid had been thought to 
be distal to the 20S CP, structural studies suggest that it flanks the side of the Rpt hexamer and 
even contact the 20S CP via the N-termini of Rpn6 and Rpn5 (ref. Figure 1.5.2.1; Glickman et al., 
1998b; Lakser et al., 2012). The lid displays deubiquitination activity (Glickman et al., 1998b; Verma 
et al., 2002; Yao & Cohen, 2002). All six PCI-domain-containing subunits can be found in the 19S 
RP lid. They have been suggested to display a solenoid structure consisting of several bihelical 
repeats upstream of the PCI domain, which has been shown for Rpn6 (Fukunaga et al., 2010; 
Lander et al., 2012; Lasker et al., 2012). All six subunits can be found in the same region of the 19S 
RP where they are arranged in a horseshoe-like manner (order: Rpn9/Rpn5/Rpn6/Rpn7/Rpn3/ 
Rpn12). The horseshoe covers a large part of the Rpt-ring and interacts with the Rpn8/Rpn11 dimer 
as well as Rpn2 and Rpn10 via its ends (Förster et al., 2010; Pathare et al., 2011; Lasker et al., 
2012). The PCI hexamer has been suggested to act as a scaffold for the AAA-ATPase ring, which is 
highly flexible in structure especially during the degradation process, as well as for Rpn11, which is 
held in position close to the opening of the AAA-ATPase ring (ref. Figure 1.5.2.1; Glynn et al., 2009; 
Smith et al., 2011; Lasker et al., 2012). Another function proposed for the PCI hexamer is that of a 
shield against the AAA-ATPases in order to prevent uncontrolled degradation (Smith et al., 2011; 
Lasker et al., 2012). 
In the 19S RP lid Rpn8 and Rpn11 form a heterodimer closely above the opening of the AAA-
ATPase ring (Lasker et al., 2012). Rpn11 displays deubiquitination activity, which can be attributed 
to the zinc-binding JAMM (JAB1/ MPN/Mov34 metalloenzyme) motif found within its MPN domain 
(Verma et al., 2002; Yao & Cohen, 2002). Rpn11 acts in an ATP-dependent manner and is only 
active when the 19S RP is fully assembled (Verma et al., 2002; Förster et al., 2010). The functions 
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of some of the other lid subunits are yet to be elucidated (Glickman et al., 1998b; Verma et al., 2002; 
Hanna & Finley, 20008; Lakser et al., 2012)  
The 19S RP assembly is highly elaborate process involving four chaperones: Nas2 (human: p27), 
Nas6 (human: gankyrin/p28), Rpn14 (Human PAAF1) and Hsm3 (human S5b), which all differ in 
structure and do not display distinct enzyme activity (Schultz et al., 1998, Verma et al., 2000; Park et 
al., 2005; Dawson et al., 2006; Letunic et al., 2009). It is very likely that chaperones involved in 19S 
RP assembly prevent premature interactions of the subunits, e.g. binding of Rpt subunits to the 20S 
CP (Kaneko et al., 2009; Roelofs et al., 2009; Saeki et al., 2009; Tomko & Hochstrasser, 2011). In 
concert with the 20S CP, acting as a scaffold during 19S RP assembly, chaperones might regulate 
20S CP-Rpt interaction (Park et al., 2009; Roelofs et al., 2009; Bedford et al., 2010). The role of the 
chaperones during this process requires further investigation, especially as there might be more than 
one pathway possible for 26S assembly (Hendil et al., 2009; Kaneko et al., 2009; Roelofs et al., 
2009; Saeki et al., 2009; Thompson et al., 2009).  
 
 
1.6 ER-ASSOCIATED DEGRADATION  
As misfolded secretory proteins are toxic it is essential for proper cellular function that these are 
recognized by the ERQC (ref. 1.3.2) and degraded by the UPS (ref. 1.5) (Kostova & Wolf, 2003; Aebi 
et al., 2010; Stolz & Wolf, 2010). ERAD, apart from vacuolar (lysosomal) degradation, is the major 
degradation pathway for secretory proteins (Hiller et al., 1996; Sommer & Wolf, 1997; Brodsky & 
McCracken, 1999). ERAD involves the recognition of misfolded proteins by the ERQC, their 
retrotranslocation into the cytosol, ubiquitination and degradation by the 26S proteasome (Hiller et 
al., 1996; Sommer & Wolf, 1997; Brodsky & McCracken, 1999). Through extensive studies, 
especially in yeast, a lot of components of ERAD have been identified (Pilon et al., 1997, 1998; 
Plemper et al., 1997, 1998, 1999a, 1999b; Römisch, 2005). In yeast there are three ERAD 
pathways, depending on the location of the lesion within the protein: ERAD-C (lesion in cytoplasmic 
domain), ERAD-L (lesion in luminal domain, either of soluble or membrane protein) and ERAD-M 
(lesion in membrane-spanning domain) (Vashist & Ng, 2004; Carvalho et al., 2006; Denic et al., 
2006). Either one of two multi-protein complexes, built around ER-resident E3 ligases, the Doa10p 
complex or Hrd1p/Der3p complex, are involved in the three pathways (ref. Figure 1.6.1; Deshaies & 
Joazeiro, 2009). Both ligases, Hrd1p and Doa10p, belong to the RING domain E3 ubiquitin ligases 
(ref. 1.5.1; Bordallo et al., 1998; Carvalho et al., 2006; Kreft et al., 2006; Deshaies & Joazeiro, 2009). 
The ERAD-C pathway is mediated by the Doa10p complex (Bordallo et al., 1998; Bays et al., 2001; 
Deak & Wolf, 2001). ERAD-C substrates are first recognized by the Hsp70/Hsp40 chaperones 
Ssa1p, Ydj1p and Hlj1p in the cytosol, followed by their degradation by the Doa10p complex (Bukau 
& Horwich, 1998; Zhang et al., 2001, Huyer et al., 2004b). Associated with the Doa10p complex are 
the E2 enzymes (ref. 1.5.1) Ubc7p and Ubc6p (Biederer et al., 1997; Hampton, 2002; Vashist & Ng, 
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2004). While Ubc6p is anchored to the ER membrane, Ubc7p is soluble and requires Cue1p as 
binding partner to recruit Ubc7p to the ER-membrane (Biederer et al., 1997). ERAD-C substrate 
ubiquitination is then mediated by the E3 ligase Doa10p (Vashist & Ng, 2004; Carvalho et al., 2006). 
Substrate ubiquitination of the ERAD-L and ERAD-M pathway is mediated by the Hrd1p ligase of the 
Hrd1p complex (Bays et al., 2001; Deak & Wolf, 2001). The ERAD-L pathway has been proposed to 
be less complex compared to ERAD-C (Carvalho et al., 2006; Willer et al., 2008; Eisele et al., 2010). 
ERAD-L substrates are recognized by ER Hsp70/Hsp40 chaperones Kar2p, Jem1p, Scj1p (Brodsky 
et al., 1999; Youker et al., 2004; Nishikawa et al., 2005; Eisele et al., 2010). Also involved in ERAD-L 
substrate recognition are Pdi1p, which also has chaperone-like activity, the lectin Yos9p as well as 
the ER-lumenal domain of the membrane-anchored protein Hrd3p (ref. 1.3.2.1; Plemper et al., 
1999a; Gardner et al., 2000; Clerc et al., 2009). Apart from interacting with ERAD substrates, Hrd3p 
is necessary to stabilize the E3 ligase Hrd1p (Gardner et al., 2000). Other components of the Hrd1p 
complex during ERAD-L are the E2 enzyme Ubc7p bound to Cue1p, and the membrane proteins 
Usa1p and Der1p (Biederer et al., 1997; Hampton, 2002; Vashist & Ng, 2004). Usa1p has been 
shown to be involved in the oligomerization of the Hrd1p complex and to mediate the link between 
Der1p and the complex (Carvalho et al., 2006; Denic et al., 2006). The precise role of Der1p is still 
unknown (Knop et al., 1996a; Hitt & Wolf, 2004; Horn et al., 2009). 
ERAD-M is less well understood than the other two pathways, but substrates of this pathway use the 
Hrd1p complex as well (Vembar & Brodsky, 2008; Ruggiano et al., 2014). No chaperone 
involvement in ERAD-M is known, which might be possible as misfolded proteins could be 
recognized directly by the E3 ligase in the ER membrane (Sato et al., 2009; Ruggiano et al., 2014). 
ERAD-M, however, shares most Hrd1p complex components with the ERAD-L pathway, apart from 
Usa1p and Der1p (Carvalho et al., 2006).  
The Cdc48p complex, consisting of Cdc48p, Npl4p and Ufd1p, acts in all three ERAD pathways 
(Rape et al., 2001; Braun et al., 2002; Rabinovich et al., 2002; Ye et al., 2001, 2003). The cofactor 
Ubx2p recruits the Cdc48p complex to the E3 ligases (Schuberth et al., 2004). For the Cdc48 
complex two roles have been proposed: as a segregase the Cdc48p complex recognizes and binds 
to ubiquitinated proteins at the ER membrane making them available for degradation by the 26S 
protasome by separating them from associated nonubiquitinated proteins (Rape et al., 2001; Braun 
et al., 2002). As a dislocase the Cdc48p complex has been proposed to extract ERAD substrates 
from the dislocon providing the energy required for the process (Ye et al., 2001, 2003). 
The central component of the Cdc48p complex is Cdc48p (yeast; mammals: p97) (Moir et al., 1982). 
Cdc48p, a member of the AAA-ATPase family, is essential in eukaryotes (Moir et al., 1982; Frohlich 
et al., 1991; Wolf & Stolz, 2011). While for Cdc48p a role has been described in protein degradation, 
it is also involved in many cellular processes such as homotypic membrane fusion, cell cycle, 
transcriptional regulation and cell death (Woodman, 2003; Jentsch & Rumpf, 2007; Braun & Zischka, 
2008; Meyer & Popp, 2008; Deichsel et al., 2009; Wilcox & Laney, 2009; Barbin et al., 2010). 
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Cdc48p is a homohexameric complex consisting of six protomers which are arranged around a 
central pore (Pye et al., 2006). Each protomer contains one flexible N-terminal domain, two 
conserved AAA domains (D1 and D2) and one disordered C-terminal domain (Pye et al., 2006). The 
AAA domains contain a Walker A and a Walker B motif each, which are necessary for nucleotide 
binding and hydrolysis, respectively (Briggs et al., 2008). Although the exact function of Cdc48p 
remains unclear it has been suggested that nucleotide binding and hydrolysis results in a 
conformational change in the complex, which might be required for Cdc48p’s function as a 
segregase (Dai & Li, 2001; Rape et al., 2001; Braun et al., 2002; Davies et al., 2008).  
Substrate-recruiting factors, which mainly bind to the N-terminal domain of Cdc48p, are thought to 
recognize Cdc48p substrates (Jentsch & Rumpf, 2007; Madsen et al., 2009; Buchberger, 2010). The 
N-terminal domain of Cdc48p binds ubiquitin, with a preference for polyubiquitin with a K48 linkage, 
but it also was found to be involved in ubiquitin-independent pathways (Krick et al., 2010). Cdc48p 
also associates with DUBs (deubiquitinating enzymes) such as Otu1, which (like Rpn11) mediate 
deubiquitination at the 26S proteasome (Rumpf & Jentsch, 2005). 
Experimentally, it is, however, complicated to distinguish between a function of the Cdc48p complex 
as a dislocase or a segregase (Rape et al., 2001; Braun et al., 2002; Ye et al., 2001, 2003). It is for 
instance not clear whether the substrates, which remain membrane-associated in Cdc48p complex 
mutants, are associated with the cytoplasmic face of the ER or reside in the ER lumen (Rape et al., 
2001). It is also not clear whether in vitro retrotranslocation assays, using permeabilized mammalian 
cells, indeed monitor extraction of the respective substrate from the ER membrane by Cdc48p and 
not its disaggregation on the cytoplasmic face of the ER by Cdc48p, as the half-life of the substrate 
is very short compared to the experimental conditions, complicating the interpretation of results 
(Wiertz et al., 1996a; Shamu et al., 1999; Ye et al., 2001, 2003).  
While Cdc48p has been suggested to bind to retrotranslocation intermediates in the dislocon, direct 
ERAD susbtrates to proteasomes and thus couple substrate extraction from the ER and degradation, 
the 19S RP proteasomal subunit is the only ERAD component for which an active role in ERAD 
substrate extraction has been demonstrated (Wiertz et al., 1996a; Glickman et al., 1998a; Rubin et 
al., 1998; Braun et al., 2002; Lee et al., 2004a; Verma et al., 2004). In S. cerevisiae the 19S RP is 
the only required cytosolic factor for the extraction of an ERAD-L substrate in vitro (ref. 1.5.2.2; Lee 
et al., 2004a). Also, an association of the 19S RP and Sec61p has been demonstrated (Kalies et al., 
2005; Ng et al., 2007). 
Extracted ERAD substrates are deglycosylated by the N-glycanase Png1p (Suzuki et al., 1998; 
Wang et al., 2009). Ufd2p (E4 ligase activity) is involved in polyubiquitination, while adaptor proteins 
Rad23p and Dsk2p (UBA-UBL domain containing proteins) recognize proteins and shuttle them to 
the 26S proteasome (Koegl et al., 1999; Funakoshi et al., 2002; Rao & Sasaki, 2002; Medicherla et 
al., 2004).  
It has been suggested that all three ERAD pathways exist in mammals as homologues to all yeast 
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ERAD components have been identified (Lilley & Ploegh, 2004; Ye et al., 2004; Carvalho et al., 
2006). There is also evidence that in mammalian cells additional pathways might operate since there 
are many more ER-resident E3 ligases (Carvahlo et al., 2006; Deshaies & Joazeiro, 2009). 
 
 
 
 
Figure 1.6.1. ERAD pathways in S. cerevisiae. (A) During ERAD-C membrane proteins with misfolded 
cytosolic regions are degraded via the Doa10p complex. Ubx2p, Cue1p, Ubc6p and Ubc7p as well as the 
Cdc48p/Npl4p/Ufd1p complex are further components during ERAD-C. Whether Sec61p forms the 
retrotranslocon during ERAD-C is still unclear. (B) Proteins with lumenal misfolded domains are degraded via 
the ERAD-L pathway. The Hrd1p/Hr3p complex formed by the Hrd1p E3 ligase and Hrd3p is the central 
component of ERAD-L. Also in the complex are Ubc7p and Cue1p as well as Der1p, Ubx2p and Usa1p. The 
lectin Yos9p interacts with Hrd3p and Kar2p (not shown) recruiting proteins destined for degradation by the 
Hrd1p/Hrd3p complex. Sec61p is believed to be part of the ERAD-L machinery. The Cdc48p/Npl4p/Ufd1p 
complex is also required for ERAD-L. Less is known about the ERAD-M pathway. Proteins with lesions within 
the membrane are degraded via this pathway,.which also conatins the Hrd1p/Hrd3p complex (adapted from 
Carvalho et al., 2006) 
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1.6.1. THE DISLOCON 
Since the components of the UPS are located in the cytosol, ERAD substrates need to be 
retrotranslocated from the ER into the cytosol through the so-called retrotranslocon (dislocon) prior 
to degradation (Jensen et al., 1995; Ward et al., 1995; McCracken & Brodsky, 1996; Wiertz et al., 
1996a). The nature of the retrotranslocon is still under debate, but several studies have suggested 
components of the protein import and ERAD machinery form the retrotranslocation channel (see 
below; Römisch, 2005; Nakatsukasa & Brodsky, 2008; Hampton & Sommer, 2012). 
One candidate for the retrotranslocon is Sec61p, the same protein forming the protein import 
channel in the ER membrane (Rapoport et al., 1996; Pilon et al., 1997, 1998; Johnson & Haigh, 
2000; van den Berg et al., 2004; Römisch, 2005; Rapoport, 2007). Employment of the same channel 
for protein import as well as for protein export not only would mean an economical solution for the 
cell, several genetic and biochemical studies have given strong evidence that Sec61p forms or is 
part of the retrotranslocon (Wiertz et al., 1996b; Pilon et al., 1997, 1998; Plemper et al., 1997; 
Johnson & van Waes, 1999, Wilkinson et al., 2000; Schäfer & Wolf, 2009). For Sec61p a switch from 
import to export mode has been suggested, the respective binding partner triggering this switch, 
however, have not been elucidated so far (Wiertz et al., 1996b; Johnson & Haigh, 2000). Further, 
due to the fact that Sec61p is encoded by an essential gene (SEC61) studies using a Δsec61 null 
mutant cannot be performed (Stirling et al., 1992). Moreover, the central role of Sec61p during the 
initial translocation of ERAD substrates into the ER (i.e. sec61 mutants defective in ERAD also 
display defects in protein import into the ER) complicates the analysis/interpretation of degradation 
kinetics (Rapoport et al., 1996; Pilon et al., 1997; 1998; Wilkinson et al., 2000). Nevertheless, due to 
the line of strong evidence a role of Sec61p during retrotranslocation cannot be denied at least for 
ERAD-L substrates (see below; Pilon et al., 1997, 1998; Römisch, 2005; Schäfer & Wolf, 2009). 
Early studies in mammalian cells have shown that the major histocompatibility complex (MHC) class 
I heavy chain (HC) is rapidly degraded in cells expressing the human cytomegalovirus (HCMV) 
protein US11, suggesting that degradation is triggered by the viral protein (Wiertz et al., 1996a). 
Another study from the same group demonstrated that the cytomegalovirus (CMV) protein US2 also 
triggers dislocation of MHC class I HC (Wiertz et al., 1996b). In mammalian cells infected with 
HCMV, a MHC class I HC degradation intermediate, in a complex with US2, was found to associate 
with the Sec61 complex prior to degradation suggesting that retrotranslocation was through the 
same channel that also mediates protein import into the ER (Rapoport et al., 1996; Wiertz et al., 
1996b). The two transmembrane ERAD substrates US2 and MHC class I HC were rapidly degraded 
in pulse-chase studies (Wiertz et al., 1996b). Upon addition of a proteasome inhibitor in those 
experiments, a degradation intermediate of MHC class I HC accumulated in the cells and could be 
coimmunoprecipitated with Sec61p (Wiertz et al., 1996b). The MHC class I HC degradation 
intermediate was also found to be associated with the proteasome, indicating that the Sec61 
complex and the proteasome are closely linked (Wiertz et al., 1996b). This study also demonstrated 
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that MHC class I HC are degraded even in normal cells when the protein fails to fold properly, i.e. 
upon the addition of DTT, and that unfolded HC reassociates with the Sec61 complex (Wiertz et al., 
1996b). 
Other early studies revealed that in wild-type cells not the whole Sec61p population is associated 
with the protein import machinery (Panzner et al., 1995; Plemper et al., 1997; Pilon et al., 1998). It 
was stated that 30-50 % of Sec61p, although associated with the trimeric Sec61 complex, are not 
involved in protein import (Panzner et al., 1995; Plemper et al., 1997). Thus, a recruitment of this 
Sec61p pool fraction to ERAD has been suggested (Panzner et al., 1995; Plemper et al., 1997; Pilon 
et al., 1998). 
Genetic and biochemical studies using sec61 mutants with mutation in TMD 3, TMD 4 and loop 7 of 
Sec16p, i.e. sec61-41, sec61-32 and sec61-3, respectively, showed defects in secretory precursor 
import as well as in the degradation of the soluble misfolded protein Δgpαf in a cell-free system 
using yeast microsomes (Stirling et al., 1992; Sommer & Jentsch, 1993; Pilon et al., 1997, 1998). 
Crosslinking experiments revealed that the fully translocated ERAD substrate Δgpαf was associated 
with Sec61p prior to export and released upon initiation of export in vitro, supporting data that 
suggest Sec61p as the retrotranslocon and at the same time excluding an indirect effect due to 
Sec61p’s role in import (Pilon et al., 1997). Also, these mutants were conditional for protein import 
into the ER but defective for export at all temperatures tested (Pilon et al., 1997). 
Pulse-chase studies monitoring the degradation of the ERAD substrates CPY* and Pdr5* (C1427Y), 
the mutant plasma membrane ATP-binding cassette (ABC) transporter, in a sec61-2 mutant 
demonstrated that retrotranslocation of the substrate was dependent on a functional Sec61p (Finger 
et al., 1993; Biederer et al., 1996; Plemper et al., 1997; 1998). The sec61-2 mutant is defective in 
the formation of retrotranslocons (Plemper et al., 1997, 1998). Further, it has been shown that 
another components of the import machinery, Sec63p, is involved in ERAD of CPY* (Servas & 
Römisch, 2013).  
In another genetic study by the same group, Sec61p was shown to functionally interact with Hrd3p, 
an ER membrane glycoprotein essential for ERAD, and the E3 ligase Hrd1p (Hampton et al., 1996; 
Bordallo et al., 1998; Plemper et al., 1999a). Initially, pulse-chase and cycloheximide-chase 
analyses in a Δhrd3 background revealed that the degradation of CPY* was slowed down and Hrd1p 
was rapidly degraded, respectively (Finger et al., 1993; Plemper et al., 1999a). It was therefore 
suggested that Hrd3p is needed for ERAD complex stability as in its absence Hrd1p is readily 
degraded via the UPS (Plemper et al., 1999a). Further, suppression of Hrd1p degradation was 
observed in a Δhrd3 sec61-2 double mutant supporting the idea that Sec61p is involved in 
retrotranslocation and degradation of Hrd1p (Plemper et al., 1997; 1999a). 
Crosslinking experiments using the export-deficient mutants sec61-32 and sec61-41 demonstrated 
that the misfolded secretory protein Δgpαf remained associated with PDI, a chaperone involved in 
ERQC (Gilbert, 1997; Gillece et al., 1999). At the same time, pdi1 mutants were deficient in export of 
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Δgpαf from yeast microsomes, indicating that PDI recognizes misfolded proteins and targets them to 
Sec61p (Gillece et al., 1999).  
Gillece and colleagues also could show that glycopeptide export requires Sec61p in a cell-free assay 
using yeast microsomes (Gillece et al., 2000). Employing a cell-free assay using yeast microsomes, 
glycopeptide export was inhibited when Sec61 channels were blocked with ribosomes (Gillece et al., 
2000). Moreover, specific sec61 alleles were defective in glycopeptide export. While mutants with 
strong import and ERAD defects for misfolded proteins, sec61-32 and sec61-41, were only 
moderately defective in glycopeptide export, in sec61 mutants, such as sec61-2 and sec61-8, that 
only show minor defects in ERAD of misfolded proteins, glycopeptide export was severely impaired 
(Pilon et al., 1997, 1998; Gillece et al., 2000). 
Experiments using mammalian microsomes saturated with RNC complexes, which block the Sec61 
channel, have shown that these membranes are incompetent for the retrotranslocation of amyloid 
beta-peptide and cholera toxin from the ER into the cytosol, further supporting a role of Sec61p 
(Sec61α) during ERAD (Schmitz et al., 2000; 2004). 
An involvement of Sec61p especially in ERAD-L has been shown in several studies (Huyer et al., 
2004b; Sato et al., 2006; Willer et al., 2008; Schäfer & Wolf, 2009). In a series of pulse-chase 
studies it was shown that while CPY* degradation was slowed down in the sec61-2 mutant, ERAD of 
Ste6p* (Q1249X), an integral membrane ERAD substrate depending on the E3 ligase Doa10p, was 
with wild-type kinetics (Huyer et al., 2004b). While ERAD of Ste6p* did not depend on Sec61p it 
seemd to require its homologue Ssh1p (Huyer et al., 2004b). ERAD of the mutant ABC transporter 
Pdr5*, which is structurally related to Ste6p*, however, depends on Sec61p (Plemper et al., 1998). It 
therefore has to be taken into account that these results might result from different strain 
backgrounds or expression levels of the substrates. Degradation of another transmembrane ERAD 
substrate, Hmg2p, in sec61-2 was with wild-type kinetics also suggesting that Sec61p is involved in 
ERAD-L rather than in the other ERAD pathways (Huyer et al., 2004b; Sato et al., 2006).  
Another study demonstrated that antigen processing and antigen presentation by MHC class I 
molecules in dendritic cells, which has as a prerequisite the access of antigens to the ER and 
subsequently transport to the cytosol where degradation occurs, was drastically decreased when 
Sec61α levels were reduced by RNAi (Imai et al., 2005). This finding strongly suggested that 
Sec61α is involved in retrotranslocation of antigens to the cytosol (Imai et al., 2005). 
Data from several studies also indicate that retrotranslocation and degradation by the proteasome 
act in concert, suggesting an association of Sec61p with the 26S proteasome (Wiertz et al., 1996b; 
Bordallo et al., 1998; de Virgilio et al., 1998; Mayer et al., 1998; Plemper et al., 1998; Ng et al., 
2007). Studies from our lab, in collaboration with Jeff Brodsky, have shown that in vitro the 19S RP 
is sufficient for export of Δgpαf (Lee et al., 2004b). Additional studies in collaboration with Kai Kalies 
have demonstrated direct binding of the 19S RP to the Sec61 channel and that proteasomes and 
ribosomes bind competitively to different sites on Sec61p (Lee et al., 2004b; Kalies et al., 2005; Ng 
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et al., 2007). Dependence of in vitro retrotranslocation of fluorescently labeled Δgpαf on ATP and the 
proteasome has also been demonstrated using mammalian microsomes (Wahlman et al., 2007). 
A switch in transport directionality of Sec61p has been suggested for the retrotranslocaion of 
misfolded ERAD substrates (Plemper et al., 1997, 1998, 1999a; Pilon et al., 1998; Romisch, 1999; 
Meusser et al., 2005). Such a change in transport directionality has also been suggested for the 
proteasomal degradation of apoliprotein B under ER stress, where the switch from import to export is 
triggered upon association with cytosolic chaperones (Pariyarath et al., 2001; Fisher and Ginsberg, 
2002; Oyadomari et al., 2006).  
Further evidence for Sec61p as a bi-directional translocation channel came form a study showing 
that Sec61p is required for ERAD of the two CPY* derivatives DPY* and OPY* and that degradation 
of those ERAD substrates is independent of import into the ER (Willer et al., 2008). This study 
employed the degradation-defective sec61-3 mutant. Cells of sec61-3 were loaded with the two 
ERAD-L substrates at the permissive temperature, at which protein import and export were 
comparable to the wild-type (Willer et al., 2008). ERAD was then monitored upon shifting the cells to 
17 °C (Willer et al., 2008). Defects in ERAD could thus not be attributed to any indirect effect due to 
disturbed import (Willer et al., 2008). 
In a more recent study in yeast, a physical contact between Sec61p and known ERAD components 
was investigated to support data from genetic and biochemical studies indicating interaction of 
Sec61p with those components (Hampton et al., 1996; Plemper et al., 1999a; Schäfer & Wolf, 2009). 
In order to circumvent the issues that coincide with the role of Sec61p as the biosynthetic translocon 
and to analyze only proteins that have been completely imported into the ER, immunoprecipitation 
experiments were performed with cells were treated with cycloheximide preventing the synthesis of 
new proteins (Schäfer & Wolf 2009). Sec61p could be immunoprecipitated with the Hrd1p-Der1p 
ligase complex (Schäfer & Wolf, 2009). Moreover, Sec61p was isolated with the ERAD-L substrate 
CPY* and it was further suggested that binding of CPY* to Sec61p is independent of the Hrd1p-
Der1p ligase complex (Schäfer & Wolf, 2009). 
Taken together, the data strongly suggest that Sec61p forms the dislocon or is at least part of the 
retrotanslocation channel. Several other studies, however, argue that Sec61p cannot be the 
retrotranslocon for all ERAD substrates, which is supported by studies that show an involvement in 
ERAD-L only (Huyer et al., 2004b; Sato et al., 2006; Willer et al., 2008; Schäfer & Wolf, 2009). 
While fluorescence quenching experiments have proposed that the ribosome-engaged translocon 
has a pore diameter of 40-60 Å, the crystal structure of the archaeal Sec61 complex homologue 
SecYEG has indicated a diameter of 10-12 Å (Hamman et al., 1997; van den Berg et al., 2004; 
Osborne & Rapoport, 2007). Due to the latter finding some groups argue that the retrotranslocon 
would be too small to accommodate ERAD substrates (Fiebiger et al., 2002; Tirosh et al., 2003; 
Lilley & Ploegh, 2004). The crystal structure, however, does not provide data on flexibility of the 
translocon (Hamman et al., 1997; Johnson & van Waes, 1999; Wirth et al., 2003). 
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Although some studies suggest Ssh1p as an alternative retrotranslocon, data are inconclusive 
(Wilkinson et al., 2001; Huyer et al., 2004b). In yeast, Ssh1p is not required for export of 
glycopeptides and CPY*, at least in thie strain background used (Gillece et al., 2000; Plemper et al., 
1997). 
Data from in vitro studies have demonstrated that sbh1 and sbh2 mutants, which are not essential in 
yeast, are defective for import when both are deleted only at high temperature (Finke et al., 1996). 
Export in a cell-free system has shown that sbh1 sbh2 mutants are competent for ERAD (Römisch, 
2005, unpublished data). Deletion of SBH1 and SBH2 did not affect CPY* steady-state levels 
(Plemper et al., 1997). 
Doa10p and Hrd1p are ER membrane resident E3 ligases involved in ERAD (ref. 1.5.1; Vashist & 
Ng, 2004; Carvalho et al., 2006). Doa10p has 6 TMDs and is responsible for degradation of ERAD-C 
substrates (Bays et al., 2001; Swanson et al., 2001; Kreft et al., 2006). Hrd1p has 4 TMDs and is 
involved in degradation of ERAD-L and ERAD-M substrates (Hampton et al., 1996; Deak & Wolf, 
2001). Especially for Hrd1p a role as the dislocon has been proposed due to the large number of 
hydrophilic residues in its transmembrane domains, leading to the idea that the E3 ligase, apart from 
its ubiquitination function, might be able to recognize mislocalized TMDs by their hydrophilic amino 
acids (Sato et al., 2009). Also, interaction of multiple Hrd1p molecules, mediated by Usa1p, has 
been demonstrated, leading to the idea that a channel could be formed, which would be sufficient for 
retrotranslocation of ERAD substrates (Hom et al., 2009). Pore formation, however, has not been 
demonstrated so far. Other studies have demonstrated that Hrd1p is sufficient for mediation of 
ERAD even in the absence of other ERAD components, such as Der1p, Hrd3p and Usa1p (Gardner 
et al., 2000; Sato et al., 2009; Carvalho et al., 2010). These studies, however do not rule out a role of 
Sec61p by the use of e.g. ERAD-deficient sec61 mutants (Gardner et al., 2000; Carvalho et al., 
2010; Sato et al., 2009). Crosslinking experiments using Hrd1p, which was modified with 
photocrosslinking residues at various positions in the protein, and a derivative of the ERAD-L 
substrate CPY*, have shown that the substrate contacts the E3 ligase at specific residues located in 
the ER membrane which was interpreted as retrotranslocation of the ERAD substrate through a 
channel formed by Hrd1p (Carvalho et al., 2010; Stanley et al., 2011). As ERAD substrate 
ubiquitination is a prerequisite for proteasomal degradation of many substrates one would, however, 
expect an interaction of the E3 ligase with ERAD substrates. Thus, the above study could “merely” 
be another indication for the mediation of substrate recognition by the transmembrane region of 
Hrd1p (Sato et al., 2009; Carvalho et al., 2010). An earlier study investigated the role of Hrd1p as 
the retrotranslocation channel using the Hmg1p-Hrd1p (fusion of RING-H2 domain of Hrd1p and 
HMGR (TMD of Hmg1 isozyme of yeast)) fusion protein which self-ubiquitinates independently of 
Hrd1p and undergoes proteasomal degradation (Garza et al., 2009). In vitro retrotranslocation of the 
Hmg1p-Hrd1p fusion protein was shown even in microsomes derived from a Δhrd1 null strain (Garza 
et al., 2009). Further, cycloheximide chases demonstrated that the fusion protein was rapidly 
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degraded in a Δhrd1 null mutant as well as in a Δhrd1 Δdoa10 double mutant questioning a role of 
both E3 ligases as the retrotranslocation channel (Garza et al., 2009). 
Der1p (yeast), a protein in the ER membrane with four TMDs, has been suggested as another 
retrotranslocon candidate (Knop et al., 1996a; Wahlman et al., 2007). Yeast Der1p, the first protein 
found to be required for ERAD of soluble substrates CPY* and PrA*, has since been demonstrated 
to act during ERAD-L (Knop et al., 1996a; Taxis et al., 2003; Hitt & Wolf, 2004). In yeast, a Δder1 
null mutant displays more or less severe defects in the degradation of various ERAD-L substrates, 
suggesting a central role of Der1p during the degradation of misfolded soluble proteins (Hill & 
Cooper, 2000; Walter et al., 2001; Taxis et al., 2003; Vashist & Ng, 2004; Willer et al., 2008). ERAD-
M substrates do not seem to require Der1p for degradation, as seen in a study using Hmg2p, ERAD 
of which does not require Der1p, it homologue Dfm1p or even Sec61p (Sato et al., 2006; Garza et 
al., 2009). Further, due to its composition of four TMDs it cannot form the retrotranslocation channel 
alone (Knop et al., 1996a; Hitt & Wolf, 2004). Der1p, however, has been shown to form 
homooligomers, which might be sufficient to form the retrotranslocation channel, but the fact that 
Der1p is not required for ERAD of all substrate also suggests that Der1p cannot be the only 
retrotranslocation channel (Knop et al., 1996a; Vashist & Ng, 2004; Ye et al., 2004, 2005). Its 
important role during ERAD-L is also demonstrated by the fact that in Δder1 cells ER stress is 
increased leading to the induction of the UPR, during which Der1p itself is strongly up-regulated 
(Knop et al., 1996; Travers et al., 2000; Ye et al., 2004). In a more recent study Der1p could be 
crosslinked to ERAD substrates as well as to the substrate receptor Hrd3p suggesting that it plays a 
role in the initiation of protein export from the ER by threading substrates into the ER membrane and 
directing them to Hrd1p (Mehnert et al., 2014). For the mammalian homoloque Derlin-1, one of three 
homologues in mammals (Derlin-1, Derlin-2 and Derlin-3), a central role during ERAD has also been 
demonstrated. Studies in mammalian cells suggest that Derlin-1 rather than Sec61p forms the 
retrotranslocation channel (Lilley & Ploegh, 2004; Ye et al., 2004). In cells expressing the CMV 
protein US11, the degradation of a MHC class I HC retrotranslocation intermediate is triggered by 
the viral protein, and US11 also recruits MHC class I HC to DERLIN-1 (Lilley & Ploegh, 2004). For a 
mutant form of US11, rendering the protein capable of complex formation with MHC class I HC, 
retrotranslocation is disturbed (Lilley & Ploegh, 2004). As wild-type (US11WT-HC) but not mutant 
MHC class I HC-US11 (US11Q192L-HC) complexes contained Derlin-1, it was suggested that 
dislocation requires Derlin-1 (Lilley & Ploegh, 2004). A dominant-negative version of Derlin-1 (Derlin-
1GFP) further revealed that Derlin-1 interferes with US11-mediated MHC class I dislocation (Lilley & 
Ploegh, 2004). The authors favour Derlin-1 as part of the retrotranslocon and at the same time 
question Sec61p as the export channel, as, to them, the diameter of the SecY (∼ 15-20 Å) complex 
is not sufficient enough to mediate dislocation especially of more complex substrates (Lilley & 
Ploegh, 2004; van den Berg et al., 2004). Ye and colleagues demonstrated in a similar study using 
canine microsomes that the AAA-ATPase p97 associates with Derlin-1 and VCP-interacting 
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membrane protein (VIMP). RNAi studies in the nematode C. elegans have shown that depletion of 
Derlin-1 results in ER stress (Ye et al., 2004). This is in concordance with studies in yeast, which 
have shown that the UPR is induced in the absence of Der1p (Knop et al., 1996a). 
It has been indicated that Derlins are involved in the dislocation of cholera toxin from the ER into the 
cytosol and in the liberation of polyomavirus-encoded proteins from the ER, further implicating that 
the role of the Derlins is multifaceted (Lilley et al., 2006; Bernardi et al., 2007). 
An involvement of Derlin-1 in ERAD has been further suggested in various studies in which the 
protein could be coimmunoprecipitated with ERAD components, such as HRD1 and p97, as well as 
with ERAD substrates (Katiyar et al., 2005; Schulze et al., 2005; Lilley & Ploegh, 2005; Ye et al., 
2005; Younger et al., 2006; Okuda-Shimizu & Hendershot, 2007). 
In a more recent study, Derlin-1 and not Sec61α, was implicated as the putative dislocon (Wahlman 
et al., 2007). Here, fluorescently labeled Δgpαf (Δgpαf-BOF) was retrotranslocated in a cell-free 
assay using canine microsomes and mammalian cytosol (Wahlman et al., 2007). This study 
demonstrated that in the presence of the irreversible proteasome inhibitor lactacystine 
retrotranslocation did not occur, showing that the proteasome is required for retrotranslocation 
(Wahlman et al., 2007). In this study blocking the translocation pore by adding RNCs or antibodies 
against Sec61α (αSec61α) did not affect retrotranslocation of the fluorescently labeled ERAD 
substrates, while antibodies against Derlin-1 drastically reduced retrotranslocation, questioning the 
idea of ERAD substrate retrotranslocation through the protein conducting channel (Crowley et al., 
1994; Hamman et al., 1998; Gillece et al., 2000; Schmitz et al., 2000; Wahlman et al., 2007). The 
authors did, however, not show that the Sec61α-antibodies were able to block ribosome binding to 
the microsomes, or that their epitope was accessible in intact microsomes (Wahlman et al., 2007). 
Photocosslinking of Δgpαf to Derlin-1 but not to Sec61α was also demonstrated, but export 
substrates were not stalled (Wahlman et al., 2007). 
Channel formation of Der1p is unlikely due its structure and further has not been shown so far (Hitt & 
Wolf, 2004). It has been suggested, however, that it might form a part of the retrotranslocation 
channel (Lilley & Ploegh, 2004; Ye et al., 2004, Hampton & Sommer, 2012). Data, which could 
demonstrate this, are still missing.  
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1.7 AIM OF THIS STUDY 
The aim of this study was to get a deeper insight into the role of the Sec61 channel during ERAD. 
More specifically, I tried to elucidate which domain(s) of Sec61p (yeast; Sec61α in mammals), the 
pore-forming component of the Sec61 complex, mediate(s) the interaction between the 19S RP of 
the 26S proteasome and the protein translocation channel and whether a disturbed Sec61p-19S RP 
interaction leads to defects in ERAD (Andrews & Johnson, 1996; Hanein et al., 1996; Wiertz et al., 
1996b; Pilon et al., 1997). 
In a previous study, two sec61 mutants, sec61-302 (D168G, S179P, F263L, S353C) and sec61-303 
(D168G, F263L), sharing two of the same point mutations, were isolated which both displayed 
defective cotranslational import into the ER (Ng et al., 2007). In a binding assay using 19S RP and 
reconstituted proteoliposomes derived from ER membranes of each mutant, however, only sec61-
302 displayed a reduction in proteasome affinity (Ng et al., 2007). These results suggested that one 
of the two point mutations in sec61-302, S179P and/or S353C, which do not occur in sec61-303 was 
responsible for the observed reduction in proteasome binding (Ng et al., 2007). 
My initial aim was to generate sec61 mutants which contained the amino acid substitution S179P, 
S353C or both and to elucidate which of the two point mutations mediate the observed defect in 
proteasome binding (Ng et al., 2007). In addition, I wanted to investigate ERAD defects using 
specific substrates, UPR induction and synthetic effects with Δire1.  
The purpose of my work was to further understand the role of Sec61p and 19S RP during misfolded 
protein dislocation from the ER. 
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2 MATERIALS AND METHODS 
 
2.1 MATERIALS AND GENERAL PROCEDURES 
 
2.1.1 LABORATORY EQUIPMENT, REAGENTS, CHEMICALS AND THEIR SUPPLIERS 
Laboratory equipment used in this study is listed in Table 2.1. Reagents, chemicals and 
consumables are listed in Table 2.2. 
 
Table 2.1. Laboratory equipment used in this study. 
Company Products 
Beckman Coulter Inc. Optima™ MAX-XP Benchtop Ultracentrifuge 
Optima™ L-90 K Ultracentrifuge 
Adapter for Microfuge® Tubes 1.5 ml 
Bio-Rad Laboratories Inc. PowerPac™ HC Power Supply 
Trans-Blot® Electrophoretic Transfer Cell (with plate 
electrodes and super cooling coil) 
Model 583 Gel Dryer (with vacuum pump) 
ChemiDoc™ XRS 
Image Lab™ Software 
MicroPulser™ Electroporator 
Bio Spec Products Inc. Mini-Beadbeater-24 
Carl Roth® GmbH & Co. KG Hemocytometer Neubauer Improved 
Cawo Solutions CAWOMAT 2000 IR (X-ray film processor) 
Eppendorf AG Concentrator Plus (vacuum concentrator, evaporator) 
Thermomixer® Comfort (24 x 1.5 ml) 
MiniSpin® Centrifuge 
Microcentrifuge 5415R  
GE Healthcare Typhoon™ Trio Variable Mode Imager (Phosphorimager) 
Storage Phosphor Screens (with exposure cassettes) 
Ultrospec 2100 pro UV/Visible Spectrophotometer 
(Amersham Biosciences) 
Amersham Hypercassette Autoradiography Cassettes 
ImageQuant™ TL Software 
Hamilton Beach® Brands Inc. Rio™ Commercial Bar Blender (stainless steel blender) 
Hellma® Analytics  Quartz Glass Cuvettes (QS; pathlength: 10 mm) 
IKA®-Werke GmbH & Co. KG RH basic2 IKAMAG® 
EUROSTAR Power Basic (laboratory overhead stirrer) 
Infors AG Multitron Standard Incubation Shaker 
Invitrogen™ (Life Technologies part of Thermo 
Fisher Scientific Inc.) 
XCell SureLock™ Mini-Cell (Novex®) 
KGW Isotherm Dewar Carrying Flask 4 L 
Leica Microsystems Microscope 
Merck Millipore (part of Merck KGaA) Milli-Q® Integral Water Purification System 
neoLab® Migge Laborbedarf.Vertrieb s GmbH Overhead Rotator (20 tubes) 
neoLab-Rocking Shaker 
PEQLAB Biotechnologie GmbH (part of VWR) E-Box VX2 Gel Documentation System 
peqSTAR 2 X Gradient Thermocycler 
PerfectBlue Gel System Mini S/M 
Scientific Industries Inc. Vortex-Genie® 2 
Sigma Laborzentrifugen GmbH SIGMA 4K15 Refrigerated Centrifuge 
Thermo Scientific (Thermo Fisher Scientific 
Inc.) 
Sorvall Evolution® RC Centrifuge 
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Wheaton® Potter-Elvehjem Style Tissue Grinder with PTFE Pestle, 55 
ml 
 
Table 2.2. Chemicals, reagents and consumables used in this study. 
Company Products 
AGFA HealthCare GmbH Agfa Developer G153 
Agfa Fixer G354 
Applichem GmbH Ampicillin Sodium Salt (BioChemica) 
DEPC (BioChemica) 
Kanamycin Sulfate (BioChemica) 
Tunicamycin 
HEPES – Sodium Salt 
Sodium Chloride 
Magnesium Chloride 
Sodium Acetate 
Magnesium Acetate 
Ammonium Acetate 
Avanti® Polar Lipids, Inc L-α-Phosphatidylcholine (Liver, Bovine), Chloroform 
L-α-Phosphatidylethanolamine (Liver, Bovine), Chloroform 
BD (Becton, Dickinson & Company) Bacto™ Casamino Acids 
Bacto™ Peptone 
Bacto™ Yeast Extract 
Difco™ Yeast Nitrogen Base without Amino Acids & 
Ammonium Sulfate 
Difco™ Yeast Nitrogen Base without Amino Acids 
Beckman Coulter GmbH Polycarbonate Bottles, thick-walled, 70 ml (rotor type 45 Ti) 
Polyallomer Tubes, thin-walled, 4.4 ml (rotor type SW 60 
Ti) 
Polycarbonate Tubes, thick-walled, 1.0/1.4 ml (TLS-55) 
Polycarbonate Tubes, thick-walled, 3.0/3.5 ml (TLA-100.3) 
Microfuge® Tubes, Polyallomer, 1.5 ml 
Bioline (part of Meridian Life Science® 
Company) 
Alpha-Select Silver Efficiency (chemically competent cells) 
Quick-Stick Ligase 
Bio-Rad Laboratories Inc. Nitrocellulose Membrane (0.2 µM, 0.45 µM pore size) 
Bio-Beads®
 
SM Adsorbents 
Precision Plus Protein™ All Blue Standards 
Electroporation Cuvettes, 0.2 µm gap 
Biozym Scientific GmbH Fast-Link™ DNA Ligation Kit (Epicentre®) 
Carl Roth® GmbH & Co. KG PMSF (≥99 %) 
Roti®-Aqua-Phenol (RNA extraction) 
Rotiphorese® Gel 30 (37,5:1) 
β-Mercaptoethanol (99 %, p.a.) 
TEMED (99 %, p.a.) 
Roti®-Phenol/Chloroform/Isoamyl-Alcohol (Nucleic acid 
extraction) 
Peptone (from Casein) 
Yeast Extract 
Glycine (PUFFERAN®, ≥99 %, p.a.) 
Agar-Agar, Kobe I 
Ammonium Peroxydisulfate (≥98 %, p.a.)  
SDS Pellets (≥99 %) 
RNase AWAY® 
Glycerol (≥98 %) 
Triton X 100, pure 
2-Nitrophenyl-β-D-Galactopyranoside 
Fermentas (part of Thermo Fisher Scientific 
Inc.) 
Conventional and FastDigest® Restriction Enzymes 
T4 DNA Ligase 
FastAP™ Thermosensitive Alkaline Phosphatase 
GeneRuler™ 1 kb DNA Ladder 
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GeneRuler™ 1 kb Plus DNA Ladder 
PageRuler™ Prestained Protein Ladder 
PageRuler™ Plus Prestained Protein Ladder 
ATP, 100 mm Solution 
GTP, 100 mM Solution 
RNase A, DNase and Protease-free (10 mg/ml) 
5-Fluoroorotic Acid  
Formedium™ Synthetic Complete Drop-Out Mixture, (SC) (-Ade, -His, -
Leu, -Lys, -Trp, -Ura), (Kaiser Mixture) 
FujiFilm Medical X-ray Film (Super HR-E30) 
GE Healthcare Life Sciences (part of GE 
Healthcare) 
Protein A Sepharose™ CL-4B  
Disposable PD-10 Desalting Columns (empty) 
Invitrogen™ (Life Technologies part of Thermo 
Fisher Scientific Inc.) 
TOPO® TA Cloning® Kit for Sub-cloning  
NuPAGE® Novex® 4-12 % Bis-Tris Gel 1.5 mm, 10 Well 
(Novex®) 
NuPAGE® MOPS SDS Running Buffer (20X) (Novex®) 
UltraPure™ Agarose  
Merck Millipore (part of Merck KGaA) AEBSF, Hydrochloride (Calbiochem®) 
Cycloheximide (Calbiochem®) 
MF-Millipore™ Membrane Filters (0.025 µm pore size, 
Microdialysis of DNA) 
Centricon® YM-100 Centrifugal Filter Devices 
New England BioLabs® (NEB) GmbH  Micrococcal Nuclease, 2000000 gel units/ ml 
Conventional Restriction Enzymes 
PEQLAB Biotechnologie GmbH (part of VWR) KAPA HiFi™ PCR Kit 
Electroporation Cuvettes (#71-2020) 
Perkin Elmer Inc. EXPRE35S35S Protein Labeling Mix, [35S]-, 50mM Tricine 
(pH 7.4), 10 mM 2-Mercaptoethanol 
L-[35S]-Methionine (Activity > 1000 Ci) 
[Methyl-14C] Methylated Protein Molecular Weight Marker  
Promega GmbH Recombinant RNasin® Ribonuclease Inhibitor 
SP6 RNA Polymerase 
Ribo m7G Cap Analog 
rATP, rCTP, rUTP, rGTP, 100 mM 
Roche Life Science (Roche Diagnostics) Complete™, Mini, EDTA-free Protease Inhibitor Cocktail 
Tablets  
Creatine Phosphate, > 97 % 
Rockland™ Immunochemicals Inc. Anti-HA Antibody (Biomol) 
Sartorius AG Minisart® Plus Syringe Filters (0.2, 0.45 µm pore size) 
Sigma-Aldrich® Co. LLC. Adenine (≥99 %) (Sigma) 
L-Cysteine (≥98 %) (Sigma) 
L-Histidine (Sigma) 
Uracil (≥99 %) (Sigma) 
L-Leucine (≥98.5 %) (Sigma) 
L-Tryptophan (≥98 %) (Sigma) 
L-Methionine (≥99 %) (Sigma) 
L-Cysteine (≥99 %) (Sigma) 
ANTI-FLAG® M2 Affinity Agarose Gel (Sigma) 
ANTI-FLAG® Antibody, produced in rabbit (Sigma) 
FLAG® Peptide, lyophilized powder (Sigma) 
DL-Dithiothreitol, BioUltra, ≥99.0 % (Sigma) 
Sucrose BioXtra, ≥99.5 % (Sigma) 
Tryptone, enzymatic digest from casein (Fluka) 
D-(+)-Glucose (≥99.5 %) (Sigma) 
Deoxyribonucleic Acid Sodium Salt, from salmon testes 
(Sigma) 
Absolute Ethanol 
ACS Reagent, ≥99.5 % (Sigma-Aldrich) 
Bromophenol Blue Sodium Salt (Sigma) 
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Trizma® Base, BioUltra, for molecular biology, ≥99.8 % 
(Sigma) 
Urea (Sigma) 
MES, low moisture content, ≥99 % (Sigma) 
Sodium Azide, BioUltra, ≥99.5 % 
Tween® 29 (Sigma) 
DMSO 
Glass Beads, acid-washed 425-600 μm (Sigma) 
EDTA, anhydrous, ≥99 % (Sigma-Aldrich) 
EGTA (≥97 %) (Sigma) 
Lithium Acetate Dihydrate, BioXtra (Sigma) 
Polyethylene Glycol, BioXtra, average mol wt 3,350 
(Sigma-Aldrich) 
D-(+)-Galactose (≥99 %) (Sigma-Aldrich) 
D-(+)-Raffinose Pentahydrate (≥98 %) (Sigma) 
Sodium Chloride, for molecular biology (≥98 %) 
GenElute™ PCR Clean-Up Kit (Sigma) 
GenElute™ HP Plasmid Maxiprep Kit (Sigma) 
GenElute™ Gel Extraction Kit (Sigma) 
Puromycin Dihydrochloride (10 mg/ml) (Sigma) 
Corning® Cryogenic Vials, internal thread (2.0 mL) 
Creatine Phosphokinase, from rabbit muscle 
Sucofin Skimmed Milk Powder 
Thermo Fisher Scientific Inc. Pierce 660 nm Protein Assay Reagent 
SuperSignal West Dura Extended Duration 
Chemiluminescent Substrate (ECL) 
Filter Units – 115/250/500 ml capacity, MF75™ Series, 0.45 
µm pore size 
DMSO  
MS(PEG8) (Methyl-PEG-NHS-Ester reagent) (Pierce) 
VWR® International Essigsäure 99 % GPR RECTAPUR® 
Ethanol Absolut AnalaR NORMAPUR® 
ZChL * All other chemicals not mentioned above but mentioned 
in the respective sections of this chapter 
 
  
2.1.2 BACTERIAL AND S. CEREVISIAE STRAINS 
Origin and genotype for bacterial and S. cerevisiae strains are listed in Tables 2.3 and 2.4 
respectively.  
 
Table 2.3. E. coli strains used in this study. 
Strain Genotype Source 
DH5α F- endA1 glnV44 thi-1 recA1 relA1 gyrA96 deoR 
nupG Φ80dlacZΔM15 Δ(lacZYA-argF)U169, 
hsdR17(rK- mK+), λ– 
Hanahan, 1983 
Top10 F- mcrA Δ(mrr-hsdRMS-mcrBC) φ80lacZΔM15 
ΔlacX74 nupG recA1 araD139 Δ(ara-leu)7697 
galE15 galK16 rpsL(StrR) endA1 λ- 
Invitrogen® 
Alpha-Select 
Silver 
Efficiency 
Competent 
Cells 
F- deoR endA1 recA1 relA1 gyrA96 hsdR17(rk-, 
mk+) supE44 thi-1 phoA Δ(lacZYA-argF)U169 
Φ80lacZΔM15 λ- 
Bioline 
KRB3 Lyticase expressing E. coli 
(in DH5α) 
Shen et al., 1991 
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KRB38 pDJ100  
(ppαf cloned into pSP65, behind SP6 promoter) 
(in HB101) 
R. Schekman 
Hansen et al., 1986 
KRB41 pαF3Q (pΔgpαf in MC1600) Mayinger & Meyer et al., 1993 
KRB257 pGEM2αF Mayinger & Meyer et al., 1993 
KRB319 pDN431 (CPY*HA; URA3) Ng et al., 2000 
KRB351 p416 pΔgpαf 
(in DH5α) 
Mumberg et al., 1994 
KRB356 pBW11 (SEC61 WT in pRS315) Stirling et al., 1992 
KRB733 pJC30  
(UPRE-LacZ reporter construct; pRS314 
backbone) 
D. Ng 
KRB734 pJC31  
(CYC1 TATA box fused to LacZ 
control for KRB733; pRS314 backbone) 
D. Ng 
KRB842 pRS315 in DH5α M. Schmitt 
Sikorski & Hieter, 1989 
KRB855 pRS313-CPY-URA3 Ng et al., 1996 
KRB856 pRS313-PHO8-URA3 
(in DH5α) 
Ng et al., 1996 
KRB857 pRS313 
(in DH5α) 
J. Brown 
Sikorski & Hieter, 1989 
KRB862 pRS315-sec61-S179P 
(in DH5α) 
This study 
KRB863 pRS315-sec61-S353C 
(in DH5α) 
This study 
KRB864 pRS315-sec61-S179P/S353C 
(in DH5α) 
This study 
KRB865 pRS306-truncsec61-S179P 
(in DH5α) 
This study 
KRB866 pRS306-truncsec61-S353C 
(in DH5α) 
This study 
KRB867 pRS306-truncsec61-S179P/S353C 
(in DH5α) 
This study 
KRB882 pSM70 
KHN-HA (URA3) 
D. Ng 
Vashist et al., 2001 
Vashist et al., 2004 
KRB883 pSM101 
KWW-HA (URA3) 
D. Ng 
Vashist & Ng, 2004 
KRB884 pSM1083 
ste6-166-HA (URA3) 
D. Ng (S. Michaelis) 
Vashist et al., 2004 
Loayza et al., 1998 
KRB899 pRS306-truncsec61-302 
(in DH5α) 
This study 
KRB900 pRS306-truncsec61-303 
(in DH5α) 
This study 
 
 
 
 
 
 
 
2 MATERIALS AND METHODS 
 
	   71	  
Table 2.4. S. cerevisiae strains used in this study*. 
Name Genotype Use Source/Reference 
KRY40/ 
GPY60 
MATα leu2-3,112 ura3-52 his4-579 
trp1-289 prb1 pep4::URA3 gal2 
Translation extract  Baker et al., 1988 
KRY47 MATα leu2-3,112 ura3-52 WT strain (micro-
some preparation, 
integration of trun-
cated sec61 genes 
into genome 
Pilon et al. 1997 
KRY92 ade2-1 ura3-1 his3-11,15 leu2-3,112 
trp1-1 can1-100 
DER1 (W303-1B) Knop et al., 1996 
(Dieter Wolf) 
KRY93 ade2-1 ura3-1 his3-11,15 leu2-3,112 
trp1-1 can1-100 
Δder1 
Δder1 (W303-1B 
Δder1) 
Knop et al., 1996 
(Dieter Wolf) 
KRY159 MATa leu2-3, 112 his3-11,15 trp1-1 
ura3-1 ade2-1 can1-100 
leu2-3,112::LEU+UPRE-lacZ MET+ 
IRE1 Sidrauski/Peter Walter 
Shamu & Walter, 1996 
KRY160 MATa eu2-3,112 his3-11,15 trp1-1 
ura3-1 ade2-1 can1-100 leu2-
3,112::LEU+ UPRE-lacZ MET+ 
ire1::TRP1 pRS304 (entire Ire1p 
coding sequence deleted) 
Δire1 Sidrauski/Peter Walter 
Shamu & Walter, 1996 
KRY161 MATα ade2-1 ura3-1 his3-11,15 leu2-
3,112 trp1-1 can1-100 prc1- 
W303-1C D. Wolf 
Knop et al., 1996 
KRY200 MATα can1-100 leu2-3,112 his3-
11,15 trp1-1 ura3-1 ade2-1 
sec61::HIS3 
[pDQ sec61-32] 
sec61-32 R. Schekman 
Pilon et al., 1998 
KRY201 MATα can1-100 leu2-3,112 his3-
11,15 trp1-1 ura3-1 ade2-1 
sec61::HIS3 
pDQ1[sec61-41] 
sec61-41 R. Schekman 
Pilon et al., 1998 
KRY221 MATα sec61-3 trp1-1 leu2-3,112 
ura3-52 
sec61-3 C. Stirling 
KRY275 leu2-3,112 ura3 his3-11,15 Cytosol preparation Hiller et al. 1996 
KRY333 his3Δ200 leu2-3.112 lya2-801 
trp1Δ63 ura3-52 
RPT1FH::YIplac211(URA3) 
26S, 19S RP 
preparation 
Verma et al., 2000 
KRY461 MATα sec61::HIS3 leu2 trp1 prc1-1 
his3 ura3 [pGAL-SEC61-URA3] 
pGAL-SEC61 
cross of RSY764 with 
W303-1C 
KB Römisch 
(Römisch Lab) 
KRY706 BMA38a, kanr-pGAL-SEC61, his3-
Δ200 leu2-3.112 trp1-Δ1 ura3-1 
ade2-1 can1-100 [pRS313-
SEC61(HIS-CEN)] 
SEC61 Ng et al., 2006 
KRY712 BMA38a, kanr-pGAL-SEC61, his3-
Δ200 leu2-3.112 trp1-Δ1 ura3-1 
ade2-1 can1-100 [pCEN-LEU-sec61-
D168G/ S179P/F263L/S353C] 
[pRS313 (HIS-CEN)] 
sec61-302 Ng et al., 2006 
KRY715 BMA38a, kanr-pGAL-SEC61, his3-
Δ200 leu2-3.112 trp1-Δ1 ura3-1 
ade2-1 can1-100 [pCEN-LEU-sec61-
D168G, F163L] [pRS313 (HIS-CEN)] 
sec61-303 Ng et al., 2006  
KRY849 BMA38a, kanr-pGAL-SEC61, his3-
Δ200 leu2-3.112 trp1-Δ1 ura3-1 
ade2-1 can1-100 [pCEN-LEU-sec61-
S179P]  
sec61-S179P  
(transformation of 
KRB862 into KRY858) 
This study 
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KRY850 BMA38a, kanr-pGAL-SEC61, his3-
Δ200 leu2-3.112 trp1-Δ1 ura3-1 
ade2-1 can1-100 [pCEN-LEU-sec61-
S353C]  
sec61-S353C 
(transformation of 
KRB863 into KRY858) 
This study 
KRY851 BMA38a, kanr-pGAL-SEC61, his3-
Δ200 leu2-3.112 trp1-Δ1 ura3-1 
ade2-1 can1-100 [pCEN-LEU-sec61-
S179P/S353C]  
sec61-S179P/S353C 
(transformation of 
KRB864 into KRY858) 
This study 
KRY852 MATα leu2-3,112 ura3-52 
[pRS306-truncsec61-S179P] 
Truncated version of 
sec61-S179P 
(KRB865) integrated 
into KRY47 (for in 
vitro studies) 
This study 
KRY853 MATα leu2-3,112 ura3-52 
[pRS306-truncsec61-S353C] 
Truncated version of 
sec61-S353C 
(KRB866) integrated 
into KRY47 (for in 
vitro studies) 
This study 
KRY854 MATα leu2-3,112 ura3-52 
[pRS306-truncsec61-S179P/S353C] 
Truncated version of 
sec61-S179P/S353C 
(KRB867) integrated 
into KRY47 (for in 
vitro studies) 
This study 
KRY858/ 
JDY638 
 
BMA38a, kanr-pGAL-Sec61, his3-
Δ200 leu2-3.112 trp1-Δ1 ura3-1 
ade2-1 can1-100  
WT SEC61 under Gal 
promoter 
J. Brown  
KRY878 MATα ire1::KANMX, leu2-3, his3-
11,trp1-1, ura3-1, can1-100, ade2-1 
Δire1  C. Servas 
(Römisch Lab) 
KRY879 MATα ade2-1 ura3-1 his3-11,15 leu2-
3,112 trp1-1 can1-100 der1::natNT2 
Δder1 in W303-1B 
background 
C. Servas 
(Römisch Lab) 
KRY880 MATα ade2-1 ura3-1 his3-11,15 leu2-
3,112 trp1-1 can1-100 prc1-1 
der1::natNT2 
W303-1C (prc1-1) 
Δder1 
C. Servas 
(Römisch Lab) 
KRY901 IRE1 [pRS306-truncsec61-S179P] Truncated version of 
sec61-S179P 
(KRB865) integrated 
into KRY159  
This study 
KRY902 IRE1 [pRS306-truncsec61-S353C] Truncated version of 
sec61-S353C 
(KRB866) integrated 
into KRY159 
This study 
KRY903 IRE1 [pRS306-truncsec61-
S179P/S353C] 
Truncated version of 
sec61-S179P/S353C 
(KRB867) integrated 
into KRY159 
This study 
KRY904 IRE1 [pRS306-truncsec61-302] Truncated version of 
sec61-302 (KRB899) 
integrated into 
KRY159 
This study 
KRY905 IRE1 [pRS306-truncsec61-303] Truncated version of 
sec61-303 (KRB900) 
integrated into 
KRY159 
This study 
KRY906 Δire1 [pRS306-truncsec61-S179P] Truncated version of 
sec61-S179P 
(KRB865) integrated 
into KRY160  
This study 
KRY907 Δire1 [pRS306-truncsec61-S353C] Truncated version of 
sec61-S353C 
This study 
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(KRB866) integrated 
into KRY160 
KRY908 Δire1 [pRS306-truncsec61-
S179P/S353C] 
Truncated version of 
sec61-S179P 
(KRB867) integrated 
into KRY160 
This study 
KRY909 Δire1 [pRS306-truncsec61-302] Truncated version of 
sec61-302 (KRB899) 
integrated into 
KRY160 
This study 
KRY910 Δire1 [pRS306-truncsec61-303] Truncated version of 
sec61-303 (KRB900) 
integrated into 
KRY160 
This study 
* Long-time storage of the microorganisms was in sterile glycerol. In brief, a fresh overnight culture of each 
strain was mixed with sterile glycerol (final concentration: 50 % (v/v)) and stored in cryogenic tubes at – 80 °C. 
 
Table 2.4 contains all S. cerevisiae strains that were added to the strain-catalogue and stored at – 
80 °C. Strains that were generated by transformation with CEN plasmids to use in the respective 
assays (eg. liquid β-Galactosidase assay, reporter plasmid translocation assay) were not stored. 
Here, the respective plasmid (transformed into E. coli) was stored at – 80 °C (ref. Table 2.5). 
 
 
2.1.3 PLASMIDS 
The plasmids used and created in this study were taken from the strain collection of the Department 
of Microbiology (Saarland University, Germany) and are listed in Table 2.5. 
Figure 2.1.3.1 shows the simplified vector maps of pRS306 and pRS315 both of which were used to 
create the appropriate sec61 constructs. Simplified plasmid maps of the resulting sec61 constructs 
are shown in Figure 2.1.3.2. 
 
Table 2.5. Plasmids used in this study. 
Plasmid 
(Strain cat. #) 
Characteristics Use Reference/Source 
p416pΔgpαf 
(KRB351) 
Overexpression of pΔgpαf 
(URA3) 
Contains: MET25 promoter 
Pulse-chase 
experiments (pΔgpαf 
expression) 
Mumberg et al., 1994 
pαF3Q 
(KRB41)  
Gene for pΔgpαf in MC1600. 
Linearization with SalI for 
transcription. 
In vitro transcription 
and translation of 
pΔgpαf 
Mayinger & Meyer, 1993 
pBW11 
(KRB356) 
WT SEC61 in pRS315  Template for SOE-
PCR 
Stirling et al., 1992 
Wilkinson et al., 1996 
pDJ100 
(KRB38) 
(ppαf cloned into pSP65, 
behind SP6 promoter) 
(in HB101) 
Linearization with XbaI for 
transcription. 
In vitro transcription 
and translation of 
ppαf 
Schekman 
Hansen et al., 1986 
pDN106 
(KRB855) 
CPY-Ura3p fusion protein 
(pRS313-CPY-URA3; HIS3) 
 
Import analysis 
(post-translational 
import) 
D. Ng 
Ng et al., 1996 
pDN431 CPY*HA in YCP50 (URA3) Pulse-chase D. Ng 
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(KRB319) experiments Ng et al., 2000 
pGEM2αF 
(KRB257) 
Gene for ppαf (wild type; 
serine variant) in pGEM. SP6 
promoter.  
Linearization with SalI to 
transcribe. 
In vitro transcription 
and translation of 
ppαF. 
Mayinger & Meyer, 1993 
pJC30 
(KRB733) 
(UPRE-LacZ reporter 
construct; pRS314 
backbone) 
Liquid β-
Galactosidase assay 
D. Ng 
pJC31 
(KRB734) 
(CYC1 TATA box fused to 
LacZ; pRS314 backbone) 
 
Liquid β-
Galactosidase assay 
(control for pJC30) 
D. Ng 
pJEY203 
(KRB856) 
Pho8p-Ura3p fusion protein 
(pRS313-PHO8-URA3; 
HIS3) 
 
 
Import analysis (co-
translational import) 
D. Ng 
Ng et al., 1996 
pRS306 
(KRB368) 
Yeast integration vector 
(URA3) 
Cloning of mutant 
sec61 into pRS306; 
integration of sec61 
into yeast genome 
R. Duden 
Sikorski & Hieter et al., 
1989 
pRS306-truncsec61-
302 
(KRB899) 
Truncated version of sec61-
302 (generated from C. Ng’s 
plasmid # 14*) 
Integration plasmid This study 
pRS306-truncsec61-
303 
(KRB900) 
Truncated version of sec61-
303 (generated from C. Ng’s 
plasmid # 18*) 
Integration plasmid This study 
pRS306-truncsec61-
S179P 
(KRB865) 
Truncated version of sec61-
S179P cloned into pRS306 
Integration plasmid This study 
pRS306-truncsec61-
S179P/S353C 
(KRB867) 
Truncated version of sec61-
S179P/S353C cloned into 
pRS306  
Integration plasmid This study 
pRS306-truncsec61-
S353C (KRB866) 
Truncated version of sec61-
S353C cloned into pRS306 
Integration plasmid This study 
pRS313 
(KRB857) 
Empty vector Control for import 
analysis (co- and 
posttranslational 
import) 
J. Brown 
pRS315 
(KRB842) 
CEN vector (LEU2) Cloning of mutant 
sec61 into pRS315 
Sikorski & Hieter, 1989 
pRS315-sec61-S179P 
(KRB862) 
sec61-S179P cloned into 
pRS315 
 
CEN plasmid This study 
pRS315-sec61-
S179P/S353C 
(KRB864) 
sec61-S179P/S353C cloned 
into pRS315 
CEN plasmid This study 
pRS315-sec61-S353C 
(KRB863) 
sec61-S353C cloned into 
pRS315 
CEN plasmid This study 
pSM101 
(KRB883) 
KWW-HA (URA3) Pulse-chase 
experiments 
D. Ng 
Vashist & Ng, 2004 
pSM1083 
(KRB884) 
Ste6-166p-HA (URA3) 
(in pRS316) 
Pulse-chase 
experiments 
D. Ng 
(S. Michaelis) 
Loayza et al., 1998 
* Plasmids were stored at – 20 °C by C. Ng. 
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Figure 2.1.3.1. Simplified vector maps of pRS306 and pRS315. (A) The yeast integrative vector pRS306 
does not replicate autonomously, but integrates into the yeast genome by homologous recombination. It 
contains the auxotrophic marker URA3 and an ampicillin resistance gene for selection in E. coli. In this study 
pRS306 was used to create the desired pRS306-truncsec61* constructs for the integration into the yeast 
genome (ref. Figure 2.1.3.2.A). Strains transformed with integration plasmids are extremely stable. (B) The 
yeast centromer vector pRS315 is an autonomously replicating vector, containing a centromer sequence (CEN) 
and an autonomously replicating sequence (ARS). It further contains the auxotrophic marker LEU2 and an 
ampicillin resistance gene for selection in E. coli. In this study pRS315 was used for the expression of the 
desired sec61 mutants. The full-length sec61 mutants were cloned into pRS315. The resulting constructs are 
shown in Figure 2.1.3.2.B.  
 
 
A!
B!
pRS315!
6018 bp!
Ampicillin!
amp prom!
LEU2!
T7 prom!
lacZ_a reporter!T3 prom!
lac prom!
pBR322 origin!
f1 origin!
MCS!
CEN6_ARS4!
pRS306!
4373 bp!
Ampicillin!
pBR322 origin!
f1 origin!
lac prom!
URA3!
T3 prom!
lacZ_a reporter!
T3 prom!
amp prom!
URA3 prom!
MCS!
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Figure 2.1.3.2. Simplified plasmid maps of the pRS306-truncsec61* and pRS315 -sec61* constructs. The 
mutated versions of SEC61 were generated by SOE-PCR (ref. 2.2.4.1, Table 2.14). (A) Truncated versions of 
the respective sec61 mutants were cloned into the HindIII site (truncsec61-S179P, truncsec61-S353C, 
truncsec61-S179P/ S353C) or the EcoRI/XhoI site (truncsec61-302, truncsec61-303) of pRS306. The 
constructs were used to transform KRY47 (+ KRY159, KRY160). An SfiI restriction site (nucleotide exchange: 
T201G  resulting aa substitution: R67R) was introduced into the truncated sec61 mutants by SOE-PCR. 
Linearization of the pRS306-truncsec61* constructs with SfiI prior to transformation creates linear ends that are 
recombinogenic which directs integration to the site in the genome that is homologous to these ends. The yeast 
strains constructed with the pRS306-truncsec61* plasmids were examined by PCR analysis to confirm the 
correct site of integration. (B) Full-length versions of the respective sec61 mutants were cloned into the HindIII 
site of pRS315 to create the desired pRS315-sec61* constructs. The sec61 mutants were generated by SOE-
PCR (ref. 2.2.4.1, Table 2.14). The constructs were used to transform KRY858 (JDY638).  
(* designates (trunc)sec61-S179P, (trunc)sec61-S353C, (trunc)sec61-S179P/S353C, truncsec61-302 and 
truncsec61-303). 
A!
B!
pRS315-sec61*!
8228 bp!
Ampicillin!
amp prom  !
LEU2!
T7 prom!
lacZ_a reporter!
T3 prom!
lac prom!
pBR322 origin!
f1 origin!
CEN6_ARS4!
sec61*!
pRS306-sec61*!
6081 bp!
truncsec61*!
Ampicillin!
pBR322 origin!
f1 origin!
lac prom!
URA3!
T3 prom!
lacZ_a reporter!
T3 prom!
amp prom! URA3 prom!
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2.1.4 PRIMERS 
Primers used in this study (e.g. in order to create the appropriate sec61 constructs (ref. Figure 
2.1.3.1 and 2.1.3.2)) are listed in Table 2.6. 
 
Table 2.6. Oligonucleotides used in this study. 
Name Sequence (5’   3’) Length 
(Tm [°C]*) 
Application 
5’ HindIII SEC61 5’UTR 
#-445 (445 bp upstream 
of ATG) 
aagcttAAGCTTGCTATAAGC
TAGAATGTATTGAATGTAT
TC 
36 
(59) 
SOE-PCR full length sec61 
mutants (#-445=bp upstream 
of ATG) 
5’ EcoRI SEC61#57 
(57 bp downstream of 
ATG) 
gaattcAGTGATTGCTCCAG
AAAGGAAGGTTCC 
27 
(60) 
Truncated sec61-302, sec61-
303 
5’ HindIII SEC61#57  
(57 bp downstream of 
ATG) 
aagcttAGTGATTGCTCCAG
AAAGGAAGGTTCC 
27 
(60) 
SOE-PCR (truncated sec61 
mutants; #57=bp downstream 
of ATG) 
5’ SOE SEC61 T201G 
(R67R) 
CTGTACTGGCTACGGGCC
ATGCTGGC 
26 
(66) 
SOE-PCR (truncated sec61 
mutants; T201G, silent 
mutationSfiI site creation) 
3’ SOE SEC61 T201G 
(R67R) 
GCCAGCATGGCCCGTAGC
CAGTACAG 
26 
(66) 
SOE-PCR (truncated sec61 
mutants; T201G, silent 
mutationSfiI site creation) 
5’ SOE SEC61 T535C 
(S179P) 
GTTACGGCTTGGGTCCCG
GTATTTCTCTG 
29 
(64) 
SOE-PCR (sec61-S179P; 
T535C) 
3’ SOE SEC61 T535C 
(S179P) 
CAGAGAAATACCGGGACC
CAAGCCGTAAC 
29 
(64) 
SOE-PCR (sec61-S179P; 
T535C) 
5’ SOE SEC61 C1058G 
(S353C) 
CATTAATGTCTTTATGCGA
AGCTCTTCTGGAC 
32 
(61) 
SOE-PCR (sec61-S353C; 
C1058G) 
3’ SOE SEC61 C1058G 
(S353C) 
GTCCAGAAGAGCTTCGCA
TAAAGACATTAATG 
32 
(61) 
SOE-PCR (sec61-S353C; 
C1058G) 
3’ SEC61 3’UTR #1765 
HindIII 
aagcttGCGCATTTGCTTAAG
CAAGGATACC 
25 
(58) 
SOE-PCR(sec61 mutants) 
(#1765=bp downstream of 
ATG) 
3’ SEC61 3’UTR #1765 
XhoI  
ctcgagGCGCATTTGCTTAA
GCAAGGATACC 
25 
(58) 
Truncated sec61-302, sec61-
303 
5’ SEC61 CHR #403 GCAAGTAGAAAAACTGAC
ACTGGTTCACG 
29 
(60) 
sec61 integration (primer 
position: chromosomal part of 
SEC61 upstream of integrated 
sec61) 
3’ pRS306 URA3 #621 
(621 bp downstream of 
URA3 ATG) 
GTTGACCCAATGCGTCTC
CCTTGTC 
25 
(61) 
sec61 integration (primer 
position: URA3 marker) 
5’ SalI Ydj1 gtcgacATGGTTAAAGAAAC
TAAGTTTTACGATATTCTA
GG 
35 
(57) 
Control PCR for sec61 
integration (target: Ydj1p) 
3’ Ydj1 XbaI tctagaTCATTGAGATGCACA
TTGAACACCTTC 
27 
(57) 
Control PCR for sec61 
integration (target: Ydj1p) 
Oligo-d(T) 18 rev TTTTTTTTTTTTTTTTTT 18 
(28) 
HAC1 mRNA splice assay 
RT-PCR_ACT1 fwd ATTCTGAGGTTGCTGCTTT
G 
20 
(50) 
Control  
HAC1 mRNA  splice assay 
RT-PCR_ACT1 rev GTGGTGAACGATAGATGG
AC 
20 
(52) 
Control  
HAC1 mRNA  splice assay 
RT-PCR_HAC1 fwd CTGGCTGACCACGAAGAC
GC 
20 
(58) 
HAC1 mRNA  splice assay 
RT-PCR_HAC1 rev TTGTCTTCATGAAGTGATG 20 HAC1 mRNA  splice assay 
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A (46) 
T3 ATTAACCCTCACTAAAGGG
A 
20 
(48) 
Sequencing 
T7 TAATACGACTCACTATAGG
G 
20 
(48) 
Sequencing 
SEC61 PBW11 SEQ  AAATAGAGGGAGGGGTGT
GG 
20 
(54) 
Sequencing 
* Tm = 4 x (G+C) + 2 x (A+T) [°C] 
 
 
2.1.5 ANTIBODIES  
Antibodies used in this study are listed in Table 2.7. 
 
Table 2.7. Primary and secondary antibodies used in this study. 
Antibody Use & Dilution Source 
anti-alpha factor 
(rabbit)  
Western blot: 1:2000 
IP: 1:100 (per 1.5 OD600) 
KB Römisch 
anti-BiP 
(rabbit) 
Western Blot: 1: 2000 KB Römisch 
anti-CPY 
(rabbit) 
Western Blot: 1: 2000 
IP: 1:100 (per 1.5 OD600) 
KB Römisch 
anti-Eug1 
(rabbit) 
Western Blot: 1: 5000 KB Römisch 
anti-FLAG M2 
monoclonal 
(mouse) 
Proteasome binding assay: 1:2000 Sigma-Aldrich: cat. # F1804 
(affinity purified antibody) 
anti-FLAG M2 
polyclonal 
(rabbit) 
Proteasome binding assay: 1:2000 Sigma-Aldrich: cat. # F7425 
(affinity purified antibody) 
Agarose-linked anti-
FLAG M2  
Proteasome purification: 1: 100 
(using yeast cytosol extracted from cells 
with 10000 OD600) 
Sigma-Aldrich: cat. # A2220 
anti-HA 
(rabbit) 
Western Blot: 1: 5000 
IP: 1:250 (per 1.5 OD600) 
Rockland: cat. # 600-401-384S 
(Anti-HA epitope tag antibody) 
anti-mouse 
(rabbit) 
Western Blot: 1: 1000000 Sigma-Aldrich: cat. # A9044 
anti-Pdi1p 
(rabbit) 
Western Blot: 1: 5000 KB Römisch 
anti-Sbh1p 
(rabbit) 
Western Blot: 1: 5000 KB Römisch 
anti-Sec61p (C-
terminal) 
(rabbit) 
Western Blot: 1: 2000 KB Römisch 
(Affinity purified antibody) 
anti-Sec61p (N-
terminal) 
(rabbit) 
Western Blot: 1: 2000 KB Römisch 
(Affinity purified antibody (N-terminal 
peptide: PFESFLPEVIAPERKC)) 
anti-rabbit (HRP) 
(goat) 
Western Blot: 1:20000 (X-ray) 
1:200000 (Biorad Gel Documentation 
CCD camera) 
Rockland™: cat. # 611-1302 
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2.1.6 ENZYMES 
Enzymes routinely used in this study are listed in Table 2.8. 
 
Table 2.8. Enzymes used in this study and their sources. 
Enzyme Company 
Restriction enzymes 
EcoRI 
HindIII 
MscI 
XbaI 
XhoI 
SacI 
SalI 
SfiI 
 
New England Biolabs (NEB) 
NEB 
NEB 
NEB 
NEB 
NEB 
NEB 
NEB 
Polymerases 
KAPA HiFi™ Hot Start Polymerase 
Sp6 RNA polymerase 
T7 RNA polymerase 
 
Peqlab 
Promega 
Promega 
Reverse transcriptase 
Maxima® RT  
 
Fermentas 
Ligase 
Fast-Link™ DNA Ligation Kit 
 
Biozym (Epicentre®)  
Other enzymes 
FastAP™ Thermosensitive Alkaline Phosphatase  
Lyticase 
 
Thermo Fisher Scientific Inc. 
Römisch Lab 
 
 
2.1.7 MEDIA AND BUFFERS 
S. cerevisiae and E. coli media routinely used in the course of this study are listed in Table 2.9 and 
2.11 respectively. All other media and all buffers are listed in the respective section of this chapter. 
 
Table 2.9. S. cerevisiae media used routinely in this study. 
Medium Composition 
YP (Yeast Extract, Peptone) 1 (w/v) % Yeast Extract, 2 (w/v) % Peptone (For 
solid media: 2 (w/v) % Agar-Agar) 
YPD* (Yeast Extract, Peptone, Dextrose) 1 (w/v) % Yeast Extract, 2 (w/v) % Peptone, 2 (w/v) 
% Glucose (For solid media: 2 (w/v) % Agar-Agar) 
Minimal Medium** 0.67 (w/v) % Yeast Nitrogen Base without Amino 
Acids, 0.13 (w/v) % Synthetic Complete Drop-Out 
Mixture*** (-Ade, -His, -Leu, -Lys, -Trp, -Ura), 2 (w/v) 
% Glucose, Amino Acids according auxotrophies 
(ref. Table 2.10) 
(For solid media: 2 (w/v) % Agar-Agar) 
* Glucose was autoclaved separately at a concentration of 50 % and added to the YP solution prior to use. 
** For the preparation of minimal medium, all components were dissolved in MilliQ-water and sterile filtered. For 
1 L solid media 800 ml water containing agar-agar were autoclaved while all other components were dissolved 
in 200 ml MilliQ water and filter-sterilized. The two solutions were mixed prior to pouring the minimal medium 
plates. The supplements Ade, His, Leu, Lys, Trp and Ura were added according to the strains’ auxotrophies as 
listed in Table 2.10. 
*** The composition of the synthetic complete “drop-out” mixture used is listed in Table 2.10. 
 
OD600 = 1: 2.7 x 107 cells (diploid yeast), 2.8 x 108 cells (haploid yeast) 
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Table 2.10. Composition of Synthetic Complete amino acid drop-out mixture* for S. cerevisiae.  
Formula mg/l 
Adenine 18 
L-Alanine 76 
L-Arginine HCl 76 
L-Asparagine 76 
L-Aspartic acid 76 
L-Cysteine 76 
L-Glutamine 76 
L-Glutamic acid 76 
Glycine 76 
L-Histidine 76 
myo-Inositol 76 
L-Isoleucine 76 
L-Leucine 380 
L-Lysine 76 
L-Methionine 76 
para-Aminobenzoic acid 8 
L-Phenylalanine 76 
L-Proline 76 
L-Serine 76 
L-Threonine 76 
L-Tryptophan 76 
L-Tyrosine 76 
Uracil 76 
L-Valine 76 
* Drop-out mix without Ade, His, Leu, Lys, Trp, and Ura according to Kaiser et al., 1994. The remaining amino 
acids were added according to the auxotrophies of the strains used. 
 
Table 2.11. E. coli media used routinely in this study. 
Medium Composition 
LB (Lysogeny Broth) 0.5 % (w/v) Yeast Extract, 1 % (w/v) Tryptone, 0.05 
% (w/v) NaCl, 1.0 mM NaOH 
(For solid media: 2 % Agar-Agar) 
LB-Amp LB with 100 µg/ml Ampicillin* 
(For solid media: 2 % Agar-Agar) 
LB-Kan LB with 50 µg/ml Kanamycin* 
SOC (Super Optimal broth with Catabolite 
repression) 
2 % (w/v) Tryptone, 0.5 % (w/v) Yeast Extract, 0.05 
% (w/v) NaCl 
* Antibiotics stock solutions were sterile filtered and added to the media prior to use at the designated 
concentration. 
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2.2 METHODS 
 
2.2.1 STERILIZATION  
All glassware and media were sterilized by autoclaving at 100 kPa and 120 °C for 20 min if not 
stated otherwise. 
 
 
2.2.2 GROWTH OF S. CEREVISIAE 
S. cerevisiae cells were grown at 30 °C in YPD or in minimal medium with continuous shaking at 225 
rpm or on YPD or drop out plates at 30 °C if not stated otherwise (ref. Table 2.9 and 2.10).  
 
 
2.2.3 GROWTH OF E. COLI 
E. coli cells were grown at 37 °C, if not stated otherwise, in LB medium with continuous shaking at 
225 rpm or on LB medium plates (ref. Table 2.11). 
 
 
2.2.4 POLYMERASE CHAIN REACTION  
During Polymerase Chain Reaction (PCR) specific DNA sequences are selectively amplified. This is 
achieved using short single-stranded oligonucleotides, which are designed to specifically bind to the 
template DNA at the 5’ and 3’ end of the target sequence. During the course of the reaction the 
template DNA is denatured which enables the oligonucleotides to anneal to the template. This allows 
for the DNA polymerase to bind and synthesize the complementary DNA strand(s).  
PCRs essentially consist of three steps and about 20-35 cycles (mainly depending on the DNA 
polymerase used and the target sequence; ref. Table 2.13). During the first step, the PCR mix (ref. 
Table 2.12) containing the template DNA is denatured at a high temperature, resulting in single-
stranded DNA. Single-stranded DNA is needed in the second step. Primer annealing (step 2) is 
performed at a lower, sequence-specific temperature to ensure specific binding of the primer pair to 
the template DNA. During the elongation step (step 3) DNA polymerase extends the primers and 
adds nucleotides complementary to the template DNA. The target sequence is exponentially 
amplified by cycling of the three steps 20-35 times. 
During this study the DNA polymerase KAPAHiFi™ Hot Start DNA Polymerase (1 U/μl; Peqlab) was 
routinely used for PCRs if not stated otherwise. The reaction setup was as described in Table 2.12. 
Temperature and duration of each step (ref. Table 2.13) were optimized for each reaction/sequence. 
The peqSTAR 2X Gradient Thermocycler (Peqlab) was used routinely for PCRs. The correct size of 
each PCR product was verified by agarose gel electrophoresis (ref. 2.2.8). 
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During this study PCR was performed in order to amplify full-length sec61 and truncated sec61 
containing the appropriate point mutation(s) (ref. Figure 2.1.3.2). S. cerevisiae SEC61 (amplified 
from pBW11, ref. Table 2.5) was used as the template. Gene-specific primers (ref. Table 2.6) for the 
amplification of the SEC61 gene and for the introduction of the respective point mutation(s) were 
designed using the SEC61 sequence (www. yeastgenome.org). The resulting PCR products were 
cloned into pRS315 (full-length sec61) and pRS306 (truncated sec61) to create the respective 
constructs. 
 
Table 2.12. Standard reaction mixture for PCRs. 
 PCR Reaction  
Component Volume (µl) Final concentration/ 
Quantity 
5X KAPAHiFi™ Reaction Buffer 
KAPA dNTP Mix (10 mM each)  
Forward primer (10 μM) 
Reverse primer (10 μM) 
Template DNA  
KAPAHiFi™ Hot Start DNA 
Polymerase (1 U/μl)  
dH2O 
10 
1.5 
1.5 
1.5 
1 
1 
 
to 50 
1X 
0.3 mM 
0.3 μM 
0.3 μM 
10 ng plasmid DNA 
0.02 U/μl 
 
--- 
 
Table 2.13. Standard thermal cycler program for PCRs. 
Step Operation Temperatur (°C) Duration  
1 Initial template denaturation 95 5 sec 
2 Template denaturation 98 20 sec 
3 Primer annealing 57* 15 sec 
4 Primer extension 72 30 sec/ kb 
Steps 2 to 4 were cycled 35 times 
5 Final primer extension 72 5 min 
6 Store 4 ∞ 
 * Primer annealing for the generation of all sec61 mutants was performed at 57 °C. For all other PCRs (eg. 
HAC1 mRNA splice assay) primer annealing was performed at the Tm given in Table 2.6 or in the respective 
section of this chapter. 
 
 
2.2.4.1. SPLICE OVERLAP EXTENSION (SOE) PCR 
PCR-driven overlap extension was used for site-directed mutagenesis during this study in order to 
generate the desired sec61 mutants. During SOE-PCR overlapping gene fragments are generated 
that are then used as templates in order to generate the fused (full-length) product. By choosing 
appropriate internal primers overlapping, complementary 3’ ends in the intermediate fragments are 
created and the desired nucleotide exchange is introduced. The intermediate fragments are then 
fused together in a final PCR using flanking primers (Ho et al., 1989; Horton et al., 1989; ref. Figure 
2.2.4.1.1). 
During SOE-PCR segments of the target sequence (SEC61) were amplified using template DNA 
(pBW11) and specific sets of primers (ref. Table 2.6). Mutagenic primers were designed 
complementary to each other (about 30 bp) containing the desired nucleotide exchange in the centre 
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of the primer. This results in two fragments that share a complementary sequence of about 30 bp at 
their 3’ end (fragment 1) and 5’ end (fragment 2). During a second PCR using the flanking primers, 
the complementary overlapping sequences hybridize which leads to the extension of the full-length 
PCR product (ref. Figure 2.2.4.1.1). Flanking primers also contained restriction sites (HindIII (or 
EcoRI/XhoI for sec61-302 and sec61-302; ref. Table 2.6) for cloning into pRS315 (full-length sec61) 
or pRS306 (truncated sec61). 
The SOE-PCR protocol was essentially as previously described (Heckman and Pease, 2007). The 
reaction setups were as described in Table 2.14. 
 
 
 
 
 
Figure 2.2.4.1.1. SOE-PCR. (A) Site-directed mutagenesis using PCR-driven overlap extension is achieved by 
using flanking primers (a and d) and mutagenic primers (b and c) to generate the overlapping intermediate 
PCR products AB (primer a + b) and CD (primer c + d). (B) Fragments AB and CD are then used as templates 
in the next PCR using the flanking primers a and d. The intermediates hybridize at their overlapping 
complementary 3’ ends and are fused together generating the full-length PCR product AD (adapted from 
Heckman & Pease, 2007). 
 
 
 
 
 
a! c!
b! d!*!
*!
AB!
CD!
*!
*!
PCR #1!
primer a+b, c+d!
AB! *!
*!
*!AD!a!
d!
PCR #2!
primer a+d!
a!
d!*!
A!
B!
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Table 2.14. SOE-PCR setups for the generation of sec61 mutants*. 
SEC61 
mutation 
Fragment No. Primer Pair Template 
S179P #1 5’ HindIII SEC61 5’UTR #-445 
3# SOE SEC61 T535C 
S179P #2 5’ SOE SEC61 T535C 
3’ SEC61 3’UTR #1765 HindIII 
pBW11 sec61-S179P 
(full-length) 
S179P #3 
(S179P #1 + 2 fusion) 
5’ HindIII SEC61 5’UTR #-445 
3’ SEC61 3’UTR #1765 HindIII 
S179P #1 
S179P #2 
S353C #1 5’ HindIII SEC61 5’UTR #-445 
3’ SOE SEC61 C1058G 
S353C #2 5’ SOE SEC61 C1058G 
3’ SEC61 3’UTR #1765 HindIII 
pBW11 sec61-S353C 
(full-length) 
S353C #3 
(S353C #1 + 2 fusion) 
5’ HindIII SEC61 5’UTR #-445 
3’ SEC61 3’UTR #1765 HindIII 
S353C #1 
S353C #2 
S179P/S353C #1 5’ HindII SEC61 5’UTR #-445 
3’ SOE SEC61 T535C 
S179P/S353C #2 5’ SOE SEC61 T535C 
3’ SOE SEC61 C1058G 
S179P/S353C #3 5’ SOE SEC61 C1058G 
3’ SEC61 3’UTR #1765 HindIII 
pBW11 
S179P/S353C #4 
(S179P/S353C #1 + 2 
fusion) 
5’ HindIII SEC61 5’UTR #-445 
3’ SOE SEC61 C1058G 
S179P/S353C #1 
S179P/S353C #2 
sec61-
S179P/S353C 
(full-length) 
S179P/S353C #5 
(S179P/S353C # 3 + 4 
fusion) 
5’ HindIII SEC61 5’UTR #-445 
3’ SEC61 3’UTR #1765 HindIII 
S179P/S353C #3 
S179P/S353C #4 
truncS179P #1 5’ HindIII SEC61 #57 
3’ SOE SEC61 T201G 
truncS179P #2 5’ SOE SEC61 T201G 
3’ SOE SEC61 T535C 
pBW11 
truncS179P #3 
(S179P #1+ 2 fusion) 
5’ HindIII SEC61 #57 
3’ SOE SEC61 T535C 
truncS179P #1 
truncS179P #2 
truncS179P #4 5’ SOE SEC61 T535C 
3’ SEC61 3’UTR #1765 HindIII 
pBW11 
truncsec61-
S179P 
(truncated) 
truncS179P #5 
(S179P/S353C # 3 + 4 
fusion) 
5’ HindIII SEC61 #57 
3’ SEC61 3’UTR #1765 HindIII 
truncS179P #3 
truncS179P #4 
truncS353C #1 5’ HindIII SEC61 #57 
3’ SOE SEC61 T201G 
truncS353C #2 5’ SOE SEC61 T201G 
3’ SOE SEC61 C1058G 
pBW11 
truncS353C #3 
(S353C #1 + 2 fusion) 
5’ HindIII SEC61 #57 
3’ SOE SEC61 C1058G 
truncS353C #1 
truncS353C #2 
truncS353C #4 5’ SOE SEC61 C1058G 
3’ SEC61 3’UTR #1765 HindIII 
pBW11 
truncsec61-
S353C 
(truncated) 
truncS353C #5 
(truncS353C #3 + 4 
fusion) 
5’ HindIII SEC61 #57 
3’ SEC61 3’UTR #1765 HindIII 
truncS353C #3 
truncS353C #4 
truncS179P/S353C #1 5’ HindIII SEC61 #57 
3’ SOE SEC61 T201G 
truncS179P/S353C #2 5’ SOE SEC61 T201G 
3’ SOE SEC61 T535C  
pBW11 
truncS179P/S353C #3 
(truncS179P/S353C 
#1 + 2 fusion) 
5’ HindIII SEC61 #57 
3’ SOE SEC61 T535C 
truncS179P/S353C #1 
truncS179P/S353C #2 
truncS179P/S353C #4 5’ SOE SEC61 T535C 
3’ SOE SEC61 C1058G 
truncsec61-
S179P/S353C 
(truncated) 
c 
c 
c 
c 
c 
 
c truncS179P/S353C #5 5’ SOE SEC61 C1058G 
pBW11 
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truncS179P/S353C #5 3’ SEC61 3’UTR #1765 HindIII  
truncS179P/S353C #6 
(truncS179P/S353C # 
4 + 5 fusion) 
5’ SOE SEC61 T535C 
3’ SEC61 3’UTR #1765 HindIII 
truncS179P/S353C #4 
truncS179P/S353C #5 
c 
c 
c 
c 
c 
c 
c 
truncS179P/S353C #7 
(truncS179P/S353C 
#3 + 6 fusion) 
5’ HindIII SEC61 #57 
3’ SEC61 3’UTR #1765 HindIII 
truncS179P/S353C #3 
truncS179P/S353C #6  
trunc302 #1 5’ EcoRI SEC61 #57 
3’ SOE SEC61 T201G 
trunc302 #2 5’ SOE SEC61 T201G 
3’ SEC61 3’UTR #1765 XhoI 
Plasmid #14 (C. Ng) truncsec61-302 
(truncated) 
trunc302 #3 
(trunc302 # 1 + 2 
fusion) 
5’ EcoRI SEC61 #57 
3’ SEC61 3’UTR #1765 XhoI 
trunc302 #1 
trunc302 #2 
trunc303 #1 5’EcoRI SEC61 #57 
3’ SOE SEC61 T201G 
trunc303 #2 5’ SOE SEC61 T201G 
3’ SEC61 3’UTR #1765 XhoI 
Plasmid #18 (C. Ng) truncsec61-303 
(truncated) 
trunc303 #3 
(trunc303 #1 + 2 
fusion) 
5’ EcoRI SEC61 #57 
3’ SEC61 3’UTR #1765 XhoI 
trunc303 #1 
trunc303 #2 
* Table 2.14 describes the PCR setup, i.e. combination of templates and primers for the generation of each 
individual sec61 mutant. 
 
 
2.2.5 LARGE SCALE EXTRACTION OF PLASMID DNA 
Large-scale extraction of plasmid DNA from E. coli was prepared using the GenElute™ HP Plasmid 
Maxiprep Kit (Sigma-Aldrich). In brief, a single colony was picked from an LB-Amp (or LB-Kan) plate 
and used to inoculate 150 ml of LB medium (1.0 % (w/v) Tryptone, 0.5 % (w/v) Yeast Extract, 0.05 % 
(w/v) NaCl, 1.0 mM NaOH) containing either 100 µg/ml Amp or 50 µg/ml Kan (depending on the 
plasmid’s selection marker). The culture was incubated overnight at 37 °C with rapid shaking. The 
next day, bacteria were harvested by centrifugation (rotor: SLA-3000; Sorvall Evolution® RC 
centrifuge) at 5400 rpm, RT for 10 min. Plasmid DNA was then extracted using the GenElute™ HP 
Plasmid Maxiprep Kit according to the supplied protocol as follows. The cell pellet was resuspended 
in 12 ml of Resuspension/RNase A Solution. For cell lysis 12 ml of Lysis Solution were added to the 
cells. The mixture was inverted 6 to 8 times. Lysis was for 3 - 5 min at RT. Next, 12 ml of chilled 
Neutralization Solution were added. The mixture was inverted 4 to 6 times in order to neutralize the 
lysed cells. Then, 9 ml of Binding Solution were added to the lysate. After careful inversion (1 to 2 
times), the lysate was immediately transferred to the barrel of a filter syringe and incubated for 5 
min. Columns were equilibrated by adding 12 ml of Column preparation solution to a GenElute™ HP 
Maxiprep Binding column. The column was centrifuged at 3000 rpm, RT for 2 min (rotor: #11140 
(swing-out); SIGMA 4K15 Refrigerated Centrifuge). The eluate was discarded and the cleared lysate 
was loaded onto the equilibrated column and centrifuged again at 3000 rpm, RT for 2 min. The 
process was repeated until all of the lysate had been passed through the column. The plasmid DNA 
bound to the ion exchange resin on the column. In order to remove impurities, the column was 
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washed with 12 ml of Wash 1 Solution (centrifugation at 3000 rpm, RT for 2 min) followed by a wash 
with 12 ml of Wash 2 Solution (centrifugation at 3000 rpm, RT for 5 min). The Binding column was 
transferred to a clean collection tube. Plasmid DNA was eluted by adding 3 ml of Elution Solution to 
the column, which was centrifuged at 3000 rpm, RT for 5 min. The eluate was transferred to a SS34 
polycarbonate tube. Plasmid DNA was precipitated with 0.1 volumes of 3.0 M sodium acetate pH 5.2 
and 0.7 volumes of isopropanol and pelleted by centrifugation at 16.000 rpm, 4 °C for 30 min (rotor: 
SS34; Sorvall Evolution® RC). The plasmid DNA was washed with 70 % (v/v) ethanol (EtOH), 
recentrifuged as before and air-dried. The plasmid DNA was resuspended in a suitable volume of 
Milli-Q water. Plasmid DNA was stored at – 20 °C. 
 
 
2.2.6 SMALL SCALE EXTRACTION OF PLASMID DNA: ALKALINE LYSIS MINIPREPS 
The Alkaline Lysis methods by Birnboim and Doly (1979) was employed for the extraction of small 
amounts of plasmid DNA. In brief, 3 ml of sterile LB medium containing 100 µg/ml Amp or 50 µg/ml 
Kan were inoculated with one single bacterial colony and shaken overnight at 37 °C. 1.5 ml of the 
cell culture were transferred to a clean microcentrifuge tube and centrifuged at 13400 rpm, RT for 1 
min in a bench top centrifuge (MiniSpin®, Eppendorf) to pellet the cells. The pellet was resuspended 
in 100 µl of E1 Solution (50 mM Glucose, 25 mM Tris-HCl pH 8.0, 1 mM EDTA pH 8.0) containing 1 
µg/ml RNase A (Fermentas) and incubated at RT for 5 min. Cells were then lysed by adding 200 µl 
of E2 Solution (0.2 M NaOH, 1 % (w/v) SDS). The mixture was inverted and placed on ice for 5 min. 
Next, 150 µl of E3 Solution (3 M Potassium Acetate pH 4.8) were added. The lysate was mixed by 
inversion placed back on ice for 5 min, followed by centrifugation at 13400 rpm, RT for 5 min to 
pellet the cell debris and chromosomal DNA. The supernatant was transferred to a clean 
microcentrifuge tube and mixed with 800 µl of absolute ethanol. After mixing and incubation at RT for 
2 min, the sample was centrifuged at 13400 rpm for 3 min to pellet the plasmid DNA. To remove the 
salts in the sample, the pellet was washed with 1 ml of 70 % (v/v) ethanol. The ethanol was then 
discarded and the pellet air-dried. The DNA pellet was resuspended in 20 µl of either sterile TE (10 
mM Tris-HCl pH 8.0, 1 mM EDTA pH 8.0) or MilliQ-water. Plasmid DNA was stored at – 20 °C. 
 
 
2.2.7 ETHANOL PRECIPITATION 
DNA precipitation was conducted by adding 1/10 volume of 3 M sodium acetate (pH 5.2) and 2.5 
volumes of absolute ethanol to the DNA solution. To precipitate small nucleic acids, the mixture was 
incubated at – 20 °C for a minimum of 30 min. The pellet was then washed with 1 ml of 70 % (v/v) 
ethanol and air-dried. The DNA was dissolved in a suitable volume of TE (10 mM Tris-HCl pH 8.0, 1 
mM EDTA pH 8.0) or sterile dH2O and stored at – 20 °C. 
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2.2.8 AGAROSE GEL ELECTROPHORESIS 
Agarose gel electrophoresis was performed to separate, identify and purify DNA fragments. In 
general, DNA samples were mixed with DNA Loading Dye (6X: 50 % (w/v) Sucrose, 0.15 % (w/v) 
Bromophenol Blue, 0.02 M EDTA) amd loaded onto a 1 % Agarose Gel (1 % (w/v) Agarose, 2 % 
(v/v) 50X TAE, 90 % (v/v) dH2O) containing 0.5 µg ml-1 Ethidium Bromide (EtBr)). The gel was 
placed in a Peqlab gel tank containing 1X TAE buffer (Tris Acetate EDTA; 50X: pH 8.4: 20 M Tris-
HCl, 10 M Acetic Acid, 0.05 M EDTA). Electrophoresis was then carried out at 100 - 120 V for ~1-2 
hr. GeneRuler™ 1 kb DNA ladder (Fermentas) was used as the size standard (0.5 µg loaded). The 
gel was placed over a transilluminator for visualization of the DNA, which was photographed using 
the Molecular Imager ChemiDoc™ XRS (Bio-Rad) or the E-Box VX2 Gel Documentation System 
(Peqlab). 
 
 
2.2.9 RECOVERY OF DNA FRAGMENTS 
In order to recover DNA from agarose gels, the GenElute™ Gel Extraction Kit (Sigma-Aldrich) was 
used. The appropriate DNA band was excised from the agarose gel using a sterile scalpel, and then 
transferred into a 1.5 ml microcentrifuge tube. The gel slice was resuspended in 3 gel volumes of 
Gel Solubilization Solution. The mixture was incubated at 60 °C until the gel was dissolved followed 
by the addition of 1 gel volume of 100 % isopropanol. The gel solution was loaded onto an 
equilibrated binding column and spun for 1 min at full speed in a benchtop centrifuge (MiniSpin®, 
Eppendorf). The flow-through liquid was discarded each time. Next, 700 µl of Wash Solution were 
added to the binding column and the column centrifuged for 1 min at RT, full speed. Once all of the 
gel solution had been passed through the binding column, the column was centrifuged as before in 
order to remove residual Wash Solution. The DNA was eluted by addition of 50 µl Elution Solution to 
the membrane of the binding column and incubated for 1 min at RT followed by centrifugation for 1 
min at full speed. DNA was stored at – 20 °C until needed. 
 
 
2.2.10 RESTRICTION DIGESTION OF PCR PRODUCTS AND PLASMID DNA 
All endonuclease restriction digestions were carried out in a 50 µl reaction mixture containing the 
appropriate buffer, as recommended by the supplier (NEB, if not stated otherwise), and 10 units of 
enzyme per µg of DNA. Reaction mixtures were incubated for 1-2 hr at 37 °C (SfiI: 50 °C) and 
afterwards heat-inactivated as recommended. Plasmid DNA was then analyzed by gel 
electrophoresis (ref. 2.2.8).  
In the case of two enzymes being used, the buffer in which both enzymes exhibit the highest 
efficiency was used at the appropriate concentration. The standard reaction mixture is outlined in 
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Table 2.15. For digestions of larger amounts of DNA, the amounts of enzymes and buffer were 
increased and the amount of water adjusted accordingly. 
 
Table 2.15. Standard reaction mixture for the restriction digestion of DNA. 
Component DNA Buffer* Restriction 
Enzyme 
100 X BSA** dH2O 
Volume (µl) x 
(1 µg) 
5 1 
(10 U) 
0.5 to 50  
*  The buffers were those recommended by the suppliers. 
** BSA was added depending on the enzyme. 
 
 
2.2.11 DEPHOSPHORYLATION OF VECTOR DNA 
FastAP™ Thermosensitive Alkaline Phosphatase (Thermo Fisher Scientific) was used to hydrolyze 5’ 
phosphate group prior to each ligation in order to avoid re-ligation of the digested vector. The 
reaction mix (ref. Table 2.16) consisted of 1 unit of FastAP™ Thermosensitive Alkaline Phosphatase, 
1/10 volume of 10X FastAP™ buffer and 1 µg of vector DNA. The sample was incubated at 37 °C for 
10 min and heat-inactivated at 65 °C for 15 min. 
 
Table 2.16. Reaction mixture for the dephosphorylation of digested vector DNA. 
Component Digested DNA 10X Buffer FastAP dH2O 
Volume (µl) x 
(1 µg) 
2 1 to 20 
 
 
2.2.12 LIGATION OF VECTOR DNA AND INSERT DNA 
In general, following digestion of vector and insert DNA with the appropriate enzyme(s) to create 
matching sticky ends, the ligation was carried out for 10 min at 22 °C in a thermal cycler using the 
Fast-Link™ DNA Ligation Kit (Biozym). The reaction mixture contained 10X ligation buffer, 2 units of 
Fast-Link™ DNA ligase (2 U/µl) and a 3:1 ratio of insert to vector. The reaction was heat-inactivated 
by incubation at 70 °C for 15 min. Ligations were prepared according to the reaction mixture 
presented in Table 2.17. Generally, 5 µl of the ligation were used to transform E. coli cells. 
 
Table 2.17. Standard reaction mixture for the ligation of vector and insert DNA. 
Component 10X 
Ligation 
buffer 
10 mM 
ATP 
Vector 
DNA 
Insert DNA H2O Fast-Link™ 
Ligase 
Volume (µl) 1.5 1.5 x 
(50 ng) 
y 
(3:1*) 
to 14  1 
* Molecular ratio insert : vector 
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2.2.13 MICRODIALYSIS 
Microdialysis was carried out after ligation and prior to electroporation to lower salt concentrations in 
the sample and thus to increase the efficiency of electroporation and to prevent later shorting of the 
Bio-Rad MicroPulser™ electroporator. Therefore, the ligation products were placed onto a Millipore 
filter paper (0.25 µm) floating on sterile MilliQ-water in a Petri dish for 1 hr. 
 
 
2.2.14 TRANSFORMATION OF E. COLI CELLS WITH PLASMID DNA 
 
2.2.14.1 PREPARATION OF ELECTROCOMPETENT CELLS 
Preparation of electrocompetent cells was performed according to a procedure described by Dower 
et al. (1988). All steps in this protocol were performed at 4 °C or on ice. 1 L of LB was inoculated 
with 10 ml of an overnight culture (1/100 dilution) of Top10 or DH5α cells. The cells were grown with 
vigorous shaking at 37 °C until an OD600 of 0.5 - 0.6 was reached. The culture was harvested by 
centrifugation at 5200 rpm for 10 min (rotor: SLA3000, Sorvall Evolution® RC Centrifuge). The 
supernatant was discarded and the cells were washed with 1 L and 0.5 L of cold sterile MilliQ H2O 
respectively and centrifuged as before. The pellets were resuspended in 20 ml of cold 10 % (v/v) 
glycerol and centrifuged at 3500 rpm for 10 min. Finally, the cells were resuspended in 3 ml of 10 % 
(v/v) glycerol and 100 µl aliquots of the electrocompetent cells were transferred to sterile 
microcentrifuge tubes and stored at – 80 °C. 
 
 
2.2.14.2 TRANSFORMATION OF ELECTROCOMPETENT CELLS 
For electroporation, 100 µl aliquots of electrocompetent cells were thawed on ice and the 
appropriate DNA was added. The cells and DNA were then transferred to a pre-chilled 
electroporation cuvette (Peqlab #71-2020). The cuvette with a 0.2 cm gap was placed into the 
cuvette chamber and pulsed using a Bio-Rad MicroPulser™ electroporator at 200 Ω, 2.5 V, 25 µFD. 
The sample was immediately resuspended in 1 ml ice-cold SOC medium (0.5 % (w/v) Yeast Extract, 
2 % (w/v) Tryptone, 10 mM NaCl, 2.5 mM KCl, 10 mM MgCl2, 10 mM MgSO4*7H2O, 20 mM 
Glucose), transferred to a 1.5 ml microcentrifuge tube and incubated at 37 °C for 1 hr with vigorous 
shaking to allow cells to recover. Serial dilutions (neat - 10-3) were prepared from the cell suspension 
and 100 µl plated on LB Agar plates containing the appropriate antibiotic. The plates were incubated 
at 37 °C overnight. The next day, single colonies were selected for screening. All clones that were 
found to be real transformants were named, purified and stored at - 80 °C in 50 % (v/v) glycerol. 
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2.2.14.3 TRANSFORMATION OF CHEMICALLY COMPETENT CELLS 
The NEB 5-alpha (high efficiency) chemically competent E. coli cells (cat. # C2987, NEB) were used 
for transformations with the appropriate constructs when transformations using electrocompetent 
cells was unsuccessful. 
Transformation was performed according to the supplier’s instructions. In brief, NEB 5-alpha cells 
were carefully thawed on ice and 50 µl of competent cells were used per transformation. Next, about 
5 µl (∼ 50 ng DNA) of plasmid DNA was added to the cells and the microcentrifuge tube was gently 
flicked 5 times to mix DNA and cells. The mixture was incubated on ice for 30 minutes followed by a 
heat shock at 42 °C for 30 seconds. The mixture was then placed back on ice and incubated for 
another 5 minutes. For cell recovery the sample was incubated in 950 µl of RT SOC medium at 37 
°C and 250 rpm for 1 hr. Following the incubation several serial dilutions (neat - 10-3) were prepared 
and 100 µl of each dilution plated onto LB agar plates containing the appropriate antibiotic. The 
plates were incubated at 37 °C overnight. The next day, single colonies were selected for screening. 
All clones that were found to be real transformants were named, purified and stored at – 80 °C in 50 
% (v/v) glycerol. 
 
 
2.2.15 DNA SEQUENCING 
In order to analyze DNA sequences all plasmids were sequenced. Miniprep DNA samples of all 
transformants of interest were sent for sequencing. Sequencing (single read sequencing) was 
performed by GATC Biotech AG (Konstanz) according to the sequencing method by Sanger et al. 
(1977). For sequencing of the various sec61 sequences the primer T3, T7 and SEC61 PBW11 SEQ 
(ref. Table 2.6) were routinely used if not stated otherwise. The results were analyzed with the 
Vector NTI® (Invitrogen) software. 
 
 
2.2.16 PREPARATION OF LYTICASE 
Preparation lyticase was accordimg to a protocol from R. Schekman’s laboratory. In brief, from a 200 
ml overnight culture of the strain RSB805 10 L (8 x 1.25 L) LB-Amp medium were inoculated with 15 
ml of the culture. Cells were grown at 37 °C, 200 rpm to an OD600 of 0.5. The cultures were then 
induced with IPTG which was added to a concentration of 0.5 mM each. Inducation was usually for 5 
hr at 37 °C, 200 rpm. Cells were harvested for 10 min, 4 °C, 4200 rpm (rotor: SLA3000, Sorvall 
Evolution® RC Centrifuge). Pellets were resuspended with ∑ 400 ml 25 mM Tris pH 7.4 and pooled. 
The resulting pellet was centrifuged for 5 min, 4 °C at 8000 rpm. The supernatant was discarded and 
the pellet resuspended with ∼ 200 ml 25 mM Tris pH 7.4/2 mM EDTA. An equal volume of 25 mM 
Tris pH 7.4/ 40 % sucrose was slowly added to the suspension which was stirred very slowly for 20 
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min at RT on a magnetic stirrer (RH basic 2 IKAMAG®, IKA®). The suspension was then centrifuged 
as before and the supernatant discarded carefully (in the cold room) as the resulting pellet was very 
soft. The pellet was resuspended with 150 ml of ice-cold 0.5 mM MgSO4, slowly stirred in the cold 
room for 20 min and centrifuged as before. The supernatant containing the lyticase was aliquoted in 
15 ml falcon tubes, snap-frozen in liquid nitrogen and stored at – 80 °C. Lyticase activity was 
determined using the yeast strain RSY255 (or RSY607) (ref. Table 2.18). RSY255 (∼ 50 ml) was 
grown in YPD to an OD600 of 2, harvested for 5 min at 4200 rpm (rotor: SS34, Sorvall Evolution® RC 
Centrifuge), RT and resuspended with 50 mM Tris-HCL pH 7.4/ 10 mM DTT to an OD600 of ∼ 2 
(OD600 START). Aliquots (1 ml) of the yeast culture (duplicates or triplicates) were incubated with 
various concentrations of lyticase (0.2, 1.0, 2.0, 5.0, 10 µl). Samples were incubated at 30 °C for 30 
min and the OD600 was immediately measured. The lyticase activity was determined as follows. 
 
Table 2.18. Calculation of lyticase activity (example: OD600 START = 1.85). 
Volume 
Lyticase 
(µl/ml) 
0.2 0.5 1.0 2.0 5.0 10.0 
Lyticase 
preparation 
Sample 1 
0.75 0.36 0.17 0.04 0.01 0.05 
Lyticase 
preparation 
Sample 2 
0.75 0.36 0.14 0.08 0 0.02 
% OD600 
START 
40.5 19.5 8.4 3.2 - - 
Δ % 59.5  80.5 91.6 96.8 - - 
10 % of Δ % 5.95  
(10 % of Δ 
%)/VLyticase 
5.95/0.2 µl  
Units/ml 29750 U/ml 
 
 
2.2.17 TRANSFORMATION OF S. CEREVISIAE 
Transformation of S. cerevisiae using the Lithium Acetate method (LiAc/SS-DNA/PEG) procedure 
was as described by Gietz et al. (1995) and Gietz & Woods (2002). Briefly, a 50 ml culture of S. 
cerevisiae was grown overnight at 30 °C with vigorous shaking. The cells were harvested at 5000 
rpm for 5 min at RT (rotor: #12169, Sigma 4K15 Refrigerated Centrifuge) and washed in 25 ml of 
sterile dH2O. The pellet was resuspended in 1 ml of 100 mM LiAc and centrifuged for 30 sec at 
8000 rpm (Microcentrifuge 5415R, Eppendorf), RT. The pellet was then resuspended in 100 mM 
LiAc to a final volume of 500 µl. Aliquots of 50 µl were used for the transformation. The 50 µl were 
centrifuged for 30 sec at full speed, RT. For the transformation the ingredients were added in the 
following order: 240 µl 50 (w/v) % PEG (MW 3350), 36 µl 1 M LiAc, 50 µl of carrier DNA (DNA from 
salmon testes, 2 mg/ml (Sigma), boiled for 5 min prior to use), 50 µl plasmid DNA* (∼ 1 µg). The 
mixture was vortexed for 1 min (full speed). The transformation was incubated for 30 min at 30 °C 
2 MATERIALS AND METHODS 
 
	   92	  
followed by 20 min at 42 °C (water bath). The samples were centrifuged for 1 min at 8000 rpm. The 
transformation mix was discarded and the cell pellet was taken up in 200 µl TE (10 mM Tris-HCl pH 
8.0, 1 mM EDTA pH 8.0). Cells were plated onto the appropriate minimal medium plates and 
incubated at 30 °C for 2-4 days. The LiAc method was applied to transform the S. cerevisiae strains 
RSY255 (pRS306-truncsec61 constructs) and JDY638 (pRS315-sec61 constructs) with the 
appropriate plasmid DNA (ref. Table 2.5) to create the desired sec61 strains. Moreover, it was used 
to transform sec61 strains etc. with the appropriate CEN plasmids for various assays. 
 
* The transformation with yeast integrative plasmids required the linearization of the respective 
plasmid DNA prior to transformation (ref. 2.2.18). This allows for directed integration of the 
respective sequence into the yeast genome.  
 
 
2.2.18 VERIFICATION OF S. CEREVISIAE TRANSFORMANTS 
For transformations into RSY255 plasmid DNA was linearized prior to transformation to allow for 
integration of the respective sequence into the yeast genome. Digestion with SfiI (NEB) was as 
described in Table 2.15. The reaction mix was incubated at 50 °C for 1 hr and then immediately 
used for transformation. 
Verification of the various sec61 strains was as follows. Positive transformants in the RSY255 
background were picked and plated onto minimal medium plates lacking URA (growth) or LEU (no 
growth) using appropriate strains as positive and negative controls. True positive transformants were 
further analyzed. First, genomic DNA was isolated (ref. 2.2.22) which was used in a PCR (ref. 2.2.4) 
with the primers 5’ HindIII SEC61 5’UTR #-445 and 3’ pRS306 URA3 #621 to verify proper 
integration of the desired sec61 sequence from the respective pRS306-truncsec61* construct into 
the yeast genome. 
Transformants (pCEN-LEU2-sec61*) in the JDY638 (pGAL-SEC61 promotor) background were 
verified by plating onto minimal medium w/o LEU (2 % (w/v) Galactose/ 0.2 % (w/v) Raffinose) after 
the transformation. Plates were incubated at 30 °C for 2-4 days. Transformants that came up were 
plated onto both YPD and 5-FOA plates (0.002 % (w/v) Uracil, supplements according to 
auxotrophies (lacking Uracil)*, 0.67 % (w/v) YNB w/o Amino Acids, 2 % (w/v) Glucose, 2 % (w/v) 
Agar, 0.1 % (w/v) 5-Fluoroorotic acid (Fermentas)). Real positive transformants were able to grow on 
both plates. 
 
* According to Table 2.10. 
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2.2.19 S. CEREVISIAE GROWTH ON PLATES (DROP TEST) 
Drop tests were performed as follows. For overnight cultures 5 ml YPD were inoculated with a single 
colony of the respective yeast strain and incubated at 30 °C and 220 rpm. The next day the cells 
were counted in a hemocytometer (Neubauer improved) and the cell number per ml was determined. 
For each strain serial dilutions in sterile dH2O were prepared and 5 µl of each dilution were dropped 
onto YPD or minimal medium (concentrations on plate: 105 – 100). The plates were incubated at 
various temperatures (usually: 20, 25, 30 and 37 °C) for 3 days. 
 
 
2.2.20 S. CEREVISIAE TRANSLOCATION ASSAY 
The translocation assay was performed in order to verify whether any of the newly generated 
JDY638 (pGAL-SEC61) derivatives with pCEN-LEU2-sec61* (sec61*: sec61-S179P, sec61-S353C, 
sec61-S179P/S353C) were defective in either co- or posttranslational import compared to sec61-
302, sec61-303 and SEC61. Each yeast strain was therefore transformed with the reporter plasmids 
pDN106 (pRS313-CPY-URA3; posttranslational import), or pJN203 (pRS313-PHO8-URA3; 
cotranslational import), or the empty vector pRS313 (control) (Sikorski & Hieter, 1989; Ng et al., 
1996; 2007). Cells were plated onto HIS-LEU d/o plates and incubated for 2 - 4 days at 30 °C. 
Overnight cultures of positive transformants were prepared and incubated overnight at 30 °C and 
225 rpm. Serial dilutions of each strain were prepared and dropped onto minimal medium w/o 
HIS/LEU/URA (monitors translocation defect for URA3 reporter) and w/o HIS/LEU d/o (monitors 
Sec61p function, i.e. maintenance of SEC61-containing plasmid) plates (105-101). Plates were 
incubated at 30 °C for 3 days. 
 
 
2.2.21 ISOLATION OF S. CEREVISIAE RNA 
The preparation of yeast RNA was according to Current Protocols in Molecular Biology (ref. chapter 
13.12.1: Preparation of yeast RNA by Extraction with Hot Acidic Phenol). In brief, 10 ml of a yeast 
culture were grown to an OD600 of 1 at 30 °C, 220 rpm. Cells were harvested for 5 min at 4 °C, 7000 
rpm (rotor: #11140; Sigma 4K15 Refrigerated Centrifuge). The supernatant was discarded and the 
pellet was resuspended in 1 ml of ice-cold RNase-free dH2O (DEPC-treated) and transferred to 
clean RNase-free microcentrifuge tube. The cells were centrifuged at full speed, 4 °C for 10 sec 
(Microcentrifuge 5415R, Eppendorf). The supernatant was discarded and the pellet resuspended 
with 400 µl TES Solution (10 mM Tris-HCl pH 7.7, 10 mM EDTA, 0.5 % (w/v) SDS). Next, 400 µl of 
Acid Phenol (Roti®-Aqua-Phenol, C. Roth) were added and the sample vortexed for 10 sec and 
incubated at 65 °C for 1 hour with occasional vortexing. After the incubation step, the sample was 
placed on ice for 5 min, followed by a centrifugation at full speed, 4 °C for 5 min (Microcentrifuge 
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5415R, Eppendorf). The aqueous (top) phase was transferred to a clean microcentrifuge tube. 400 
µl Roti®-Aqua-Phenol were added and the sample was vortexed for 20 sec, incubated on ice for 5 
min and centrifuged as before. The resulting aqueous phase was transferred to a clean 
microcentrifuge tube and mixed with 400 µl chloroform, vortexed for 20 sec and centrifuged as 
before. The aqueous phase was transferred to a clean microcentrifuge tube and 40 µl of 3 M NaAc 
(pH 5.3) and 1 ml of ice-cold 100 % ethanol were added. The sample was vortexed and centrifuged 
as before. The resulting pellet was washed with 1.5 ml 70 % (v/v) ethanol, centrifuged as before and 
resuspended in 50 µl RNase-free dH2O (DEPC-treated). The concentration was determined by 
measuring the OD260 of a 1:200 dilution in dH2O. RNA was stored at – 20 °C. 
 
 
2.2.22 ISOLATION OF S. CEREVISIAE CHROMOSOMAL DNA 
Yeast chromosomal DNA was prepared according to Hoffman & Winston (1987). In brief, 10 ml of a 
yeast overnight culture (in YPD or the appropriate drop-out medium) were harvested at 3000 rpm, 
RT for 5 min (rotor: #11140, SIGMA 4K15 Refrigerated Centrifuge). The pellet was resuspended in 
0.5 ml of cold dH2O. The cells were transferred to a 1.5 ml microcentrifuge tube and centrifuged for 5 
sec at full speed, RT (MiniSpin® Centrifuge, Eppendorf). The supernatant was discarded and the 
pellet resuspended in 200 µl Breaking Buffer (2 % (v/v) Triton X-100, 1 % (w/v) SDS, 100 mM NaCl, 
100 mM Tris-HCl pH 8.0, 1 mM EDTA pH 8.0). Next, 1 volume (∼ 0.3 g) of acid-washed glass beads 
and 200 µl of PCI (Phenol/Chloroform/Isoamyl Alcohol, 25:24:1) were added. The sample was 
vortexed for 3 min at full speed. Next, 200 µl of TE Buffer (10 mM Tris-HCl pH 8.0, 1 mM EDTA pH 
8.0) were added. The sample was vortexed briefly and centrifuged at full speed for 5 min. The 
resulting aqueous phase was transferred to a clean microcentrifuge tube and 1 ml 100 % EtOH was 
added. The sample was mixed by inversion and centrifuged for 3 min at full speed. The pellet was 
resuspended in 400 µl TE Buffer. 15 µl of DNase-free RNase (10 mg/ml, Fermentas) were added 
and the mixture incubated for 10 min at 37 °C. After the incubation, 10 µl 4 M Ammonium Acetate 
and 1 ml 100 % EtOH were added, the sample was mixed by inversion and centrifuged at full speed 
for 3 min. The supernatant was discarded, the pellet dried at RT and resuspended in 100 µl TE 
buffer. Yeast DNA concentration was determined by measuring the OD260 of a 1:200 dilution of the 
sample in dH2O. 
 
 
2.2.23 PREPARATION OF CELL EXTRACTS 
For the preparation of yeast cell extracts fresh overnight cultures were used to inoculate 25 ml YPD. 
Cells were grown to an OD600 of 2 at 30 °C, 220 rpm. Next, cells were harvested at 8000 rpm for 1 
min (MiniSpin® Centrifuge, Eppendorf) and the supernatant was discarded. The pellet was 
2 MATERIALS AND METHODS 
 
	   95	  
resuspended in 120 ml 1X SDS-PAGE Sample Buffer (62.5 mM Tris-HCl pH 6.8, 2 % (w/v) SDS, 5 
% (v/v) β-Mercaptoethanol, 0.001 % (w/v) Bromophenol Blue, 10 % (v/v) Glycerol). About 100 µl of 
glass beads (acid washed glass beads 400 – 600 µm, Sigma) were added and the cells disrupted in 
the cold room using a bead beater (Mini-Beadbeater-24; Bio Spec Products Inc.). Disruption was 
conducted 3 times for 1 min (with 1 min incubation on ice between each cycle). The samples were 
heated for 10 min at 65 °C and centrifuged at 12000 rpm for 1 min. The supernatant was transferred 
to a clean microcentrifuge tube, mixed and aliquoted into 20 µl, snap frozen in liquid nitrogen and 
stored at – 20 °C. Samples were analyzed by Western Blot Analysis (ref. 2.2.24). 
 
 
2.2.24 PROTEIN GEL ELECTROPHORESIS AND WESTERN BLOT ANALYSIS 
 
2.2.24.1 PROTEIN GEL ELECTROPHORESIS  
Protein gel electrophoresis (SDS-PAGE) was routinely conducted using NuPAGE® Novex® Pre-Cast 
Bis-Tris gels (generally 4-12 % gels, 1.5 mm, 10 wells) and the XCell SureLock™ Mini-Cell (both 
Invitrogen) if not stated otherwise.  
Prior to loading an appropriate volume of the protein sample onto the gel, samples were prepared by 
adding the appropriate volume of 4X SDS-PAGE Sample Buffer (4X: 240 mM Tris-HCl pH 6.8, 8 % 
(w/v) SDS, 20 % (v/v) β-Mercaptoethanol, 0.004 % (w/v) Bromophenol Blue, 40 % (v/v) Glycerol) 
and heating samples at 95 °C (60 °C for membrane proteins) for 5 min in a block heater 
(Thermomixer® comfort (Eppendorf) or block heater SBH200D/3, Stuart®). The samples were run in 
1X NuPAGE® MOPS SDS Running Buffer (Invitrogen) at 150-180 V, RT using a Bio-Rad 
PowerPac™ HC power supply, until the blue dye ran off the bottom of the gel. The PageRuler™ 
Prestained Protein Ladder or the PageRuler™ Plus Prestained Protein (both Fermentas) were used 
as the size standard according to the supplier’s instructions. The gel was then either stained with 
Coomassie and dried (ref. 2.2.24.2) or subjected to Western Blot analysis (ref. 2.2.24.3). 
 
 
2.2.24.2 COOMASSIE STAINING AND DRYING OF PROTEIN GELS 
In order to stain proteins for detection on protein gels the EZBlue™ Gel Staining Reagent (Sigma-
Aldrich) was used. This reagent is a ready-to-use Coomassie® Brilliant Blue G-250 based stain. Gels 
were stained according to the supplier’s instructions. In brief, after electrophoresis the gel was rinsed 
3 times for 5 min with dH2O. Next, the gel was fixed* for 15 min using Fixing Solution (50 % (v/v) 
Methanol, 10 % (v/v) Acetic Acid). Following the fixing step, the gel was washed for 15 min with 
excess dH2O. The EZBlue™ Gel Staining Reagent (20-40 ml) was added to the gel, which was 
incubated for 1 hr at RT. The gel was then washed with dH2O until the background became clear. 
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The dH2O was changed frequently to enhance the contrast between the protein bands and the 
background. 
Optional, the protein gel was dried in a gel dryer (Model 583, Bio-Rad) at 80 °C for 1 hr if desired.  
 
* For native gels run in Tris-Glycine Buffer a fixing was not required. 
 
 
2.2.24.3 WESTERN BLOT ANALYSIS 
Western Blotting was employed to identify the desired proteins using appropriate antibodies. Protein 
transfer and immunoblotting were as follows: Proteins were transferred from the protein gel (ref. 
2.2.24.1) onto nitrocellulose (NC) membranes (0.45 µm pore size, Bio-Rad). The blot was 
assembled using the NC as well as 3 MM Chromatography Paper (Whatman®) and sponges soaked 
in Transfer Buffer (25 mM Tris, 200 mM Glycine, 20 % (v/v) Methanol, 0.2 % (w/v) SDS). The protein 
transfer was conducted in Transfer Buffer for 2 hr at 100 V in the cold room using a Trans-Blot® 
Electrophoretic Transfer Cell (with plate electrodes and super cooling coil, Bio-Rad).  
Following the transfer, the membrane was blocked in Blotto (50 mM Tris-HCl pH 7.4, 150 mM NaCl, 
2 % (w/v) Milk Powder, 0.1 % (v/v) Tween-20, 5 mM Sodium Azide) for 1 hr shaking at RT. The 
membrane was then incubated with the primary antibody (diluted in Blotto, ref. Table 2.7) overnight 
in the cold room shaking. The next day, the membrane was washed twice for 10 min in Blotto 
followed by 2 washes for 10 min in 1X TBS-T (50 mM Tris-HCl pH 7.4, 150 mM NaCl, 0.1 % (v/v) 
Tween-20, 5 mM Sodium Azide). Next, the membrane was incubated with the secondary antibody 
(ref. Table 2.7, generally anti-rabbit 1:200000 in TBS-T for detection with the ChemiDoc™ XRS 
System) shaking for 1 hr at RT. The membrane was washed 4 times for 10 min with TBS-T. 
The blot was prepared for detection using the SuperSignal™ West Dura Extended Duration 
Chemiluminescent Substrate (Pierce) according to the supplier’s instructions. Signals were detected 
using the Molecular Imager ChemiDoc™ XRS System (Bio-Rad; CCD camera detection) and 
evaluated/ quantified with the ImageLab™ software (Bio-Rad). 
 
 
2.2.25 PREPARATION OF ROUGH MICROSOMAL MEMBRANES 
The isolation of rough microsomal membranes from S. cerevisiae was performed according to 
Lyman & Shekman (1995) and Pilon et al. (1997). Briefly, 2.5-10 L of a yeast culture were grown 
overnight in YPD at 30 °C and 200 rpm to an OD600 of ∼ 2. The cells were harvested at 5000 rpm 
and RT for 3 min (rotor: SLA3000; Sorvall Evolution® RC centrifuge), the pellet was resuspended in 
100 mM Tris-HCl pH 9.4/10 mM DTT to 100 OD600/ml and then incubated for 10 min at RT in order 
to weaken the cell walls. Cells were pelleted for 5 min at 5000 rpm, RT and then resuspended in 
Lyticase Buffer (50 mM Tris-HCl pH 7.5, 0.75 X YP, 700 mM Sorbitol, 0.5 % Glucose, 10 mM DTT) 
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to 100 OD600/ml. Lyticase was added to a final concentration of 40 U per OD600 of cells. Incubation 
was for 20 min at 30 °C, 80 rpm (Multitron Standard Incubation Shaker, Infors HT (Infors AG)). 
Following the incubation, the cells were chilled on ice for 2 min and then pelleted for 5 min at 5000 
rpm, 4 °C. The supernatant was carefully discarded and the pellet washed with 2X JR Buffer (40 mM 
Hepes-KOH pH 7.4, 400 mM Sorbitol, 100 mM KOAc, 4 mM EDTA) to 250 OD600/ml and centrifuged 
at 10.000 rpm and 4 °C for 10 min (rotor: SS34, Sorvall Evolution® RC centrifuge). The resulting 
pellet was resuspended in 2X JR buffer to 500 OD600/ml and frozen at – 80 °C for at least 1 hr. 
The spheroplasts were thawed in an ice-cold water bath and mixed with an equal volume of cold 
MilliQ water. PMSF and DTT were added to a final concentration of 1 mM and the spheroplasts were 
disrupted with ten strokes of a motor-driven Potter Elvehjem homogenizer (EUROSTAR power 
basic, IKA®) in the cold room. The lysate was centrifuged for 5 min at 3000 rpm, 4 °C (rotor: SS34; 
Sorvall Evolution® RC Centrifuge) and the supernatant transferred to a clean polycarbonate SS34 
tube and centrifuged at 17500 rpm, 4°C for 15 min to pellet the membranes. The sample was placed 
on ice and the pellet was resuspended in a minimum volume (∼ 0.5 ml) of B88 (20 mM Hepes-KOH 
pH 6.8; 250 mM Sorbitol; 150 mM KOAc, 5 mM Mg(OAc)2) and gently homogenized on ice using a 
small teflon pestle and carefully resuspended using a 1000 µl Gilson® pipette. The sample was 
loaded onto a 1.2 M/1.5 M Sucrose Gradient (20 mM Hepes-KOH pH 7.5, 50 mM KOAc, 2 mM 
EDTA, 1 mM DTT, 1.2 M or 1.5 M Sucrose) and centrifuged at 44000 rpm, 4 °C for 1 hr (rotor: SW 
60 Ti; Optima™ L-90 K Ultracentrifuge). For the sucrose gradient, 1.5 ml of each sucrose solution 
(1st: 1.5 M, 2nd: 1.2 M) was layered into an SW60Ti tube (Beckman Coulter #344062). ER-derived 
microsomes were collected at the interphase of the 1.2 M/1.5 M sucrose gradient and washed with 
25 ml of cold B88. The sample was centrifuged at 17500 rpm, 4 °C for 15 min (rotor: SS34; Sorvall 
Evolution® RC Centrifuge). The microsome pellet was carefully resuspended in the appropriate 
volume of B88. Membrane concentration was measured at OD280 in 2 % (w/v) SDS at a 1:100 
dilution. The concentration was adjusted to an OD280 of ∼ 30 with B88 and the samples aliquoted (50 
µl), snap-frozen in liquid nitrogen and stored at – 80 °C.  
 
 
2.2.26 PREPARATION OF RIBOSOME- AND PROTEASOME-STRIPPED MEMBRANES 
The preparation of ribosome- and proteasome-stripped membranes (PK-RMs) from RMs by 
treatment with puromycin and potassium acetate was modified from Neuhof et al. (1998). The 
reaction was set up on ice. In brief, about 3 ml of rough microsomal membranes (∼ 5500 eq*) were 
mixed with an equal volume of 2X Buffer A (3 mM DTT, 100 mM Hepes-KOH pH 7.6, 300 mM 
KOAc, 10 mM Mg(OAc)2, 2X Protease Inhibitors, 500 mM Sucrose) as well as 12 µl of 100 mM GTP, 
3.3 mg of Puromycin and 6 µl of (40 U/µl) RNasin respectively. The sample was homogenized by 
five strokes with a motor-driven Potter-Elvehjem homogenizer (EUROSTAR power basic, IKA®) and 
incubated on ice for 1 hour. Next, 1/1000 volume (6 µl) of 100 mM GTP was added, the sample 
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homogenized as before and incubated at 37 °C for 30 min. Following the incubation, 1/10 volume of 
8 M KOAc and 1/100 volume of 1 M Mg(OAc)2 were added and the sample carefully resuspended. 
The sample was carefully laid on top of a 950 µl Sucrose Cushion (50 mM Hepes-KOH pH 7.6, 1.6 
M Sucrose, 500 mM KOAc, 10 mM Mg(OAc)2) in a TLA100.3 thick wall polycarbonate tube 
(Beckman Coulter #349622) and centrifuged at 100000 rpm, 18 °C for 1 hour, followed by 1 hour at 
100000 rpm, 4 °C (rotor: TLA 100.3, Optima™ MAX-XP Benchtop Ultracentrifuge). The supernatant 
was carefully removed and the PK-RMs were collected at the interphase. In order to isolate the 
ribosomes at the bottom of the tube, the cushion layer was carefully removed and the ribosomal 
pellet resuspended in 600 µl of Buffer A (1.5 mM DTT, 50 mM Hepes-KOH pH 7.6, 150 mM KOAc, 5 
mM Mg(OAc)2, 1X Protease Inhibitors, 250 mM Sucrose), snap-frozen in liquid nitrogen and stored 
at – 80 °C. In order to remove the sucrose and puromycin, the PK-RMs were resuspended in 7.5 ml 
of 50 mM Hepes-KOH pH 7.2, homogenized and centrifuged for 30 min at 100000 rpm, 4 °C. The 
resulting pellet was resuspended in 6 ml 50 mM Hepes-KOH pH 7.2, homogenized and centrifuged 
as before. The pellet was resuspended with 3 ml PK-RM Membrane Buffer (50 mM Hepes-KOH pH 
7.2, 250 mM Sucrose, 50 mM KOAc, 2 mM Mg(OAc)2), 1 mM β-Mercaptoethanol), homogenized and 
centrifuged as before. Finally, the pellet was resupended in 0.3 volumes of Membrane Buffer (to a 
final concentration of ∼ 2 eq/µl), aliquoted (25 µl), snap-frozen in liquid nitrogen and stored at – 80 
°C. The concentration of PK-RMs was determined by Western Blotting using anti-Sec61p antibody 
(ref. 2.2.24.1, 2.2.24.3 and Table 2.7). RMs were used as the standard (standards: 0.25 eq, 0.5 eq, 
0.75 eq, 1.0 eq, 1.5 eq of RMs). 
 
* 1 eq of microsomes = 50 A280 units/µl (Walter & Blobel, 1981). 
 
 
2.2.27 PREPARATION OF RECONSTITUTED PROTEOLIPOSOMES 
Reconstituted proteoliposomes were prepared according to Görlich & Rapoport (1993), Kalies et al. 
(1994) and Jungnickel & Rapoport (1995). Generally, a 200 µl reaction was set up. In brief, 200 eq of 
PK-RMs (concentration: ∼ 2 eq/µl) were solubilized in 66 µl of 3X Solubilizing Buffer (150 mM 
Hepes-KOH pH 7.6, 1200 mM KOAc, 30 mM Mg(OAc)2, 48 % (v/v) Glycerol, 6 mM DTT, 1X 
Protease Inhibitors) and Deoxy-BigCHAP (Sigma-Aldrich) was added to a final concentration of 3 % 
(v/v). Samples were incubated on ice for 30 min and then centrifuged at 14000 rpm, 4 °C for 5 min 
(Microcentrifuge 5415R, Eppendorf) in order to remove undissolved membranes. The supernatant 
was transferred to a clean 2 ml microcentrifuge tube containing 200 µl washed SM-2 Bio-Beads 
(Biorad) and 5 µl of Phosphatidylcholine/Phosphatidyl-ethanolamin (PC/PE = 4:1  c = 20 µg/µl; ref. 
2.2.28). SM2 BioBeads were prepared by washing 200 µl of the beads (stored in ethanol) three 
times with 200 µl of cold dH2O, followed by three washes with 200 µl of Wash Buffer (50 mM Hepes-
KOH pH 7.6, 400 mM KOAc, 16 % (v/v) Glycerol, 1 mM DTT). The beads were vortexed for 3 sec 
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and centrifuged for 1 min at full speed, 4 °C (Microcentrifuge 5415R) each time. The reaction mix 
was vortexed for 1 min and placed in a thermomixer (Thermomixer® comfort, Eppendorf) in the cold 
room overnight and mixed at 1100 rpm, 8-12 °C. The next day, the sample was centrifuged at full 
speed, 4 °C for 5 min (Microcentrifuge 5415R), the supernatant transferred to a clean 
microcentrifuge tube and the beads were washed three times with cold dH2O. The supernatant and 
the washes were pooled and transferred to an ultracentrifuge TLA100.3 1.5 ml tube (Beckman 
Coulter #357448; used with adapters Beckman Coulter #355919) and proteoliposomes pelleted at 
77000 rpm, 4 °C for 30 min (rotor: TLA100.3, Optima™ MAX-XP Benchtop Ultracentrifuge). The 
resulting pellet was resuspended in 100 µl of Binding Buffer (20 mM Hepes-KOH pH 7.2, 120 mM 
KOAc, 5 mM Mg(OAc)2, 1 mM DTT, 5 mM ATP, 250 mM Sucrose), aliquoted (10 µl), snap-frozen in 
liquid nitrogen and stored at –80 °C. Reconstituted membranes were quantified by Western Blot 
analysis using anti-Sec61p antibody (ref. 2.2.24.1, 2.2.24.3 and Table 2.7) and using RMs as the 
standard (standards: 0.25 eq, 0.5 eq, 0.75 eq, 1.0 eq, 1.5 eq of RMs). 
 
 
2.2.28 PREPARATION OF PHOSPHATIDYLCHOLINE/PHOSPHATIDYLETHANOLAMINE 
The Phosphatidylcholine/Phosphatidylethanolamine (PC/PE) mix was prepared as follows: 320 µl of 
PC (10 mg/ml; Avanti-polar® Polar Lipids Inc. #840055C) were mixed with 80 µl of PE (10 mg/ml; 
Avanti-polar® Polar Lipids Inc # 840026C), 60 µl 10 % (v/v) Deoxy-BigCHAP (Sigma) and 2 µl 1 M 
DTT. The reaction mix was dried in a vacuum concentrator (Concentrator Plus; Eppendorf) at RT for 
a few hours and the resulting pellet dissolved in 250 µl of 96 % (v/v) ethanol. The reaction mix was 
dried as before overnight. The pellet was dissolved in 200 µl Ro-Buffer (16 % (v/v) Glycerol, 50 mM 
Hepes-KOH pH 7.6) (final concentration: 20 µg/µl (PC/PE = 4:1)). The sample was aliquoted (10 µl), 
snap-frozen in liquid nitrogen and stored at - 80 °C. 
 
 
2.2.29 PREPARATION OF S. CEREVISIAE CYTOSOL FOR PROTEASOME PURIFICATION 
The preparation of yeast cytosol was conducted according to Current Methods in Molecular Biology 
(ref. Chapter 13.13.5-9). In brief, 10 L of KRY333 were grown in YPD at 200 rpm, 30 °C overnight to 
an OD600 of 2. The cells were harvested by centrifugation at 5000 rpm, RT for 5 min (rotor: SLA3000; 
Sorvall Evolution® RC Centrifuge). The cell pellets were resuspended in 400 ml of cold dH2O, pooled 
and centrifuged as before. After resuspension of the pellet with 3-5 ml of B88 (20 mM Hepes-KOH, 
pH 6.8; 250 mM Sorbitol; 150 mM KOAc, 5 mM Mg(OAc)2), cells were frozen in liquid nitrogen. First, 
about 500 ml of liquid nitrogen were poured into a Tri-Pour® plastic beaker (VWR®), which was 
placed on a magnetic stirrer. The liquid nitrogen was stirred at moderate speed using a large 
magnetic stir bar. The cells were poured slowly into the liquid nitrogen. Once the cells were frozen, 
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the liquid nitrogen was decanted. The resulting frozen material was transferred to 50 ml falcon tubes 
and stored at – 80 °C. Next, about 500 ml of liquid nitrogen were added to a stainless-steel blender 
(Rio™ Commercial Bar Blender, Hamilton Beach®) running at the lowest setting (in the cold room). 
Once the cells had been added the blender was run at the highest setting. Lysis was performed for 
10 min with addition of liquid nitrogen every minute to maintain the volume of the liquid nitrogen. 
After 10 min the blender was turned off, the liquid nitrogen evaporated, and the powder transferred 
to 50-ml falcon tubes. The powder was stored at – 80 °C until needed.  
 
 
2.2.30 PURIFICATION OF S. CEREVISIAE PROTEASOME 26S HOLOENZYME AND 19S RP 
SUBCOMPLEX 
The purification of S. cerevisiae 26 S proteasome and 19S RP (Regulatory Particle) was according 
to Verma et al. (2000), Leggett et al. (2002) and Lee et al. (2004a) using the yeast strain KRY333 
which expresses a FLAG®-tagged version of the rpt1 19S RP subunit. Briefly, cytosol was prepared 
as described in 2.2.29. The frozen cytosol was thawed in a cold water bath, mixed with an equal 
volume of Buffer A (50 mM Tris-HCL pH 7.5, 150 mM NaCl, 10 % (v/v) Glycerol, 5 mM MgCl2) and 
then centrifuged at 17500 rpm, 4 °C for 45 min (rotor: SS34, Sorvall Evolution® RC Centrifuge). For 
purification of 26S proteasomes, ATP (pH 7.0) was added to a final concentration of 5 mM to all 
solutions. Following the centrifugation, the supernatant was carefully taken off and mixed with Buffer 
A-equilibrated anti-FLAG® M2 agarose beads (Sigma-Aldrich #A2220) in a 50 ml falcon tube. The 
sample was incubated for 4 hr (up to overnight) at 4 °C with gentle agitation. Equilibration of the 
FLAG® M2 agarose beads was as follows: In brief, the appropriate amount of beads was transferred 
to a disposable PD-10 column (Amersham Biosciences, GE Healthcare) using a blue pipette tip, 
which had been cut off. The column had been rinsed once with Buffer A. The beads were then 
equilibrated by adding 3 column volumes of 0.1 M Glycine-HCl (pH 3.5) followed by 5 column 
volumes of Buffer A. The bead bed was never allowed to run dry. About 500 µl of beads were used 
per 50 ml of supernatant prepared from a yeast culture of 10000 OD600. Following the incubation, the 
whole sample was passed through a PD-10 column and the beads were washed twice with Buffer 88 
(20 mM Hepes-KOH pH 6.8, 250 mM Sorbitol, 150 mM KOAc, 5 mM Mg(OAc)2) followed by two 
washes with Buffer 88/0.2 % Triton X-100 (B88, 0.2 % (v/v) Triton X-100). Again, the gel bead was 
not allowed to run dry. The beads were carefully resuspended in B88 (final volume: 2 ml), 
transferred to a clean 2 ml microcentrifuge tube and eluted with 150 µg/ml FLAG® peptide at 4 °C for 
4 hr (or overnight) on a rotating wheel. Following the elution the sample was purified by passing it 
through a PD-10 column and the eluate was concentrated at 3000 rpm, 4 °C (SIGMA 4K15 
Refrigerated Centrifuge) using a Centricon® YM-100 centrifugal filter (Merck Millipore) until a final 
concentration of 1-2 µg/µl was reached.  
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The resulting 19S RP or 26S proteasomes were aliquoted (10 µl), snap-frozen in liquid nitrogen and 
stored at – 80 °C. Protein concentration was determined using the Pierce™ 660nm Protein Assay 
Reagent (Pierce, Thermo Fisher Scientific) according to the supplier’s instructions and a microplate 
reader (Bio-Rad, measuring at 655 nm). 
Samples taken throughout the purification (i.e. cytosol, flow through, washes ans purified sample) 
were analyzed by SDS-PAGE (ref. 2.2.24.1). 
 
 
2.2.30.1 PEPTIDASE ACTIVITY ASSAY 
Proteasome activity was monitored using the fluorogenic peptide substrate N-Succinyl-Leu-Leu-Val-
Tyr-7-Amido-4-Methylcoumarin (Suc-LLVY-AMC, Sigma #S6510). The assay was performed as 
described by Leggett et al. (2002). The substrate is cleaved in the presence of active proteasome 
(i.e. by the chymotryptic-like peptidase activity of the proteasome). The resulting free AMC 
fluoresces and can be monitored on a UV transilluminator. The activity assay was perfomed as an 
in-gel activity assay. In brief, native gel electrophoresis was performed using a 4 % nondenaturing 
polyacrylamide gel (40 % (v/v) Acrylamide (37.5:1), 1X Native Gel Buffer, 1 mM ATP, 1 mM DTT, 1 
% (v/v) 10 % (w/v) APS, 0.1 % (v/v) TEMED). 5X Native Gel Loading Buffer (250 mM Tris-HCl pH 
7.4, 50 % (v/v) Glycerol, 0.007 % (w/v) Xylene Cyanol) was added to each sample (usually 1-5 µg of 
proteasome were loaded) and the gel was run in 1X Native Gel Buffer (5X: 450 mM Tris-borate pH 
8.35, 25 mM MgCl2, 2.5 mM EDTA) containing 1 mM ATP and 1 mM DTT at 100 V, 4 °C until the 
tracking dye ran off the bottom of the gel (∼ 2 hr). The gel was then incubated in Buffer A (10 % (v/v) 
Glycerol, 25 mM Tris-HCl pH 7.4, 10 mM MgCl2, 1 mM ATP, 1 mM DTT) containing 100 µM Suc-
LLVY-AMC and 0.02 % (w/v) SDS* for 15 min at 30 °C and visualized on a UV transilluminator at 
365 nm. 
 
* Optional: SDS was added to capture 20S CP activity. 
 
 
2.2.31 PROTEASOME BINDING ASSAY 
The proteasome binding assay was performed as described by Kalies et al. (2005). In brief, 20 eq of 
reconstituted proteoliposomes (ref. 2.2.27) were mixed with 2 pmole of 19S RP proteasomal subunit 
or the 26S holoenzyme (ref. 2.2.30) in 30 µl Binding Buffer (20 mM Hepes-KOH pH 7.2, 250 mM 
sucrose, 120 mM KOAc, 5 mM Mg(OAc)2, 5 mM ATP, 1 mM DTT). The reaction mix was first 
incubated on ice for 20 min followed by 10 min at RT. Next, 270 µl of Sucrose Cushion (20 mM 
Hepes-KOH pH 7.2, 2.5 M Sucrose, 120 mM NH4OAc, 5 mM Mg(OAc)2, 5 mM ATP, 1 mM DTT) 
were added and the sample was vortexed for 10 sec. 800 µl of Separating Cushion (20 mM Hepes-
KOH pH 7.2, 1.8 M Sucrose, 120 mM NH4OAc, 5 mM Mg(OAC)2, 5 mM ATP, 1 mM DTT) were 
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added to a polycarbonate thickwall tube (rotor: TLS-55, Beckman Coulter #343778). The Separating 
Cushion was carefully underlaid with the sample (300 µl). The sample was topped off with 200 µl of 
binding buffer and centrifuged at 55000 rpm, 4 °C for 1 hr (rotor: TLS55, Optima™ MAX-XP Benchtop 
Ultracentrifuge). After ultracentrifugation, the sample was divided into nine fractions (from top to 
bottom) using a 200 µl pipette tip which had been cut off. For TCA precipitation, an equal volume of 
ice-cold TCA was added to each fraction. The samples were vortexed briefly and incubated on ice 
for 30 min, followed by centrifugation at full speed, 4 °C for 10 min (Microcentrifuge 5415R, 
Eppendorf). The supernatants were taken off with a gel-loading tip and 500 µl of ice-cold Acetone 
added to the pellets. The samples were vortexed and centrifuged as before. The supernatants were 
taken off and the pellet dried at RT. About 20 µl of 2X SDS-PAGE Sample Buffer (125 mM Tris-HCl 
pH 6.8, 4 % (w/v) SDS, 10 % (v/v) β-Mercaptoethanol, 0.002 % (w/v) Bromophenol Blue, 20 % (v/v) 
Glycerol) were added to each pellet and the proteins resolved by SDS-PAGE (ref. 2.2.24.1). Western 
Blotting was performed as described in 2.2.24.3 using anti-FLAG® M2 antibody (1:2000, Sigma 
#F7425) as the primary antibody and anti-rabbit HRP (1:200000, Rockland™ #611-1302) as the 
secondary antibody (ref. Table 2.7). 
 
 
2.2.32 UNFOLDED PROTEIN RESPONSE ASSAYS 
 
2.2.32.1 QUANTITATIVE LIQUID ß-GALACTOSIDASE ASSAY 
The quantitative liquid ß-galactosidase assay was essentially as described by Miller (1972), 
Guarente (1983) and Staglar et al. (1998). All yeast strains of interest were transformed with the 
plasmids (ref. Table 2.5) pJC30 (UPRE-LacZ reporter construct) and pJC31 (control for pJC30) as 
described in 2.2.17. 
20 ml cultures* were grown in minimal medium (LEU-TRP d/o medium for pRS315-sec61**) at 30 
°C, 220 rpm to an OD600 of about 0.5. Aliquots of 1 ml were centrifuged at 8000 rpm (MiniSpin® 
centrifuge, Eppendorf), 4 °C for 5 min. The pellets were resuspended in 1 ml Z Buffer (pH 7; 60 mM 
Na2HPO4, 40 mM NAH2PO4, 10 mM KCl, 1 mM MgSO4) containing 0.27 (v/v) % β-mercaptoethanol. 
Next, 100 µl chloroform and 50 µl 0.1 (w/v) % SDS were added to the samples, which were agitated 
on a vortex mixer (Vortex-Genie 2®, Scientific Ind.™) for 10 sec. The samples were then pre-
incubated for 5 minutes at 28 °C (water bath). The reaction was induced with the addition of 200 µl 4 
mg/ml 2-nitrophenyl-β-D-galactopyranoside (ONPG) in Z Buffer. The samples were incubated at 
28 °C (water bath) until a pale yellow colour was visible (for strains transformed with pJC30). ONPG 
is converted to a yellow product by β-galactosidase, which absorbs light at a wavelength of 420 nm. 
The reaction was stopped by adding 500 µl of 1 M Na2CO3, the samples were centrifuged at full 
speed (MiniSpin® Centrifuge), RT for 10 minutes and the OD420 of the supernatant was measured in 
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a quartz cuvette (Hellma® Analytics). Generally, for each strain samples were prepared in triplicates. 
The activity is expressed as β-galactosidase units as follows:  
 
β-Gal units = 1000 x [OD420/(OD600 x v x t)] 
 
OD420: optical density of the product (o-nitrophenol) 
OD600: optical density of the culture 
v: volume of culture used in the assay (ml) 
t: time elapsed during the assay (after ONPG addition) 
 
* All cultures were prepared in duplicates or triplicates. One culture was used as a positive control. In 
brief, when an OD600 of about 0.4 was reached tunicamycin (Tm) was added to a final concentration 
of 1 µg/ml. The cultures were then incubated for another hour at 30 °C, 220 rpm and the assay 
conducted as described above. 
 
**: pRS315-sec61-S179P, pRS315-sec61-S353C, pRS315-sec61-S179P/S353C, pRS315-sec61-
302, pRS315-sec61-303 
 
 
2.2.32.2 GROWTH DEFECTS ON TUNICAMYCIN PLATES (DROP TEST) 
In order to monitor growth defects of the appropriate strains on plates containing tunicamycin drop 
tests were performed as in 2.2.19. Briefly, 5 ml cultures of the respective strains were prepared and 
the cells counted using a hemocytometer (Neubauer improved). Serial dilutions were prepared and 5 
µl of each dilution were dropped onto YPD (+/- 0.25 µg/ml Tm, 0.5 µg/ml Tm) plates or minimal 
medium plates (+/- 0.25 µg/ml Tm, 0.5 µg/ml Tm). Plates were incubated at various temperatures 
(routinely: 20, 25, 30 and 37 °C) for 3 days. 
 
 
2.2.32.3 HAC1 MRNA SPLICE ASSAY 
Upon induction of the UPR the HAC1 mRNA is spliced. Thus, the comparison of the two species, 
HAC1u and HAC1i (u = uninduced; i = induced), allows for the evaluation of the UPR status of 
various yeast strains. 
Cultures of the appropriate strains were prepared in minimal medium and grown at 30 °C, 220 rpm 
to an OD600 of 1. For positive controls each strain was grown in the presence of tunicamycin. In this 
case, when an OD600 of 1 was reached, 2 µg/ml Tm were added to the cultures. The cultures were 
then incubated for another 3 hr at 30 °C, 220 rpm. 10 ml of each culture were used to isolate yeast 
RNA according to 2.2.21.  
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The RNAs were used in reverse transcription reactions to generate cDNA. As the reverse 
transcriptase the Maxima® Reverse Transcriptase (Fermentas) was used. RNAs were diluted to a 
final concentration of 0.1 µg/µl. The reaction setup was as shown in Table 2.19. The samples were 
incubated for 30 minutes at 50 °C, followed by an inactivation at 85 °C for 5 minutes. 
 
Table 2.19. Reverse transcription reaction mixture. 
Component Volume (µl) Final concentration 
RNA 1 0.1 µg 
Oligo(dT18)-primer (100 mM) 1 100 pmol 
dNTP mix (10 mM) 1 0.5 mM 
RNase-free dH2O  to 14.5 to 14.5 µl 
5X RT buffer 4 1X 
RNasin (40 U/µl) 0.5 20 U 
Maxima® RT  1 200 U 
 
1 µl of each cDNA was used in a PCR using the HAC1- as well as the ACT1-specific primers (ref. 
Table 2.6). The PCR setup was as described in Table 2.12. The thermal cycler program was as 
described in Table 2.13 with the following exceptions: primer annealing (step 3) was at 50 °C, primer 
extension (step 4) was for 45 sec, final primer extension was for 3 min and steps 2 to 4 were cycled 
24 times.  
10 µl of the PCR product were run on a 1 % Agarose Gel in 1X TAE Buffer (50X TAE pH 8.4: 20 M 
Tris-HCl, 10 M Acetic Acid, 0.05 M EDTA) at 100 V and RT for 1 hr (ref. 2.2.8). Bands were 
visualized and photographed using the E-BOX VX2 gel documentation system (PEQLAB).  
 
 
2.2.33 PULSE-CHASE EXPERIMENTS 
 
2.2.33.1 PULSE LABELING 
Pulse chase experiments were performed as described by Gillece et al., (1999) and Verma et al. 
(2000). In brief, cells were grown overnight at 30 °C, 220 rpm in Growth Medium (0.67 % (w/v) Yeast 
Nitrogen Base (YNB) w/o Amino Acids (AA), 0.13 % (w/v) SC drop-out mix*, 0.2 % (w/v) Casamino 
Acids (CAA), 5 % (w/v) Glucose, Supplements as required by the strain’s auxotrophies**) to an 
OD600 of 0.5–1. Cells were harvested at 3000 rpm, RT for 5 min (rotor: SS34, Sorvall Evolution® RC 
Centrifuge). The cells were washed twice with Labeling Medium (0.67 % (w/v) YNB w/o AA and 
Ammonium Sulfate, 5 % (w/v) Glucose, Supplements as required by the strain’s auxotrophies**) and 
resuspended in Labeling Medium to an OD600 of 6 (pulse chase experiments) or 4 (pulse 
experiments). Aliquots of 1.5 OD600 (pulse chase experiments) or 2 OD600 (pulse experiments) were 
transferred to clean 1.5 ml microcentrifuge tubes. The samples were pre-incubated at 30 °C, 600 
rpm for 30 min (Thermomixer® comfort, Eppendorf). Cells were then pulsed with 0.35 mCi/ml 
EXPRESS35S35S Protein Labeling Mix (Perkin Elmer) and incubated for 2, 5 or 10 min (depending on 
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the substrate) at 600 rpm, 30 °C. Following the pulse, cells were immediately transferred to ice and 
labeling was terminated by adding 750 µl of cold Tris-Azide Buffer (20 mM Tris-HCl pH 7.5, 20 mM 
Sodium Azide). The cells were then centrifuged for 1 min at full speed, RT (Microcentrifuge 5415R, 
Eppendorf), the pellets resuspended in 1 ml of Resuspension Buffer (100 mM Tris-HCl pH 9.4, 10 
mM DTT, 20 mM Ammonium Sulfate) and incubated for 10 min at RT. The samples were centrifuged 
as before and resuspended in 150 µl of Lysis Buffer (20 mM Tris-HCl pH 7.5, 2 % (w/v) SDS, 1 mM 
PMSF, 1 mM DTT). Acid washed glass beads (∼ 150 µl; 450-600 µm, Sigma) were added and the 
cells disrupted in a Mini-Beadbeater-24 (Bio Spec Products Inc.) for 2 x 1 min with an incubation of 1 
min on ice in between bursts. Next, the samples were heated at 90 °C for 5 min (membrane 
proteins: 5 min at 60 °C) in a block heater (SBH200D/3, Stuart®). 3 x 250 µl of IP Buffer w/o SDS 
(150 mM NaCl, 1 % (v/v) Triton X-100, 15 mM Tris-HCl pH 7.5, 2 mM Sodium Azide) were added 
and the samples vortexed (Vortex-Genie® 2, Scientific Ind.™), centrifuged as before each time and 
the supernatants pooled in a clean 2 ml microcentrifuge tube. Immunoprecipitation using the 
appropriate antibody/antiserum and preparation for gel electrophoresis were as described in 
2.2.33.3. 
For pulse-chase experiments, the chase was initiated as described in 2.2.33.2. 
 
* According to Kaiser et al., 1994 (Formedium™; ref. Table 2.10). 
** Table 2.10 
 
 
2.2.33.2 CHASE 
For pulse-chase experiments, the chase was initiated by adding 250 µl of 2X Chase Mix (0.6 mg/ml 
Cysteine, 0.8 mg/ml Methionine, 2.6 mg/ml Ammonium Sulfate and 200 mg/ml Casamino Acids 
(CAA)) to the cells. For time-course experiments, multiple aliquots per strain were prepared. The 
samples were incubated at 600 rpm, 30 °C (Thermomixer® comfort, Eppendorf) over the desired 
period of time. Samples were taken at appropriate time points (e.g. t = 0, 5, 10, 15, 20, 30, 60 min), 
i.e. the chase was immediately terminated after each time point by the addition of cold Tris-Azide 
Buffer (20 mM Tris-HCl pH 7.5, 20 mM Sodium Azide). The samples were centrifuged at full speed, 
RT for 1 min (Microcentrifuge 5415R, Eppendorf) and resupended in 1 ml of fresh Tris-Azide Buffer 
and placed on ice until all samples were taken. The cells were then centrifuged for 1 min at full 
speed, RT, the pellets resuspended in 1 ml of Resuspension Buffer (100 mM Tris-HCl, pH 9.4, 10 
mM DTT, 20 mM Ammonium Sulfate) and incubated for 10 min at RT. The samples were centrifuged 
as before and resuspended in 150 µl of Lysis Buffer (20 mM Tris-HCl pH 7.5, 2 % (w/v) SDS, 1 mM 
PMSF, 1 mM DTT). Acid washed glass beads (∼ 150 µl; 450-600 µm, Sigma) were added and the 
cells disrupted in a Mini-Beadbeater-24 (Bio Spec Products Inc.) for 2 x 1 min with an incubation of 
1 min on ice between bursts. Next, the samples were heated at 90 °C for 5 min (membrane proteins: 
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5 min at 60 °C) in a block heater (SBH200D/3, Stuart®) and 3 x 250 µl of IP Buffer w/o SDS (150 mM 
NaCl, 1 % (v/v) Triton X-100, 15 mM Tris-HCl pH 7.5, 2 mM NaN3) were added. The samples were 
briefly vortexed (Vortex-Genie® 2, Scientific Ind.™) and centrifuged as before each time and the 
supernatants pooled in a clean 2 ml microcentrifuge tube. Immunoprecipitation using the appropriate 
antibody/antiserum and preparation for gel electrophoresis were as described in 2.2.33.3. 
 
 
2.2.33.3 IMMUNOPRECIPITATION 
The samples were prepared for the preclear by adding 60 µl of 20 % (w/v) Protein A Sepharose™ 
CL-4B (GE Healthcare) in IP Buffer with SDS (150 mM NaCl, 1 % (v/v) Triton X-100, 15 mM Tris-HCl 
pH 7.5, 2 mM Sodium Azide, 0.1 % (w/v) SDS). Preclear of the samples was on a rotating wheel for 
30 min, at RT. Following the incubation the samples were centrifuged for 2 min at full speed, RT 
(Microcentrifuge 5415R, Eppendorf) and each supernatant was transferred to a clean 
microcentrifuge tube containing 60 µl of 20 % (w/v) Protein A Sepharose™ CL-4B as well as the 
appropriate antibody/antiserum (ref. Table 2.7). The samples were incubated either overnight at 4 °C 
(cold room) or at RT for 2 hours on a rotating wheel. Next, the samples were centrifuged for 2 min at 
full speed, RT (Microcentrifuge 5415R, Eppendorf), followed by two washes each with 1 ml of IP 
Buffer with SDS and 1 ml of Urea Wash (2 M Urea, 200 mM NaCl, 1 % (v/v) Triton X-100, 100 mM 
Tris-HCl pH 7.5, 2 mM Sodium Azide) and one wash each with 1 ml of ConA Wash (500 mM NaCl, 1 
% (v/v) Triton X-100, 20 mM Tris-HCl pH 7.5, 2 mM NaN3) and 1 ml of Tris-NaCl Wash (50 mM, 10 
mM Tris-HCl pH 7.5, 2 mM NaN3). The samples were vortexed (Vortex-Genie® 2, Scientific Ind.™) 
briefly, centrifuged for 1 min at full speed, RT, and the supernatants discarded each time. After the 
washes, 20 µl of 2X SDS-PAGE Protein Sample Buffer (125 mM Tris-HCl pH 6.8, 4 % (w/v) SDS, 10 
% (v/v) β-Mercaptoethanol, 0.002 % (w/v) Bromophenol Blue, 20 % (v/v) Glycerol) were added and 
the samples incubated at 95 °C for 5 min (membrane proteins: 60 °C) in a block heater (SBH200D/3, 
Stuart®). Samples were centrifuged for 10 sec at full speed, RT and the supernatant carefully loaded 
onto a protein gel using a gel-loading tip to avoid transfer of sepharose. Generally, proteins were 
resolved using a 4-12 % Bis-Tris gel (NuPAGE® Novex® Pre-Cast gels) as described in 2.2.24.1. 
Following the electrophoresis protein gels were incubated in Fixative 1 (10 % (v/v) Acetic Acid, 40 % 
(v/v) Methanol, 2 % (v/v) Glycerol) for 15 min and in Fixative 2 (50 % (v/v) Methanol, 1 % (v/v) 
Glycerol) for 30 min, shaking. Gels were then dried at 80 °C for 1 hour in a gel dryer (Model 583, 
Bio-Rad) and exposed to Storage Phosphor Screens (GE Healthcare). Usually an exposure of 1 - 3 
days was sufficient. Radioactivity was visualized using a phosphorimager (Typhoon Trio™ Variable 
Mode Imager, GE Healthcare). Signal were analyzed and quantified using the ImageQuant™ TL 
software (GE Healthcare). 
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2.2.34 IN VITRO TRANSCRIPTION, TRANSLATION, TRANSLOCATION AND RETROTRANSLO-
2.2.34 CATION 
 
2.2.34.1 PREPARATION OF S. CEREVISIAE CYTOSOL FOR IN VITRO ASSAYS 
Concentrated yeast cytosol was prepared using the yeast strain KRY275 according to Sorger & 
Pelham (1987) and McCracken & Brodsky (1996). 10 L yeast cells were grown in YPD to an OD600 
of ∼ 2 at 30 °C with vigorous shaking. The cells were harvested at 5000 rpm, RT for 3 min (rotor: 
SLA3000, Sorvall Evolution® RC Centrifuge). The pellets were resuspended in 400 ml dH2O, the 
pellets pooled and recentrifuged as before. The resulting pellet was resuspended in a minimal 
amount of B88 (< 3-5 ml) (20 mM Hepes-KOH pH 6.8, 250 mM Sorbitol, 150 mM KOAc, 5 mM 
Mg(OAc)2). For freezing the cells, about 500 ml of liquid nitrogen were added to a Tri-Pour® plastic 
beaker (VWR®), which was placed on a magnetic stirrer. The liquid nitrogen was stirred at moderate 
speed using a large magnetic stir bar. The cells were poured slowly into the liquid nitrogen. Once the 
cells were frozen, the liquid nitrogen was decanted. The resulting frozen material was transferred to 
50 ml falcon tubes and stored at – 80 °C. Next, about 500 ml of liquid nitrogen were added to a 
stainless-steel blender (Rio™ Commercial Bar Blender, Hamilton Beach®) running at the lowest 
setting (in the cold room). Once the cells had been added the blender was run at the highest setting. 
The yeast was lysed for 10 min with addition of liquid nitrogen every minute to maintain the volume 
of the liquid nitrogen. After 10 min the blender was turned off, the liquid nitrogen evaporated, and the 
powder transferred to 50-ml falcon tubes. The powder was stored at – 80 °C until needed. The 
powder was then thawed in a cold water bath. As the material started to melt, about 0.5 ml B88 per 
40 ml of broken yeast was added to the powder. DTT was added to a final concentration of 1 mM. 
The lysate was centrifuged at 9200 rpm for 10 min at 4 °C (rotor: SS34, Sorvall Evolution® RC 
Centrifuge). The supernatant was collected and centrifuged as before. The resulting supernatant 
was transferred to polycarbonate tubes (Beckman Coulter #349622) and centrifuged at 74600 rpm, 4 
°C for 1 hour (rotor: TLA100.3, Optima™ MAX-XP Benchtop Ultracentrifuge). The resulting cytosol 
was aliquoted (100 µl), snap-frozen in liquid nitrogen and stored at – 80 °C. Protein concentration 
was determined using the Pierce™ 660nm Protein Assay Reagent (Pierce, Thermo Fisher Scientific) 
according to the supplier’s instructions. Cytosol with a concentration > 20 mg/ml was best for ER-
associated degradation (ERAD) assays. 
 
 
2.2.34.2 PREPARATION OF S. CEREVISIAE TRANSLATION EXTRACT 
Yeast translation extract was prepared as modified from Schekman et al. (1994) and Baker et al. 
(1988). The preparation was performed under RNase-free conditions. In brief, 10 L of the protease-
deficient yeast strain GPY60 (Table 2.4) were grown in YPD to an OD600 = 2 - 4. The cells were 
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harvested by centrifugation (5000 rpm, RT, 3 min, rotor: SLA3000, Sorvall Evolution® RC Centrifuge) 
and washed with RNase-free water. The yeast pellets were pooled and resuspended in a small 
volume of cold RNAs-free Buffer A (100 mM KOAc, 2 mM MgOAc, 20 mM Hepes-KOH pH 7.4, 1 
mM PMSF, 2 mM DTT) to yield a “thick paste”. The material was poured in a thin stream into a 
plastic beaker containing 500 µl liquid nitrogen and a large magnetic stir bar in order to freeze the 
cells. The material was stirred slowly until all cells were frozen. The frozen cells could be stored at – 
80 °C for up to a year at this point. Next, for liquid nitrogen lysis, the frozen cells were added to a 
stainless steel blender (Rio™ Commercial Bar Blender, Hamilton Beach®) containing liquid nitrogen*. 
The cells were continuously blended under liquid nitrogen for 10 min at high speed (with ∼ 100 ml of 
liquid nitrogen added every minute). The resulting yeast cell powder was transferred into 50 ml 
falcon tubes and stored at – 80 °C until needed. 
The cell powder was thawed in a water bath at RT. As soon as it started to melt, 40 ml** Buffer A 
(100 mM KOAc, 2 mM MgOAc, 20 mM Hepes-KOH pH 7.4, 1 mM PMSF, 2 mM DTT) were added 
and the powder was continued to thaw until all ice particles had melted. The cell lysate was 
transferred to 50 ml polycarbonate tubes (SS34) and centrifuged at 9000 rpm, 4 °C for 10 min (rotor: 
SS34). The supernatant was carefully transferred to a 45Ti tube (RNase-free) and centrifuged at 
36000 rpm, 4 °C for 30 min (rotor: 45 Ti; Optima™ L-90 K Ultracentrifuge). The resulting clear 
yellowish supernatant was collected, avoiding the lipid layer on top and the white material above the 
pellet and along the sides of the tube. In order to determine the concentration of ribosomal RNA in 
the extract at this point of the preparation the OD260 of a 1:200 dilution in dH2O was measured. 
The supernatant was then loaded onto a Sephadex® G-25 (GE Healthcare) Econo-Column (393 ml; 
of the BioLogic LP System, Bio-Rad) column (“S100”). The S100 column was equilibrated with 2 
column volumes of Buffer A + 14 % (v/v) glycerol and run with a flow rate of 1 ml/min. Fractions of 3 
ml were collected (Model 2110 Fraction Collector, Bio-Rad) as soon as a yellowish band was visible 
in the lower part of the column. This band contains the fractions that show the highest activity. The 
OD260 of each fraction was measured as before. Fractions with an OD260 > 30 were pooled 
(excluding borderline fractions) and the OD260 of the pool measured. Translation extracts worked 
most efficiently when the OD260 of the pool was in the range of 60 – 100. The extract was snap-
frozen in liquid nitrogen in 1 ml aliquots and stored at – 80 °C. 
 
* The blender was run at low speed and the liquid nitrogen immediately added. Once the cells were 
added the blender was run at the highest setting. 
** 10 ml Buffer A per 10 g of frozen cells 
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2.2.34.3 LINEARIZATION AND RE-ISOLATION OF PLASMID DNA 
For in vitro translation the appropriate mRNA was prepared using linearized plasmid DNA containing 
the desired gene (pDJ100: pαF3Q; ref. Table 2.5 and Table 2.15). Linearisation of plasmid DNA and 
the transcription reaction was performed under RNAse-free conditions. Generally, a 400 µl digest 
was set up containing 150 U restriction enzyme (NEB; ref. Table 2.15), 40 µg plasmid DNA and 1X 
restriction buffer. Plasmid DNA was digested at 37 °C for 2 hr. After the incubation the DNA was re-
isolated as follows. 400 µl of P/C/I/H/I (50 % (v/v) Phenol, 48 % (v/v) Chloroform, 2 % (v/v) Isoamyl 
Alcohol, 0.1 % (w/v) 8-Hydroxy-quinoline) were added to each microcentrifuge tube, which was 
vortexed (Vortex-Genie® 2, Scientific Ind.™) for 3 sec and centrifuged for 1 min at full speed 
(Microcentrifuge 5415R, Eppendorf). The upper phase was collected and transferred to a clean 
RNAse-free microcentrifuge tube. The lower phase was extracted with 100 µl dH2O (i.e. vortexed 
and centrifuged as before). The upper phase was collected and combined with the previous upper 
phase. To the upper phases 500 µl C/I (96 % (v/v) Chloroform/ 4 % (v/v) Isoamyl Alcohol) were 
added, the sample vortexed and centrifuged as before. The upper phase was transferred to a clean 
RNase-free microcentrifuge tube and 50 µl 3 M NaAc and 1 ml 95 % (v/v) ethanol were added. 
Incubation was for 30 min at – 70 °C. The sample was then centrifuged at full speed, 4 °C for 10 min 
in a pre-cooled desktop centrifuge (Microcentrifuge 5415R, Eppendorf) and the supernatant 
discarded. The pellet was resuspended in 1.5 ml 70 % (v/v) ethanol, centrifuged as before and the 
supernatant discarded. The pellet was dried for 5 min at RT in the fume hood and resuspended in a 
final volume of 188 µl DEPC-H2O. The DNA concentration was determined by measuring the OD260 
of a 1:100 dilution of the sample in dH2O. 
The DNA concentration was calculated as follows: 
 
OD260 = 1 equals 50 µg/ml for double-stranded DNA 
 
 
2.2.34.4 IN VITRO TRANSCRIPTION REACTION 
The in vitro transcription of linearized plasmid DNA was according to Rothblatt & Meyer (1986). The 
transcription reaction was prepared at RT as shown in Table 2.20. Transcription reactions were 
performed under RNase-free conditions. 
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Table 2.20. In vitro transcription reaction setup. 
Component Volume (µl) Final Concentration 
5X Transcription Buffer 80 1X 
0.5 M DTT 8 10 mM 
10 mM GTP  4 0.1 mM 
GpppG (Cap)  20 0.25 mM 
10 mM CTP  20 0.5 mM 
10 mM UTP  20 0.5 mM 
10 mM ATP 20 0.5 mM 
- Vortex - 
RNasin (2500 U/ml)  20 1.2 U/µl 
- Vortex - 
linearized plasmid DNA 40 (40 µg) 0.1 µg/µl 
SP6 RNA polymerase 20 1 U/µl 
DEPC-H2O  to 400 --- 
- Vortex - 
 
Incubation was for 1 hour at 40 °C in a Thermomixer® comfort (Eppendorf). Following the incubation, 
the sample was EtOH-precipitated by 40 µl 3 M NaAc and 1 ml 100 % (v/v) ethanol. The sample was 
mixed, incubated at – 70 °C for 30 min and then centrifuged at full speed and 4 °C for 10 min 
(Microcentrifuge 5415R, Eppendorf). The supernatant was discarded and 1.5 ml 70 % (v/v) ethanol 
added to the pellet. The sample was centrifuged as before, the supernatant discarded and the pellet 
air-dried at RT for 5 min. The pellet was resuspended in a final volume of 188 µl DEPC-dH2O. The 
RNA concentration and purity of the sample was determined by measuring the optical density at 260 
and 280 nm (OD260 and OD280; 1 OD260 = 40 µg/ml RNA) of a 1: 200 dilution of the sample in dH2O. 
For optimal purity, the OD260/OD280 should be > 2 (otherwise the sample contains significant protein 
impurities). 
 
 
2.2.34.5 IN VITRO TRANSLATION REACTION 
Prior to the translation of the appropriate substrate (in vitro transcribed α-factor precursor (ppαf) or 
mutant α-factor precursor (pΔgpαf); ref. 2.2.34.4) the S-100 translation extract (ref. 2.2.34.2) was 
nuclease-treated. Generally, 1.8 ml of the S-100 yeast translation extract was thawed at RT and 
combined with 50 µl micrococcal nuclease (20 kU/ml; NEB) and 25 µl 40 mM CaCl2 (Sigma-Aldrich). 
The sample was incubated at 20 °C (water bath) for 20 min. Following the incubation 25 µl 100 mM 
EGTA (Sigma-Aldrich) were added and the sample incubated at 20 °C for another 5 min. 
A translation reaction was generally set up as described in Table 2.21. The reaction mixture was 
carefully resuspended and incubated at 20 °C (water bath) for 50 min. After the incubation the 
sample was snap-frozen in liquid nitrogen in 50 µl aliquots and stored at – 80 °C until needed. 
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Table 2.21. Standard in vitro translation reaction setup. 
Component Volume 
Nuclease-treated Translation Extract 450 µl 
3X Translation Buffer* 450 µl 
RNasin (25000U/ml) 15 µl 
Creatine Phosphokinase (10 mg/ml) 27 µl 
DEPC-H2O  to 1.35 ml 
mRNA 125 µg 
L-[35S]-Methionine  0.5 mCi 
* 3X Translation buffer (75 mM Creatine Phosphate, 2.25 mM ATP, 300 µM GTP, 120 µm Amino Acids, 
360mM KOAc, 6 mM Mg(OAc)2, 66 mM Hepes-KOH pH 7.4, 5.1 mM DTT) 
 
 
2.2.34.6 IN VITRO TRANSLOCATION ASSAY 
In vitro assays were performed as described by Lyman and Shekman (1995) and McCracken & 
Brodsky (1996) and Pilon et al., (1997). For in vitro translocation reactions 35S-methionine-labeled 
ppαf and pΔgpαf were transcribed and translated as above (ref. 2.2.34.4 and 2.2.34.5). For a 60 µl 
translocation reaction the set-up was as described in Table 2.22. For negative controls either 
microsomes or 35S-Met-labeled pΔgpαf were omitted from the reaction. The reactions were set up on 
ice, mixed very gently and incubated at 20 °C for 50 minutes. Following the incubation, an equal 
volume of ice cold 20 % (w/v) TCA was added to the sample. The sample was agitated on a vortex 
mixer (Vortex-Genie® 2, Scientific Ind.™) for 10 seconds, chilled on ice for 15 min and centrifuged for 
5 min at 4 °C, full speed (Microcentrifuge 5415R, Eppendorf). The supernatant was removed using a 
gel-loading tip and the pellet washed in sufficient ice-cold acetone to cover the pellet. The sample 
was centrifuged as before and dried at RT for 10 min. The pellet was then taken up in 25 µl 2X SDS-
PAGE Sample Buffer (125 mM Tris-HCl pH 6.8, 4 % (w/v) SDS, 10 % (v/v) β-Mercaptoethanol, 0.002 
% (w/v) Bromophenol Blue, 20 % (v/v) Glycerol) and the sample incubated for 15 min at 70 °C 
(Thermomixer® Comfort, Eppendorf). Radiolabeled proteins were resolved using an 18 % denaturing 
SDS-polyacrylamide gel containing 4 M urea (ref. Table 2.23). The gel was run overnight at 90 V, RT 
until the dye front was near the bottom of the gel. The next day, the gel was incubated (shaking) 4 x 
10 min in Fixative 1 (10 % (v/v) Acetic Acid, 40 % (v/v) Methanol, 2 % (v/v) Glycerol), followed 30 
minutes in Fixative 2 (50 % (v/v) Methanol, 1 % (v/v) Glycerol). The gel was then dried in a gel dryer 
(Model 583, Bio-Rad) for 1 hour at 80 °C and the gel exposed to a storage phosphor screen (GE 
Healthcare). Generally, a 1- to 3-day exposure to a storage phosphor screen was sufficient to 
monitor the desired signal. Radioactivity was visualized using a phosphorimager (Typhoon™ Trio 
variable mode imager, GE Healthcare). Translocation efficiencies were quantified using the 
ImageQuant™ TL (GE Healthcare) software. 
For time-course experiments, multiple reactions were set up as follows: 470 µl B88, 60 µl 10X ARS, 
20 µl microsomes and 50 µl in vitro translated 35S-Met-labeled ppαf or pΔgpαf. The reaction was set 
up on ice, gently resuspended and aliquoted into 60 µl aliquots. The samples were incubated at 20 
°C over a time course of 60 min (samples were taken at time points t = 0, 5, 10, 15, 20, 30, 60 min). 
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Samples were immediately placed on ice and the reactions stopped with the addition of an equal 
volume of ice-cold 20 % (w/v) TCA. The samples were prepared for SDS-PAGE as described above.	  
 
* 10X ARS was aliquoted (100 µl, single-use tubes), snap-frozen in liquid nitrogen and stored at – 80 
°C. 
 
Table 2.22. Standard translocation reaction setup. 
Component Volume 
B88* 47 µl 
Microsomes (OD280 = 30) 2 µl 
10X ATP** 6 µl 
35S-Met-labeled pΔgpαf***  5 µl 
* B88: 20 mM Hepes-KOH pH 6.8; 250 mM Sorbitol, 150 mM KOAc, 5 mM Mg(OAc)2 
** 10 X ARS: 10 mM ATP, 500 mM Creatine Phosphate, 2 mg/ml Creatine Phosphokinase, B88 to volume  
*** ∼ 200000 cpm per reaction of in vitro translated 35S-Met-labeled ppαf or pΔgpαf  
 
Table 2.23. Composition of 18 % denaturing polyacrylamide 4 M urea gels. 
Component Separating gel 
(40 ml) 
Stacking gel 
(25 ml) 
Acrylamide* 24 ml 4.15 ml 
1.5 M Tris-HCl pH 8.8 10 ml --- 
0.5 M Tris-HCl pH 6.8 --- 6.25 ml 
20 % (w/v) SDS 200 µl 125 µl 
Urea 9.6 g 6 g 
dH2O --- 10 ml 
TEMED** 16.7 µl 15 µl 
10 % APS** 200 µl 200 µl 
* Rotiphorese® Gel 30 (Carl Roth®) 
** TEMED and APS were added after the urea was dissolved completely. 
 
 
2.2.34.7 IN VITRO RETROTRANSLOCATION ASSAY 
The in vitro retrotranslocation assay was performed in order to examine the retrotranslocation and 
degradation efficiencies of Δgpαf in sec61 mutant microsomes. Prior to the actual retrotranslocation 
reaction the retrotranslocation substrate pΔgpαf had to be translocated into ER-derived microsomes. 
This was accomplished by an in vitro translocation assay as described in 2.2.32.6 using in vitro 
transcribed and translated pΔgpαf (ref. 2.2.34.4 and 2.2.34.5). For retrotranslocation assays time-
course experiments were conducted. Therefore, multiple translocation reactions were set up as a 
single “master” translocation reaction (∑600 µl: 10 x 60 µl) as described in 2.2.32.6 (ref. Table 2.22). 
The translocation reaction was incubated for 50 min at 20 °C in a water bath. Next, the membranes 
were pelleted at full speed and 4 °C for 5 min (Microcentrifuge 5415R, Eppendorf) and gently 
washed with 600 µl cold B88 (20 mM Hepes-KOH, pH 6.8, 250 mM Sorbitol, 150 mM KOAc, 5 mM 
Mg(OAc)2). To the microcentrifuge tube containing the membranes the appropriate amount of cold 
B88 was added to a final volume of 600 µl. Further, 60 µl of 10X ARS (400 mM Creatine Phosphate, 
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2 mg/ml Creatine Phosphokinase, 10 mM ATP; prepared in B88) were added. Initiation of 
retrotranslocation and degradation was started by the addition of cytosol to 1-3 mg/ml in the final 
volume of 600 µl. The reaction mix was then divided into 60 µl aliquots which were incubated at 30 
°C over a time course of 60 min (samples were taken at t = 0, 5, 10, 15, 20, 30, 60 min). Samples 
were immediately placed on ice and the reactions stopped with the addition of 60 µl 20 % (w/v) TCA. 
The samples were agitated on a Vortex mixer for 10 seconds and incubated on ice for 15 min. The 
samples were then centrifuged at full speed for 15 min, at 4 °C and the supernatant removed with a 
gel-loading tip. Next, sufficient ice-cold acetone was added to cover each pellet. Samples were 
agitated on a Vortex mixer for 10 seconds and centrifuged as before. The supernatant was removed 
with a gel-loading tip and the pellets air-dried and resuspended in 25 µl 2X SDS-PAGE Sample 
Buffer (125 mM Tris-HCl pH 6.8, 4 % (w/v) SDS, 10 % (v/v) β-Mercaptoethanol, 0.002 % (w/v) 
Bromophenol Blue, 20 % (v/v) Glycerol). The samples were heated at 70 °C for 15 min 
(Thermomixer® Comfort, Eppendorf). Proteins were resolved using an 18 % denaturing 
polyacrylamide gel containing 4 M urea (ref. Table 2.23) and 1X Running Buffer (5X: 0.5 % (w/v) 
SDS, 1.5 % (w/v) Tris Base, 7.2 % (w/v) Glycine). Gels were run overnight at RT and 90 V. The next 
day, when the dye front was near the bottom of the gel, the plates were disassembled and the gels 
fixed and dried as in 2.2.34.6. Exposure of the gels to storage phosphor screens was 2-3 days. 
Radioactivity was visualized using a phosphorimager (Typhoon™ Trio variable mode imager, GE 
Healthcare). The amount of degradation was quantified using the ImageQuant™ TL software (GE 
Healthcare). 
 
 
2.2.35 PEGYLATION ASSAY 
For the anaylsis of conformational changes in mutant Sec61p compared to wild-type Sec61p the 
PEGylation reagent Methyl-PEG8-N-hydroxysuccinimide ester (MS(PEG)8, Thermo Fisher Scientific) 
was used to modifiy accessible primary amines (in lysine residues and the N-terminus) in the 
protein. 
In brief, generally in a final volume of 20 µl 2 µl (OD280 = 30) PKRMs (ref. 2.2.26) of the respective 
sec61 mutants or the wild-type (SEC61) were carefully resuspended with the appropriate volume of 
Buffer 88 (20 mM Hepes-KOH pH 6.8, 250 mM Sorbitol, 150 mM KOAc, 5 mM Mg(OAc)2), followed 
by the addition of 20 mM of MS(PEG)8*. Samples were incubated for 30 min at 24 °C in a 
Thermomixer® comfort (Eppendorf) and reactions were stopped by addition of 1 µl 8 M ammonium 
acetate solution and incubated on ice for 15 min. Samples were analyzed by SDS-PAGE and 
Western Blot analysis (ref. 2.2.24) using the anti-Sec61p (N-terminal) and anti-Sbh1p (control) 
antibody (Römisch lab, ref. Table 2.7). Detection of signals and determination of relative mobility of 
PEGylated proteins was using the ChemiDoc™ XRS system and the Image Lab™ software (both Bio-
Rad). The PageRuler™ (Fermentas, Thermo Fisher Scientific) was used as the molecular weight 
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standard. 
 
* The MS(PEG)8 stock solution was prepared in water-free DMSO (Thermo Fisher Scientific) and the 
amount of DMSO in each sample was kept under 10 % (v/v). 
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3 RESULTS 
 
3.1 OVERVIEW 
Sec61p, the pore-forming component of the translocon in S. cerevisiae, is an ER membrane protein 
consisting of ten TMDs (TMD 1-10; ref. Figure 3.1.1). The N- and C-termini of the protein as well as 
L 2, 4, 6 and 8 are located in the cytosol while L1, 3, 5 and 7 are located in the ER lumen (ref. Figure 
3.1.1; Mothes et al., 1994; Wilkinson et al., 1996; Raden et al., 2000; van den Berg et al., 2004). 
During cotranslational and posttranslational protein import into the ER, Sec61p associates with other 
proteins to form the Sec61 complex or the SEC complex respectively (Johnson & van Waes, 1999; 
Park & Rapoport, 2012). 
Besides its role during protein import, Sec61p has been suggested to be involved in protein 
dislocation during ERAD (Hilt & Wolf, 1996; McCracken & Brodsky, 1996; Wiertz et al., 1996a; 
Johnson & Haigh, 2000; Römisch, 2005). It is still controversial, however, whether Sec61p directly 
forms the retrotranslocation channel or whether it is one of its components (Pilon et al., 1997, 
Plemper et al., 1997; Gillece et al., 1999; Schäfer & Wolf, 2009). 
One of the crucial steps during ERAD is the degradation of misfolded proteins by the 26S 
proteasome in the cytosol. It has been demonstrated that during ERAD the proteasome binds to the 
ER via Sec61p (Lee et al., 2004b; Kalies et al., 2005; Römisch, 2005; Ng et al., 2007). 
In a previous study, sec61 mutants, sec61-302 (D168G, S179P, F263L, S353C) and sec61-303 
(D168G, F263L), were isolated which showed defects in protein import into the ER for a 
cotranslational import substrate (ref. Figure 3.1.1). Only sec61-302, however, additionally displayed 
reduced proteasome binding (Ng et al., 2007). As sec61-302 and sec61-303 share two point 
mutations it has been suggested that one or both of the two remaining amino acid substitutions, 
S179P and/or S353C, are responsible for the observed reduction in proteasome affinity (Ng et al., 
2007). As the amino acid substitution S179P is located at the cytoplasmic end of TMD 5, while the 
S353C mutation is located in L7, S179P seems to be the more promising candidate for further 
studies (Ng et al., 2007).  
In order to elucidate which domain in Sec61p mediates binding to the 26S proteasome during ERAD, 
I asked which of the two amino acid substitutions, S179P or S353C, is responsible for the reduced 
proteasome affinity. The sec61 mutants generated in this study (ref. 3.2.1. and 3.2.2.) were further 
characterized using various genetic and biochemical methods. 
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Figure 3.1.1. Topology model of Sec61p. Shown is a simplified topology model of the ER membrane protein 
Sec61p. The protein consists of ten TMDs (TMD 1 - 10) and four cytosolic loops (L 2, 4, 6 and 8) as well as 
four ER-lumenal loops (L1, 3, 5 and 7, not indicated). Both termini are located in the cytosol. Positions of point 
mutations (i.e. the resulting amino acid substitutions) in the sec61 mutants sec61-302 (amino acid 
substitutions: D168G, S179P, F263L, S353C) and sec61-303 (D168G, F263L) are indicated (). Both mutants 
share two of the same point mutations (D168G, F263L) and are defective in cotranslational protein import into 
the ER. Since only sec61-302 shows reduced proteasome binding, S179P and/or S353C have been suggested 
to mediate the observed binding defect (Ng et al., 2007; adapted from Wilkinson et al., 1997; Raden et al., 
2000; van den Berg et al., 2004) 
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3.2 GENERATION OF S. CEREVISIAE SEC61 MUTANTS 
 
3.2.1 GENERATION AND VERIFICATION OF THE SEC61 MUTANTS SEC61-S179P, SEC61-
S353C AND SEC61-S179P/S353C  
As this study was based on previous work on sec61 mutants, including sec61-302 (D168G, S179P, 
F263L, S353C) and sec61-303 (D168G, F263L), the same genetic background (JDY638 (pGAL-
SEC61), ref. Table 2.4) was used to create the desired sec61 mutants (Ng et al., 2007). This was 
done to be able to use sec61-302 and sec61-303 as controls and thus compare results from 
previous studies (i.e. the reporter plasmid translocation assays and proteasome binding 
experiments) with those obtained from this study. 
The desired sec61 mutants, designated sec61-S179P, sec61-S353C and sec61-S179P/S353C, 
were generated by SOE-PCR (ref. 2.2.4.1) followed by the transformation (ref. 2.2.17) of the S. 
cerecisiae strain JDY638 with the respective construct (ref. 2.1.3; Ho et al., 1989; Horton et al., 
1989; Gietz et al., 1995). 
During SOE-PCR plasmid pBW11 (ref. Table 2.5) consisting of the full-length wild-type SEC61 gene 
cloned into the centromeric vector pRS315 was used as the template along with the appropriate 
oligonucleotides (ref. Table 2.6; Ho et al., 1989; Horton et al., 1989; Sikorski & Hieter, 1989; Stirling 
et al., 1992; Wilkinson et al., 1996). The desired point mutations T535C (sec61-S179P) and/or 
C1058G (sec61-S353C) were introduced into SEC61 using specific mutagenic primers (ref. Table 
2.6 and Table 2.14). The resulting mutant full-length sec61 sequences, containing HindIII restriction 
sites at the 5’ and the 3’ ends, were cloned into the HindIII restriction site of the centromeric vector 
pRS315 (CEN, ARS, LEU2; Sikorski & Hieter, 1989). Next, the resulting plasmids (pRS315-sec61-
S179P, pRS315-sec61-S353C, pRS315-sec61-S179P/S353C; ref. Table 2.5) were transformed into 
chemically competent E. coli cells (ref. 2.2.14.3) and plasmid DNA preparations (ref. 2.2.6) from 
resulting single colonies (clones) were verified by sequencing (ref. 2.2.15) (Sanger et al., 1977; 
Birnboim & Doly, 1979). The DNA of positive clones was then used to transform the S. cerevisiae 
strain JDY638 using the lithium acetate method (Gietz et al. 1995; Ng et al., 2007). The procedure is 
outlined in Figure 3.2.1.1.A. In S. cerevisiae strain JDY638 the expression of SEC61 is under the 
control of the GAL1 promoter, which was achieved using a cassette amplified with the kanamycin 
resistence gene and the GAL1 promoter (kanr-pGAL-SEC61) (Ng et al., 2007; J. Brown, personal 
communication). Selection of positive transformants was initially on Synthetic Complete (SC) plates 
without leucine (SC -LEU), containing 2 % (w/v) galactose and 0.2 % (w/v) raffinose, at 30 °C for 
three days. Cells expressing mutant sec61 only were grown on rich medium (YPD) and SC -LEU 
plates both containing 2 % (w/v) glucose. This allows for the selection of those transformants, which 
are viable expressing mutant sec61 (pCEN-LEU2-sec61). At the same time the expression of wild-
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type SEC61, which is under the control of the GAL1 promoter, is repressed. Thus, successful 
transformations led to growth of selected transformants on YPD and SC –LEU plates.  
Results are shown in Figure 3.2.1.1.B. Following the selection of positive transformants on SC -LEU 
(2 % (w/v) galactose/ 0.2 % (w/v) raffinose) plates (not shown), two single colonies per 
transformation were plated onto SC -LEU plates (Figure 3.2.1.1.B Top) and YPD (Figure 3.2.1.1.B 
Bottom), both containing 2 % (w/v) glucose. The cells were grown at 30 °C for three days. The two 
wild-type strains JDY638 and RSY255 (SEC61) were used as controls. While the former does not 
grow on medium containing glucose (i.e. no growth on SC -LEU and YPD), the latter does, but 
needs leucine for growth (i.e. growth on YPD only). Thus, both control strains behaved as expected. 
As seen in Figure 3.2.1.1.B, all of the sec61 mutants (sec61-S179P, sec61-S353C, sec61-
S179P/S353C) selected were viable as they grew on YPD (Bottom) as well as on SC -LEU medium 
(Top). Thus, the sec61 mutants could be used during further for analyses. 
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Figure 3.2.1.1 Generation and verification of sec61 mutants in the JDY638 background. (A) Schematic 
representation of JDY638 (kanr-pGAL-SEC61) transformation with constructs expressing mutant sec61 
(pRS315-sec61-S179P, pRS315-sec61-S353C, pRS315-sec61-S179P/S353C). Initial selection was on SC 
plates without leucine (2 % (w/v) galactose/ 0.2 % (w/v) raffinose) (not shown) to select for the plasmid only. 
Viability of cells expressing mutant sec61 only was monitored on YPD and SC -LEU plates (2 % (w/v) glucose) 
to test for function of mutant Sec61p. (B) JDY638 derivatives (pCEN-LEU2-sec61) were grown on SC plates 
without leucine d/o (Top) and YPD (Bottom) plates for 3 days at 30 °C in order to select for transformants 
containing the sec61 expression plasmid. JDY638 and RSY255 were used as controls. 
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3.2.2 GENERATION AND VERIFICATION OF THE SEC61 INTEGRATION MUTANTS SEC61-
S179P, SEC61-S353C, SEC61-S179P/S353C, SEC61-302 AND SEC61-303 
The sec61 integration mutants, designated sec61-S179P, sec61-S353C, sec61-S179P/ S353C, 
sec61-302 and sec61-303, were created to be used in the in vitro retrotranslocation assay using pαf, 
a soluble ERAD substrate, and the in vitro translocation assay using wild-type ppαf, the precursor of 
3gpαf (Caplan et al., 1991; McCracken & Brodsky, 1996; Brodsky, 2010). 
The respective integration constructs consisted of the appropriate truncated sec61 sequences 
cloned into the yeast integrative vector pRS306 (URA3; Sikorski & Hieter, 1989). Truncated versions 
of the mutated sec61 sequences sec61-S179P, sec61-S353C, sec61-S179P/S353C (ref. 3.2.1), 
sec61-302 and sec61-303 were created using SOE-PCR (ref. 2.2.4.1 and Table 2.14) (sec61-302 
and sec61-303: ref. Ng et al., 2007). This was achieved by using the appropriate centromeric 
plasmids (pRS315-sec61-S179, pRS315-sec61-S353C and pRS315-sec61-S179P/S353C, ref. 
Table 2.5) containing the respective full-length sec61 sequences, described in 3.2.1, as templates 
for the amplification of each truncated sec61 sequence. Further, the sec61 integration mutants 
sec61-302 and sec61-303 were created using plasmids from a previous study, containing the 
respective mutant full-length sec61 sequences cloned into pRS315, as templates (sec61-302: 
plasmid #14; sec61-303: plasmid #18; Ng et al., 2007). The truncation of each sec61 sequence at 
the 5’ end was achieved by using a specific primer (5’ HindIII SEC61 #57; ref. Table 2.6), which 
truncated the sec61 sequences + 57 base pairs (bp) relative to the start codon (ATG) of the gene. 
In order to be able to integrate the respective sec61 sequences into the yeast strain RSY255 (ref. 
Table 2.4) linearization of the respective integrative plasmid in the region of the truncated sec61 
sequence was necessary prior to transformation. As there was no unique restriction site available in 
the desired region of the sec61 sequence that could be used for linearization, a silent mutation was 
introduced at nucleotide position 201 (+ 201 bp relative to the ATG; nucleotide exchange: T201G  
amino acid substitution: R67R) of SEC61 which created an SfiI restriction site (ref. Table 2.6 and 
Table 2.14). The introduction of a restriction site at this position created a sufficient recombinogenic 
stretch between the restriction site and the first point mutation in sec61-302 and sec61-303, A503G 
(amino acid substitution: D168G). This allows for efficient integration of the respective sec61 
sequences into the yeast genome, as the recombinogenic ends of the linearized integrative 
constructs direct the sec61 sequences to the appropriate homologous site in the yeast genome. 
Following SOE-PCR, the resulting truncated sec61 sequences were cloned (ref. 2.2.12) into the 
yeast integrative vector pRS306 (Sikorski & Hieter, 1989). Chemically competent DH5α E. coli cells 
were transformed (ref. 2.2.14.3) and plasmid DNA (ref. 2.2.5) of resulting single colonies was 
prepared and sent for sequencing (ref. 2.2.15). Once, the appropriate sec61 mutants were obtained, 
the yeast strain RSY255, which is routinely used for in vitro assay, was transformed with the 
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respective linearized plasmid (ref. 2.2.17 and Table 2.5; Ho et al., 1989; Horton et al., 1989; Gietz et 
al., 1995).  
The linearized integration constructs enter the chromosome by homologous recombination as shown 
in Figure 3.2.2.1.A. The recombinogenic ends of the linearized constructs direct the plasmid to 
integrate at the wild-type SEC61 locus homologous to the ends of the linearized sequence. Upon 
successful integration, the chromosome contains one complete copy of the mutant sec61 gene 
followed by the pRS306 backbone, including the URA3 marker, and a truncated version of SEC61 
(#sec61).  
Following the transformation, positive tansformants were selected on SC -URA plates (- Uracil) at 30 
°C for three days. Growth of transformants (two per transformation) that came up on SC -URA plates 
were restreaked onto the same plates to verify their ability to grow on SC -URA medium. 
Integration of the respective sec61 sequences into the genome of RSY255 at the correct 
chromosomal locus was verified by PCR. Following the selection of real transformants (ref. Figure 
3.2.2.1.B), chromosomal DNA (ref. 2.2.22) of several positive transformants was prepared. The 
isolated chromosomal DNAs were used as templates for the PCR (ref. 2.2.18) along with a set of 
specific primers (Forward primer: 5’ HindIII SEC61 5’ UTR #-445; Reverse primer: 3’ pRS306 URA3 
#621; ref. Table 2.6). The primers were chosen to bind in the chromosomal part of SEC61 (- 445 bp 
relative to the ATG) upstream of the integrated sec61 sequence as well as in the backbone of the 
pRS306-based plasmid (i.e. the URA3 marker; + 621 bp relative to the ATG of URA3). This allows 
for verification of properly integrated sec61 sequences. Only upon integration at the SEC61 locus, a 
PCR product of 5556 bp could be amplified. The control primers (5’ SalI YDJ1 and 3’ YDJ1 XbaI; ref. 
Table 2.6) targeted YDJ1 (Ydj1p). The amplified product using these primers was 1230 bp in size. 
YDJ1 codes for Ydj1p, a cytoplasmic type I Hsp40 co-chaperones belonging to the Hsp40/DnaJ 
family. Ydj1p is involved in the regulation of Hsp70s and Hsp90s and also protein translocation 
across membranes, protein folding and ubiquitin-dependent degradation (Caplan & Douglas, 1991; 
Caplan et al., 1992; Kimura et al., 1995; Lee et al., 1996). 
Thus, positive transformants were expected to display two bands, one at 1230 bp (YDJ1) and one 
band at 5556 bp (sec61 int. (integrated)). Chromosomal DNA of RSY255 (SEC61) was used as a 
control. Here, only a band at 1230 bp was expected. Of the positive transformants shown in Figure 
3.2.2.1.B, chromosomal DNA was prepared and tested. The results are shown in Figure 3.2.2.1.C. 
For each transformant tested, the integration into the genome of RSY255 at the SEC61 locus was 
successful (sec61 int.: lanes 2-6 and 9-11) as the desired band of 5556 bp was successfully 
amplified. The control PCRs were also positive (YDJ1: lanes 2-6 and 9-11), as for all transformants 
the 1230 bp band could be amplified. As a further control, PCRs using chromosomal DNA of 
untransformed RSY255 (YDJ1. lanes 1 and 8) were performed. While for PCRs performed with DNA 
of the sec61 integration strains bands were detected for YDJ1 as well as for sec61 (sec61 int.), for 
the PCR using RSY255 chromosomal DNA, only a band at 1230 bp should be detectable using both 
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primer sets (sec61 int./YDJ1: lanes 1 and 8). This was as expected. Thus, the generation of the 
sec61 integration strains sec61-S179P, sec61-S353C, sec61-S179P/S353C, sec61-302 and sec61-
303 was successful and the transformants could be used for in vitro studies. 
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Figure 3.2.2.1 Generation and verification of sec61 integration mutants. (A) Schematic representation of 
sequence integration into the yeast genome by homologous recombination. Yeast transformation with the 
linearized integration plasmid pRS306-sec61, containing the appropriate truncated sec61 gene, leads to the 
integration of the sequence at the SEC61 locus homologous to the digested sequence, resulting in one 
complete copy of sec61 containing the appropriate point mutation(s) (sec61★) followed by the pRS306 
backbone sequence including URA3 and a truncated version of SEC61 (#sec61). (B) RSY255 was transformed 
with the linearized (SfiI) plasmids pRS306-truncsec61* (*: S179P; S353C; S17PP/S353C; 302; 303). Selection 
of positive transformants was on SC -URA plates at 30 °C for 3 days. Controls: JDY638 (SEC61) and RSY255 
(both: no growth on - Uracil). (C) Verification of integration of the appropriate sec61 sequence at the SEC61 
locus was by PCR using chromosomal DNA of positive transformants and specific primers (sec61 int. (5556 
bp): lanes 2-6 and 9-11). Control primers targeted YDJ1 (YDJ1 (1230 bp): lanes 1-6 and 8-11). Chromosomal 
DNA of untransformed RSY255 (YDJ1 and sec61 int.: lanes 1 and 8) was used as another control. (int. = 
integrated). 
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3.3 GROWTH ANALYSIS OF THE SEC61 MUTANTS 
The JDY638 derivatives sec61-S179P, sec61-S353C and sec61-S179P/S353C that are described in 
3.2.1, were initially tested for growth (i.e. viability) at various temperatures.  
Serial dilutions (105 – 100 cells) of each strain were plated onto rich medium (YPD), minimal medium 
(SC) and on the same media containing the ER stress inducer tunicamycin (Tm). The plates were all 
incubated at the designated temperaures (37 °C, 30 °C, 25 °C and 20 °C) for three days (ref. Figure 
3.3.1). The two sec61 mutants isolated in a previous study, sec61-302 and sec61-303, were 
included in the analysis. Both strains were in the same genetic background (JDY638) as the newly 
generated mutants (Ng et al., 2007). Further, sec61-3 (G341E; maps to the ER-lumenal loop 7) and 
sec61-32 (C150Y; maps to the ER-lumenal end of TMD 4) were used as controls. The mutant 
sec61-32 has been shown to be cold-sensitive (Cs) for growth and protein translocation into intact 
cells (Pilon et al., 1997, Pilon et al., 1998). The mutant sec61-3 has been described to be cold- (Cs) 
and temperature-sensitive (Ts) (Sommer & Jentsch, 1993; Stirling et al., 1992; Pilon et al., 1997; 
Wilkinson et al., 1997). Further, membranes isolated from both strains have been shown to be 
deficient in translocation into the ER as well as in ER degradation, as shown in an in vitro 
retrotranslocation assay reproducing the export of an ERAD substrate from the ER for degradation in 
the cytosol (Pilon et al., 1998). 
Results are shown in Figure 3.3.1.  As seen in Figure 3.3.1 (YPD, - Tm), none of the sec61 mutants 
sec61-S179P, sec61-S353C, sec61-S179P/S353C, sec61-302 and sec61-303 exhibited growth 
defects on rich medium compared to wild-type cells at the temperatures tested. While at 30 °C and 
25 °C (105-101 cells) growth was optimal, it was reduced at 20 °C (105-102 cells) and 37 °C (105-103 
cells) for all strains. The control strains, sec61-3 (Cs, Ts) and sec61-32 (Cs), displayed impaired 
growth at 20 °C (restrictive temperature: 18 °C). At this temperature the effect for sec61-32 (reduced 
growth at 105 cells) was more pronounced as for sec61-3 (105-104 cells). Moreover, sec61-3 
(reduced growth even at 105 cells) displayed reduced growth at 37 °C (restrictive temperature) as 
described previously (Stirling et al., 1992; Sommer & Jentsch, 1993; Pilon et al., 1998). Growth at 25 
°C and 30 °C of both strains was comparable to the wild-type (SEC61). It has, however, to be noted 
that SEC61 is not the isogenic wild-type for sec61-3 and sec61-32. Since the two mutants grew as 
described previously at the restrictive and permissive temperatures, growth rates of the two control 
strains were compared to this wild-type (Sommer & Jentsch, 1993; Pilon et al., 1997, 1998). 
As none of the sec61 mutants, except sec61-3 and sec61-32, displayed growth defects on rich 
medium at any of the temperatures tested, growth was also tested on minimal medium (SD), i.e. 
under more restrictive nutritional conditions (Figure 3.3.1, SD, - Tm). As for growth experiments on 
YPD, growth of the sec61 mutants (JDY638 derivatives) on SD medium was comparable to the wild-
type (SEC61) at all temperatures tested. For all strains tested, however, single colonies were smaller 
when grown on SD medium. While growth of the JDY638 derivatives at 30 °C and 25 °C (both 105-
102 cells) was comparable to growth on YPD, it was reduced at 37 °C (105-104 cells) and 20 °C (105-
3 RESULTS 
 
	   125	  
103 cells). Further, on SD medium, the sec61 mutants sec61-3 and sec61-32 showed the same 
growth defects at 20 °C (sec61-3: 105-104 cells; sec61-32: reduced growth at 105-104 cells) and 37 
°C (sec61-3: strongly reduced growth at 105 cells), which were a little more pronounced than those 
observed for growth on YPD, while growth at 25 °C (105-102 cells) and 30 °C (105-102 cells) was 
comparable to the wild-type (SEC61).  
Further growth analyses were performed in the presence of the UPR inducer tunicamycin (Tm). The 
antibiotic tunicamycin interferes with N-linked glycosylation in the ER, leading to increased ER stress 
and eventually to the induction of the UPR (Kuo & Lampen, 1974; Duksin & Mahoney, 1982; Langan 
& Slater, 1991; Torrez-Quiroz et al., 2010).  
First, strains were grown on YPD plates containing 0.25 µg/ml Tm for three days at the respective 
temperatures (ref. Figure 3.3.1, YPD, + Tm). Growth on medium containing Tm was monitored in 
order to analyze whether any of the mutations in SEC61 lead to a reduced capacity of the respective 
strain to recover from an increase in ER stress compared to any of the other strains. I reasoned that 
if either of the mutations in SEC61 affected protein translocation across the ER membrane, and 
especially dislocation, this would affect the cells’ ability to recover from the accumulation of 
unglycosylated proteins in the ER. This would result in growth defects on medium containing (Tm). 
As shown in Figure 3.3.1 (YPD, + Tm), the sec61 mutants, sec61-S179P, sec61-S353C, sec61-
S179P/S353C, sec61-302 and sec61-303 showed growth rates comparable to the corresponding 
wild-type (SEC61) when Tm was added at a concentration of 0.25 µg/ml, i.e. no severe growth 
defect was visible. Upon addition of Tm to the medium, however, the growth of these strains was 
altogether reduced compared to growth on rich medium alone, indicating that under the conditions 
tested none of the sec61 mutants was more severely affected than the wild-type (SEC61) at neither 
temperature. At 25 °C, 30 °C and 37 °C growth was reduced by one dilution step compared to 
growth of these strains on YPD only. At 20 °C a reduction in growth of two dilution steps was 
detected (ref. Figure 3.3.1, YPD, +/- Tm). It has been shown previously that the mutation in sec61-3 
(isolation via an UPR screen) leads to an activation of the UPR in this strain (Sommer & Jentsch, 
1993). Thus, I expected sec61-3 to be sensitive to Tm. For sec61-32, I reasoned that this strain, as it 
is Cs and defective in protein import and export, would also be sensitive to the antibiotic (Pilon et al., 
1007; Pilon et al., 1998). The control strains sec61-3 and sec61-32 showed a reduction in growth at 
all temperatures compared to the remaining strains. As expected, this effect was more pronounced 
at 20 °C (almost two dilution steps) and 37 °C (growth even more compromised at 105 cells) for 
sec61-3 and at 20 °C (unable to form single colonies at 105 cells) for sec61-32. Thus, growth defects 
at the restrictive temperatures are more severe under the influence of the ER stress inducer. 
Additionally, growth was tested on minimal medium containing two concentrations of Tm (0.25 µg/ml 
and 0.5 µg/ml). The higher concentration was chosen, as on YPD in the presence of 0.25 mg/ml Tm, 
the effects were only subtle. As seen in Figure 3.3.1 (SD, + Tm), growth of the JDY638 derivatives at 
30 °C in the presence of 0.25 µg/ml Tm was only slightly reduced compared to growth on SD alone. 
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This effect was slightly more pronounced when 0.5 µg/ml Tm were added to the medium. Here, a 
reduction in growth of almost one dilution step compared to growth on SD (- Tm) was observed. The 
same was found for mutants sec61-3 and sec61-32 at this temperature. When grown at 25 °C in the 
presence of 0.25 µg/ml Tm, growth of the JDY638 derivatives was comparable growth on SD (- Tm). 
When 0.5 µg/ml Tm was added to the medium, a reduction in growth of one dilution step was 
observed. However, as for growth at 30 °C, growth rates of all sec61 mutants were comparable to 
the wild-type (SEC61). At a Tm concentration of 0.25 µg/ml, sec61-3 grew on SD as without the 
addition of Tm. For this strain growth was reduced by almost two dilution steps at a Tm 
concentration of 0.5 µg/ml. The effect was more severe for sec61-32. While growth at 0.25 µg/ml Tm 
was comparable to growth on SD without Tm, at a concentration of 0.5 µg/ml hardly any growth was 
detected. At 20 °C a reduction in growth rate by about two dilution steps was observed for the 
JDY638 derivatives in the presence of 0.25 µg/ml Tm. At the higher Tm concentration hardly any 
growth was detected at this temperature. The mutant sec61-3 displayed growth comparable to 
growth on SD alone at the lower Tm concentration, while at the higher concentration there was 
hardly any growth. As for sec61-32 growth was already compromised on SD without the addition of 
Tm, there was no growth at both Tm concentrations. Finally, at 37 °C there was a slight reduction in 
growth for the JDY638 derivatives at the lower Tm concentration, which was slightly more 
pronounced at 0.5 µg/ml Tm. Since for the mutant sec61-3 there was hardly any growth on SD 
alone, growth was still compromised when Tm was added. The mutant sec61-32, although at this 
temperature overall growth was stronger than for the JDY638 derivatives, growth was reduced by 
almost to dilution steps when 0.2 µg/ml Tm were added. This effect was more pronounced when 0.5 
µg/ml Tm was added. 
Under the conditions tested, the newly generated sec61 mutants as well as sec61-302 and sec61-
303 are viable and are not cold-sensitive or temperature-sensitive as e.g. sec61-3 or sec61-32 
(Stirling et al., 1992; Sommer & Jentsch, 1993; Pilon et al., 1997; Pilon et al., 1998; Ng et al., 2007). 
Comparing their abilities to grow on rich medium or minimal medium to the corresponding wild-type 
(SEC61), they do not show any growth defects on either medium and drop out medium (ref. Figure 
3.3.1, YPD, SD). Even when Tm (i.e. upon ER stress induction) was added the sec61 mutants grow 
comparable to the wild-type (SEC61). The results therefore imply that the mutations in SEC61 in the 
respective sec61 mutants (sec61-S179P, sec61-S353C, sec61-S179P/S353C, sec61-302 and 
sec61-303) do not affect the function of Sec61p as severely as e.g. those found in sec61-3 and 
sec61-32. Even the sec61 mutants sec61-302 and sec61-303, which are defective in cotranslational 
protein import into the ER, displayed no growth defects, suggesting that the import defect is not 
severe enough to disturb cell viability under the conditions tested.  
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Figure 3.3.1. Growth analyses of the sec61 mutants. Growth analyses were performed using the sec61 
mutants sec61-S179P, sec61-S353C and sec61-S179P/S353C, generated in this study, as well as sec61-302 
and sec61-303 (all in the JDY638 background; Ng et al., 2007). Serial dilutions (105-100 cells) of each yeast 
strain were dropped onto the respective plates and incubated at 20, 25, 30 and 37 °C for 3 days. Initially growth 
was monitored on rich medium in the absence (YPD, -Tm) or presence (YPD, +Tm) of tunicamycin. In order to 
analyze whether any of the strains showed growth defects under more restrictive nutritional conditions the 
growth analyses were repeated using minimal medium (SD, - Tm). Again, in order to evaluate the impact of 
induced ER stress on the growth of the different sec61 mutants (i.e. on their capacity to cope with the 
accumulation of misfolded proteins in the ER), growth was additionally monitored in the presence of 
tunicamycin (SD, +Tm). Growth rates were compared to the corresponding SEC61 wild-type strain. The 
mutants sec61-3 and sec61-32 were used as controls. Plates were photographed using the E-Box VX2 Gel 
Documentation System (Peqlab). 
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3.4 TESTING FOR TRANSLOCATION DEFECTS USING URA3-REPORTER FUSION 
PROTEINS 
The sec61 mutants sec61-302 and sec61-303 isolated in a previous study are defective in 
cotranslational protein import into the ER (Ng et al., 2007). In the study mentioned, protein import 
capacities of the sec61 mutants sec61-301 (R67C), sec61-302 (D168G, S179P, F263L, S353C) and 
sec61-303 (D168G, F263L) were monitored using a URA3-reporter plasmid translocation assay and 
results compared to the corresponding wild-type (SEC61) (all in the JDY638 background; Ng et al., 
1996; Ng et al., 2007). The assay was performed using reporter constructs for co- and 
posttranslational translocation (Ng et al., 1996, 2007). As all of the above sec61 mutants showed 
defects in cotranslational import, but only membranes of the mutant sec61-302 displayed reduced 
proteasome binding, it was reasoned that the two amino acid substitutions D168G and F263L, which 
sec61-302 and sec61-303 share, mediate the cotranslational import defect observed in these 
mutants. Therefore, it has been concluded that the two remaining amino acid substitutions in sec61-
302, F179P and/or S353C, are responsible for the reduction in proteasome affinity (Ng et al., 2007).  
In order to analyze whether the amino acid substitutions S179P and/or S353C cause a 
cotranslational import defect on their own, I repeated the reporter translocation assay using the 
mutants sec61-S179P, sec61-S353C and sec61-S179P/S353C described in 3.2.1 (ref. 2.2.20). The 
mutant sec61-302 was used as a control as well as the corresponding wild-type (SEC61) strain. All 
strains were in the JDY638 background in order to compare the data with previous results (Ng et al., 
2007).  
For the reporter translocation assay the JDY638 derivatives SEC61, sec61-302, sec61-S179P, 
sec61-S353C and sec61-S179P/S353C (Ng et al., 2007; this study), which are uracil auxotrophic 
strains, were transformed with a plasmid containing a reporter construct for either cotranslational 
import, pJEY203  (Ng et al., 2007) or posttranslational import, pDN106  (Ng et al., 1996), or the 
empty pRS313 vector (Sikorski & Hieter, 1989). The reporter plasmid pNY203 (pRS313-PHO8-
URA3) expresses a fusion protein of the first 70 amino acids of PHO8 and the whole open reading 
frame (ORF) of URA3. The fusion sequence is under the control of the PHO5 promoter (Ng et al., 
2007). PHO8 encodes alkaline phosphatase, which is involved in the dephosphorylation of 
phosphotyrosyl peptides in S. cerevisiae and is cotranslationally imported into the ER (Donella-
Deana et al., 1993). URA3 encodes the Orotidine-5'-phosphate (OMP) decarboxylase which is 
involved in the ne novo biosynthesis of pyrimidines in the cytosol (Lacroute, 1968). The fusion 
protein is cotranslationally imported into the ER. The second reporter plasmid used in this 
experiments was pDN106 (pRS313-CPY-URA3), which has been created by fusing the promoter 
sequence of PRC1 (CPY) and its amino-terminal 110 amino acids in frame with URA3. The initiator 
methionine of Ura3p was replaced by glycine as a linker. As for pJEY203, the resulting recombinant 
gene was cloned into the yeast centromeric vector pRS313 (Sikorski & Hieter, 1989; Ng et al., 1996). 
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The PRC1 (CPY) portion of the fusion gene encodes the yeast vacuolar carboxy peptidase Y, which 
is involved in protein degradation in the vacuole (van den Hazel et al., 1996). The fusion protein is 
posttranslationally imported into the ER. 
Following the transformation of the sec61 mutants and the wild-type (SEC61) with the reporter 
constructs or the empty vector, transformants were selected on minimal medium containing glucose 
but lacking histidine and leucine (-HIS/LEU) at 30 °C for three days. For the assay, serial dilutions 
(104-101 cells) of an overnight culture of each strain were plated onto minimal medium plates lacking 
HIS/LEU (+ Uracil) and onto the same plates also lacking uracil (-HIS/LEU/URA; - Uracil), 
respectively. Growth on minimal medium -HIS/LEU plates selects for the reporter plasmid and the 
plasmid encoding the sec61 mutants whereas growth on minimal medium -HIS/LEU/URA plates 
monitors translocation defects. In sec61 mutants with disturbed protein translocation the Ura3p 
fusion protein remains in the cytosol and thus allows growth on plates lacking uracil (ref. Figure 
3.4.1.A). 
The results are shown in Figure 3.4.1.B. On minimal medium -HIS/LEU (+ Uracil) plates all of the 
sec61 mutants transformed with the reporter plasmids and the control grew comparable to wild-type 
(SEC61) cells (Figure 3.4.1.B, + Uracil, PHO8, CPY, pRS313). This is in concordance with data from 
growth experiments that have shown that the sec61 mutants analyzed are all viable, i.e. Sec61p 
function is not disturbed to the extent that cell viability is compromised (ref. 3.3). 
As shown in Figure 3.4.1.B, growth on minimal medium -HIS/LEU/URA (- Uracil) plates, which 
monitors translocation defects, was only detectable for sec61-302 transformed with the reporter 
plasmid for cotranslational import (pRS313-PHO8-URA3). This supports data from a previous study, 
which has shown that the mutant sec61-302 is defective in protein import of the cotranslational 
import substrate Pho8p (Ng et al., 2007). For the remaining sec61 mutants tested as well as for the 
wild-type (SEC61) no growth on minimal medium -HIS/LEU/URA (- Uracil) plates was detectable 
when transformed with either pRS313-PHO8-URA3 or pRS313-CPY-URA3. The vector pRS313 was 
used as a negative control (Figure 3.4.1.B, none, pRS313). The fact that the cells failed to grow 
indicates that the reporter fusion protein was translocated into the ER, i.e. none of these strains is 
defective in co- or posttranslational protein import.  
Since none of the sec61 mutants created in this study (ref. 3.2.1) display defects in co- or 
posttranslational protein import during the reporter plasmid translocation assay, I reasoned that 
these mutants would be great tools for elucidating which domain(s) of Sec61p are involved protein 
dislocation (ERAD), i.e. proteasome binding during retrotranslocation. Hence, defects that might be 
detectable here could then be solely attributed to the effect of the amino acid exchange S179P 
and/or S353C on Sec61p’s function during these processes and would thus not be a result of 
disturbed protein import.   
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Figure 3.4.1. Detection of translocation defects using a reporter translocation assay. (A) Schematic 
representation of the reporter translocation assay. Yeast strains transformed with the reporter plasmid for 
cotranslational (pRS313-PHO8-URA3 (shown), or posttranslational import (pRS313-CPY-URA3), or the empty 
vector pRS313 (control) were grown on minimal medium plates lacking leucine and histidine (not shown). 
Translocation defects of the respective reporter fusion protein results in growth on minimal medium lacking 
histidine, leucine and uracil (- Uracil). (B) Serial dilutions (104-100 cells) of the indicated JDY638 derivatives, 
transformed with either of the reporter plasmids or pRS313, were grown at 30 °C for 3 days on minimal medium 
lacking histidine and leucine (+ Uracil; controls for Sec61p function) and on the same plates lacking uracil (- 
Uracil; controls for translocation defects) (N = 3; Sikorski & Hieter, 1989; Ng et al., 1996; Ng et al., 2007).  
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3.5 PROTEASOME BINDING ASSAY 
In a previous study the sec61 mutant sec61-302 (D168G, S179P, F263L, S353C) was shown to 
display reduced proteoliposome binding to purified 19S RP (Ng et al., 2007). From the binding 
experiments and additional data it has been suggested that the amino acid substitutions S179P 
and/or S353C are responsible for the reduction in proteasome affinity (Ng et al., 2007). S179P being 
the only residue accessible from the cytosol has been speculated to be the more likely candidate 
(Ng et al., 2007). Therefore, in order to elucidate which of the two point mutations cause the 
reduction in proteasome affinity, I performed binding experiments using the mutants sec61-S179P, 
sec61-S353C and sec61-S179P/S353C. 
 
 
3.5.1 PURIFICATION OF 19S REGULATORY PARTICE 
For proteasome binding assays the 19S proteasome subcomplex was isolated by affinity purification 
(ref. 2.2.30). In this study the S. cerevisiae strain KRY333 was routinely used to purifiy 19S RP (ref. 
Table 2.4). The strain expresses a version of the 26S proteasome that is FLAG®-tagged on Rpt1p of 
the 19S RP base subunit (ref. Figure 3.5.1.1.A; Verma et al., 2000). The presence of the Flag®-tag 
does not disturb proteasome function, such as assembly and activity (Verma et al., 2004; Sone et 
al., 2004). FLAG®-tagged 19S RPs were used routinely for proteasome binding assays as it has 
been shown that binding of the 26S proteasome to ER membranes is mediated by the base subunit 
of the 19S RP (Ng et al., 2007). 
Cytosol of S. cerevisiae strain KRY333 was prepared and 19S RP immunoprecipitated overnight 
using anti-FLAG® M2 agarose beads. Immunoprecipitated 19S RP was eluted using FLAG® peptide 
and concentrated to 1 -2 µg/µl. In order to monitor the sufficiency and success of the purification, 
samples were taken during the purification. This was also done to ensure purity of the 19S RP 
preparation as a contamination with 26S proteasomes was not desired. Samples of the cytosol and 
washes following the immunoprecipitaion, as well as of the purified 19S RPs were analyzed by SDS-
PAGE (ref. 2.2.24.1) and stained with Coomassie (ref. 2.2.24.2). 
As shown in Figure 3.5.1.1.B the purification of FLAG®-tagged 19S RP was successful (lane 6: 19S 
RP). The distinct protein pattern that the 19S RP display when resolved by SDS-PAGE was as 
shown previously (Verma et al., 2000; Leggett, Glickman and Finley, 2005; Ng et al., 2007). Lane 2 
(Cytosol) shows the protein content of the samples before the incubation of the yeast lysate with 
anti-FLAG resin. Lane 5 shows the sample enriched in 19S RP in the course of the purification. Also, 
the loss of 19S RP during washes following the incubation with the anti-FLAG resin was minimal 
(lane 3: Wash 1 and lane 4: Wash 2). Hence, the purification was successful and the 19S RP 
proteasomes could be used for proteasome binding assays (ref. 3.5.2). 
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As results from the binding experiments were compared to those from a previous study, 
contaminations with 26S proteasomes had to be avoided. In addition to the Coomassie stain, a 
proteasomal activity assay was performed in order to assess the puritiy of the preparation. As a 
control purified 26S from the same yeasts strain were used. 
The peptidase activity of proteasomal preparations was monitored using an in gel activity assay (ref. 
2.2.30.1). Native gel electrophoresis of purified proteasomal preparations (about 5 µg of 26S, 20S C 
and 19S RP) was performed using 4 % nondenaturing polyacrylamide gels. Gels were immediately 
incubated with the fluorogenic peptide substrate N-succinyl-Leu-Leu-Val-Tyr-7-amido-4-
methylcourmarin (Suc-LLVY-AMC) for 10 min at 30 °C (Glickman et al., 1998b; Verma et al., 2000). 
Suc-LLVY-AMC is a fluorogenic chymotrypsin substrate for the 20S proteasome. The 20S 
proteasome consisting of four heptameric rings, two outer α-rings and two inner β-rings, harbours 
chymotrypsin-like activity (Hiller et al., 1996; Verma et al., 2000). The protease-active sites (β 1, 2 
and 5) which perform the proteolysis reactions during protein degradation are located in the 20S CP 
lumen (Finley, 2009). Suc-LLVY-AMC is cleaved due to the chymotrypsin-like enzyme activity of 
active proteasomes, resulting in the free fluorophore 7-amido-4-methylcoumarin (AMC), which can 
then be monitored under UV light (360 nm). Thus, samples containing active 20S CP are fluorescent 
under UV light (Hiller et al., 1996).  
Results are shown in Figure 3.5.1.1.C. Shown are the results from the peptidase activity assay 
(RIGHT) as well as the coomassie stain (LEFT) of the same gel. The Coomassie stain revealed all 
three samples used in the peptidase activity assay (26S: lane1; 20S CP: lane2; 19S RP: lane 3). 
Further, the 19S RPs (lane 3) do not run as a distinct band, which has been shown before (Verma et 
al., 2000). As expected, a fluorescent signal was detectable for the control samples containing 26S 
(lane 1) and 20S CP (lane 2), respectively (ref. Figure 3.5.1.1.C, RIGHT). The double band in lane 1 
can be attributed to the existence of singly (R1P) and doubly (R2P) capped proteasomes in the 26S 
preparation. For the sample containing 19S RP (lane 3) no fluorescent band was detectable. This, 
too, was as expected, as this sample does not contain 20S CP. Thus, there was no contamination of 
the 19S RP preparation detectable. 
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Figure 3.5.1.1 Affinity purification of the 19S RP. (A) Schematic representation of the 26S proteasome and 
its subunits 19S RP and 20S CP. The position of the FLAG®-tag for purification is indicated. The Rpt1-FLAG® 
strain KRY333 was routinely used for the purification of 19S RPs and 26S proteasomes (control). Isolation of 
26S proteasomes was in the presence of ATP (adapted from Hanna & Finley, 2007). (B) Affinity purification of 
FLAG®-tagged 19S RP was from cleared yeast lysate using anti-FLAG® M2 agarose (Sigma). Bound proteins 
were eluted with 100 µg/ml FLAG® peptide (Sigma), concentrated using a Centricon® YM-100 centrifugal filter 
and quantified using the Pierce™ 660nm Protein Assay Reagent (Thermo Scientific). Sample of the cytosol and 
after various washes during the purification and 5 µg of 19S proteasome were resolved on a NuPAGE® Novex® 
4-12 % Pre-Cast gel at 150 V using 1X MOPS Running Buffer (Invitrogen). The gel was then stained using the 
EZBlue™ gel staining reagent (Sigma) and dried in a gel dryer (Model 583, BioRad). (C) Peptidase activity of 
proteasomal preparations (i.e. purified FLAG®-tagged 19S RP and 26S from the same strain as control; 20S 
CP purified from KRY332) was evaluated using an in-gel activity assay (RIGHT). The fluorogenic chymotrypsin 
substrate Suc-LLVY-AMC was used as the substrate. Proteasome samples were resolved on a 4 % 
nondenaturing polyacrylamide gel containing DTT, ATP and glycerol. The gel was incubated for 10 min at 30 
°C in the presence of 100 µM substrate and 1 mM ATP. Visualization of fluorescent bands was upon exposure 
to UV light (360 nm). The same gel was stained with Coomassie blue as a control (LEFT). 
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3.5.2 PROTEASOME BINDING ASSAYS 
As mentioned earlier, the mutant sec61-302, apart from being defective in cotranslational import, 
also displays a reduction in proteasome affinity (Ng et al., 2007). The point mutations S179P 
(cytoplasmic end of TMD 5 of Sec61p) and/or S353C (loop 7 of Sec61p) which sec61-302 shares 
with the remaining three sec61 mutants sec61-S179P, sec61-S353C and sec61-S179P/S353 did not 
cause defects in co- or posttranslational import into the ER (ref. 3.2.1 and 3.4). In order to analyze 
which of these point mutations is responsible for the reduction in proteasome binding observed in 
sec61-302, I performd proteasome binding assays (ref. 2.2.31). 
For proteasome binding assays, I isolated rough microsomes (RMs) from the sec61 mutants sec61-
302 (D168G, S179P, F263L, S353C), sec61-S179P, sec61-S353C and sec61-S179P/S353C and 
the corresponding wild-type strain (SEC61) (ref. 2.2.25). Prior to the actual binding assay I treated 
RMs with puromycin and high salt (potassium acetate) (ref. 2.2.26). The aminonucleoside antibiotic 
puromycin (from Streptomyces alboniger) is an analogue of the 3’ end of a tyrosyl-tRNA, which 
causes premature chain termination during translation (Darken, 1964; Pesta, 1971). Treatment with 
puromycin and high concentrations potassium acetate causes release of nascent chains from 
ribosomes and the dissociation of the ribosomes from the membranes (Görlich et al., 1992). The 
purpose of this step is to free up the maximal number of proteasome binding sites (i.e. Sec61 
channel) in the microsomes prior to the binding experiment. I then solubilized the stripped S. 
cerevisiae microsomal membranes (PK-RMs) and reconstituted total protein into proteoliposomes 
(RECs) (ref. 2.2.27; Kalies et al., 2005). The reconstitution step is required when using S. cerevisiae 
membranes during proteasome binding assays, as the use of intact yeast PK-RMs produces data 
that are not interpretable and the use of proteoliposomes also increases overall binding of 
proteasomes to the membranes (Kalies et al., 2005; Ng et al., 2007). 
It has been speculated that the binding of 19S RP to the membranes is not efficient enough when 
using yeast PK-RMs and hence, no differences between wild-type and mutant membranes are 
detectable when using PKRMs instead of reconstituted proteoliposomes during binding experiments 
and the use of proteoliposomes also increases overall binding to the membranes (Kalies et al., 2005; 
Ng et al., 2007). Reconstituted proteoliposomes were produced by treating PK-RMs with Deoxy-
BigCHAP, a detergent dissolving the membranes, followed by the reconstitution of total protein using 
phosphatidylcholine (PC) and phosphatidylethanolamine (PE) membranes (ref. 2.2.27 and 2.2.28). 
During the reconstitution of total protein into proteoliposomes 50 % of all ER membrane proteins are 
expected to be in the inside-out orientation. Therefore, the amount of yeast proteoliposomes had to 
be adjusted accordingly. Reconstituted proteoliposomes were quantified (i.e. determination of 
Sec61p contents) was by immunoblotting with anti-Sec61p antibody using different concentrations of 
RMs of the appropriate strain as the standard (not shown). 
For the proteasome binding assays, reconstituted proteoliposomes prepared from PK-RMs of the 
wild-type (SEC61) and the sec61 strains were incubated with purified 19S RP (ref. 3.5.1 and 2.2.31). 
3 RESULTS 
 
	   135	  
In brief, reconstituted proteoliposomes (20 eq*) from the appropriate S. cerevisiae strain were 
incubated with of purified S. cerevisiae 19S RP (2 pmol). After binding was complete, membranes 
were floatated in 1.8 M sucrose, resulting in a distribution of unbound 19S RP at the bottom and 
membranes with bound 19S RP at the top of the sucrose gradient (ref. Figure 3.5.2.1.A). Following 
the ultracentrifugation step, the gradients were fractionated from the top (9 fractions). Proteins in 
each fraction were then resolved by SDS-PAGE (ref. 2.2.24) and proteasome binding was detected 
by immunoblotting for the FLAG®-tagged Rpt1 subunit (ref. 2.2.24.3). Reconstituted proteoliposomes 
were quantified prior to the assays, and proteasome binding efficiencies (i.e. bound fractions (1 - 3) 
vs unbound fractions (7 - 9)) evaluated using the ChemiDoc™ XRS system and the Image Lab™ 
software (both Bio-Rad). 
The results are shown in Figure 3.5.2.1.B and 3.5.2.1.C. Proteasome binding to reconstituted 
proteoliposomes results in a signal in the top fractions, indicating an interaction between Sec61p in 
the ER membrane and the proteasomal 19S RP (Figure 3.5.2.1.B SEC61, lanes 2-4). Mock binding 
assays containing 19S RP alone were used as a control (ref. Figure 3.5.2.1.B no membranes). For 
proteasome binding assays using only 19S RP, there should only be a signal detectable in the 
bottom fractions of the gradient (unbound) as there are no membranes for the proteasomal subunits 
to bind to in the sample. The results of the control experiment was as expected (ref. Figure 3.5.2.1.B 
no membranes, lanes 7-9). For sec61-302 membranes (19 % bound), which were used as another 
control, a reduction in 19S RP binding compared to wild-type membranes (39 % bound) could be 
detected (ref. Fig. 3.5.2.1.B and 3.5.2.1.C SEC61 and sec61-302). Membranes of the mutant sec61-
S179P did not show a defect or reduction 19S RP binding (38 % bound). In the mutants sec61-
S353C (17 % bound) and sec61-S179P/S353C (30 % bound), however, a reduction in membrane-
19S RP interaction could be detected (ref. Fig. 3.5.2.1.B and 3.5.2.1.C sec61-S353C and sec61-
S179P/S353C). For the latter, the proteasome binding defect was less pronounced compared to 
sec61-S353C and sec61-302. 
As shown in Figure 3.5.2.1.B I was able to reproduce results from proteasome binding assays with 
sec61-302 showing that ER membranes from this strain have reduced affinity for 19S RP (Ng et al., 
2007). Surprisingly, the mutation in sec61-S179P did not affect 19S RP binding compared to wild-
type membranes (Figure 3.5.2.1.B and 3.5.2.1.C sec61-S179P). In sec61-S353C and sec61-
S179P/S353C I saw a reduction in the interaction between membranes and 19S RP, leading to the 
conclusion that the point mutation S353C, and not S179P as initially anticipated, is responsible for 
the reduced interaction of 19S RP with mutant Sec61p in sec61-302, sec61-S353C and sec61-
S179P/S353C (ref. Figure 3.5.2.1.B and 3.5.2.1.C). The results presented here, together with those 
from the reporter plasmid translocation assay (ref. 3.4), strongly suggest that among the mutations in 
sec61-302, D168G and/or F263L are responsible for the cotranslational import defect, whereas 
S353C probably causes the observed reduction in binding of 19S RP to membranes derived from 
sec61-302, sec61-S353C and sec61-S179P/S353C (Ng et al., 2007; this study). This finding is 
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striking, as S353C is located in the ER-lumenal loop 7, a region of Sec61p inaccessible from the 
cytoplasmic side of the membrane. One possible explanation for the observed effect could be that 
the amino acid substitution S353C has a certain impact on the conformation of Sec61p, leading to a 
conformational change (distortion) of the protein, which in turn could mask the proteasomal binding 
site on the cytosolic face of the protein. I therefore attempted tot rule out this possibility during the 
course of this study (also ref. 2.9). 
 
 
 
 
 
 
 
 
 
 
 
 
 
3 RESULTS 
 
	   137	  
 
 
Figure 3.5.2.1 Proteasome binding assay. (A) Schematic representation of the proteasome binding assay. 
ER-derived membranes (BLUE), i.e. reconstituted proteoliposomes from yeast RMs, of the wild-type (SEC61) 
and the mutant sec61 strains were incubated with purified 19S RP (RED) in the presence of ATP. Sample were 
loaded under a sucrose gradient and subjected to ultracentrifugation. The distribution of the proteasomes and 
ER membranes before and after flotation through a 1.8 M sucrose cushion is shown. Free proteasomes stay in 
the fraction at the bottom of the gradient while proteasomes bound to membranes float with the membranes to 
the top. After ultracentrifugation the gradient was fractionated from the top. Proteasomes in each fraction were 
detected by SDS-PAGE and immunoblotting. (B) 20 eq* of reconstituted proteoliposomes were incubated with 
2 pmol 19S RP proteasomal subcomplex FLAG®-tagged on Rpt1p and analyzed by flotation through a 1.8 M 
sucrose gradient. Gradients were fractionated from top to bottom and subjected to SDS-PAGE and 
immunoblotting with anti-FLAG® antibody. Detection of signals was using chemiluminescence and a CCD 
camera system (ChemiDoc™ XRS, Bio-Rad). The positions of 19S RP bound to yeast membranes and of 
unbound proteasomal subunits are indicated. (N = 3) (C) Binding efficiencies were quantified using the Image 
Lab™ software (Bio-Rad). Results of three experiments (N = 3) were averaged and the amount (%) of 19S RP 
bound to membranes for each strain are shown. Error bars indicate the standard error. * 1 eq of microsomes = 
50 A280 units/µl (Walter & Blobel, 1981). 
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3.6 ANALYSES OF UPR INDUCTION IN THE SEC61 MUTANTS 
The UPR is induced as a response to ER stress, such as the accumulation of misfolded proteins in 
the ER, which, if not cleared from the ER, are toxic to the cell (Menzel et al., 1997; Ng et al., 2000; 
Ron & Walter, 2007). In S. cerevisiae the induction of the UPR involves the activation of the Ire1p-
mediated signal transduction pathway, resulting in the upregulation of the expression of genes 
involved in ERAD, such as ER chaperones (Cox et al., 1993; Mori et al., 1993). This pathway 
ensures cell homeostasis as it enables the cell to cope with the high load of those species and 
mediate their degradation (Lee, 1987; Kozutsumi et al., 1988; Travers et al., 2000). As the UPR 
pathway is tightly linked to ERAD, a UPR induction would be expected when Sec61p function is 
disturbed (Pilon et al., 1997; Casagrande et al., 2000; Friedlander et al., 2000; Travers et al., 2000; 
Tsai et al., 2002; Kostova & Wolf, 2003).  
 
 
3.6.1 DETECTION OF UPR INDUCTION IN THE SEC61 MUTANTS USING THE QUANTITATIVE 
LIQUID β-GALACTOSIDASE ASSAY  
Initially, the quantitative liquid β-galactosidase assay was employed to monitor the constitutive UPR 
activation in the newly generated sec61 mutants (JDY638 background; ref. 3.2.1) (ref. 2.2.32.1; 
Miller, 1972; Guarente, 1982; Stagljar et al., 1998).  
The induction of the UPR was measured by using the plasmid pJC30 (TRP1, CEN/ARS), containing 
the 22 bp Unfolded Protein Response Element (UPRE) of KAR2 (BiP) upstream of the LacZ gene 
under the control of the disabled CYC1 promoter (Guarente & Mason, 1983; Sorger & Pelham, 1987; 
Sikorski & Hieter, 1989; Mori et al., 1992, Cox et al., 1993; Cox & Walter, 1996). The UPRE, a 
sequence found in the promoter region of UPR-activated genes, induces Lacz gene expression as a 
response to UPR activation (Miller, 1972; Guarente, 1982). As a control the same plasmid, pJC31, 
lacking the UPRE was used (Cox et al., 1993; Kawahara et al., 1997; Cox & Walter, 1996; Menzel et 
al., 1997).  
Upon UPR induction, cells containing the reporter plasmid pJC30 express β-galactosidase. The 
enzyme activity in turn is measured by the conversion of ortho-nitrophenyl-β-D-galactopyranoside 
(ONPG), a β-galactoside. ONPG is a chromogenic substrate, resulting in ortho-nitrophenol when 
hydrolyzed by the enzyme (Miller et al., 1972). The product has a yellow colour and absorbs light at 
a wavelength of 420 nm (Miller et al., 1972). The amount of o-nitrophenol formed can be measured 
by determining the absorbance at 420 nm. Thus, this simple quantitative colorimetric measure allows 
for an indirect determination of enzyme activity by measuring the formation of yellow colour. 
The strains sec61-S179P, sec61-S353C, sec61-S179P/S353C, sec61-302, sec61-303 and the 
corresponding wild-type (SEC61) as well as the strains sec61-3, DER1 and Δder1 were transformed 
with the reporter plasmids and transformants selected on the respective minimal medium. The 
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mutant sec61-3 as well as DER1 and Δder1 were used as controls. The sec61-3 mutant, which was 
isolated via a UPR screen, is defective in ERAD and therefore is expected to display an increased 
UPR even when the UPR is not induced using tunicamycin (Tm) (Sommer & Jentsch, 1993; Pilon et 
al., 1997; Zhou & Shekman, 1999). Der1p has been shown to be part of the ERAD machinery (Knop 
et al., 1996). In the absence of Der1p ER stress is increased, which in turn activates the UPR (Knop 
et al., 1996; Taxis et al., 2003). Therefore, in the Δder1 strain, a strong UPR inducation is expected . 
For the actual assay, cells were grown in minimal medium to an OD600 of 0.5 at 30 °C. For the assay 
1 OD600 per sample was harvested. As a control each strain was grown in the presence of 1 µg/ml 
tunicamycin (Tm). The antibiotic interferes with the glycosylation in the ER, thereby inducing the 
UPR due to increased ER stress (Kuo & Lampen, 1974; Duksin & Mahoney, 1982; Langan & Slater, 
1991; Torrez-Quiroz et al., 2010). The antibiotic was added at an OD600 of 0.4 (this was usually 
sufficient) and cells grown for another hour. Triplets of each strain were prepared. The cells were 
permeabilized and resulting lysates pre-incubated in a 28°C water bath. Lysates were then 
incubated with ONPG until the samples turned yellow (i.e. strains transformed with pJC30). 
Reactions were stopped and supernatants were measured in spectrophotometer at 420 nm.  
Averaged results of four independent experiments are shown in Figure 3.6.1.1. The sec61 mutants 
sec61-S179P (∼ 3.1 β-gal units), sec61-S353C (∼ 3.7 β-gal units), sec61-S179P/S353C (∼ 3.7 β-gal 
units), sec61-302 (∼ 2.3 β-gal units) and sec61-303 (∼ 2.7 β-gal units) did not show an elevated UPR 
in the absence of tunicamycin (- Tm) compared to the corresponding wild-type (SEC61: ∼ 3.5 β-gal 
units). When tunicamycin was added (+ Tm) an onset of the UPR was detected in all strains. The 
sec61 mutants generated in this and another study, i.e. sec61 mutants sec61-S179P (∼ 8.3 β-gal 
units), sec61-S353C (∼ 7.9 β-gal units), sec61-S179P/S353C (∼ 8.6 β-gal units), sec61-302 (∼ 9.9 β-
gal units) and sec61-303 (∼ 8.1 β-gal units), showed an activation of the UPR when tunicamycin was 
added that was still comparable to the wild-type (SEC61: ∼ 9.6 β-gal units) (Ng et al., 2007). This 
effect, however, was less pronounced compared to the control strains. 
The controls sec61-3 (∼ 11.4 β-gal units) and Δder1 (∼ 12.8 β-gal units), displayed an elevated β-
galactosidase activity compared to the wild-type (SEC61: ∼ 3.5 β-gal units; DER1: (∼ 2.2 β-gal units) 
or the remaining sec61 mutants without the addition of tunicamycin (- Tm), suggesting a 
constitutively elevated UPR under the experimental conditions tested. This was as expected. The 
effect was even more pronounced when the cells were treated with tunicamycin (+ Tm): sec61-3 (∼ 
17.4 β-gal units), Δder1 (∼ 20.5 β-gal units) and DER1 (∼ 7.9 β-gal units). Moreover, in the deletion 
mutant Δder1 the β-galactosidase levels were higher compared to sec61-3. The fact that for all 
strains the β-galactosidase units are comparable when tunicamycin was added suggests that the 
concentration used results in a maximum induction of the UPR. As seen in Figure 3.6.1.1, values 
gained from strains transformed with pJC31 (control) are shown in the same column of respective 
strain transformed with pJC30. They represent the background of the individual samples and 
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therefore display low β-galactosidase units. 
The fact that under the conditions tested, the sec61 mutants only displayed an increase in β-
galactosidase activities in the presence of tunicamycin suggests that the point mutations in SEC61 in 
these mutants do not have a severe enough impact on Sec61p function to cause ER stress and thus 
an induction of the UPR. 
 
 
 
 
Figure 3.6.1.1. Analysis of UPR induction in the sec61 mutants using the liquid quantitative β-galacto-
sidase assay. The indicated sec61 mutants, the corresponding wild-type (SEC61) as well as the control 
strains DER1, Δder1, sec61-3 co-expressing a reporter plasmid containing UPRE-CYC1-LacZ (pJC30) or the 
same plasmid lacking UPRE (pJC31: control) were grown in the respective minimal medium at 30 °C to an 
OD600 of 0.5. The UPR was induced using 1 µg/ml Tm. Tm was added at an OD600 of 0.4 and incubation was 
continued for 1 hour. Lysates of 1 OD600 were prepared using chloroform and 0.1 % (w/v) SDS. Samples were 
pre-incubated for 5 min in a 28 °C water-bath, followed by the addition of 200 µl ONPG (4 mg/ml). Samples 
were incubated at 28 °C until the substrate turned yellow. The reactions were stopped using 0.5 ml 1 M 
Na2CO3 and supernatants measured at a wavelength of 420 nm. β-galactosidase units were normalized to the 
OD600 of cells used for the assay. For each experiment, triplets of each strain (+/- Tm) were analyzed. Results 
from four (N = 4) independent experiments were averaged and graphed. Error bars indicate the standard error. 
 
  
+- +- +- +- +- +- +- +- +-
SE
C6
1
sec
61
-30
2
sec
61
-30
3
sec
61
-S1
79
P
sec
61
-S3
53
C
sec
61
-S1
79
P/S
35
3C

sec
61
-3
DE
R1

Δ d
er1

Tm
0
5
10
15
20
25
β 
-g
ala
ct
os
id
as
e 
un
its

UPRE-LacZ
LacZ
3 RESULTS 
 
	   141	  
3.6.2 DETECTION OF THE UPR INDUCTION IN THE SEC61 MUTANTS ON THE RNA LEVEL 
In order to further assess UPR induction in the sec61 mutants I employed an assay monitoring 
HAC1 mRNA splicing (ref. 2.2.32.3).  
In S. cerevisiae, upon induction of the UPR the HAC1 pre-mRNA (HACu mRNA) is spliced releasing 
an intron (ref. 1.4). The resulting exons are ligated by a tRNase (Cox & Walter, 1996; Shamu and 
Walter, 1996; Kawahara et al., 1997; Bertolotti et al., 2000; Papa et al., 2003; Credle et al., 2005; 
Zhou et al., 2006; Oikawa et al., 2007; Lee et al., 2008). The resulting species, HACi mRNA, 
encodes the transcription factor Hac1p, which is transported to the nucleus where it induces the 
expression of UPR target genes (Cox & Walter, 1996; Mori et al., 1996; Travers et al., 2000; Kimata 
et al., 2006). The two HAC1 species, HACu and HACi, differ in size. While the unspliced form, HACu  
(u = uninduced), displays a size of 720 bp, the spliced form, HACi (i = induced), is 470 bp in size. 
Thus, the formation of the spliced HAC1 mRNA species (HAC1i) is a direct measure for the induction 
of the UPR in the cells.  
The strains sec61-S179P, sec61-S353C, sec61-S179P/S353C, sec61-302, sec61-303 and the 
corresponding wild-type (SEC61), as well as sec61-3, Δder1 and DER1 were grown in minimal 
medium at 30 °C to an OD600  of 1. As a control the UPR was induced in all strains by treatment with 
2 µg/ml tunicamycin (Tm) for another 3 hours when an OD600 of 1 was reached. Additionally, sec61-
3 was grown at 17 °C in the presence and absence of tunicamycin (+/- Tm) for another 3 hours 
when an OD600 of 1 was reached. The RNA of each strain was isolated and the cDNA prepared 
which was used as the template during PCR. Specific primers targeting HAC1 or ACT1 (control) 
were used during the PCRs. Amplification of ACT1, encoding actin, was used as a loading control.  
Results are shown in Figure 3.6.2.1. Induction of the UPR using tunicamycin (+ TM) was successful 
in all strains, indicating that induced UPR is detectable. The magnitude of HAC1i formation in the 
sec61 mutants sec61-S179P, sec61-S353C, sec61-S179P/S353C, sec61-302 and sec61-303 was 
comparable to the wild-type (SEC61) when the UPR inducer was added (ref. Figure 3.6.2.1 TOP: + 
Tm). In the absence of tunicamycin (- Tm) there was no HACi species detectable in these strains 
(TOP: - TM).                                                                
In the control strain sec61-3 an induction of the UPR was detecable even in the absence of 
tunicamycin (- Tm) at both temperatures tested (ref. Figure 3.6.2.1 BOTTOM: - TM, 17 °C and 30 
°C) (Sommer & Jentsch, 1993). At 17 °C a slightly stronger UPR induction was detected (ref. Figure 
3.6.2.1 BOTTOM: - Tm, 17 °C). When tunicamycin was added this effect was even more 
pronounced (ref. Figure 3.6.2.1 BOTTOM: + Tm, 17 °C and 30 °C). The same was true for Δder1 
(Knop et al., 1996). This strain showed an induction of the UPR in the absence (- Tm) and presence 
(+ Tm) of tunicamycin, which too was in concordance with results from the liquid quantitative β-
galactosidase assay (ref. Figure 3.6.1.1). The corresponding wild-type (DER1) behaved as 
expected, i.e. no HACi species was detectable under normal growth conditions (- Tm), but could be 
detected when tunicamycin was added (ref. Figure 3.6.2.1 BOTTOM: + Tm).  
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Thus, the results further indicate that in the sec61 mutants analyzed, except sec61-3,  the UPR is 
not induced under normal growth conditions supporting data from the liquid quantitative β-
galactosidase assay (ref. 3.6.1).   
 
 
 
 
Figure 3.6.2.1. Analysis of UPR induction in the sec61 mutants using the HAC1 pre-mRNA splicing 
assay. Total RNA of each strain was prepared from cultures grown in minimal medium at 30 °C to an OD600 of 
1. For positive controls, cultures were grown in the presence of 2 µg/ml TM for another 3 hours when an OD600 
of 1 was reached. For sec61-3 RNA was additionally prepared from cultures grown at 17 °C (+/- Tm). Here, 
cells were grown to an OD600 of 1 at 30 °C and then shifted to 17 °C for another 3 hours. Total RNA  (0.1 µg) 
was subjected to RT-PCR using an Oligo(dT18)-dT primer to produce cDNA. The resulting cDNA (1 µg) was 
subjected to PCR of HAC1 with a set of primers targeting HAC1 to monitor the UPR. PCR fragments derived 
from HAC1u mRNA (HAC1u = uninduced; ∼ 720 bp) and HAC1i mRNA (i = induced; ∼ 470 bp) are indicated. 
ACT1 RT-PCR was conducted as a loading control. Samples were resolved on a 1 % agarose gel. As a control 
PCR was conducted without RT-PCR product (- RT)  (here: RT = Reverse Transcription). 
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3.6.3 GROWTH ANALYSES OF THE SEC61 MUTANTS IN THE Δ IRE BACKGROUND 
Additionally, I conducted growth analyses of the sec61 mutants in the sensitized genetic background 
of Δire1.  
IRE1, encoding Ire1p, is required for the UPR (Cox et al., 1993). It has been shown that under 
normal growth conditions IRE1 is not needed (Nikawa & Yamashita, 1992; Cox et al., 1993). Upon 
accumulation of misfolded proteins in the ER, however, it is vital as a central component of the UPR 
(Cox et al., 1993). Therefore, this assay is a sensitive method for detecting even slight defects in 
retrotranslocation of misfolded proteins due to mutations in SEC61. 
The strains IRE1 (wild-type) and Δire1 were transformed (ref. 2.2.17) with linearized integration 
plasmids (pRS306-truncsec61*) containing the truncated versions of the mutant sec61 sequences to 
create the respective integration mutants (ref. 3.2.2; Ho et al., 1989; Horton et al., 1989; Gietz et al., 
1995). Transformants were selected on the appropriate minimal medium and integration of the 
individual sequences at the correct locus was verified using chromosomal DNA and specific primers 
(Forward primer: 5’ HindIII SEC61 5’ UTR #-445; Reverse primer: 3’ pRS306 URA3 #621; ref. Table 
2.6) (ref. 2.2.18; data not shown). 
Results are shown in Figure 3.6.3.1. Serial dilutions (105-100 cells) of each strain grown at 30 °C 
were plated onto rich medium (YPD) lacking (- TM) or containing (+ Tm) the UPR inducer 
tunicamycin (Kuo & Lampen, 1974; Duksin & Mahoney, 1982; Langan & Slater, 1991; Torrez-Quiroz 
et al., 2010). Plates were grown at various temperatures (20 °C, 25 °C, 30 °C and 37 °C) for 3 days. 
As seen in Figure 3.6.3.1, none of the mutants IRE1 sec61-S179P, IRE1 sec61-S353C, IRE1 sec61-
S179P/S353C, IRE1 sec1-302 and IRE1 sec61-303 exhibited growth defects on rich medium (YPD) 
at the temperatures tested when compared to the wild-type (IRE1 SEC61) (YPD, - Tm). While 
growth at 37 °C (105-101 cells), 30 °C (105-101 cells) and 25 °C (105-101 cells) was optimal for these 
strains, a reduction in growth was detectable at 20 °C (105-104 cells). In the presence of tunicamycin 
(+ Tm) growth of these strains was still comparable to the wild-type (IRE1 SEC61) at all 
temperatures. At 37°C (105-101 cells), 30 °C (105-101 cells) and 25 °C (105-101 cells) growth in the 
presence of 0.25 µg/ml tunicamycin (YPD, + Tm, 0.25 µg/ml) was least affected when compared to 
growth in the absence on tunicamycin (YPD, -Tm). At 20 °C (105 cells) a strong reduction in growth 
was detected in the presence of the lower tunicamycin concentration (YPD, +Tm, 0.25 µg/ml). This 
effect was even more pronounced (i.e. hardly any growth) when cells were grown in the presence of 
the higher tunicamycin concentration (YPD, + Tm, 0.5 µg/ml). At 37 °C (105-101 cells) and 30 °C 
(105-101 cells) growth at the higher tunicamycin concentration was comparable to growth on rich 
medium only (YPD, - Tm) and on medium containing 0.25 µg/ml tunicamycin. At 25 °C (105-104 
cells) the addition of 0.5 µg/ml tunicamycin (YPD, + Tm, 0.25 µg/ml) led to further reduction in growth 
compared to growth on rich medium alone (YPD, - Tm) or in the presence of 0.25 µg/ml tunicamycin 
(YPD, + Tm, 0.25 µg/ml). 
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The mutants Δire1 sec61-S179P, Δire1 sec61-S353C, Δire1 sec61-S179P/S353C, Δire1 sec61-302 
and Δire1 sec61-303 displayed growth comparable to the Δire1 SEC61 strain on rich medium alone 
(YPD, - Tm) at all temperatures tested (37 °C: 105-101 cells; 30 °C: 105-101 cells; 25 °C: 105-101 
cells; 20 °C: 105-104 cells). Moreover, growth of these strains was comparable to the respective 
sec61 mutants in the IRE1 background at 25 °C, 30 °C and 37 °C. At 20 °C (105-104/103 cells) 
growth of Δire1 sec61-S179P, Δire1 sec61-S353C, Δire1 sec61-S179P/S353C, Δire1 sec61-302 and 
Δire1 sec61-303 was a little more efficient compared to the same sec61 mutants in the IRE1 
background at the same temperature (YPD, 20 °C). 
All sec61 mutants in the Δire1 background displayed an extreme sensitivity towards tunicamycin. 
This was as described before, as ER stress is lethal to cells in the absence of the protective UPR 
(Cox et al., 1993). For these mutants no growth was detected at the various temperatures tested 
when grown in the presence of the lower as well as the higher tunicamycin concentration (+ Tm: 
0.25 µg/ml, 0.5 µg/ml).  
Results from this and the remaining assays monitoring the UPR (ref. 3.6.1 and 3.6.2) in the sec61 
mutants indicate that the UPR is not induction these mutants under normal growth conditions. 
 
*: -S179P, -S353C, -S179P/S353C, -302, -303 
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Figure 3.6.3.1. Growth analyses of the sec61 mutants in the IRE1 and Δ ire1 bakground. Serial dilutions 
(105-100 cells) of the indicated strains, grown overnight at 30 °C, were grown on rich medium (YPD) in the 
presence (+ Tm) or absence (- Tm) of tunicamycin (0.25 µg/ml or 0.5 µg/ml). Plates were incubated for 3 days 
at the indicated temperatures and photographed using the E-Box VX2 Gel Documentation System (Peqlab). 
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3.7 ERAD IN THE SEC61 MUTANTS  
The sec61-S353C mutant created in this study is a candidate for analyzing the domains of Sec61p 
that are directly involved in proteasomal degradation during ERAD, as it has no defects in growth or 
protein translocation into the ER (ref. 3.3 and 3.4). Thus, any defects in protein degradation (ERAD) 
cannot be an indirect result of impaired protein import. 
Pulse-chase experiments using the sec61 mutants sec61-S179P, sec61-S353C and sec61-
S179/S353C, together with sec61-302, sec61-303 and the corresponding wild-type (SEC61) were 
performed in order to investigate whether any of the mutants, especially sec61-S353C, sec61-
S179P/S353C and sec61-302, are defective in the degradation of substrates of various ERAD 
pathways (CPY*, Δgpαf, KWW and Ste6-166p) (Ng et al., 1996; Vashist et al., 2001; Vashist & Ng, 
2004; Ng et al., 2007).  
 
 
3.7.1 CPY*HA ERAD IN THE SEC61 MUTANTS 
The first ERAD substrate studied was the mutant S. cerevisiae vacuolar protease carboxypeptidase 
Y (CPY), CPY*, a soluble, glycosylated secretory protein that is translocated posttranslationally into 
the ER (Knop et al., 1996b; Ng et al., 1996). CPY* is a model ERAD (ERAD-L) substrate which has 
been extensively studied. This mutated form of CPY is the result of a point mutation in the gene 
PRC1, leading to the amino acid substitution of glycine to arginine at position 255 (G255R; allele: 
prc1-1). Due to this point mutation, the protein misfolds irreversibly and consequently cannot move 
further along the secretory pathway and reach its correct native conformation (Finger et al., 1993). 
CPY* is rather recognized by the ERQC machinery, retrotranslocated into the cytosol and degraded 
by the 26S proteasome (Hiller et al., 1996; Kostova & Wolf, 2003). Import into the ER, however, is 
not disturbed and CPY* can also be fully glycosylated (Finger et al., 1993). 
Wild-type CPY, encoded by PRC1, is a vacuolar C-terminal exopeptidase, belonging to a family of 
highly conserved serine carboxypeptidases. CPY is, among other vacuolar proteinases, vital for the 
proteolytic capacity of the vacuole (Chiang & Schekman, 1991; Stennicke et al., 1996; van den 
Hazel et al., 1996). It contains four glycosylation sites (positions: Asn13, Asn87, Asnl68, Asn368) 
and further contains disulfide bonds (Knop et al., 1996; Kostova & Wolf, 2003). It is synthesized as a 
precursor (ppCPY; cytosolic form), which is imported into the ER, where the signal sequence is 
cleaved off (pCPY) and CPY becomes promptly N-glycosylated (inactive p1 or ER form). CPY is 
then further modified in the Golgi apparatus leading to the p2 or Golgi form. Once it reaches its final 
destination, the vacuole, CPY is activated by proteolytic cleavage resulting in the mature or vacuolar 
form (mCPY) (Steven et al., 1982). Thus, for CPY there are several species and molecular weights 
possible during its maturation: ppCPY (prepro CPY, ∼ 59 kDa), pCPY (pro CPY, ∼ 57 kDa), p1 CPY 
(ER form, 67 kDa), p2 CPY (Golgi form, 69 kDa), mCPY (mature form, 61 kDA).  
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The degradation of CPY* in the sec61 mutants (JDY638 background, ref. 3.2.1) sec61-S179P, 
sec61-S353C, sec61-S179P/S353C, sec61-302, sec61-303 and the corresponding wild-type 
(SEC61) was analyzed by pulse-chase experiments (Ng et al., 2000; Ng et al., 2007). Pulse-chase 
experiments were performed as described in 2.2.33. In brief, initially all of the above strains were 
transformed with the plasmid pDN431 (CEN, URA3), carrying the gene encoding an epitope-tagged 
version of CPY*, CPY*HA (Sikorski & Hieter, 1989; Ng et al., 1996; Ng et al., 2000). This recombinant 
version of CPY* was created by site-directed mutagenesis and was finally cloned into the vector 
pDN201 (Sikorski & Hieter, 1989; Ng et al., 1996; Ng et al., 2000). It has been shown to behave as a 
proper ERAD substrate in pulse-chase experiments, where it is degraded in the same manner and 
with similar degradation kinetics as CPY* (Finger et al., 1993; Biederer et al., 1997; Ng et al., 2000; 
Taxis et al., 2002). The degradation of CPY*HA in wild-type cells has been shown to be with a half-
life (t1/2) of around 30 min, compared to untagged CPY* (t1/2 ∼ 20 min) (Finger et al., 1993; Ng et al., 
2000; Vashist et al., 2004). Transformants were selected on minimal medium lacking leucine and 
uracil.   
For pulse-chase experiments the cells were grown in growth medium containing the appropriate 
supplements to an OD600 of about 1, and aliquots of 1.5 OD600 were preincubated for 30 minutes in 
labeling medium (i.e. growth medium lacking ammonium sulfate, methionine and cysteine). 
Preincubation was performed to use up the remaining methionine and cysteine in the samples. Cells 
were pulse-labeled by adding 0.35 mCi/ml of L-[35S]-methionine/cysteine (EXPRE35S35S [35S]-
Protein Labeling Mix, Perkin Elmer) for 10 min at 30 °C, followed by a chase to monitor degradation 
kinetics of the ERAD model substrate (ref. Vashist et al., 2001). Initiation of the chase was by the 
addition of chase mix containing unlabeled cysteine and methionine. The chase was up to 90 min as 
indicated (ref. Figure 3.7.1.1.A). After various time points, the chase was terminated by adding ice-
cold Tris-azide buffer. Cells were lysed by agitation in a Mini-Beadbeater-24 (BioSpec Products Inc.) 
and CPY*HA immunoprecipitated from lysate with 10 µl polyclonal anti-CPY serum (rabbit; Römisch 
lab) overnight at 4 °C. For the CPY*HA pulse-chase experiments the CPY antibody, instead of the 
anti-HA antibody (Rockland™), was used for economic reasons. The amount of antibody used was 
sufficient to be saturating for the immunorecipitation of protein from 1.5 OD600 cells (data not shown). 
Following the immunoprecipitation, the samples were analyzed by SDS-PAGE (ref. 2.2.24.1), using 
4–12 % Bis-Tris gels (NuPAGE® Novex® Pre-Cast gels, Invitrogen). Dried gels were then exposed to 
storage phosphor screens (GE Healthcare). Usually an exposure of 2-3 days was most sufficient. 
Proteins were visualized using a phosphorimager system (Typhoon Trio™ Variable Mode Imager, GE 
Healthcare). Signals were analyzed and quantified using the ImageQuant™ TL software (GE 
Healthcare.  
Results of a representative pulse-chase experiment are shown in Figure 3.7.1.1.A. Using the CPY 
antibody, a faster migrating band around 60 kDa (*), in addition to the band corresponding to CPY*HA 
(∼ 67 kDa), could be detected. The upper band represents CPY*HA. The additional band represents 
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mature chromosomal CPY (mCPY) (ref. Figure 3.7.1.1.A, *). In order to confirm this, pulse-chase 
experiments with the wild-type (SEC61) and sec61-302 (cotranslational import defect) strain were 
performed, using the anti-HA antibody (Rockland™) for immunoprecipitations (data not shown). 
Using the anti-HA antibody, the band at ∼ 60 kDa was not detected throughout the course of the 
experiment, indicating that it corresponds to chromosomal CPY. Degradation kinetics for the two 
strains using the anti-HA antibody were comparable to those when the CPY antibody was used (data 
not shown). This experiment also indicates that under the experimental conditions tested, there was 
no accumulation of pre-pro-CPY*HA in the cells, which is in concordance with data showing that the 
sec61 mutants analyzed are not defective in posttranslational import (ref. 3.4).  
As shown in Figure 3.7.1.1, CPY*HA was degraded rapidly in the wild-type strain (SEC61) with a t1/2 
of ∼ 20 min (ref. Figure 3.7.1.1.B, SEC61). The results show that there was no delay in CPY*HA 
turnover in the sec61 mutants analyzed. The sec61 mutant defective in protein translocation into the 
ER (ref. 3.4) but not in proteasome binding (ref. 3.5.2), sec61-303 (t1/2 ∼ 21 min), showed no 
stabilization of the substrate. In sec61-S179P (t1/2 ∼ 21 min) CPY*HA had degradation kinetics similar 
to the wild-type. None of the sec61 mutants displaying a reduction in proteasome binding, sec61-
S353C (t1/2 ∼ 19 min), sec61-S179P/S353C (t1/2 ∼ 21 min) and sec61-302 (t1/2 ∼ 24 min ), showed a 
significant delay in CPY*HA turnover. At the end of the 90 min chase 93 – 97 % of the substrate had 
been degraded in all strains. 
The fact that none of the sec61 mutants, especially those with reduced proteasome binding, were 
defective in the degradation of CPY*HA, could be attributed to several things. The reduction in 
proteasome binding observed in sec61-S353C, sec61-S179P/S353C and sec61-302 might not be 
severe enough to also affect ERAD. It is also possible that the sec61 mutants tested are merely not 
disturbed in the degradation of CPY*HA. Thus, as no defect in ERAD of the soluble, glycosylated, 
posttranslationally imported ERAD-L substrate CPY*HA was detected, further ERAD substrates were 
analyzed, in order to assess substrate stability in each strain (ref. 3.7.2 – 3.7.5; Swanson et al., 
2001; Vashist et al., 2001). 
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Figure 3.7.1.1 Degradation of mutant Carboxypeptidase Y (CPY*) in the sec61 mutants. (A) For pulse-
chase experiments, sec61 and wild-type (SEC61) cells expressing CPY*HA from the plasmid pDN431 (CEN, 
URA3), were grown to an OD600 ∼ 1 in growth medium containing the appropriate supplements. Aliquots of 1.5 
OD600 were preincubated in labeling medium, lacking methionine and cysteine, at 30 °C for 30 min, followed by 
pulse-labeling with 0.35 mCi/ml 35S-methionine/cysteine (EXPRE35S35S [35S]-Protein Labeling Mix, Perkin 
Elmer) at 30 °C for 10 min. Cells were chased for the indicated periods of time, lysed by bead beating and 
CPY*HA was immunoprecipitated from lysates using 10 µl of CPY antibody (Römisch lab) and analyzed by 
SDS-PAGE on 4-12 % Bis-Tris gels (NuPAGE® Novex® Pre-Cast gels, Invitrogen). Dried gels were exposed to 
storage phosphor screens for 2 days and signals detected using a phosphorimager. Shown is a representative 
result of three independent experiments (N = 3). (B) CPY*HA degradation efficiencies of the various strains were 
determined by analyzing and quantifying the band intensities (A) using the ImageQuant™ TL software (GE 
Healthcare). Data of three independent experiments were averaged and graphed accordingly. Error bars 
indicate the standard error.  
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3.7.2 MUTANT ALPHA FACTOR PRECURSOR ERAD IN THE SEC61 MUTANTS 
ERAD of mutant S. cerevisiae alpha factor (α-factor) precursor, ∆gpαf, in the sec61 mutants and the 
corresponding wild-type strain (SEC61) was monitored using pulse-chase experiments (ref. 2.2.33). 
The ∆gpαf is a soluble, unglycosylated ERAD substrate, which is degraded via the ERAD-L pathway 
(Hansen et al., 1986; Rothblatt and Meyer, 1986; Waters and Blobel, 1986). 
In S. cerevisiae, mating involves the secretion and response to peptide pheromones such as the 
alpha factor (Sprague et al., 1983). The α-factor, a peptide of 13 amino acids, encoded by the genes 
MFα1 (mainly) and MFα2, is secreted by alpha cells during the mating process (Stötzler et al., 1976; 
Kurjan & Hershowitz, 1982; Singh et al., 1983; Caplan et al., 1991). Wild-type ppαf (∼ 18 kDa) 
consists of an N-terminal signal peptide (19 amino acids) followed by a proregion (64 amino acids), 
containing three glycosylation sites (Asn-X-Thr; positions: 23, 57, 67). The proregion is followed by 4 
tandem repeats of mature alpha factor sequence, which are each preceeded by a spacer peptide 
(Brake et al., 1983; Waters et al., 1988; Caplan et al., 1991). The ppαf is imported posttranslationally 
into the ER where the signal sequence is cleaved off by signal peptidase (Waters et al., 1988). The 
resulting pro-α-factor (pαf; ∼ 16 kDa) is promptly glycosylated upon entry into the ER. Glycosylated 
alpha factor precursor, designated 3gpαf (∼  28 kDa), is transported from the ER to the Golgi where 
it is proteolytically processed and eventually secreted (Emter et al., 1983; Julius et al., 1983, 1984a, 
1984b; Dmochowska et al., 1987; Fuller et al., 1988). 
As the wild-type pre-pro-α-factor, the mutant α-factor precursor, pΔgpαf (∼ 18 kDa), is efficiently 
imported into the ER. Upon entry into the ER, the signal sequence is cleaved off (McCracken & 
Brodsky, 1996). The resulting ∆gpαf (∼ 16 kDa) is an ERAD substrate, as deletion of all three 
glycosylation sites in the proregion by site-directed mutagenesis (N23Q, N57Q, N67Q) probably 
results in misfolding (Caplan et al., 1991; Mayinger & Meyer, 1993; McCracken & Brodsky, 1996; 
Werner et al., 1996). Retrotransloction of ∆gpαf to the cytosol has been shown to be via the Sec61p 
channel (Pilon et al., 1997). Moreover, the degradation of ∆gpαf has been shown to be independent 
of polyubiquitination and dependent on ATP and the proteasome 19S RP (McCracken & Brodsky, 
1996; Werner et al., 1996; Lee et al., 2004a). 
For pulse-chase experiments (ref. 2.2.33), the sec61 mutants (JDY638 background, ref. 3.2.1), 
sec61-S179P, sec61-S353C, sec61-S179P/S353C, sec61-302, sec61-303 and the corresponding 
wild-type (SEC61) were transformed with the expression plasmid p416pΔgpαf (CEN, URA3, ref. 
Table 2.5) carrying a gene encoding the unglycosylated pre-pro-alpha-factor derivative pΔgpαf 
(McCracken & Brodsky, 1996; Ng et al., 2007). From this plasmid the mutant pre-pro-α-factor is 
conditionally expressed under the control of the MET25 promoter, i.e. the gene is transcribed in the 
absence of methionine and expression is repressed in the presence of methionine in the medium 
(Mumberg et al., 1994). 
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Expression of mutant α-factor precursor in each cell clone can be very variable, making the 
evaluation of results difficult (Römisch, personal communication). Therefore, clones with similar 
expression levels were selected to perform pulse-chase experiments (data not shown). 
For pulse chase experiments, cells were grown overnight in growth medium, containing all required 
supplements, to an OD600 of about 1. Aliquots of 1.5 OD600 were preincubated in labeling medium, 
lacking methionine and cysteine, for 30 minutes, followed by pulse-labeling with 0.35 mCi/ml of L-
[35S]-Methionine/Cysteine (EXPRE35S35S [35S]-Protein Labeling Mix, Perkin Elmer) for 5 min at 30 
°C. Following the labeling, a chase was initiated by adding chase mix, containing unlabeled 
methionine and cysteine. The chase was over a period of 30 minutes with samples taken at the 
indicated intervalls (t = 0, 5, 15, 30 min) (ref. Figure 3.7.2.1.A). Termination of the chase was by 
adding ice-cold Tris-azide buffer. The cells were then lysed using a Mini-Beadbeater-24 (BioSpec 
Products Inc.) and the ∆gpαf precipitated from lysates with 10 µl of polyclonal anti-α-factor serum 
(Römisch lab) overnight at 4 °C. The amount of antiserum used was sufficient to be saturating for 
the immunoprecipitation of protein from 1.5 OD600 cells (data not shown). The samples were then 
analyzed by SDS-PAGE, using 4 -12 % Bis-Tris gels (NuPAGE® Novex® Pre-Cast gels, Invitrogen). 
The gels were dried, exposed to storage phosphor screen (GE Healthcare) generally for 2-3 days 
and signals detected using a phosphorimager (Typhoon Trio™ Variable Mode Imager, GE 
Healthcare). Signals were analyzed and quantified using the ImageQuant™ TL software (GE 
Healthcare). 
The results of a representative pulse-chase experiment are shown in Figure 3.7.2.1.A and B. In the 
pulse-chase experiments, the half-life (t1/2) of intracellular ∆gpαf in SEC61 wild-type cells was ∼ 13 
min. This was in good agreement with previous data (Caplan et al., 1991). The sec61 mutant sec61-
303 (t1/2 ∼ 14 min) did not affect the half-life of ∆gpαf. The sec61 mutants displaying reduced 
proteasome binding (ref. 3.5.2), sec61-302 (t1/2 ∼ 18 min), sec61-S353C  (t1/2 ∼ 20 min) and sec61-
S179P/S353C (t1/2 ∼ 16 min), did not show significant stabilization of ∆gpαf (Ng et al., 2007). For 
these strains t1/2 was increased compared to the wild-type (SEC61). Not only were the half-lives of 
∆gpαf similar, but also the amounts of substrate degraded at the end of the chase, were comparable 
in all strains (93 – 98 %; ref. Figure 3.7.2.1.B). For the sec61-S179P mutant (t1/2 ∼ 19 min) an 
increased t1/2 was detected as well. As seen in Figure 3.7.2.1.B a faint band (*) above the band 
displaying the degradation kinetics of ∆gpαf (∼ 16 kDa) was detected in all samples with a decrease 
in intensity of the band over the course of the pulse-chase experiment. Although the band displays 
the same molecular weight as p∆gpαf (∼ 18 kDa) the possibility that it could be attributed to p∆gpαf 
was excluded. As the translocation in the pulse-chase experiment was very efficient, detection of 
pΔgpαf would be expected only in the pulse sample (t = 0 min). Thus, the upper band (*) is probably 
nonspecific. 
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Taken together, the data from pulse-chase experiments monitoring the degradation kinetics of 
CPY*HA (ref. 3.7.1) and ∆gpαf suggest that none of the sec61 mutants, especially those impaired in 
proteasome binding (sec61-302, sec61-S353C and sec61-S179P/S353C), are deficient in the 
degradation of these two ERAD-L substrates. I therefore investigated whether the sec61 mutants 
had any effects on ERAD of substrates that are not soluble and thus substrates of another ERAD 
pathway (ERAD-C).  
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Figure 3.7.2.1 Degradation of mutant alpha factor precursor (Δgpαf) in the sec61 mutants. (A) For pulse-
chase experiments, sec61 and wild-type (SEC61) cells expressing pΔgpαf from the plasmid pDN431 (CEN, 
URA3), were grown to an OD600 of ∼ 1 in growth medium containing the appropriate supplements. Aliquots of 
1.5 OD600 were preincubated in labeling medium lacking methionine and cysteine at 30 °C for 30 min, followed 
by pulse-labeling with 0.35 mCi/ml 35S-methionine/cysteine (EXPRE35S35S [35S]-Protein Labeling Mix, Perkin 
Elmer) at 30 °C for 5 min. Cells were chased for the indicated periods and the chase was terminated by adding 
ice-cold Tris-azide buffer. Cells were lysed by bead-beating and Δgpαf precipitated from the lysates using 10 µl 
of anti-α-factor serum (Römisch lab). Samples were analyzed by SDS-PAGE using 4-12 % Bis-Tris gels 
(NuPAGE® Novex® Pre-Cast gels, Invitrogen) and phosphor-imaging. (B) Δgpαf degradation efficiencies of the 
various strains were determined by analyzing and quantifying the band intensities (A) using the ImageQuant™ 
TL software (GE Healthcare). Results of two independent experiments (N = 2) were averaged and graphed. 
Error bars indicated the standard error. 
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3.7.3 KWW ERAD IN THE SEC61 MUTANTS 
Since Sec61p has been shown to be involved in ERAD of the soluble ERAD substrate Δgpαf, I 
tested the degradation of two soluble ERAD substrates that were unglycosylated (Δgpαf, ref. 3.7.2) 
and glycosylated (CPY*HA, ref. 3.7.1) and degraded via the ERAD-L pathway (McCracken & 
Brodsky, 1996; Pilon et al., 1997; Ng et al., 2000; Vashist et al., 2001). Next, I investigated ERAD of 
a transmembrane substrate that was also degraded via ERAD-L, the chimeric protein KWW (Vashist 
& Ng, 2004). 
The ERAD substrate KWW (KHN lumenal domain/Wsc1p transmembrane domain/Wsc1p cytosolic 
domain) is a chimeric integral membrane protein in which the luminal domain of Wsc1p was 
replaced with KHN (Vahist et al., 2001; Vashist & Ng, 2004). The protein further displays a type I 
membrane orientation (Vahist et al., 2001; Vashist & Ng, 2004). The lumenal domain of KWW, KHN, 
consists of the signal sequence of S. cerevisiae Kar2p fused to the Simian Virus 5 HA-
Neuraminidase ectodomain. It contains O-linked sugars that are modified upon transport to the 
Golgi, making it possible to determine the proteins localization. It further contains four N-linked 
glycosylation sites (Loayza et al., 1998; Vashist et al., 2001; Vashist & Ng, 2004). The integral 
membrane protein Wsc1p, forming the cytosolic and transmembrane domain of KWW, is a signaling 
protein (nonessential) with one transmembrane domain. It is located at the plasma membrane 
(Lodder et al., 1999; Vashist et al., 2001; Vashist & Ng, 2004). KWW is misfolded in the lumenal 
domain leading to its degradation via the ERAD-L pathway (Vashist & Ng, 2004). 
The turnover of KWW in the sec61 mutants (ref. 3.2.1; sec61-S179P, sec61-S353C, sec61-
S179P/S353C, sec61-302, sec61-303) and the corresponding wild-type strain (SEC61) was 
monitored using pulse-chase experiments (ref. 2.2.33) (Ng et al., 2007). Prior to pulse-chase 
experiments, the strains were transformed with the expression plasmid pSM101 (CEN, URA), 
containing the gene encoding HA epitope-tagged KWW. The KHN portion of KWW was created 
using the expression plasmid pSM70, containing the fusion gene of the first 45 amino acids of Kar2p 
(signal sequence and cleavage site) to the C-terminal 528 amino acids of the SV5 HN gene. In 
pSM70, a triple HA epitope tag was added in frame with the C-terminus of KHN (Vashist et al., 
2001). The HA epitope tag was taken from pCS124 (C. Shamu, Harvard University). Insertion of the 
resulting gene was into pDN251, containing the moderate PRC1 promoter (Ng et al., 1989; Ng et al., 
1996; Vashist et al., 2001). The sequences encoding tagged KHN as well as the transmembrane 
and the cytosolic domain of WSC1 were ligated into pSM70, resulting in pSM101 (Vashist & Ng, 
2004). 
For pulse-chase experiments, cells were grown overnight to an OD600 of about 1 in growth medium 
containing all supplements required. Preincubation of 1.5 OD600 aliquots was in labeling medium, 
lacking methionine and cysteine, for 30 min. The cells were pulse-labeled for 10 min at 30 °C with 
0.35 mCi/ml of L-[35S]-Methionine/Cysteine (EXPRE35S35S [35S]-Protein Labeling Mix, Perkin Elmer) 
as described previously (Vashist & Ng, 2004). The chase, which was initiated by adding chase mix 
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containing unlabeled methionine and cysteine, was for 90 min with samples taken at the indicated 
intervals (t = 0, 30, 60 and 90 min; Figure 3.7.3.1.A). The chase was terminated with the addition of 
ice-cold Tris-azide buffer, followed by the preparation of lysates using a Mini-Beadbeater-24 
(BioSpec Products Inc.). KWW was precipitated from the resulting lysates with 4 µl of anti-HA 
antibody (Rockland™) at 4 °C overnight. Prior to the experiments, the amount of antibody needed to 
immunoprecipitate all KWW from 1.5 OD600 was determined by titration (data not shown). Samples 
were resolved on 4 -12 % Bis-Tris gels (NuPAGE® Novex® Pre-Cast gels, Invitrogen). The gels were 
dried, exposed to a storage phosphor screen (GE Healthcare) for 2 days and signals detected using 
a phosphorimager system (Typhoon Trio™ Variable Mode Imager, GE Healthcare). Signals were 
analyzed and quantified using the ImageQuant™ TL software (GE Healthcare).    
Results are shown in Figure 3.7.3.1.A and B. In SEC61 wild-type cells, the degradation of KWW was 
took place a half-life of ∼ 33 min, which was a similar to published data (t1/2 ∼ 35 min; Vashist & Ng, 
2004). Moreover, KWW, which is around 87 kDa in size when glycosylated, displays a shift in 
mobility during the time course of the experiment. This has been shown previously to be due to 
extended O-mannosylation of the protein, as KWW molecules are transported from the ER to the 
Golgi from where they are retrieved to the ER for degradation (Harty et al., 2001; Vashist et al., 
2001, Arvan et al., 2002; Vashist & Ng, 2004). Neither the mutants with a proteasome binding defect 
(ref. 3.5.2), sec61-302 (t1/2 ∼ 39 min), sec61-S353C  (t1/2 ∼ 39 min) and sec61-S179P/S353C (t1/2 ∼ 
39 min), nor the remaining mutants sec61-S179P (t1/2 ∼ 39 min) and sec61-303 (t1/2 ∼ 38 min) 
displayed significant stabilization of the substrate during pulse-chase analyses, although the half-
lives of KWW in each mutant was slightly increased compared to the wild-type (SEC61). Overall, 
degradation kinetics throughout the course of the pulse-chase experiment were comparable to the 
wild-type (SEC61). At the end of the chase period the amounts of KWW degraded were similar for 
each strain (88-99 %; Figure 3.7.3.1.B).  
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Figure 3.7.3.1 Degradation of KWW in the sec61 mutants. (A) For pulse-chase experiments, sec61 and 
wild-type (SEC61) cells expressing KWW from the plasmid pSM101 (CEN, URA3), were grown to an OD600 of 
∼ 1 in growth medium containing the appropriate supplements. Aliquots of 1.5 OD600 were preincubated in 
labeling medium, lacking methionine and cysteine, at 30 °C for 30 min, followed by pulse-labeling with 0.35 
mCi/ml 35S-methionine/cysteine (EXPRE35S35S [35S]-Protein Labeling Mix, Perkin Elmer) at 30 °C for 10 min. 
Cells were chased for the indicated periods and the chase was terminated by adding ice-cold Tris-azide buffer. 
Cells were lysed by bead beating and the lysates immunoprecipitated using 4 µl of anti-HA antibody 
(Rockland™). The lysates were subjected to SDS-PAGE analysis, using 4-12 % Bis-Tris gels (NuPAGE® 
Novex®, Invitrogen)). Dried gels were exposed to storage phosphor screens (GE Healthcare) for 3 days. 
Signals were detected using a phosphorimager system. (B) The rate of KWW degradation was determined by 
analyzing and quantifying the band intensities (A) using the ImageQuant™ TL software (GE Healthcare). 
Results were graphed accordingly. Averaged results from two independent experiments are shown (N = 2). 
Error bars indicate the standard error. 
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3.7.4 STE6-166P ERAD IN THE SEC61 MUTANTS 
Although Sec61p has been shown to be mainly involved in ERAD-L, I also tested whether any of the 
sec61 mutants were defective in the degradation of an ERAD-C substrate (Plemper et al., 1997, 
1999b; Pilon et al., 1998; Willer et al., 2008; Schäfer & Wolf, 2009). 
The ERAD-C pathway not only differs from the ERAD-L (and ERAD-M) pathway regarding the 
location of the lesion within the aberrant protein, but also in the composition of the underlying 
complex (Römisch, 2005; Vashist & Ng, 2004; Carvalho et al., 2006; Denic et al., 2006). A role of 
Sec61p in ERAD-C is still under debate. In a previous study, Sec61p has been implicated to be 
involved in the degradation of a substrate containing a cytoplasmic degron. ERAD of this substrate 
has been shown to involve the E3 ligase Doa10p, a central component of the ERAD-C pathway 
(Scott & Schekman, 2008). These findings, however, have been challenged by another study, which 
has indicated that the substrate is degraded by yet another ERAD pathway (ERAD-T) involving 
Hrd1p, questioning a role of Sec61p in ERAD-C (Rubenstein et al., 2012).  
As a substrate for the ERAD-C pathway, a mutant form of Ste6p, Ste6-166p, was used. Ste6p, the a-
factor transporter in S. cerevisiae, is a member of the ATP-binding cassette (ABC) superfamily 
(Berkower & Michaelis, 1996). As a plasma membrane ABC transporter, Ste6p moves through the 
secretory pathway to the plasma membrane, where the protein, after pumping a-factor out of the 
cell, eventually undergoes endocytosis and ubiquitin-dependent degradation in the vacuole (Kuchler 
et al., 1989; Michaelis, 1993; Kölling & Hollenberg, 1994; Kölling & Losko, 1997). Ste6p consists of 
12 transmembrane domains with major extramembrane domains of the protein predicted to be 
located in the cytosol (Kuchler et al., 1989; Geller et al., 1996). 
The nonglycosylated Ste6p mutant Ste6-166p is truncated at the C-terminus, rendering the resulting 
protein unstable (Loayza et al., 1998). The truncation is due to a mutation (Q1249X) causing 
premature termination (42 amino acids shorter than Ste6p) (Loayza et al., 1998). Due to the 
mutation, Ste6-166p is retained in the ER and promptly degraded via the ERAD-C pathway, 
involving the UPS (Berkower & Michaelis, 1996, Loayza et al., 1998; Vashist & Ng, 2004). 
Strains were transformed with the expression plasmid pSM1083, containing the gene encoding HA 
epitope-tagged Ste6-166p. This plasmid was created by hydroxylamine mutagenesis of the 
expression plasmid pSM683 (CEN, URA3, STE6::HAe), which contained the HA epitope-tagged 
STE6 gene (Berkower et al., 1994; Kaiser et al., 1994; Loayza & Michaelis, 1998; Loayaza et al., 
1998). 
For pulse-chase experiments positive transformants were grown overnight to an OD600 of about 1 in 
growth medium containing all supplements required. Aliquots of 1.5 OD600 were preincubated for 30 
minutes in labeling medium, lacking methionine and cysteine and cells were pulse-labeled for 5 min 
at 30 °C with 0.35 mCi/ml of L-[35S]-methionine/cysteine (EXPRE35S35S [35S]-Protein Labeling Mix, 
Perkin Elmer) as described previously (Vashist et al., 2001; Vashist & Ng, 2004). Chase initiation 
was by adding chase mix, containing unlabeled methionine and cysteine. The chase was over a 
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period of 30 min with samples taken at the indicated intervals (t = 0, 5, 15 and 30 min), followed with 
the addition of ice-cold Tris-azide buffer to terminate the chase. Cell lysates were prepared using a 
Mini-Beadbeater-24 (BioSpec Products Inc.) and immunoprecipitated with 4 µl of anti-HA antibody 
(Rockland™) at 4 °C overnight. Prior to the experiments, the amount of antibody needed to 
immunoprecipitate all HA-tagged protein from 1.5 OD600 was determined by titration using SEC61 
and sec61-302 strains (data not shown). Samples were resolved on 4 -12 % Bis-Tris gels 
(NuPAGE® Novex® Pre-Cast gels, Invitrogen). The gels were dried, exposed to storage phosphor 
screen (GE Healthcare) for 2-3 days and signals detected using a phosphorimager system (Typhoon 
Trio™ Variable Mode Imager, GE Healthcare). Signals were analyzed and quantified using the 
ImageQuant™ TL software (GE Healthcare).  
The results of a representative pulse-chase experiment are shown in Figure 3.7.4.1.A and B. In the 
SEC61 wild-type, Ste6-166p was degraded with a half-life of ∼ 9 minutes, which was similar to 
previously published data (Vashist et al., 2001; Vashist & Ng, 2004). The sec61 mutants displaying a 
proteasome binding defect (ref. 3.5.2) sec61-302 (t1/2 ∼ 9 min), sec61-S353C (t1/2 ∼ 7 min) and 
sec61-S179P/S353C (t1/2 ∼ 5 min) also showed degradation efficiencies comparable to or faster than 
the wild-type (SEC61). In sec61-S179P and sec61-303 Ste6-166p was degraded with a half-life of 7 
min and 10 min, respectively. It has to be mentioned that for sec61-S179P/S353C, and to a much 
lesser extent sec61-S353C, the signal was not as strong as for the other mutants tested, which may 
have affected results (ref. Figure 3.7.4.1.A). Even when the experiment was repeated the signal 
intensities remained weaker for these strains. However, signals, which were detectable, were 
quantified for sec61-S353C and sec61-S179P/S353C. Due to time constraints the experiment could 
not be repeated with newly transformed sec61-S353C and sec61-S179P/S353C. Thus, it could not 
be ruled out whether the observed weaker signal intensities were due to technical issues or whether 
they were mutant-specific and indicate that the mutants are defective in the biogenesis of polytopic 
TM proteins. 
As seen in Figure 3.7.4.1.B the amounts of Ste6-166p after the 30-min chase were comparable in 
wild-type and mutant strains (95-99 %; Figure 3.7.4.1.B).  
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Figure 3.7.3.1 Degradation of Ste6-166p in the sec61 mutants. (A) For pulse-chase experiments, sec61 
and wild-type (SEC61) cells expressing Ste6-166p from the plasmid pSM1083 (CEN, URA3), were grown to an 
OD600 of ∼ 1 in growth medium containing the appropriate supplements. Aliquots of 1.5 OD600 were 
preincubated in labeling medium, lacking methionine and cysteine, at 30 °C for 30 min, followed by pulse-
labeling with 0.35 mCi/ml 35S-methionine/cysteine (EXPRE35S35S [35S]-Protein Labeling Mix, Perkin Elmer) at 
30 °C for 5 min. The chase was initiated by adding chase mix, containing unlabeled methionine and cysteine, 
to a final concentration of 2 mM. Cells were chased for the indicated periods and the chase was terminated by 
adding ice-cold Tris-azide buffer. Cells were lysed by bead beating, Ste6-166p immunoprecipitated from 
lysates using 4 µl of anti-HA antibody (Rockland™) and analyzed by SDS-PAGE, on 4-12 % Bis-Tris gels 
(NuPAGE® Novex® Pre-Cast gels, Invitrogen). Gels were dried and exposed to storage phosphor screens (GE 
Healthcare) for 2-3 days and signals detected using a phosphorimager system. (B) The rate of Ste6-166p 
degradation was determined by analyzing and quantifying the band intensities (A) using the ImageQuant™ TL 
software (GE Healthcare). Results of two experiments (N = 2) were averaged and graphed accordingly. Error 
bars indicate the standard error. 
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3.8 ANALYSIS OF IN VITRO TRANSLOCATION AND ERAD IN THE SEC61 MUTANTS    
 
3.8.1 IN VITRO TRANSLOCATION OF PPαF INTO SEC61 MICROSOMES 
Since under the conditions tested, none of the sec61 mutants showed striking ERAD defects in vivo, 
I next analyzed the mutants’ abilities to degrade the ERAD substrate Δgpαf in vitro. 
A cell-free assay system was used to assess the effects of the mutations in SEC61 on 
posttranslational translocation (McCracken & Brodsky, 1996). This was done by measuring the 
translocation rate of the S. cerevisiae alpha factor precursor (pre-pro-alpha factor, ppαf) into ER-
derived rough microsomes (RM). Wild-type ppαf (∼ 18 kDa) is signal-cleaved and promptly 
gylcosylated upon import into the ER (ref. 3.7.1) resulting in the formation of 3gpαf (fully 
glycosylated, ∼ 28 kDa) (Emter et al., 1983; Julius et al., 1983, 1984a; Fuller et al., 1988; Waters et 
al., 1988; Brodsky, 2010). 
In vitro translocation assays using ppαf (ref. 2.2.34.6) were performed prior to examining 
degradation efficiencies of Δgpαf in order to test import capacities of microsomal membranes 
isolated from the sec61 mutants and the corresponding wild-type (SEC61) (ref. 3.2.2). In vitro 
translocation and retrotranslocation assays rely on the quality of ER-derived microsomes, which has 
an essential impact on the translocation capacities of the membranes. As sufficient import (∼ 50 %) 
is mandatory for retrotranslocation assays, translocation reactions were established to optimize the 
amounts of microsomes and ppαf necessary to gain efficient translocation. Since none of the sec61 
mutants analyzed have been shown to be defective in posttranslational import employing a reporter 
plasmid translocation assay (ref. 3.4), in vitro import of wild-type alpha factor precursor was 
expected to be functional in properly prepared microsomes. Moreover, as mentioned earlier, 
undisturbed import into the ER would also be beneficial for evaluating in vitro retrotranslocation 
assays, as ERAD defects in sec61 mutants competent for import could be linked directly to the 
respective mutation in SEC61. 
For ER import assays, microsomal membranes of the wild-type (SEC61) strain as well as the sec61 
mutants sec61-302, sec61-303, sec61-S179P, sec61-S353C, sec61-S179P/S353C and sec61-3, 
grown at 30 °C, were prepared (Lyman & Schekman, 1995; Pilon et al., 1997). Wild-type ppαf was 
transcribed from plasmid pDJ100 (ref. Table 2.5), containing the ppαf gene under the control of the 
bacteriophage promoter SP6, using SP6 polymerase (ref. 2.2.34.4; Hansen et al., 1986; Rothblatt & 
Meyer, 1986). In order to obtain radiolabeled ppαf, in vitro translation of the transcript was in the 
presence of 35S-labeled methionine (Perkin Elmer) (ref. 2.2.34.5; McCracken & Brodsky, 1996; 
Brodsky, 2010). 
Radiolabeled ppαf was translocated into wild-type or mutant microsomes (2 µl of OD280 = 30) at 24 
°C in the presence of ATP, an ATP-regenerating system and S. cerevisiae wild-type cytosol (Sorger 
& Pelham, 1987; Baker et al., 1988; McCracken & Brodsky, 1996). The optimal temperature for the 
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in vitro assays has been shown to be 24 °C (Pilon et al., 1997). The assays were performed as time 
course experiments with reactions terminated at various time points (t = 0, 0, 5, 10, 15, 20 and 30 
min) by precipitation with ice-cold trichloroacetic acid (to 10 %). As controls, the translocation 
reactions were prepared lacking either membranes (- RM) or ppaf (- ppaf) and incubated for 30 
minuted as above. As a result, only untranslocated ppaf should be detected in the first case, while in 
the second case, there should be no signal. Samples were resolved on 4 -12 % Bis-Tris gels 
(NuPAGE® Novex® Pre-Cast gels, Invitrogen). The gels were dried, exposed to storage phosphor 
screen (GE Healthcare) for 2-3 days and signals detected using a phosphorimager system (Typhoon 
Trio™ Variable Mode Imager, GE Healthcare). Signals were analyzed and quantified using the 
ImageQuant™ TL software (GE Healthcare). Translocation efficencies were measured by the 
formation of triply glycosylated 3gpαf. 
As seen in Figure 3.8.1.1.A and B, none of the sec61 mutants, except sec61-3, were severely 
defective in posttranslational import of ppαf in vitro. This confirmed data from reporter plasmid 
translocation assays in this and a previous study, which have shown that there is no 
posttranslational import defect detectable in the sec61 mutants analyzed (ref. 3.4; Ng et al., 2007). 
Import of ppαf in all sec61 mutant membranes was only slightly slower compared to import into wild-
type membranes. While after 30 min ∼ 57 % of ppaf were imported into wild-type membranes, the 
mutants sec61-302 (46 %), sec61-303 (43 %), sec61-S179P (48 %), sec61-S353C (39 %) and 
sec61-S179P/S353C (47 %) showed only moderately reduced import rates, and the initial kinetics (0 
- 10 min) were almost identical to wild-type. The import efficiencies of all sec61 mutants, except 
sec61-3, was around 39 – 48 % after 30 min and thus sufficient for subsequent ERAD experiments 
(Figure 3.8.1.1.B). It has to be noted, however, that import kinetics of ppαf in the strains is slower 
compared to published results (t1/2 = 2-5 min at 20 °C), indicating that the  
As a control for the translocation assay, membranes isolated from sec61-3 were used. In this mutant 
the underlying point mutation (G341E) is located in the same region as S353C. Further, although 
sec61-3 has been shown to be defective in posttranslational import, the defect is not as severe as in 
sec61-32 (Pilon et al., 1997, 1998). Moreover, microsomal membranes from sec61-3 have been 
shown to be defective in degradation of Δgpαf (Pilon et al., 1997, 1998). Under the conditions tested 
here, import of ppαf into sec61-3 microsomal membranes was also reduced (29 % translocated after 
30 min). The import defect was not as previously described, which is very likely due to the fact that 
the membranes were isolated and tested at the strain’s permisse temperature (Pilon et al., 1998). 
As the results in Figure 3.8.1.1.A and B show, the amount of ppαf imported into the microsomes 
increases steadily during the time course. Therefore, for the retrotranslocation assays the 
translocation of mutant alpha factor pΔgpαf was incubated for 60 min in order to ensure maximum 
import (ref. 3.8.2).  
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Figure 3.8.1.1. In vitro import of ppαf into sec61 microsomes. (A) ER-derived microsomes (2 µl of OD280 = 
30) of sec61 mutants and the corresponding wild-type (SEC61) were incubated with 35S-labeled ppαf in the 
presence of ATP and an ATP-regenerating system at 24 °C for the indicated period of time. Translocation was 
measured by the formation of fully glycosylated alpha factor (3gpαf, ∼ 28 kDa). As controls import reactions 
were performed lacking either microsomes (- RM) or ppαf (- ppαf). Samples were resolved on 4-12 % Bis-Tris 
gels (NuPAGE® Novex® Pre-Cast gels, Invitrogen). Gels were dried and exposed to storage phosphor screens 
(GE Healthcare) for 2-3 days. Signals were detected using a phosphorimager. (B) Import of ppαf was quantified 
using the ImageQuant™ TL software (GE Healthcare). Results of two independent experiments (N = 2) were 
averaged and graphed. Error bars indicate the standard error.  
 
 
 
 
 
 
 
A
B
- R
M
- p
pʸ
f
+ RM/+ ppʸf
Time (min) 0 2 5 101520303030
sec61-S353C
SEC61
sec61-302
sec61-303
sec61-S179P
sec61-S179P/S353C
3gpʸM
ppʸf
3gpʸM
ppʸf
3gpʸM
ppʸf
3gpʸM
ppʸf
3gpʸM
ppʸf
3gpʸM
ppʸf
sec61-3 3gpʸMppʸf
0
20
40
60
0 10 20 30
tra
ns
lo
ca
te
d 
pp
α
f (
%
)
Time (min)
SEC61
sec61-302
sec61-303
sec61-S179P
sec61-S353C
sec61-S179P/S353C
sec61-3
3 RESULTS 
 
	   163	  
3.8.2 IN VITRO ERAD OF ΔGPαF IN THE SEC61 MUTANTS 
ERAD involves the retrotranslocation of misfolded secretory and transmembrane proteins from the 
ER to the cytosol where they are degraded by the 26S proteasome (Hiller et al., 1996; Plemper & 
Wolf, 1999; Kostova & Wolf, 2003; Meusser et al., 2005; Römisch, 2005; Nakatsukasa & Brodsky, 
2008; Schäfer et al., 2008; Vembar & Brodsky, 2008). Sec61p, the pore-forming component of the 
translocation channel, has been shown to be involved in retrotranslocation and a role as the dislocon 
has been proposed (Pilon et al., 1997; Plemper et al., 1998; Schäfer & Wolf, 2009). 
An in vitro retrotranslocation assay was employed to analyze whether membranes derived from the 
sec61 mutants (ref. 3.2.2) were defective in the dislocation of mutant pro-alpha factor (Δgpαf), an 
ERAD substrate whose dislocation into the cytosol is dependent on 19S RP binding to the Sec61 
channel (McCracken & Brodsky, 1996). This was done in additon to the pulse-chase analyses (ref. 
3.7.2) using the same substrate to see if the slight increase in t1/2 in S353C-containing mutants was 
exacerbated in vitro. As described earlier (ref. 3.7.2), mutant pre-pro-alpha factor (pΔgpαf), unable to 
acquire N-linked oligosaccharides, is efficiently imported into the ER, where the signal sequence is 
removed (Mayinger & Meyer, 1993). In S. cerevisiae, the resulting species, Δgpαf, has been shown 
to be dislocated from the ER and degraded in the cytosol by the 26S proteasome in vitro and in vivo 
(Caplan et al., 1991; Mayinger & Meyer, 1993; McCracken & Brodsky, 1996; Werner et al., 1996; 
Lee et al., 2004a).  
For the cell-free assay, unglycosylated pre-pro-α-factor was transcribed and translated in vitro using 
the plasmid paF3Q (ref. 2.2.34.4 and 2.2.34.5). The gene encoding pΔgpαf, was created by site-
directed mutagenesis, resulting in the replacement of all three oligosaccharide-accepting asparagine 
residues in ppαf with glutamines (N23Q, N57Q, N67Q; Krieg & Melton, 1984; Kunkel et al., 1987; 
Mayinger & Meyer, 1993). Since pΔgpαf, as well as ppαf, is transported into the ER 
posttranslationally, radiolabeled substrate could be prepared prior to use (Caplan et al., 1991). 
Radiolabeled pΔgpαf was translocated posttranslationalley into wild-type (SEC61) and mutant ER-
derived microsomes at 24 °C for 60 minutes in the presence of ATP (ref. 2.2.34.6 and 3.8.1). For 
each S. cerevisiae strain, equal amounts of membranes (2 µl of OD280 = 30) and radiolabeled Δgpαf 
(5 µl translation) were used. Following import of pΔgpαf into microsomes at 24 °C, the membranes 
were washed, resulting in signal-cleaved Δgpαf in the lumen of membranes (t = 0). In order to initiate 
retrotranslocation of Δgpαf, membranes were incubated with 0 mg/ml, 1 mg/ml, 2 mg/ml and 3 mg/ml 
wild-type (KRY257) cytosol, ATP and an ATP-regenerating system (ARS) at 30 °C for the indicated 
periods of time (t = 0, 5, 10, 15, 20, 30, 60 min) (ref. 2.2.34.7). Incubations were terminated by 
precipitation with trichloroacetic acid and samples analyzed on 18 % polyacrylamide/4 M urea gels. 
The gels were dried, exposed to storage phosphor screen (GE Healthcare) for 2-3 days and signals 
detected using a phosphorimager (Typhoon Trio™ Variable Mode Imager, GE Healthcare). Signals 
were analyzed and quantified using the ImageQuant™ TL software (GE Healthcare).  
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First, the cytosol concentration at which maximal export and degradation kinetics could be detected 
was assessed using wild-type (SEC61) membranes. As seen in Figure 3.8.2.1.A and B, there was 
no export in the absence of cytosol was (0 mg/ml cytosol). This confirmed that retrotranslocation 
depends on cytosol containing functional 26S proteasomes, as shown previously (McCracken & 
Brodsky, 1996; Werner et al., 1996; Pilon et al., 1997). Also visible on the gel was pΔgpαf which was 
not degraded because it is material aggregated on the cytosolic face of the microsomes and 
therefore cannot be removed by the membrane washes and cannot translocate (McCracken & 
Brodsky, 1996; Pilon et al., 1997). Further, maximum Δgpαf degradation efficiency was detectable 
when 3 mg/ml cytosol (t1/2 ∼ 18 min) were used and slightly lower efficiencies when 1 mg/ml (t1/2 ∼ 22 
min) and 2 mg/ml (t1/2 ∼ 20 min) cytosol were used. At 1 mg/ml cytosol, however, there was a lag 
phase detectable in the first 5 min of the reaction (ref. Figure 3.8.2.1.B). Therefore, retrotranslocation 
assays were initially performed using 3 mg/ml cytosol.  
 
 
 
 
Figure 3.8.2.1. In vitro ERAD of Δgpαf in SEC61. (A) Wild-type (SEC61) microsomes were used initially to 
determine efficient cytosol concentrations for the assay. 35S-labeled pΔgpαf was introduced into wild-type 
microsomes (2µl of OD280 = 30) at 24 °C. The membranes were washed and incubated at 30 °C in the 
presence of ATP, an ATP-regenerating system and 0, 1, 2 or 3 mg/ml wild-type cytosol (KRY275) for the 
indicated periods of time. Incubations were terminated by adding trichloroacetic acid (to 10 %). Samples were 
analyzed on 18% polyacrylamide/4M urea gels and exposed to storage phosphor screens (GE Healthcare) for 
2-3 days. Signals were detected using a phosphorimager system. (B) Degradation of Δgpαf was quantified 
using the ImageQuant™ TL software (GE Healthcare). Results of two independent experiments (N = 2) were 
averaged and graphed. Error bars indicate the standard error.  
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As shown in Figure 3.8.2.2.A and B, when the in vitro retrotranslocation assay was performed using 
3 mg/ml cytosol, Δgpαf degradation in wild-type (SEC61) microsomes was with a t1/2 of ∼ 15 min. 
This was in good agreement with data from a previous study (Pilon et al., 1997). Microsomes from 
sec61-3, used as a control, have been shown to be deficient in export even at the permissive 
temperature (Pilon et al., 1997). Membranes isolated from sec61-3 behaved during in vitro 
retrotransocation assays as described previously, i.e. degradation was drastically reduced (Pilon et 
al., 1997). After a period of 60 minutes ∼ 24 % of Δgpαf had been dislocated from sec61-3 
membranes (ref. Figure 3.8.2.2.A and B).  
Membranes of the mutants sec61-S179P (t1/2 ∼ 18) and sec61-303 (t1/2 ∼ 24 min) showed only 
slightly slower kinectics than the wild-type (SEC61). Further, after an incubation of 60 minutes the 
amounts of Δgpαf retrotranslocated from membranes of sec61-S179P (∼ 79 %), sec61-303 (∼ 74 %) 
were also comparable to the wild-type (∼ 83 %). Also, in these mutants initiation of retrotransloaction 
was slightly delayed, but afterwards kinetics were similar as well as maximal export of Δgpαf. In 
contrast, export of Δgpαf from sec61-302, sec61-S353C and sec61-S179P/S353C microsomes had 
a longer initial lag phase and genuinely slower degradation kintetics, resulting in t1/2 of ∼ 55 min, 33 
min and 49 min, and maximal export after 60 min of only 52 %, 64 % and 55 %, respectively. 
Strikingly, those were the mutants with reduced affinity of the Sec61 channel for 19S RP (ref. 3.5.2). 
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Figure 3.8.2.2. In vitro ERAD of Δgpαf in the sec61 mutants (I). (A) Membranes of the designated sec61 
mutants and the corresponding wild-type (SEC61) were loaded with 35S-labeled Δgpαf and incubated at 30 °C 
in the presence of ATP, an ATP-regenerating system and 3 mg/ml wild-type cytosol (KRY275) for the indicated 
periods of time. Incubations were terminated by precipitation with trichloroacetic acid (to 10 %). Sample 
analysis was on 18 % polyacrylamide/4 M urea gels, which were exposed to storage phosphor screens (GE 
Healthcare) for 2-3 days. Signals were detected using a phosphorimager system. Membranes from sec61-3 
were used as a control. The band showing a lower mobility is pΔgpαf associated with microsomes. (B) 
Degradation of Δgpαf was quantified using the ImageQuant™ TL software (GE Healthcare). Results of two 
independent experiments (N = 2) were averaged and graphed. Error bars indicate the standard error.  
 
 
As 26 S proteasomes are present in excess when using a cytosol concentration of 3 mg/ml, assays 
were repeated using 1 mg/ml cytosol (ref. Figure 3.8.2.3.A and B). This was done in order to analyze 
whether a lower proteasome concentration would have a limiting effect on Δgpαf export and 
degradation in the mutants with a 19S RP binding defect. Membranes derived from the export-
deficient strain sec61-3 displayed a severe reduction in export at 1 mg/ml cytosol compared to wild-
type (Pilon et al., 1998). After a period of 60 min ∼ 75 % of remaining Δgpαf were detectable, which 
was comparable to results shown in Figure 3.8.2.2. As expected degradation of Δgpαf in wild-type 
membranes was slower at 1 mg/ml cytosol (t1/2 = 23 min; ref. Figure 3.8.2.1), and indistinguishable 
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from ERAD in sec61-303 (t1/2 = 22 min) and sec61-S179P microsomes (t1/2 = 24 min) (ref. Figure 
3.8.2.3). At 1 mg/ml, however, in all sec61 mutants containing the S353C replacement (sec61-302: 
t1/2 = 46 min; sec61-S353C: t1/2 = 45 min; sec61-S179P/S353C: t1/2 = 42 min) Δgpαf was degraded 
with a 2-fold increased t1/2 compared to wild-type. This suggests that in the presence of limiting 
amounts of proteasomes the Sec61p-19S RP interaction becomes limiting for export of Δgpαf from 
the ER to the cytosol. 
 
 
 
 
Figure 3.8.2.3. In vitro ERAD of Δgpαf in the sec61 mutants (II). (A) Membranes (2µl of OD280 = 30) of the 
wild-type (SEC61) strain and the designated sec61 mutants were loaded with Δgpαf and incubated at 30 °C in 
the presence of ATP, an ATP-regenerating system and 3 mg/ml wild-type cytosol (KRY275) for the indicated 
periods of time. Incubations were terminated by precipitation with trichloroacetic acid (to 10 %). Samples were 
analyzed on 18% polyacrylamide/4 M urea gels, which were exposed to storage phosphor screens (GE 
Healthcare) for 2-3 days. Signals were detected using a phosphorimager system. The band showing a lower 
mobility is pΔgpαf associated with microsomes. (B) Degradation of Δgpαf was quantified using the 
ImageQuant™ TL software (GE Healthcare). Results of two independent experiments (N = 2) were averaged 
and graphed. Error bars indicate the standard error.  
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3.9 DETECTION OF CONFORMATIONAL CHANGES IN MUTANT SEC61P  
As proteasome binding assays (ref. 3.5.2) indicated that the amino acid substitution S353C is 
responsible for the reduction in 19S RP binding to reconstituted proteoliposomes derived from the 
respective sec61 mutants, I was interested in identifying whether the observed defect was due to a 
conformational change in mutant Sec61p (Ng et al., 2007). Such a conformational change might 
have an impact on the accessibility of the proteasome binding site on the cytoplasmic face of 
Sec61p, making it less accessible for the proteasome. 
In order to understand whether there is a conformational change in Sec61p in those sec61 mutants 
causing a defect in proteasome binding, I used the following approach: The PEGylation reagent 
Methyl-PEG8-NHS ester* (MS(PEG)8; Pierce®, Thermo Scientific) was used in order to modify all 
accessible lysine (K) residues (and the N-terminus) of the wild-type or mutant Sec61p (ref. 2.2.35 
and Figure 3.9.1).  
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Figure 3.9.1. Topology model of Sec61p (modified). Shown is the topology model of Sec61p including 
positions of amino acids in the protein. Positions of theoretically accessible primary amines (lysine residues 
(K); RED) on the cytoplasmic face of Sec61p, the amino terminus (RED) and positions of amino acid 
substitutions in Sec61p of sec61-302, sec61-S179P, sec61-S353C and sec61-3 (GREEN) are indicated. 
Positions of transmembrane domains according to the M. jannashii crystal structure are also outlined (BLUE) 
(taken from Wilkinson et al., 1997; modified according to van den Berg et al., 2004).  
 
 
MS(PEG)8 belongs to a group of polyethylene glycol (PEG) compounds containing methyl- and 
amine-reactive N-hydroxysuccinimide (NHS) ester groups at opposite ends of the molecule (Harris & 
Zalipsky, 1997; Veronese & Harris, 2002). The reagent contains eight PEG units, resulting in a 
spacer length of 30.8 Å. For each successfully modified lysine (K) residue, the modifier adds 0.51 
kDa to the protein (Morar et al., 2006). Protein modifications using MS(PEG)8 occur at the primary 
amines in lysine (K) residue side chains and the N-terminus of proteins (Morar et al., 2006). During 
the PEGylation reaction, the NHS-ester reacts efficiently with primary amines, resulting in the 
formation of amide bonds while releasing the NHS group. During this reaction the PEG chains, 
containing terminal methyl groups, are covalently attached to the protein (Veronese & Harris, 2002; 
Morar et al., 2006). MS(PEG)8 is a hydrophilic reagent, a property which is transferred to the 
modified protein and thus could have an impact on the protein’s mobility.  
Due to its hydrophobic character, Sec61p (53 kDa) displays an abnormal migration behaviour during 
SDS-PAGE (Wilkinson et al., 1996; Pilon et al., 1998). Here, Sec61p generally migrates at about 37 
kDa (Wilkinson et al., 1996; Pilon et al., 1998). Since the hydrophilic property of MS(PEG)8 is 
transferred to Sec61p upon successful PEGylation, I anticipated that the migration behaviour of the 
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protein might change. This would be favourable for the detection of minor changes in the molecular 
weight of mutant Sec61p. If, however, the hydrophobic character of Sec61p was too dominant, then 
the detection of subtle differences in the molecular weight (e.g. 1.2 kDa, which would correlate with 
two MS(PEG)8 modifications) would be difficult.   
On the cytosolic face of Sec61p there are theoretically 10 accessable lysine (K) residues (plus 1 N-
terminus) according to data from the M. jannaschii crystal structure (ref. Figure 3.9.1; van den Berg 
et al., 2004). Thus, upon successful PEGylaton of all theoretically available lysine (K) residues, an 
overall increase in molecular weight of 6.6 kDa would be possible using MS(PEG)8.  
For the PEGylation assay, PK-RMs (2 µl of OD280 = 30 in 20 µl reaction volume) of the sec61 
mutants sec61-S179P, sec61-S353C, sec61-S179P/S353C, sec61-302 and sec61-3, as well as the 
corresponding wild-type (SEC61) strain were prepared. PK-RMs were prepared by treatment with 
puromycin and potassium acetate (ref. 2.2.26; Neuhof et al., 1998). The treatment causes the 
release of ribosomes and peripheral proteins from the microsomal membranes, i.e. of proteins that 
might block access to Sec61p. Using ER-derived PK-RMs, only lysine (K) residues on the cytosolic 
face of the protein as well as its N-terminus are modified. Thus, if one of the mutations in SEC61 
indeed causes a conformational change in Sec61p, this could be detected as e.g. a reduction in 
molecular weight of modified mutant Sec61p compared to modified wild-type Sec61p.  
Prior to the actual experiment, the ideal experimental conditions were determined. In two 
independent experiments the concentration of the PEGylation reagent and the incubation time 
yielding maximal PEGylation efficiency were determined. As MS(PEG)8 is moisture-sensitive, the 
reagent had to be dissolved in water-free DMSO to avoid hydrolysis of the compound’s reactive 
group. Thus, the reagent was added last to the reaction. Initial PEGylation experiments using 
MS(PEG)8 were performed in collaboration with Michael Lafontaine. 
In order to determine the time of incubation that is needed to achieve maximal PEGylation of 
Sec61p, PK-RMs (2 µl of OD280) derived from the wild-type (SEC61) strain were incubated in amine-
free buffer (B88) at RT (24 °C) using 2.5 mM MS(PEG)8 for various periods of time (t = 5, 10, 20, 30 
min). Reactions were stopped with ammonium acetate and incubated on ice for 15 min. Following 
the incubation, samples were analyzed by SDS-PAGE on 4 -12 % Bis-Tris gels (NuPAGE® Novex® 
Pre-Cast gels, Invitrogen) and immunoblotting using the anti-Sec61p (N-terminal) and anti-Sbh1p 
(control) antibody (Römisch lab). Detection of signals and determination of relative mobility of 
PEGylated proteins was using the ChemiDoc™ XRS system and the Image Lab™ software (both Bio-
Rad). The PageRuler™ (Fermentas, Thermo Scientific) was used as the molecular weight standard. 
Results are shown in Figure 3.9.2.A. Following PEGylation, distinct protein bands could be detected 
(t = 5 – 30 min). The untreated wild-type PK-RMs, however, displayed a weaker band, which was 
probably due to antibody distribution on the nitrocellulose membrane. Additionally, upon successful 
PEGylation of Sec61p an increase in protein size could be detected. This increase reached a 
maximum after an incubation period of about 20 min. Therefore, in the following experiments an 
3 RESULTS 
 
	   171	  
incubation of 30 min was chosen to alow for maximal PEGylation. Generally, signals of PEGylated 
proteins were less distinct compared to the untreated control (ref. Figure 3.9.2.A, SEC61: 30 min, - 
MS(PEG)8). This could have been due to PEGylation of Sec61p’s N-terminus, which could impede 
access of the anti-Sec61p (N-terminal) antibody. The use of anti-Sec61p (C-terminal) antibody, 
however, resulted in too much background and thus was not used for detection (data not shown).    
Next, the MS(PEG)8 concentration required for efficient PEGylation of Sec61p was determined. 
Here, the experiment was conducted as before using various concentrations of the PEGylation 
reagent ([MS(PEG)8] = 0, 0.5, 1.0, 1.5, 2.0, 2.5, 3.0, 4.0, 5.0, 10, 15, 20 mM) and incubating the 
samples for 30 min. Results are shown in Figure 3.9.2.B. For all MS(PEG)8 concentrations used 
there was an increase in protein size detectable, indicating successful PEGylation of wild-type 
Sec61p. More precisely, compared to the untreated sample (0 mM), between 0.5 and 5 mM reagent 
used bands showing slower migration of the protein was detected. Using these concentrations, 
however, PEGylation seemed not as efficient as at concentrations between 10 and 20 mM. Here, a 
further increase in Sec61p size was detectable. As between 15 and 20 mM MS(PEG)8 no further 
increase in protein size was detected, we assumed that maximal PEGylation was achieved. Thus, 
for PEGylation experiments an MS(PEG)8 concentration of 20 mM was used.   
The assay using PK-RMs (2 µl of OD280) of the sec61 mutants sec61-302, sec61-S353C, sec61-
S179P and sec61-3 and the corresponding wild-type (SEC61) was performed as described above. 
Membranes were incubated with 20 mM of MS(PEG)8 at 24 °C for 30 min and samples analyzed as 
before. In Figure 3.9.2.C, a representative result of the PEGylation experiment is shown. PEGylated 
wild-type (SEC61) PKRMs (ref. Figure 3.9.2.C SEC61: + MS(PEG)8) displayed an increase in 
molecular weight of ~ 2.9 kDa, compared to untreated wild-type PKRMs (SEC61: - MS(PEG)8), 
which would correlate with a successful PEGylation of about 6 lysine (K) residues (or 5 lysine (K) 
residues and the N-terminus). It has to be noted that not all lysine residues seem to be accessible 
for PEGylation which might be due to the overall conformation of Sec61p or the size of the modifier. 
PKRMs of sec61-S179P showed an increase in molecular weight of ∼ 2.8 kDa which was similar to 
the wild-type (SEC61), suggesting that the amino acid substitution S179P does not cause a 
conformational change in Sec61p. A slight increase in molecular weight for sec61-302 (Δ kDa ∼ 1.3 
kDa) and sec61-S353C (Δ kDa ∼ 1.2 kDa) was detected compared to the untreated sample (- 
MS(PEG)8). This suggests that for both mutants fewer lysine (K) residues were accessible (sec61-
302: ∼ 2-3 lysine (K) residues; sec61-S353C: ∼ 2 lysine (K) residues) for PEGylation than in the wild-
type (SEC61) Sec61p, indicating that this might indeed be due to a conformational change of 
Sec61p in these mutants. The ERAD-deficient mutant sec61-3 (G341E) was used as a control, as in 
this mutant the underlying amino acid substitution is located in the same region as the substitution 
S353C of sec61-S302, sec61-S353C and sec61-S179P/S353C  (Sommer & Jentsch, 1993; Pilon et 
al., 1998; Ng et al., 2007). Interestingly, for sec61-3 (Δ ∼ 1.5 kDa) the increase in protein size would 
correlate with 3 modifications) with MS(PEG)8 and was comparable to sec61-302 and sec61-S353C. 
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Moreover, signals for PEGylated Sec61-3p were fainter compared to the untreated samples (sec61-
3: - MS(PEG)8) and the other mutants, indicating that modified Sec61-3p is instable. Thus, the above 
results could give a first indication that due to the amino acid substitution S353C in sec61-302 and 
sec61-S353C a conformational change in mutant Sec61p is induced affecting proteasome binding 
by e.g. masking the proteasome binding site on the cytoplasmic face of Sec61p.  
The preliminary data gained from the PEGylation assays were not significant enough to provide 
strong evidence for a conformational change in Sec61p in the respective mutants. Therefore, I aimed 
at modifying the assay to be able to get significant results, which would give an insight into the 
conformation of mutant Sec61p. I therefore used the reagent EZ-Link® Sulfo-NHS-LC-LC-Biotin** 
(spacer length: 30.5 Å; molecular weight: 0.67 kDa) which also modifies primary amines (Pierce, 
Thermo Scientific). The biotin (0.244 kDA) moiety binds streptavidin (Sigma) with high affinity 
(Hofmann et al., 1982; Hermanson, 2008). The homotetramer streptavidin has a molecular weight of 
about 60 kDa, with each of the subunits being able to bind one biotin molecule (Green, 1975; Weber, 
1989). This property of the modifier was employed to detect a conformational change in mutant 
Sec61p. Binding of streptavidin to the biotin moiety on modified primary amines would thus yield in a 
substancial increase in molecular weight per successful biotinylation. 
Retardation assays using the biotinylation/streptavidin approach, however, could not be established 
successfully (data not shown). No discrete protein bands could be detected during Western Blot 
analysis using the reagent, but a smear over the whole lane. Unfortunately, due to time constraints, 
the assay could not be optimized. 
 
* Succinimidyl-([N-methyl]-ethyleneglycol) ester  
** Sulfosuccinimidyl-6-(biotinamido)-6-hexanamido hexanoate 
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Figure 3.9.2. Analysis of a conformational change in mutant Sec61p. (A) Determination of optimal 
incubation time for the PEGylation of wild-type Sec61p. Wild-type (SEC61) PKRMs (2 µl of OD280 = 30) were 
incubated in B88 in the presence of 2.5 mM MS(PEG)8 at 24 °C over the indicated periods of time. As a control 
untreated PKRMs (- MS(PEG)8; i.e. water-free DMSO instead of MS(PEG)8) were incubated for 30 min. 
Reactons were stopped by adding 1 µl 8M ammonium acetate solution followed by an incubation for 15 min on 
ice. Samples were analyzed by SDS-PAGE on 4-12 % BisTris gels (NuPAGE® Novex® Pre-Cast gels, 
Invitogen) and immunoblottig with Sec61p antibody (N-terminal) and Sbh1p antibody (both Römisch lab). 
Detection of bands was using the SuperSignal™ West Dura Extended Duration Chemiluminescent Substrate 
(Pierce) and the Molecular Imager ChemiDoc™ XRS System (BioRad; CCD camera detection). (B) 
Determination of optimal MS(PEG)8 concentration for PEGylation of Sec61p. Wild-type (SEC61) PKRMs (2 µl 
of OD280 = 30) were incubated at 24 °C in B88 in the presence of the indicated MS(PEG)8  concentrations over 
30 min. Detection of signal was as in A (except: no Sbh1p detection). Untreated wild-type PK-RMs were used 
as a control. (C) PKRMs of the wild-type (SEC61) and the indicated sec61 mutants were PEGylated using 20 
mM MS(PEG)8 for 30 min. Untreated PKRMs were used as controls. Detection of signals was as in A (except: 
no Sbh1p detection).  
 
 
A
B
C
sec
61
-3
SE
C6
1
sec
61
-30
2
++ + + ++ --- MS(PEG)8
Sec61p
Sec61pPEGylated
kDa
50
30
40
25
Sec61p
Sec61pPEGylated
Sbh1p
MS(PEG)8
SEC61
Time (min)
-
30
+
20
+
10
+
30
+
30
+
10
+
5
+
205
+
Sbh1pPEGylated
kDa
50
30
40
25
Sec61p
Sec61pPEGylated
205 10 155 10 15 20 -
SEC61
MS(PEG)8 (mM)kDa
50
30
40
25
Sec61p
Sec61pPEGylated
0.5 1 1.5 2 2.5 3 4 5 -
SEC61
MS(PEG)8 (mM)kDa
50
30
40
25
sec
61
-S1
79
P
SE
C6
1
sec
61
-S3
53
C
MS(PEG)8
Sec61p
Sec61pPEGylated
kDa
50
30
40
25
++ + + ++ ---
sec
61
-3
SE
C6
1
sec
61
-30
2
++ + + ++ --- MS(PEG)8
Sec61p
Sec61pPEGylated
kDa
50
3
4
25
Sec61p
Sec61pPEGylated
MS(PEG)8
SEC61
Time (min)
-
30
+
20
+
10
+
30
+
30
+
10
+
5
+
205
+
Sbh1pPEGylated
kDa
50
3
4
25
Sec61p
Sec61pPEGylated
205 10 155 10 15 20 -
SEC61
MS(PEG)8 (mM)kDa
50
3
4
25
Sec61p
Sec61pPEGylated
0.5 1 1.5 2 2.5 3 4 5 -
SEC61
MS(PEG)8 (mM)kDa
50
3
4
25
sec
61
-S1
79
P
SE
C6
1
sec
61
-S3
53
C
MS(PEG)8
Sec61p
Sec61pPEGylated
kDa
50
3
4
25
++ + + ++ ---
l
l
l
l
l l
sec
61
-3
SE
C6
1
sec
61
-30
2
++ + + ++ --- MS(PEG)8
Sec61p
Sec61pPEGylated
kDa
50
30
40
25
Sec61p
Sec61pPEGylated
Sbh1p
MS(PEG)8
SEC61
Time (min)
-
30
+
20
+
10
+
30
+
30
+
10
+
5
+
205
+
Sbh1pPEGylated
kDa
50
30
40
25
Sec61p
Sec61pPEGylated
205 10 155 10 15 20 -
SEC61
MS(PEG)8 (mM)kDa
50
30
40
25
Sec61p
Sec61pPEGylated
0.5 1 1.5 2 2.5 3 4 5 -
SEC61
MS(PEG)8 (mM)kDa
50
30
40
25
sec
61
-S1
79
P
SE
C6
1
sec
61
-S3
53
C
MS(PEG)8
Sec61p
Sec61pPEGylated
kDa
50
30
40
25
++ + + ++ ---
sec
61
-3
SE
C6
1
sec
61
-30
2
++ + + ++ --- S(PEG)8
Sec61p
Sec61pPEGylated
kDa
50
30
40
25
Sec61p
Sec61pPEGylated
Sbh1p
S(PEG)8
SEC61
Ti e ( in)
-
30
+
20
+
10
+
30
+
30
+
10
+
5
+
205
+
Sbh1pPEGylated
kDa
50
30
40
25
Sec61p
Sec61pPEGylated
205 10 155 10 15 20 -
SEC61
S(PEG)8 ( )kDa
50
30
40
25
Sec61p
Sec61pPEGylated
0.5 1 .5 2 .5 3 4 5 -
SEC61
S(PEG)8 ( )kDa
50
30
40
25
sec
61
-S1
79
P
SE
C6
1
sec
61
-S3
53
C
S(PEG)8
Sec61p
Sec61pPEGylated
kDa
50
30
40
25
++ + + ++ ---
4 DISCUSSION 
 
	   174	  
4 DISCUSSION 
The eukaryotic cell is confronted with a high load of proteins that need to undergo correct folding or 
assembly in order to function properly (Schubert et al., 2000; Trombetta & Parodi, 2003). Proteins 
that fail to fold or assemble correctly are toxic to the cell and thus threaten cell homeostasis 
(Goldberg, 2003; Römisch, 2004). Folding of secretory proteins (and membrane proteins) takes up a 
central role in overall protein folding, as those proteins make up approximately 30 % of all eukaryotic 
proteins (Ghaemmaghami et al., 2003). A quality control mechanism (ERQC; ref. 1.3.2) within the 
first compartment of the secretory pathway, the ER, ensures that only properly folded proteins move 
further along the secretory pathway to their final destinations, while misfolded proteins are subjected 
to the ERAD (ref. 1.6). The complexity of protein folding and of processes linked with it such as 
ERQC, ERAD as well as the UPR (ref. 1.4), is seen in the variety of protein aggregation diseases 
such as the neurodegenerative disorders Alzheimer’s, Parkinson’s, Huntington’s and Creutzfeld-
Jakob (CJD) disease as well as α1-antitrypsin deficiency and cystic fibrosis (Qu et al., 1996; Werner 
et al., 1996; Imai et al., 2001; Harding & Ron, 2002; Araki et al., 2003; Forman et al., 2003; Gow & 
Sharma. 2003; Pereira et al., 2004 Lukacs & Verkman, 2012; Mendoza et al., 2012; Rabeh et al., 
2012). 
The ERAD pathway involves the recognition of damaged or misfolded proteins in the ER, their 
ubiquitination and subsequent degradation by 26S proteasomes in the cytosol (McCracken & 
Brodsky, 1996; Römisch, 2005; Mehnert et al., 2010; Smith et al., 2011). Since the components of 
the UPS (ref. 1.5) act in the cytosol, a prerequisite of protein degradation is the dislocation of 
misfolded proteins from the ER to the cytosol (Jensen et al., 1995; Ward et al., 1995; Werner et al., 
1996; Wiertz et al., 1996b).  
While the nature of the dislocation channel is still under debate, various studies suggest Sec61p as 
a possible candidate for the channel-forming component during protein dislocation of ERAD-L 
substrates and at least some transmembrane proteins (MHC class I HC, Pdr5*) (ref. 1.6.1; Wiertz et 
al., 1996b; Pilon et al., 1997, 1998; Plemper et al., 1997; 1998; Gillece et al., 1999; Schmitz et al., 
2000; Römisch, 2005; Willer et al., 2008; Schäfer & Wolf, 2009). Not only has Sec61p been shown 
to associate with some ERAD-L substrates, it also interacts with components of the ERAD-L 
pathway, such as Hrd1p, as well as with 26S proteasomes (Wiertz et al., 1996b; Plemper et al., 
1999a; Ng et al., 2007; Schäfer & Wolf, 2009). Although there are studies that argue against a role of 
Sec61p during dislocation, in no case the evidence is compelling and the available evidence strongly 
suggests that Sec61p is at least part of the dislocon (Carvalho et al., 2006, 2010; Denic et al., 2006; 
Sato et al., 2006; Wahlmann et al., 2007; Garza et al., 2009). Deciphering the ERAD pathway 
requires an understanding of the contribution of its individual components, such as Sec61p.  
In a previous study from our group in collaboration with Jeremy Brown, two sec61 mutants, sec61-
302 (D168G, S179P, F263L and S353C) and sec61-303 (D168G and F263L), were isolated 
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displaying a defect in cotranslational protein import (Ng et al., 2007). Additionally, only sec61-302 
specifically displayed a reduction in proteasome binding (Ng et al., 2007). Considering the 
dimensions of the α-subunit’s TMDs derived from the crystal structure of the M. jannaschii SecY 
complex, the single amino acid substitutions are located in TMD 4 (D168G), in the cytosolic loop (L) 
4 close to the cytosolic end of TMD 5 (S179P), in TMD 6 close its cytosolic end (F263L) and in the 
ER-lumenal L 7 (S353C) of Sec61p (ref. Figure 3.9.1; Wilkinson et al., 1996; van den Berg et al., 
2004; Ng et al., 2007). 
Since the two amino acid substitutions D168G and F263L, shared by sec61-302 and sec61-303, did 
not cause a reduction in proteasome binding to membranes isolated from sec61-303, it was 
suggested that one of the remaining amino acid substitutions, S179P or S353C, is responsible for 
the observed reduction in proteasome binding (Ng et al., 2007). In order to elucidate whether S179P 
or S353C mediate the observed binding defect, I generated the respective sec61 mutants by SOE-
PCR in the same genetic background as sec61-302 and sec61-303 (JDY638), which were also 
included in my analyses (ref. 3.2; Ng et al., 2007). 
 
 
4.1 TEMPERATURE- AND STRESS-SENSITIVITY OF THE SEC61 MUTANTS  
I initially analyzed sec61-S179P, sec61-S353C and sec61-S179P/S353C with respect to cell viability 
on rich and minimal medium at various temperatures in the absence or presence of the glycosylation 
inhibitor tunicamycin, to evaluate the effects of any of the point mutations in SEC61 on its functions 
(ref. 3.3; Kuo & Lampen, 1974; Duksin & Mahoney, 1982). Growth in the presence of tunicamycin 
leads to misfolded protein accumulation in the ER and thus a sensitivity towards tunicamycin can be 
associated with defects in ERAD (Travers et al., 2000; Tran et al., 2011). The sec61 mutants were 
viable (ref. Figure 3.3.1). I found that none of my new sec61 mutants displayed severe growth 
defects at any of the temperatures tested, the only exception being sec61-S353C which showed a 
slight temperature sensitivity at 37 °C (ref. Figure 3.3.1). None of the remaining sec61 mutants 
displayed cold- or temperature-sensitivity, suggesting that none of the point mutations in SEC61 
affected protein translocation into the ER at any temperature (ref. Figure 3.3.1). The same was true 
when cells were grown on minimal medium, i.e. under more restrictive nutritional conditions (ref. 
Figure 3.3.1). Here, in the absence as well as in the presence of tunicamycin, growth of my mutants 
was comparable to the corresponding wild-type (SEC61) (ref. Figure 3.3.1). For the growth 
experiments I used two previously isolated sec61 mutants, sec61-3 (Cs, Ts) and sec61-32 (Ts), as 
controls (Stirling et al., 1992; Sommer & Jentsch, 1993; Pilon et al., 1997, 1998). Both sec61 
mutants displayed the same growth defects in my hands as shown previously (ref. Figure 3.3.1; 
Pilon et al., 1998). The cold- and temperature-sensitivities of sec61-3 and sec61-32 had been 
suggested to be due to the impact of higher or lower temperature on the mobility or structure of the 
membrane protein Sec61p (Pilon et al., 1998). The fact that none of the sec61 mutants display a 
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striking cold- or temperature-sensitivity indicates that the underlying point mutations in the respective 
mutants do not affect Sec61p stability and thus function (Pilon et al., 1997). 
Alignments of Sec61p amino acid sequences from temperate organisms and extremophiles suggest 
that amino acid substitutions in the ER-lumenal L 7 of Sec61p have an impact on channel function at 
extreme temperatures (Römisch et al., 2003). In Antarctic and Arctic fish species amino acid 
substitutions in L 7 may improve channel function in the cold (Römisch et al., 2003). The effect at 37 
°C for sec61-S353C could support this idea. At 37 °C a conformational change in Sec61p caused by 
the S353C substitution might be enhanced resulting in instability of the protein. Instability might lead 
to reduced viability at this temperature. Temperature-sensitivity of sec61-S353C was not exceeded 
when the mutant was grown in the presence of tunicamycin, which suggests that it was independent 
of ERAD (ref. Figure 3.3.1). The fact that neither sec61-302 nor sec61-S179P/S353C display 
temperature-sensitivity could be due to the existence of S179P on the cytosolic face of Sec61p in 
these mutants. Although only speculative, this amino acid substitution on the opposite side of the 
Sec61 channel could counteract the effect of S353C on the Sec61p structure leading to the observed 
temperature sensitivity (ref. 3.3). This compensatory effect of the amino acid substitution S179P in 
sec61-S179P/S353C may be due to the contribution of proline to the overall protein structure. 
Proline increases the rigidity of protein structures (Prajapati et al., 2007). At residue 179 in Sec61p, 
located in the cytoplasmic L 4 close to the cytosolic end of TMD5, it might have a stabilizing effect 
against the conformational change induced by S353C (Ng et al., 2007).     
Stability and expression levels of Sec61p in my sec61 mutants, although I did not specifically 
investigate these, did not seem to be affected (data not shown). Comparison of equal amounts of 
RMs (measured in equals; 1 eq = 50 A280 units/µl), derived from sec61 mutants and the 
corresponding wild-type (SEC61) grown at the permissive temperature, when quantifying PK-RMs 
and reconstituted proteoliposomes prior to proteasome binding assays, revealed that the amounts of 
mutant Sec61p as well as signal intensities were comparable to the wild-type (SEC61) (data not 
shown; Walter & Blobel, 1981). This, together with the fact that in my sec61 mutants cell viability was 
not affected, further emphasizes that none of the point mutations in the sec61 mutants derived from 
sec61-302 affected Sec61p stability or function during import. 
 
 
4.2 PROTEIN TRANSLOCATION INTO THE ER IN THE SEC61 MUTANTS 
In yeast, Sec61p is the pore-forming component during co- and posttranslational protein import into 
the ER (ref. 1.2; Stirling et al., 1992; Panzner et al., 1995, Römisch, 1999). In order to investigate 
whether the amino acid substitutions S179P and S353C cause the defect in co-translational import 
into the ER detected in sec61-302 and sec61-303, I employed a reporter translocation assay using 
plasmids encoding protein substrates for co- (pPHO8-URA3) or posttranslational (pCPY-URA3) ER 
import (ref. 3.4; Ng et al., 1996; Ng et al., 2007).  
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Translocation of the two reporter fusion proteins Pho8p-Ura3p and CPYp-Ura3p into the ER, if 
disturbed due to Sec61p dysfunction, leads to the accumulation of the respective fusion protein in 
the cytosol (Ng et al., 2007). This in turn enables the cells (ura3 auxotrophs) to grow on medium 
lacking uracil as the Ura3p part of the protein remains in the cytosol (Ng et al., 1996; Ng et al., 
2007). The mutants sec61-302 and sec61-303 were identified screening specifically for co-
translational import defects using these plasmids (Ng et al., 1996; Ng et al., 2007). For sec61-302, 
which was used as a control in the assay, I could reproduce the defect in cotranslational ER import 
(ref. Figure 3.4.1; Ng et al., 2007). Defects in protein translocation into the ER for my new sec61 
mutants were not apparent when employing the reporter translocation assay (ref. Figure 3.4.1).  
Since none of the sec61-302 derivatives I generated displayed defects in co- or posttranslational 
protein import into the ER in this assay, the defect in cotranslational translocation found in sec61-
302 and sec61-303 can be attributed to the amino acid substitutions D168G and/or F263L, which are 
present in both mutants (Ng et al., 2007). The individual contributions of the amino acid substitutions 
D168G and F263L to the observed cotranslational import defect in sec61-302 and sec61-303, 
however, were not investigated. It has been suggested that pore opening could be mediated by 
shifts in helices lining the Sec61 channel (van den Berg et al., 2004). These shifts might be 
promoted by a rearrangement of L 4, which is located between TMD 4 and TMD 5 (van den Berg et 
al., 2004). As the amino acid substitution D168G is located close to L 4 it might affect this 
rearrangement (van den Berg et al., 2004). Another sec61 mutant with a point mutation in TMD 4 of 
Sec61p, sec61-24 (L162P; Cs), also displays a translocation defect at the permissive temperature 
(Pilon et al., 1998). For this and other classic sec61 mutants, adjacent to the N-terminal side of the 
lateral gate, it has been suggested that the mutants might interfere with the structural transition 
between the open and closed conformation of the gate (Pilon et al., 1998; Trueman et al., 2011). 
The results further indicate that the conformational change in Sec61p induced by the ER-lumenally 
located amino acid substitution S353C does not affect co- or posttranslational import into the ER (ref. 
4.1).   
The essential role of Sec61p during protein translocation into the ER generally complicates the 
analysis of its involvement in ERAD. In many sec61 mutants defects in misfolded protein 
degradation coincide with defects in protein import into the ER. Therefore, it has been argued that 
the ERAD defects observed in these mutants may be caused indirectly by lack of ER import of one 
or more ERAD factors (Jentsch & Sommer, 1993; Pilon et al., 1997, 1998; Zhou & Schekman, 1999). 
Only sec61 mutants defective in export, but with normal ER import capacity, are therefore suitable to 
demonstrate a direct role of the Sec61 channel in ERAD (Pilon et al., 1997). Thus, the fact that none 
of the sec61 mutants that I created in this study (sec61-S179P, sec61-S353C and sec61-
S179P/S35C) is defective in protein translocation into the ER, makes them excellent tools for further 
studies of the role of the Sec61 channel in ERAD. Therefore, these mutants were not only useful for 
elucidating the domains in Sec61p involved in proteasome binding, but also for directly 
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demonstrating the importance of this interaction for ERAD, without any interfering impact of 
disturbed ER import.   
 
 
4.3 PROTEASOME BINDING IN THE SEC61 MUTANTS 
ERAD (ref. 1.6) eliminates misfolded or unassembled proteins from the ER (Römisch, 2005). The 
selection of ERAD substrates occurs in the ER by the ERQC (ref. 1.3) (Ellgaard & Helenius, 2003). 
Proteolysis of these substrates by the cytoplasmic UPS (ref. 1.5) requires their dislocation from the 
ER to the cytosol (Voges et al., 1999; Goldberg, 2003; Römisch, 2005). The central role of the 26S 
proteasome, the most downstream component of the UPS, in ERAD has been demonstrated in 
several studies (ref. 1.5.2): Misfolded secretory and transmembrane proteins accumulate in the 
cytosol (or even in the ER) upon addition of proteasome inhibitors, and mutations in 20S CP and 
19S RP subunits cause ERAD defects (Wiertz et al., 1996b; Huppa & Ploegh, 1997; Mayer et al., 
1998; Yang et al., 1998). In some, but not all cases, export and degradation of ERAD substrates is 
coupled (Hiller et al., 1996; Loayza et al., 1998; Plemper et al., 1998, Kalies et al., 2005; Ng et al., 
2007). The extraction mechanism of ERAD substrates from the ER is not fully understood so far. 
Cdc48p, which binds to the Sec61 channel, is involved in export of many ERAD substrates from the 
ER (Kalies et al., 2005; Brodsky, 2012). It can also act together with the 19S RP of the 26S 
proteasome during extraction of proteins from the ER and during degradation of substrates, which 
are difficult to unfold (Isakov & Stanhill. 2011; Morris et al., 2014). The 19S RP can also promote 
misfolded protein extraction from the ER on its own in mammalians and yeast (Lee et al., 2004a; Ng 
et al., 2007; Wahlman et al., 2007). In a cell-free system, proteasomes in the presence of ATP 
promote export from the ER and degradation of a soluble ERAD substrate (Lee et al., 2004a; 
Wahlman et al., 2007). For this ERAD substrate export and degradation can be uncoupled, and the 
19S RP is the only cytosolic factor required for dislocating the substrate from the ER into the cytosol 
in vitro (Lee et al., 2004a). Binding of the 19S RP to the Sec61 channel has been demonstrated, the 
exact binding site on the Sec61p cytosolic face, however, has not been elucidated so far (Kalies et 
al., 2005; Ng et al., 2007). Ribosomes and proteasomes bind competitively to the Sec61 channel but 
to different sites or domains (Ng et al., 2007). Binding is mediated by the ATP-bound form of the 19S 
RP base (Ng et al., 2007). The exact proteasomal binding site in the Sec61 channel had not been 
identified prior to my work (Kalies et al., 2005; Ng et al., 2007).  
I performed binding experiments with reconstituted proteoliposomes derived from my sec61 mutants 
and purified 19S RPs to elucidate which of the amino acid substitutions, S179P or S353C, is 
responsible for the defect in proteasome binding in sec61-302 (ref. 3.5.2; Verma et al., 2000; Kalies 
et al., 2005; Ng et al., 2007). The mutant sec61-302 was included as a control (Ng et al., 2007). 
Using reconstituted proteoliposomes rather than RMs treated with puromycin and high salt (PK-
RMs) to remove ribosomes was shown in the past to improve specific binding of proteasomes to 
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yeast membranes and thus the interpretability of results (Kalies et al., 2005).  
19S RP binding to reconstituted membranes isolated from sec61-S353C, sec61-S179P/S353C and 
sec61-302 was reduced, while binding to sec61-S179P was comparable to wild-type (SEC61) (ref. 
Figure 3.5.2.1; Ng et al., 2007). Affinity of sec61-S179P/S353C for 19S RP, however, was higher 
than of sec61-S353C and sec61-302 membranes (ref. Figure 3.5.2.1). This might be explained by 
the stabilizing effect of the proline residue in S179P on the Sec61p structure which might counteract 
the conformational change in Sec61p caused by S353C (ref. 4.1). This, however, does not explain 
the reduction in proteasome binding in sec61-302 (Ng et al., 2007). In this mutant proteasome 
binding was comparable to sec61-S353C (ref. Figure 3.5.2.1). Whether the remaining substitutions 
D168G and F263L have an additive effect on Sec61p’s conformation or stability and thus on 
proteasome binding was not tested, but on their own they do not affect 19S RP binding (ref. sec61-
303; Ng et al., 2007). My results indicate that the point mutation in SEC61 leading to the amino acid 
substitution S353C in the ER lumen, and not S179P on the cytosolic face of the channel, as 
suspected originally, is responsible for the reduced proteasome binding observed in sec61-302 (ref. 
3.5.2; Ng et al., 2007).  
The observation that the amino acid substitution S353C (corresponding point mutation: C1058G) 
and not S179P (corresponding point mutation: T535C) leads to a reduction in proteasome binding 
was surprising, as Sec61p’s L 7 is located in the ER lumen and thus cannot directly mediate 
proteasome binding (Wilkinson et al., 1996; van den Berg et al., 2004). The cold-sensitive mutant 
sec61-32 (C150Y), which is the sec61 mutant displaying the most severe ERAD defect known to 
date, also displays a reduction in proteasome binding, although binding defects were not as 
pronounced as in sec61-302 (Pilon et al., 1997; 1998; Ng et al., 2007). The underlying amino acid 
substitution in sec61-32, C150Y, is located towards the lumenal end of TMD 4 and, just as S353C, 
cannot directly mediate the effect on binding to the 19S RP (Pilon et al., 1997; Ng et al., 2007). Thus, 
for this mutation it has also been suggested that the point mutation induces a conformational 
change, which affects 19S RP binding (Ng et al., 2007). 
Initially, I anticipated that S179P is responsible for the observed defect in proteasome binding in 
sec61-302, due to its location in cytosolic L 4 of Sec61p (van den Berg et al., 2004; Ng et al., 2007). 
Moreover, in a previous study, other mutations in lumenal loops of Sec61p had no effect on 
proteasome binding (ref. sec61-301; Ng et al., 2007). Cytosolic L 4, however, has been proposed to 
act as a hinge during rearrangement of TMD 4 and TMD 5 during channel opening rather than as the 
direct proteasome binding site (van den Berg et al., 2004; Ng et al., 2007). Further, it has been 
suggested that S179P could not constitute the entire proteasome binding site due to its proease-
insensitivity (Kalies et al., 2005). Conformational rearrangement of Sec61p as a prerequisite for 
proteasome binding, as such a conformational change could expose the proteasome binding site, 
has also been suggested (Kalies et al., 2005; Ng et al., 2007). The N-terminus of Sec61p, conserved 
between S. cerevisiae and mammals, has been suggested as a possible proteasome binding site, 
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which might become more exposed as a result of a conformational change if there were movement 
around L4 (van den Berg et al., 2004; Kalies et al., 2005; Ng et al., 2007). 
My work together with data from Tretter et al. (2013) shows that a conformational change hinging on 
ER-lumenal L 7 of Sec61p is central for generating the 19S RP binding site in Sec61p. It might be 
possible that Sec61p’s L 7, when triggered accordingly by respective binding partners in the ER, is 
involved in the mediation of a conformational change in Sec61p which might, in turn, make the 
proteasome binding site on the cytosolic face of the channel accessible. Considering the fact that 
binding of ribosomes and proteasomes to Sec61p, although to different sites, is competitive, such a 
conformational change exposing the proteasome binding site during ERAD, and maybe masking that 
of the ribosome at the same time, could be advantageous for the cell, as a switch from import to 
export could be regulated according to the cell’s needs (Lee et al., 2004b; Kalies et al., 2005). In 
order to be able to fully understand the nature of proteasome binding to the retrotranslocation 
channel structural analysis of Sec61p associated with proteasomes would be useful. Recent 
advances in high resolution EM should make it possible to generate a Sec61 channel-19S RP 
structure (ref. Voorhees et al., 2014).  
The proposed conformational change in Sec61p induced by S353C might only partially expose or 
even partially masks the proteasome binding site on the cytoplasmic face of Sec61p, since 
proteasome binding in sec61-302, sec61-S353C and sec61-S179P/S353C is not completely blocked 
(ref. 3.5.2; Ng et al., 2007). It is also possible that S353C interferes with ER-lumenal factors, such as 
chaperones, that might trigger channel opening during ERAD. 
A comparison between the wild-type (SEC61) and sec61-S353C protein sequence indicates that the 
mutation leading to the S353C substitution causes an extension of L7 and a reduction of the helical 
propensity N-terminal of the substitution and that in this region a portion of the helix is replaced with 
an extended strand (data not shown; Jones, 1999; Yachdav et al., 2014). A thus extended L7 would 
push transmembrane helix 7 towards helix 2 thereby leading to lateral gate stabilization in the closed 
conformation on the lumenal side. It is conceivable that the extended L7 induces shifts in Sec61p 
affecting cytosolic ends of TMD 2, TMD 7 and TMD 8, altering the cytosolic face of Sec61p (van den 
Berg et al., 2004, Park et al., 2014). As a result the channel might appear tightly closed from the 
cytosol rendering it less appealing for the 26 S proteasome to bind to the channel. This, together 
with the fact that neither S179P nor S353C cause a defect in co- or posttranslational import into the 
ER indicates that the conformational change is not severe enough to affect ribosome binding or 
interaction with the Sec63 complex (ref. 3.4; Kalies et al., 1994; Jonhson & van Waes, 1999). This 
finding is in concordance with data that have shown that ribosomes and proteasomes bind to 
different sites on Sec61p (Kalies et al., 2005; Ng et al., 2007). It might, however, be interesting to 
investigate directly whether S353C has an effect on ribosome interaction with the Sec61 channel.  
Proteoliposomes derived from a mutant lacking the entire ER-lumenal L 7 and additional 14 residues 
of TMD 7, sec61ΔL7, displayed a slight increase in proteasome binding compared to the 
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corresponding wild-type (Tretter et al., 2013). This mutant was not defective for growth at 30 °C or 
37 °C, but showed an increase in sensitivity towards tunicamycin at 20 °C (Tretter et al., 2013). 
Tunicamycin sensitivity was even more pronounced than in the ERAD-deficient mutant sec61-32 
(Pilon et al., 1997, 1998; Tretter et al., 2013). From this study it was concluded that L 7, although 
important for Sec61p function, is not essential (Tretter et al., 2013). Another sec61 ER L 7 mutant, 
sec61Y345H, identified in a screen for mice (sec61-Y344H) prone to diabetes, causes a delay in 
misfolded protein export from the ER in intact yeast cells (Wheeler & Gekakis, 2012; Tretter et al., 
2013). Binding of 19S RP to this mutant was comparable to the wild-type (Tretter et al., 2013).  
In mice bearing the homologous substitution, Y344H (sec61Y344H) in Sec61p, the mutation in 
SEC61 leads the development of pancreatic β-cells with distended ER cisternae suggesting that cell 
death of β-cells is elicited by defects in ERAD and via a prolonged induction of the UPR (Lloyd et al., 
2010). Studies in mammalian cells revealed that this point mutation leads to calcium leakage from 
the ER through the Sec61 channel (Schäuble et al., 2012). The leakage could not be turned off by 
BiP suggesting that the point mutation leads to a partial opening of the channel (Schäuble et al., 
2012). 
A model of the aforementioned Sec61ΔL7p (Sec61p lacking residues 305-371) suggests that the 
mutant channel is partially open due to a disturbed interaction between transmembrane helix 2b and 
7 of Sec61p (Tretter et al., 2013). More precisely, in this mutant Sec61p the lack of ER lumenal L 7 
and the lumenal end of TMD 7, leads to a shift in transmembrane helix 2b towards the cytoplasmic 
face of the ER membrane which therefore cannot be held in place by TMD 7 (Tretter et al., 2013). In 
Sec61ΔL7p the most C-terminal residue of the gating motif, N302, which sets the hydrophobicity 
threshold for signal sequence insertion into the translocation channel, is located at the very C-
terminal end of TMD 7 (Trueman et al., 2011; Tretter et al., 2013). Due to the excision in Sec61ΔL7p 
TMD7 and TMD 8 are only connected by 2 residues, which in turn applies tension onto N302 thereby 
weakening the hydrogen bonds to its partners in the gating motif resulting in a partial opening of the 
gate (Tretter et al., 2013). The observed slight increase in proteasome affinity in this mutant might be 
explained by the partially open Sec61 channel (Tretter et al., 2013). 
Preliminary data from PEGylation of the cytosolic domains of Sec61p analyzing possible 
conformational changes in sec61 mutants indeed indicated that S353C in sec61-302 and sec61-
S353C leads to a conformational change in Sec61p, while Sec61-S179Pp seemed to display a 
conformation comparable to wild-type Sec61p  (ref. 3.9; sec61-S179P/S353C was excluded from the 
experiments). Interestingly, in this assay another mutant with a point mutation in the ER-lumenal L 7, 
sec61-3 (G341E), also seemed to adopt a conformation that deviates from wild-type Sec61p (ref. 
Figure 3.9.2). Due to technical limitations the data from this experiment, however, were not 
significant enough to be conclusive. During PEGylation assays Sec61-3p seemed to be unstable as 
the detected signal was significantly weaker compared to the remaining mutant Sec61ps analyzed 
(ref. 3.9). Sec61p instability in sec61-3 (G341E) as wells as in sec61-2 (G213D) was described in 
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the past (Stirling et al., 1992; Sommer & Jentsch, 1993; Biederer et al., 1996). The observed 
translocation defects and temperature sensitivities in these mutants are explained by the 
degradation of the respective mutant Sec61p proteins (Stirling et al., 1992; Sommer & Jentsch, 
1993; Biederer et al., 1996).  
Although the extracytoplasmic loops of Sec61p are less well conserved than the cytoplasmic loops, 
the ER-lumenal L 7 of Sec61p contains an array of residues, which are highly conserved among 
various organisms (S. cerevisiae, S. pompe, C. albicans, Dictyostelium discoideum, C. elegans, fruit 
fly, zebrafish, xenopus, mouse, rat, orangutan and human). A comparison of Sec61p protein 
sequence from S. cerevisiae with those of various orthologues shows that especially in the region 
between residue 340 and residue 353 there is a high density of highly conserved residues (data not 
shown). The importance of individual highly conserved residues for protein function is seen in 
mutants such as sec61-3 (G341E) and the tyrosine in the di-tyrosine motif in sec61Y345H, which 
when mutated have a negative impact on protein function (Stirling et al., 1992; Sommer & Jentsch, 
1993; Lloyd et al., 2010; Wheeler & Gekakis, 2012; Tretter et al., 2013). The serine residue at 
position 353 of Sec61p in S. cerevisiae is not as highly conserved. At the corresponding position in 
Sec61p of organisms such as C. elegans, fruit fly, zebrafish, Xenopus, mouse, rat, orangutan and 
human there is a glycine residue instead (G352). This glycine residue, however, is conserved among 
the organisms mentioned. But both are small residues and allow a certain flexibility of L 7 in this 
position, which might be altered in S353C. In addition, the cysteine in the ER lumen might be prone 
to formation of disufide bonds, which would keep L 7 in position. That mobility around L 7 is crucial 
for Sec61 channel opening has been shown clearly in a recent structural study from the Rapoport lab 
(Park et al., 2013). 
 
 
4.4 CHARACTERIZATION OF UPR-ACTIVATION IN THE SEC61 MUTANTS 
Since ERAD (ref. 1.6) and the UPR (ref. 1.4) are tightly linked pathways, monitoring the UPR can 
give first hints as to whether ER stress is caused in the respective sec61 mutants due to 
dysfunctional Sec61p (Friedlander et al., 2000; Travers et al., 2000). 
In none of the sec61 mutants I investigated, sec61-S179P, sec61-S353C, sec61-S179P/S353C, 
sec61-302 and sec61-303, the UPR was induced (Figures 3.6.1, 3.6.2 and 3.6.3). This is consistent 
with the modest effects on ERAD in intact cells (ref. 3.7 and 4.5). 
Initially, I monitored UPR induction with a quantitative liquid β-galactosidase assay after transforming 
the strains with a reporter plasmid containing the lacZ gene under the control of a UPRE (ref. 3.6.1). 
Colorimetric measurement of β-galactosidase activity revealed that none of the sec61 mutants 
(sec61-302, sec61-303, sec61-S179P, sec61-S353C and sec61-S179P/S353C) displayed an 
elevated UPR when compared to the corresponding wild-type (SEC61) (ref. Figure 3.6.1.1). There 
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were also no differences between mutants and wild-type when the UPR inducer tunicamycin was 
added (ref. Figure 3.6.1.1). The control strains Δder1 (corresponding wild-type DER1) and sec61-3, 
which was isolated via a UPR screen, displayed elevated β-galactosidase activities even in the 
absence of tunicamycin (ref. Figure 3.6.1.1; Sommer & Jentsch, 1993; Knop et al., 1996; Zhou & 
Schekman, 1999). When tunicamycin was added to these strains UPR induction was even more 
pronounced (ref. Figure 3.6.1.1). 
I confirmed these results investigating HAC1 mRNA splicing (ref. 3.6.2; Mori et al., 2010). I could not 
detect spliced HAC1 mRNA (HAC1i) in any of my sec61 mutants under normal growth conditions in 
the absence of tunicamycin (ref. Figure 3.6.2.1). Only in the controls Δder1 and sec61-3 spliced 
HAC1 mRNA was present in the absence of tunicamycin (ref. Figure 3.6.2.1). The effect was even 
more pronounced in the presence of tunicamycin (ref. Figure 3.6.2.1). In addition, in sec61-3 I 
investigated HAC1 mRNA at the restrictive temperature (17 °C) and found it to be stronger 
compared to splicing at 30 °C which, again, was expected (ref. Figure 3.6.2.1; Sommer & Jentsch, 
1993). Upon addition of tunicamycin, the UPR was induced resulting in the detection of the spliced 
HAC1i mRNA species in all strains as expected (ref. Figure 3.6.2.1).  
Results from investigating synthetic effects of my sec61 mutants with Δire1 were in concordance 
with those from the HAC1 mRNA splice assay and the β-galactosidase assay (ref. 3.6.3). Since cells 
lacking IRE1 are hypersensitive to the accumulation of misfolded proteins in the ER, disturbed 
protein retrotranslocation due to point mutations in SEC61 should result in a growth defect (Shamu & 
Walter, 1996). In the absence of tunicamycin none of the double mutants (Δire1 sec61-302, Δire1 
sec61-303, Δire1 sec61-S179P, Δire1 sec61-S353C and Δire1 sec61-S179P/S353C) displayed 
growth defects at any of the temperatures tested compared to the wild-type (SEC61) (ref. Figure 
3.6.3.1). Upon addition of tunicamycin, growth was severely compromised in all strains, i.e. none of 
the strains were viable (ref. Figure 3.6.3.1). As the tunicamycin concentration used in this 
experiment very likely was too high to detect growth or even differences in tunicamycin sensitivity in 
the double mutants the experiment would have to be repeated using lower tunicamycin 
concentrations.  
Data from the UPR assays suggest that, although a reduction in proteasome binding was detected in 
the S353C-containing mutants, the observed reduction in proteasome binding does not, under the 
conditions tested, result in significant accumulation of misfolded proteins in the ER (ref. Figure 
3.5.2.1, 3.6.1.1, 3.6.2.1 and 3.6.3.1). One explanation for this observation is that the high 
concentration of proteasomes in the cytosol sufficiently compensates for the proteasome binding 
defect in intact cells. This was confirmed by my in vitro experiments (ref. 4.6). 
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4.5 ERAD OF SOLUBLE AND TRANSMEMBRANE SUBSTRATES IN THE SEC61 
MUTANTS 
I investigated the effect of my new sec61 mutants on ERAD in intact cells with pulse-chase 
experiments using the ERAD-L substrates Δgpαf, CPY* and KWW and the ERAD-C substrate Ste6-
166p (ref. 3.7.1, 3.7.2 and 3.7.3; McCracken & Brodsky, 1996; Loayza et al., 1998; Vashist et al., 
2001; Vashist & Ng, 2004). I also included sec61-302 and sec61-303 in the analyses, as ERAD had 
not been investigated in theses mutants (Ng et al., 2007). Sec61p has been suggested to be mainly 
required in ERAD-L, but this may be an effect of the sec61 mutants selected to test Sec61p-
dependence of specific substrates (Pilon et al., 1998; Willer et al., 2008; Schäfer & Wolf, 2009). An 
involvement of Sec61p in ERAD-C has been suggested, as Sec61p could be isolated with a complex 
containing Doa10p, but has not been explicitely demonstrated (Stolz et al., 2010). Therefore, I also 
investigated degradation of the ERAD-C substrate, Ste6-166p (ref. 3.7.4; Vashist & Ng, 2004). 
The glycosylated ERAD-L substrates KWW and CPY* employ the same chaperone equipment and 
other requirements during ERAD, which might explain why degradation of these ERAD-L substrates 
is not affected in the same way as degradation of Δgpαf (Vashist & Ng, 2004). In the soluble CPY* a 
point mutation (G255R) leads to protein misfolding and rapid ERAD (Knop et al., 1996). The 
chimeric single-spanning transmembrane ERAD substrate KWW, containing a lesion in its ER-
lumenal domain, has been shown to be a bonafide ERAD substrate (Vashist & Ng, 2004). Both 
substrates require the ER-to-Golgi transport for degradation as well as BiP, Cue1p, Hrd1p and 
Der1p (Vashist et al., 2001; Vashist & Ng, 2004). While for CPY*, which is imported into the ER 
posttranslationally, the primary driver for export from the ER is Cdc48p, for KWW the main driving 
force for export from the ER is not known (Vashist et al., 2001; Vashist & Ng, 2004).  
Among the ERAD-L substrates tested the unglycosylated Δgpαf, whose precursor pΔgpαf is 
translocated into the ER posttranslationally, takes in a distinct role (McCracken & Brodsky, 1996). In 
this substrate N-glycosylation sites in the proregion were removed which leads to misfolding 
(McCracken & Brodsky, 1996). The requirements for degradation of Δgpαf differ from those of CPY* 
and KWW (Vashist et al., 2001; Vashist & Ng, 2004). Not only is this ERAD-L substrate degraded 
fastest, it also does not require the ER-to-Golgi transport for degradation, both in vitro and in vivo 
(Caplan et al., 1991; McCracken & Brodsky, 1996). ERAD of Δgpαf, despite the lack of N-linked 
oligosaccharides, depends on Cne1p, the yeast homologue of mammalian calnexin (McCracken & 
Brodsky, 1996). In addition to its role as an ER lectin, calnexin displays glycan-independent 
chaperone functions (Swanton et al., 2003; Fontanini et al., 2004; Helenius & Aebi, 2004). For 
Cne1p a function similar to the mammalian calnexin has been proposed in vitro (Xu et al., 2004). As 
opposed to most other ERAD substrates investigated so far, degradation of Δgpαf does not require 
ubiquitination but export from the ER depends on the 19S RP (McCracken & Brodsky, 1996; Werner 
et al., 1996; Lee et al., 2004a). Degradation of Δgpαf also depends on BiP (Vashist et al., 2001; 
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Vashist & Ng, 2004). Thus, it has been suggested that for Δgpαf a distinct ER checkpoint might exist  
(Vashist & Ng, 2004). 
The ERAD-C substrate Ste6-166p (Gln1249X leads to truncation of 42 aa), mutant a-factor 
transporter in yeast, has been suggested to be retained in the ER (Berkower & Michaelis, 1996; 
Loayza et al., 1998). It is also highly unstable and rapidly degraded (Loayza et al., 1998). 
Degradation of this ERAD substrate requires the UPS (ref. 1.5) (Loayza et al., 1998; Vashist et al., 
2001). It is not clear how or whether Ste6-166p is extracted from the ER membrane for degradation 
by the proteasome (Loayza et al., 1998). Ste6-166p is degraded independently of Hrd1p, Der1p and 
BiP, but requires Doa10p for degradation (Loayza et al., 1998; Vashist et al., 2001; Vashist & Ng, 
2004). Degradation of mutants Ste6p has been suggested to be independent of Sec61p, although 
this could also be due to the sec61 background used in the experiments (Huyer et al., 2004b). In a 
previous study an alternative pathway for mutant Ste6p degradation was suggested (Huyer et al., 
2004a). Ste6-166p was shown to induce the formation of so-called ERACs (ER-associated 
compartments) from which it was subjected to ERAD without entering the secretory pathway (Huyer 
et al., 2004a). In a more recent study it was shown that mutant Ste6p is extracted from the ER 
membrane and that degradation requires polyubiquitination, Cdc48p and ATP (Nakatsukasa et al., 
2008).  
When I investigated degradation efficiencies of the ERAD-L substrates in the sec61 mutants, I found 
that ERAD of Cdc48p-dependent substrate CPY* and the chimeric substrate KWW, was not affected 
in any of the sec61 mutants (ref. Figure 3.7.1.1 and 3.7.3.1; Finger et al., 1993; Vashist et al., 2001; 
Vashist & Ng et al., 2004). ERAD of Δgpαf on the other hand was moderately affected in the sec61-
302 derivatives (ref. Figure 3.7.2.1). 
Degradation of CPY* and KWW was barely affected in the sec61 mutants (ref. Figure 3.7.1.1 and 
Figure 3.7.3.1). The half-life of CPY* in the wild-type (t1/2 = 21 min) was in agreement with published 
data (Knop et al., 1996). Degradation efficiencies in the sec61 mutants were also comparable to the 
wild-type, except sec61-302 which displayed slightly slower degradation of the substrate (t1/2  ∼ 24 
min) (ref. 3.7.1; Ng et al., 1996). For KWW, the half-life in the wild-type (t1/2 ∼ 33 min) was close to 
the published data (t1/2 ∼ 35 min) (Vashist & Ng, 2004). The degradation kinetics of all sec61 
mutants was similar (t1/2 ∼ 38 min) but slightly slower than the wild-type (ref. Figure 3.7.3.1). 
The degradation of Δgpαf was more variable in the sec61 mutants I investigated (ref. Figure 3.7.2.1). 
While in sec61-303 (t1/2 ∼ 14 min) ERAD degradation of Δgpαf was not affected, in the sec61-302 
derivatives (t1/2 ∼ 18 min) degradation of the substrate was slower than in the wild-type (t1/2 ∼ 13 min) 
(ref. Figure 3.7.2.1). Especially in sec61-S353C turnover of Δgpαf was affected (t1/2 ∼ 20 min). I also 
observed a delay during degradation initiation for Δgpαf (ref. Figure 3.7.2.1). CPY* and KWW have 
identical requirements for ERAD, which are distinctive from those for Δgpαf ERAD. This might 
explain the difference between these substrates and Δgpαf with respect to turnover in my sec61 
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mutants (Vashist et al., 2001; Vashist & Ng, 2004).  
Degradation of the ERAD-C substrate Ste6-166p was not affected in the sec61 mutants (ref. Figure 
3.7.4.1). For Ste6-166p, however, transformation rates were poor especially for sec61-S353C and 
sec61-S179P/S353C. This might explain why the signal for Ste6-166p in sec61-S353C and sec61-
S179P/S353C was weaker compared to the remaining strains, which complicated the interpretation 
of results (ref. Figure 3.7.4.1). Due to technical difficulties I was not able to repeat the experiment 
and thus to elucidate whether in the two mutants Ste6-166p signal intensities were weaker due to 
technical issues or whether the observed effects were mutant-specific defects in the biogenesis of 
polytopic transmembrane proteins (ref. Figure 3.7.4.1). From the data I did obtain, I concluded that 
ERAD of this transmembrane ERAD-C substrate was also undisturbed in sec61S353C and sec61-
S179P/S353C mutants (ref. Figure 3.7.4.1).  
The results show that degradation of the ERAD-L substrate Δgpαf, whose export from the ER 
depends on the 19S RP, is affected the most in sec61-S353C (ref. Figure 3.7.3.1). This suggests 
that the 19S RP-Sec61 channel interaction is important for ERAD. The fact that in sec61-302 and 
sec61-S179P/S353C degradation of Δgpαf is less affected supports the idea that, although in these 
mutants proteasome binding (ref. 3.5.2) is also reduced, the substitution S179P counteracts the 
effect of S353C on the conformation of Sec61p (ref. 4.4 and Figure 3.5.2.1 and Figure 3.7.3.1).  
 
 
4.6 ERAD OF ΔGPαF IN A CELL-FREE SYSTEM 
The limiting step for export of Δgpαf from the ER is 19S RP binding to the Sec61 channel 
(McCracken & Brodsky, 1996; Lee et al., 2004a). In intact cells the effect of Δgpαf degradation was 
subtle, as here the high proteasome concentration in the cytosol would compensate for a reduction 
in 19S RP affinity for mutant Sec61 channel, as in sec61-S353C (ref. Figure 3.7.2.1 and 4.5; Kalies 
et al., 2005; Russell et al., 1999). 
ATP and proteasomes are the minimum requirements for in vitro ERAD of Δgpαf (Werner et al., 
1996; McCracken & Brodsky, 1996; Verma et al., 2000; Lee et al., 2004b). When I analyzed ATP-
dependent Δgpαf retrotranslocation in a cell-free system using membranes derived from my sec61 
mutants I found a delay in ERAD of Δgpαf in the sec61 mutants containing the S353C substitution 
when proteasomes were limiting (ref. Figure 3.8.2.3; McCracken & Brodsky, 1996). Degradation 
kinetics of Δgpαf in the ERAD-deficient sec61-3 mutant (G341E), which I used as a control, because 
the underlying point mutation is also located in the ER-lumenal L 7, were in concordance with 
previous results (Stirling et al., 1992; Sommer & Jentsch, 1993; Pilon et al., 1997, 1998).  
Usually, in in vitro assays for ER export of Δgpαf a cytosol concentration of 3 mg/ml is used in which 
the proteasome concentration is still in the saturating range for the wild-type Sec61 channel 
(McCracken & Brodsky, 1996; Pilon et al., 1997). The effects using 3 mg/ml cytosol in the in vitro 
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assay were comparable to those in intact cells (ref. Figure 3.7.2.1, Figure 3.8.2.2 and 4.5). In the 
S353C mutants the reduction in affinity of the Sec61 channel for the 19S RP would be partially 
compensated by the high proteasome concentration in the cytosol in intact cells and in vitro using 3 
mg/ml cytosol (McCracken & Brodsky, 1996; Russell et al., 1999; Kalies et al., 2005).  
Using a non-saturating concentration of 1 mg/ml cytosol, I observed a delay in ERAD of Δgpαf for 
the mutants with reduced 19S RP affinity sec61-302, sec61-S353C and sec61-S179P/S353C (t1/2 ∼ 
45 min) compared to the wild-type (t1/2 ∼ 23 min), which, however, was not as severe as for sec61-3, 
for which export was severely reduced, or sec61-32 (not tested here) (ref. Figure 3.8.2.3; Stirling et 
al., 1992; Sommer & Jentsch, 1993; Pilon et al., 1997, 1998). Although export was delayed in my 
mutants it was not fully compromised. Since sec61 mutants displaying a reduction in proteasome 
binding also display a delay in Δgpαf ERAD, my results indicate that Sec61 channel interaction with 
the 19S RP is important for the dislocation of Δgpαf. The fact that export of Δgpαf from sec61-
S17P/S353C membranes was affected to the same extent as for sec61-S353C, although 19S RP 
binding was only moderately reduced in this mutant, implies that 19S RP binding to the Sec61 
channel, apart from requiring a specific conformation of Sec61p on its cytoplasmic face, also induces 
a conformational change in the channel necessary for promoting export of misfolded proteins (ref. 
Figure 3.8.2.3; Vorhees et al., 2014). This would explain that while in the double mutant the amino 
acid substitution S179P might counteract the destabilizing effect of S353C on Sec61p conformation 
and thus on proteasome binding, S353C would still inhibit the initial steps for export (ref. 4.4). As the 
ER-lumenal L 7 might also promote export and act as a binding site of ER-lumenal binding partners 
required during retrotranslocation, such as ER chaperones, it seems plausible that in sec61-
S179P/S353C export is still negatively affected while 19S RP binding is only mildly reduced (ref. 
3.5.2 and 3.8.2). From my data it is evident that in intact cells the proteasome concentration is 
sufficient enough to compensate 19S RP binding defects especially in the sec61-S353C mutant (ref. 
4.3 and 4.5). Therefore, in order to investigate the importance of the 19S RP-Sec61p interaction in 
ERAD one would have to express sec61-S353C with reduced proteasome concentration and test 
UPR and various ERAD substrates. 
Thus, the S353C substitution could not only cause a conformational change in Sec61p that has a 
negative effect on proteasome binding, it could also impair a conformational change or movement of 
individual domains in Sec61p which might be necessary for the exposure of the proteasome binding 
site and for priming of misfolded protein export from the ER. 
Another explanation for the observed effects in sec61-302, sec61-S353C and sec61-S179P/S353C 
might be that a disulfide bond is formed via the cysteine (S353C) with PDI, which is involved in 
export of Δgpαf, causing the delay in export (Gillece et al., 1999). Although I prefer the first scenario, 
at this point both scenarios are speculative.  
A role of ER-lumenal L 7 during proteasome binding and retrotranslocation would be in addition to its 
important role during translocon gating as has been demonstrated by Trueman et al. (2011). In this 
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study the effects of sec61 L7 mutants on Sec61 channel protein function were investigated. The 
authors found that specific insertion mutations in L 7 caused a delay in channel gating resulting in 
mostly posttranslational translocation defects (Trueman et al., 2011). Channel gating requires a 
concerted movement of TMD 7 and TMD 8, a process that is disturbed in the sec61 L7 insertion 
mutants (Trueman et al., 2011; Park et al., 2014). The mutations in ER-lumenal L 7 have been 
proposed to cause breakage of side-chain contacts linking TMD 7 and TMD 8 via the minihelix in L 
7, which would lead to an uncoordinated movement of TMD 7 and TMD8 during translocon gating 
(van den Berg et al., 2004; Trueman et al., 2011). This would result in delayed signal sequence 
insertion into the signal sequence binding site (Trueman et al., 2011). One of the initial sec61 L7 
mutants in the Trueman study, sec61 E345-HA, in which the insertion is located eight residues N-
terminal of the residue S353, was not defective in import of pCPY into the ER (Trueman et al., 2011). 
Among the other sec61 L7 mutants sec61 I320-HA and sec61 S340-HA displayed severe defects in 
CPY translocation (Trueman et al., 2011). This further confirms that specific mutations in ER-
lumenal L 7 can result in very different phenotypes. 
 
 
4.7 CONCLUSION 
In this study, by generating sec61 mutants containing individual point mutations, I was able to 
identify that the amino acid substitution S353C, located in the ER-lumenal L 7 of Sec61p leads to a 
reduction in proteasome binding in the mutant sec61-302 (D168G, S179P, F263L and S353C) (Ng et 
al., 2007). The respective sec61 mutants were all viable and showed no defects in growth or co- or 
posttranslational protein import into the ER, which suggests that import defects in sec61-302 and 
sec61-303 (D168G and F263L), which share two of the same point mutations, can be attributed to 
the remaining point mutations leading to the amino acid substitutions D168G and F263L (Ng et al., 
2007). In the mutants I generated for this study the UPR was not induced, indicating that protein 
homeostasis was not disturbed due to the amino acid substitutions. At the same time I found that 
ERAD of the mutant alpha factor precursor, Δgpαf, was disturbed in the sec61 mutants containing 
the S353C substitution in vitro and in vivo. ERAD of other ERAD-L substrates and one ERAD-C 
substrate was not or barely delayed in the initial phases of degradation.  
Although data from this study do not reveal the exact proteasome binding site on the cytoplasmic 
face of Sec61p, they indicate that the conformation of Sec61p during ERAD determines the 
efficiency of proteasome binding. My work indicates that the amino acid substitution S353C leads to 
or prevents a conformational change in Sec61p, hinging on ER-lumenal L 7, which affects the 
proteasome binding site on the cytoplasmic face of the protein and that the 19S RP/Sec61 channel 
interaction is important for export of a subset of ERAD substrates. This suggests that a specific 
conformation of Sec61p is required for efficient interaction with the proteasome as has been 
speculated previously (Kalies et al., 2005; Ng et al., 2007; Tretter et al., 2013). My results, together 
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with those from previous work in our group and by others, stress that the large ER-lumenal lL 7 of 
Sec61p is involved in ERAD (Wheeler & Gekakis, 2012; Tretter et al., 2013). Whether L7 functions 
as a binding site for chaperone/substrate complexes as a prerequisite for retrotranslocation channel 
opening or proteasome binding still requires elucidation. Nevertheless, my work identifies a second 
mutation in Sec61p L 7 which is ERAD-specific, confirming Sec61p’s direct role as part of the ERAD 
machinery.   
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6 ABBREVIATIONS 
 
Δgpαf Signal-cleaved form of pΔgpαf (ERAD substrate) 
3gpαf  Triply N-glycosylated, signal-cleaved form of wild-type alpha factor 
precursor (ppαf) 
5-FOA 5-Fluoroorotic acid 
Å  Angstrom 
AA  Amino acid 
AAA  ATPase associated with various cellular actvities 
AAA-ATPase  ATPases associated with different cellular activities 
Ab  Antibody 
ABC  ATP-binding cassette 
ACT1  Actin 1  
ADP  Adenosine diphosphate 
AEBSF  4-(2-Aminoethyl)benzenesulfonyl fluoride 
AMC  7-Amido-4-methylcoumarin  
Amp  Ampicillin 
AP-1/3  Activator protein 1/3 
APS  Ammonium persulfate 
ARS  Autonomously replicating sequence; ATP regenerating sytem 
ATF6  Activating transcription factor-6 (PKR)-like ER kinase 
ATP  Adenosine triphosphate 
BiP  Binding immunoglobulin protein  
BOF BODIPY FL  
bp  base pair 
BSA  Bovine serum albumin 
C. elegans  Caenorhabditis elegans 
CAA  Casamino acids 
CaAc  Calcium acetate 
Cdc48p  Cell Division Cycle  
CDK2-like  Cyclin-dependent kinase 2-like 
cDNA  Complementary DNA 
CEN  Centromere 
CGN  cis Golgi network 
CI Chloroform-isoamyl alcohol 
CJD  Creutzfeld-Jakob disease 
CMV  Cytomegalovirus  
CNX  Calnexin 
COP9  Constitutive photo-morphogenesis 9 
COPI/II  Coat protein complex I/II 
CP  Core particle, 20S CP of the proteasome 
CPY  Carboxypeptidase Y 
CPY*  Mutant carboxypeptidase Y (ERAD substrate in yeast) 
CRT  Calreticulin 
C-terminus   Carboxy-terminus 
Cue1p   Coupling of ubiquitin conjugation to ER degradation 
D   Aspartic acid  
Da   Dalton 
dATP   2’ Deoxyadenosine 5’-triphosphate 
dCTP   2’ Deoxycytidine 5’-triphosphate 
DEPC   Diethylpyrocarbonate 
dGTP   2’ Deoxyguanosine 5’-triphosphate 
Deoxy BigCHAP  N,N-Bis[3-(D-gluconamido)propyl]deoxycholamide 
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Der1p   Degradation in the ER  
DMSO   Dimethylsulfoxide 
DNA   Deoxyribonucleic acid 
dNTP   Deoxyribonucleotide triphosphate (dATP, dCTP, dGTP, dTTp) 
d/o   Drop-out 
Doa10p   Degradation of alpha 2 protein 10 
DPAP-B   Dipeptidyl aminopeptidase B 
DPY  CPY* where the targeting sequence was replaced with that of DPAP-B 
ds  Double-stranded 
Dsk2   Dominant suppressor of kar1 protein 2 
DTT   Dithiothreitol 
DUB   Deubiquitinating enzymes 
E   Glutamic acid 
E1   Ubiquitin-activating enzyme 
E2   Ubiquitin-conjugating enzyme 
E3   Ubiquitin-protein ligase 
E4   Enzymes involved in polyubiquitination of substrates 
ECL   Enhanced chemiluminescence 
E. coli   Escherichia coli 
EDEM  ER degradation-enhancing α-mannosidase-like protein 
EDTA  Ethylenediamine tetraacetic acid 
EGTA   Ethylene glycol tetraacetic acid 
elF3   Eukaryotic translation initiation factor 3 
EM Electron microscopy 
Eq  Equal (unit definition for ER membranes) 
ER  Endoplasmic reticulum 
ERAC  ER-associated compartment 
ERAD  ER-associated degradation 
ERGIC  ER-Golgi intermediate compartment  
ERQC  ER quality control 
ERSE  ER stress response element 
EtBr  Ethidium bromide 
EtOH  Ethanol 
F  Phenylalanine 
Flag-tag  A polypeptide protein tag (N-DYKDDDDK-C) for affinity purification 
G Glycine 
Gal  Galactose 
GEF  Guanine nucleotide exchange factor  
GET   Guided entry of TA proteins 
GFP  Green fluorescent protein 
GlcNAc2Man9Glc3  N-acetylglucosamine2Mannose9Glucose3 
GPI-anchor Glycosylphophatidylinositol anchor   
GRP-78 78 kDa Glucose-regulated protein  
GTP  Guanosine triphosphate 
H2O dest.  Distilled water 
Hac1p  Homologous to Atf/Creb1 
HbYX  Hydrophobic-tyrosine-X	  
HC  Heavy chain 
HCl  Hydrochloric acid 
HCMV  Human cytomegalovirus   
HECT   Homologous to the E6-AP carboxy-terminus 
Hepes   4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid 
His  Histidine 
HIV  Human immunodeficiency virus 
Hlj1p  Homologous to E. coli DnaJ protein 1 
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Hmg1p  3-Hydroxy-3-methylglutaryl-coenzyme A reductase 
HMG-CoA  Hydroxymethylglutaryl-CoA reductase 
Hr  Hour(s) 
Hrd1p  HMG-CoA reductase degradation protein 1  
HRP  Horseradish peroxidase 
Hsm3  Enhanced spontaneous mutability 
Hsp  Heat shock protein (e.g. Hsp70: heat shock protein of about 70 kDa) 
Htm1  Homologous to mannosidase 1 
Ig  Immunoglobulin 
IP  Immunoprecipitation 
IPTG  Isopropyl-β-D-thio-galactopyranoside 
Ire1p  Inositol-requiring protein 1	  
Jem1p  DnaJ-like protein of the ER membrane  
K  Lysin 
KAc  Potassium acetate 
Kan Kanamycin 
kanr Kanamycin resistence 
Kar2p  Karyogamy 2 protein 
kb  Kilobase  
kbp  Kilobase pair 
KCl  Potassium chloride  
kDa  Kilodalton 
KOAc  Potassium acetate 
KOH  Potassium hydroxide 
KWW  KHN lumenal domain/Wsc1p TMD/Wsc1p cytosolic domain 
L  Loop; Leucine 
LB  Lysogeny broth 
Leu  Leucine 
LiAc  Lithium acetate 
LRR  Leucine-rich repeat   
M. jannaschii Methanocaldococcus jannaschii 
MCS  Multiple cloning site 
Met  Methionine 
MgCl2  Magnesium chloride 
Mg(OAc)2 Magnesium acetate 
MgSO4 Magnesium sulfate 
MHC Major histocompatibility complex 
min  Minute(s) 
Mnl1  Mannosidase-like protein 1 
MOPS 3-(N-morpholino)propanesulfonic acid 
MPN domain  Mpr1-Pad1-N-terminal domain 
MRH  Mannose 6-phosphate receptor homology 
mRNA  Messenger RNA 
MS(PEG)8  Methyl-PEG8-N-Hydroxysuccinimide-ester  
NaAc  Sodium acetate 
NaCl  Sodium chloride 
NaOH  Sodium hydroxide 
NaH2PO4  Sodium dihydrogen phosphate 
Na2HPO4  Disodium hydrogen phosphate	  
NaN3  Sodium Azide 
Nas  Non-ATPase Subunit  
NC  Nitrocellulose 
NEDD8  Neuronal-precursor-cell-expressed developmentally down-regulated protein-
8 
NEF  Nucleotide exchange factors  
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NH4OAc  Ammonium acetate 
NHS  N-hydroxysuccinimide 
Npl4p  Nuclear protein localization 
NLS  Nuclear localization signals 
N-Terminus  Amino-termimus 
OD  Optical density 
OMP  Orotidine-5'-phosphate  
ONPG  2-Ortho-nitrophenyl-β-D-galactopyranoside 
OPY*  CPY* where the targeting sequence was replced with that of Ost1p 
ORF  Open reading frame 
OST  Oligosaccharyl-transferase 
Otu1p  Ovarian tumor 
P  Proline 
pΔgpαf  Mutant alpha factor precursor (ERAD substrate) 
PAAF1  Proteasomal ATPase-associated factor 1 
PAGE Polyacrylamide gel electrophoresis 
PC  Phosphatidylcholine 
PCI  Phenol-chloroform-isoamyl alcohol  
PCI complex  Proteasome/COP9/eIF3 complex 
PCI domain  Proteasome-COP9-eIF3 domain 
PCR  Polymerase chain reaction 
PC repeat  Proteasome cyclosome repeat  
PDI/Pdi1p  Protein disulfide isomerase 
Pdr5p  Pleiotropic drug resistance 
PE  Phosphatidylethanolamine 
PEG  Polythylene glycol 
PERK  Protein kinase RNA (PKR)-like ER kinase 
PK-RM  Puromycin and high-salt (potassium acetate) stripped rough microsomes 
derived from ER membranes 
Png1p  Peptide N-glycanase 
PMSF  Phenylmethanesulfonyl fluoride 
ppαf  Prepro-alpha factor (wild-type alpha factor precursor) 
PPIases  Peptidyl prolyl isomerases 
PrA*  Proteinase A (mutant form) 
Rab  Ras-related in brain 
Rad23p  Radiation sensitive protein 23 
Ras  Rat sarcoma	  
RNC  Ribosome nascent chain	  
RNP  Ribonucleoprotein particle 
RING   Really interesting new gene 
RM  Rough microsomes (rough ER membranes) 
RNA  Ribonucleic acid 
RNAi  RNA interference  
RNase  Ribonuclease 
RNC  Ribosome-nascent chain 
RNP  Ribonucleoprotein particle  
RP  Regulatory particle, 19S RP of the proteasome 
rpm  Rounds per minute 
Rpn  Regulatory Particle Non-AAA-ATPase 
Rpt  Regulatory Particle AAA-ATPase 
RT  Room temperature (in 3.6.2. Reverse transcription) 
Rub1  Related to ubiquitin 
S  Serine 
Sbh1p  Sec61 beta homologue 1  
S. cerevisia  Saccharomyces cerevisiae 
6 ABBREVIATIONS 
 
	   246	  
SC  Synthetic complete 
Scj1  S. cerevisiae DnaJ   
SD  Synthetic defined 
SDS  Sodium dodecyl sulfate (Sodium lauryl sulfate) 
SDS-PAGE  SDS-polyacrylamide gel electrophoresis 
Sec61p  Secretory  
SNARE  Soluble N-ethylmaleimide-sensitive-factor attachment receptor 
SOC  Super optimal broth with catabolite repression 
SOE  Splicing by overlapping extension 
SP  Signal peptidase 
S. pombe  Schizosaccharomyces pombe 
SR  Sigal recognition particle receptor 
SRP  Sigal recognition particle  
ss  Single-stranded 
S-S  Disulfide bonds 
Ssa1p  Stress-seventy subfamily A protein 1 
Ssh1p  Sec sixty-one homologue 
Sss1p  Sec sixty-one suppressor 
Ste6  Sterile 
Suc-LLVY-AMC  N-succinyl-Leu-Leu-Val-Tyr-7-amido-4-methylcourmarin  
SUMO  Small ubiquitin-like modifier 
SV5 HN  Simian virus 5 hemagglutinin-neuraminidase 
t1/2  Half-life 
TA  Tail-anchored  
TAE  Tris, acetate, EDTA  
Taq  Therminus aquaticus 
TBE  Tris, borate, EDTA 
TBS  Tris-buffered saline 
TBS(T)  TBS + 0.1 % Tween 
TCA  Trichloroacetic acid 
TE  Tris-EDTA 
TEMED  N,N,N’,N’-Tetramethylethan-1.2-diamine 
TES  Tris-HCl, EDTA, SDS 
TF  Transcription factor 
Tm  Tunicamycin (also melting temperature) 
TM  Transmembrane 
TMD  Transmembrane domain 
TGN  trans Golgi network  
TRAM  Translocation-associated membrane protein 
TRAP  Translocon-associated protein  
Tris-HCl  Tris(hydroxymethyl)aminomethane hydrochloride 
TRC  Transmembrane recognition complex 
Trp  Tryptophan 
Tris  Tris(hydroxymethyl)aminomethane 
t-SNARE  target-SNARE 
U  Unit 
Ub  Ubiquitin 
UBA  Ubiquitin-associated domain 
Ubc6p  Ubiquitin conjugating protein 6 
UBL  Ubiquitin-like  
Ubp6  Ubiquitin-specific protease 6 
Ubx2p  Ubiquitin regulatory X  
UDP  Uridine diphosphate 
Ufd1p  Ubiquitin fusion degradation protein 
UGGT  UDP-glucose:glycoprotein glucosyltransferase  
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UPR  Unfolded protein response 
UPRE  Unfolded protein response element 
UPS  Ubiquitin-proteasome-system 
Ura  Uracil 
US2, 11  Unique short region protein 2, 11 
Usa1p  U1-Snp1 Associating 
UTP  Uridine 5'-triphosphate	  
UTR    Untranslated region   
UV  Ultra violet 
VCP  Valosin-containing protein 
v-SNARE  vesicle-SNARE 
VSP  Vacuolar protein sorting 
v/v  Volume per volume 
vWF-A  von Willebrand factor A domain 
W/O  Without 
wt  Wild-type 
w/v  Weight per volume 
X-Gal  5-Brom-4-chloro-3-indoxyl-ß-D-galactopyranosid 
Ydj1p  Yeast DnaJ protein 1 
VIMP  VCP-interacting membrane protein  
YNB  Yeast nitrogen base 
Yos9p  Yeast OS-9 homologue  
YP  Yeast peptone 
YPD  Yeast peptone dextrose 
YPG  Yeast peptone galactose 
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Mein großer Dank gilt vor allem den beiden Menschen, die mich täglich ertragen haben: Birgit und 
Carmen danke ich von ganzem Herzen für vier Jahre fachmännische und menschliche 
Unterstützung. An dieser Stelle möchte ich mich auch dafür bedanken, dass sie mir während der 
gesamten Zeit, weit über das Selbstverständliche hinaus, viele Aufgaben abgenommen haben. Birgit 
bin ich unendlich dankbar für ihre Hilfe bei einfach allem, besonders während der Praktika, die mir 
mit ihr sehr viel Spaß gemacht haben. Meiner lieben Carmen danke ich dafür, dass sie mich jeden 
Tag in jeder Hinsicht unterstützt und motiviert hat, und mein Ruhepool war. Danke für viele schöne 
und humorvolle Momente. Die Zeit mit euch wird mir unvergesslich bleiben.  
 
Meinen Mädels Nina Tran und Marie-Christine Klein danke ich für ihre Herzlichkeit, ihren Humor und 
viele schöne Erlebnisse ... (die Liste ist lang) … Nina, danke, dass du mich so immer zum Lachen 
gebracht hast und es nie übel genommen hast, wenn ich mich länger nicht gemeldet habe (und 
danke für dein traumhaftes Curry). Tina, danke, dass du dich mit meiner Einleitung geplagt hast und 
mich während der gesamten Zeit sehr geduldig unterstützt hast. xoxo 
 
Meiner großartigen Freundin Martina Pitz danke ich von Herzen für einfach alles. You are the cat’s 
meow. Ich danke dir dafür, dass du für mich da warst, es irgendwie immer wieder geschafft hast 
mich zu motivieren und für die unsagbar große Hilfe beim Lesen meiner Arbeit. Danke, dass du 
meine Freundin bist.  
 
Mein innigster Dank gilt meiner lieben Famile, die mir bei allem unterstützend und liebevoll zur Seite 
stand. Danke. 
 
 
